‫תש"ע‬/‫י‬
7/2010
‫רשומות‬
ISRAEL STATE RECORDS
‫כ"ג בכסליו התשע"א‬
November 30 ,2010
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
Page/‫עמוד‬
Patents
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Changes in particulars entered in
register
Corrections
Country codes
Indices of applications accepted
4
127
338
339
340
341
345
‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקע‬
‫פטנטים שחודשו לעשרים שנה‬
‫שינויים בפרטים רשומים בפנקס‬
345
356
346
‫תיקונים‬
‫קודים למדינות‬
‫מפתחות לבקשות שהתקבלו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
.‫ ירושלים‬,‫ מלחה‬5 ‫ בנין‬,‫ גנים טכנולוגיים ירושלים‬,‫רשם הפטנטים והמדגמים‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬.0-24145-2
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office
together with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
‫זכות היוצרים בתקצירים אלה שמורה למדינת‬
‫ אין להעתיק מתקצירים אלה אלא‬,‫ישראל‬
.‫ברשות לשכת הפטנטים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PATENTS
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
applications complying with the provisions
of rule 32(a) of the Patent Regulations, 57281968:
Particulars of the applications are given in
the following order:
Number and date of application and the first
four symbols of the International
Classification.
Title of invention (as proposed by applicant)
Applicant
Priority right:
Convention countryNumber and date of
Foreign application
International Application Number
International Publication Number
‫פטנטים‬
-‫ תשכ"ז‬,‫ לחוק הפטנטים‬16 ‫הודעה לפי סעיף‬
1967
‫להלן רשימת בקשות חדשות הממלאות אחר‬
‫(א) לתקנות‬32 ‫הדרישות שנקבעו בתקנה‬
:1968-‫ תשכ"ח‬,‫הפטנטים‬
:‫פרטי הבקשות מובאים לפי סדר זה‬
‫מספר הבקשה – ותאריך הגשתה וארבעה‬
‫הסמנים הראשונים של הסיווג הבינלאומי‬
)‫שם האמצאה (כפי שהוצע ע"י המבקש‬
‫המבקש‬
– ‫מדינת האיגוד‬
:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
‫מספר בקשה בינלאומית‬
‫מספר פרסום בינלאומי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
201512
14/10/2009
PASSIVE (SELF-ACTUATING)
PROTECTION FOR AN ASSAILABLE
SURFACE OF ARMORED VEHICLES
VALERY GOUREVICH
04/11/2009
‫הגנה פסיבית (מופעלת עצמית) למשטח‬
‫פגיע של רכבים משוריינים‬
‫ולרי גורביץ‬
201915
WARM BODY PRESENCE PORTABLE
DETECTION DEVICE AND METHOD
LIOR SEGAL
09/11/2009
G08B )2010.01(
‫מכשיר נייד ושיטה לזיהוי נוכחות חום גוף‬
‫ליאור סגל‬
202000
FRACTIONAL FREQUENCY REUSE
DEPLOYMENT METHOD FOR
WIRELESS SYSTEM
ALVARION LTD.
11/11/2009
F41H )2010.01(
G01S )2010.01(
‫שיטה לפריסת מערכת אלחוטית הכוללת‬
‫שימוש חוזר בתדרי שידור‬
‫אלווריון בע"מ‬
202062
APPARATUS, SYSTEM AND METHOD
FOR SELF ORIENTATION
DROR NADAM
G01N )2010.01(
‫שיטה ומערכת לאוריינטציה עצמית‬
‫במרחב‬
‫דרור נדם‬
November 30, 2010-‫כג' בכסלו התשע"א‬
12/11/2009
202066
FLEXIBLE OPTICAL
COMMUNICATAION NETWORK
ECI TELECOM LTD.
12/11/2009
‫רשת תקשורת אופטית בעלת גמישות‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
202067
ETHERNET NETWORK WITHIN MPLS
NETWORK
ECI TELECOM LTD.
12/11/2009
SYSTEM AND METHOD FOR
EFFICIENT COLLABORATIVE
IDENTIFICATION OF MALICIOUS
APPLICATIONS IN A
COMMUNICATION NETWORK
G02B )2010.01(
MPLS ‫ בתוך רשת‬ETHERNET ‫רשת‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
202068
OPTICAL COMMUNICATION
NETWORK HAVING FLEXIBLE
OPERABILITY
ECI TELECOM LTD.
12/11/2009
G02B )2010.01(
G02B )2010.01(
‫רשת תקשורת אופטית בעלת גמישות‬
‫הפעלה‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
202085
G06F )2010.01(
‫מערכת ושיטה יעילות של שיתוף פעולה‬
‫לזיהוי יישומים זדוניים ברשת תקשורת‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
DEUTSCHE TELEKOM AG
12/11/2009
202086
A SYSTEM FOR FAULT TOLERANT
COLLABORATIVE IDENTIFICATION
OF MALICIOUS APPLICATIONS IN A
COMMUNICATION NETWORK
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
12/11/2009
202109
MODULAR VEHICULAR
PROTECTIVE ASSEMBLY
MICHAEL COHEN
12/11/2009
VEHICULAR VENT - CONTAINING
ASSEMBLY
MICHAEL COHEN
G06F )2010.01(
‫מערכת שיתוף פעולה העמידה בפני‬
‫ לזיהוי יישומים זדוניים ברשת‬,‫תקלות‬
‫תקשורת‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
F41H )2010.01(
‫התקן מודולרי מוגן לכלי – רכב‬
‫מיכאל כהן‬
202110
B60J )2010.01(
‫מתקן כלי – רכב המכיל פתח‬
‫מיכאל כהן‬
November 30, 2010-‫כג' בכסלו התשע"א‬
16/11/2009
202148
‫מערכת לנשיאת מטען‬
‫פלסן סאסא בע"מ‬
LOAD CARRYING SYSTEM
PLASAN SASA LTD.
16/11/2009
202150
202275
A SYSTEM FOR PROVIDING
PROTECTION AGAINST AN
EXPLOSIVE THREAT
PLASAN SASA LTD.
26/11/2009
CAMOUFLAGE SYSTEM
F41H )2010.01(
‫מערכת להגנה נגד איום פיצוצי‬
‫פלסן סאסא בע"מ‬
202372
F41H )2010.01(
‫מיגון‬
‫פלסן סאסא בע"מ‬
ARMOR
PLASAN SASA LTD.
29/11/2009
B64F )2010.01(
‫תא נפלט‬
‫מיכאל כהן‬
EJECTIBLE COMPARTMENT
MICHAEL COHEN
23/11/2009
F41A )2010.01(
202410
F41H )2010.01(
‫מערכת הסוואה‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫פיברוטקס טכנולוגיות בע"מ‬
FIBROTEX TECHNOLOGIES LTD
01/12/2009
202460
METHOD AND SYSTEM OF
GENERATING A THREE DIMENSIONAL VIEW OF A REAL
SCENE
RAFAEL-ADVANCED DEFENSE
SYSTEMS LTD
14/12/2009
– ‫שיטה ומערכת ליצירת ראייה תלת‬
‫מימדית של זירה אמיתית עבור תכנון‬
‫ומבצעים צבאיים‬
202712
PRE - SET AND ADAPTIVE
MODIFICATIONS IN MICRO OPTO ELECTRO - MECHANICAL SYSTEMS
(MOEMS) FOR IMPROVING
PERFOMANCE OF SAME
RAFAEL-ADVANCED DEFENSE
SYSTEMS LTD
15/12/2009
TRACKING STATION BASE
DOTAN LTD.
G06F )2010.01(
H03H )2010.01(
‫אופטו– אלקטרוניות לצורך שיפור הבצוע‬
‫לפני או – התאמות הנעשות על גבי‬
‫מערכות מיקרו בזמן בצוע משימה‬
202732
G01S )2010.01(
‫בסיס לתחנת עקיבה‬
‫דותן בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
15/12/2009
202749
LASER THREAT WARNING SYSTEM
AND METHOD
ELBIT SYSTEMS LTD.
17/12/2009
METHOD AND SYSTEM FRO
ENHANCING A SAR IMAGE
ELTA SYSTEMS LTD.
22/12/2009
‫שיטת ומערכת התרעת איום לייזר‬
‫אלביט מערכות בע"מ‬
202788
A SYSTEM AND METHOD FOR
DETECTING CONCEALED
EXPLOSIVES AND WEAPONS
ISRAEL AEROSPACE INDUSTRIES
LTD.
G01S )2010.01(
SAR ‫שיטה ומערכת לשיפור תמונת מכ"מ‬
‫אלתא מערכות בע"מ‬
202879
METHOD AND YSSEM FOR
COMBINING ECM JAMMING AND
RADAR CAPABILITIES
NETLINE COMMUNICATIONS
TECHNOLOGIES (NCT) LTD
29/12/2009
F41A )2010.01(
G01S )2010.01(
‫מערכת וישטה לשילוב יכולות לוחמה‬
‫אלקטורנית ומכ"מ‬
).‫טי‬.‫סי‬.‫נטליין טכנולוגיות תקשורת (אנ‬
‫בע"מ‬
203015
G08B )2010.01(
‫שיטה לגילוי נשק וחומרי נפץ מוסתרים‬
‫התעשייה האוירית לישראל בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
31/12/2009
203053
METHO AND APPARATUS FOR
TRANSMITTING WIRELESS
COMMUNICATIONS
ALVARION LTD.
29/12/2009
‫שיטה ומכשיר לשידור תשדורות אלחוטיות‬
‫אלווריון בע"מ‬
203060
ASSAULT RIFLE MAGAZINE
EJECTOR EXTENSION
TACTICAL ARMS LTD.
31/12/2009
F41A )2010.01(
‫תוספת לרובה סער לשליפת מחסניות‬
‫טקטיקל ארמס בע"מ‬
203066
SYSTEM FOR SECURE FACE
IDENTIFICATION (SCIFI) AND
METHODS USEFUL IN
CONJUNCTION THEREWITH
CARMEL-HAIFA UNIVERSITY
ECONOMIC CORP. LTD.
IL
199657
02/07/2009
31/12/2009
H04W )2010.01(
G06F )2010.01(
‫מערכת לזיהוי בטוח של פרצופים ושיטות‬
‫השימושיות לצורך כך‬
‫החברה הכלכלית של אוניברסיטת‬-‫כרמל‬
‫חיפה בע"מ‬
203089
G01C )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
SYSTEM AND METHOD FOR
RECONSTRUCTION OF RANGE
IMAGES FROM MULTIPLE TWODIMENSIONAL IMAGES USING A
RANGE BASED VARIATIONAL
METHOD
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
10/01/2010
‫מערכת ושיטה לשחזור תחום מבט מריבוי‬
‫מבטים דו – מימדיים תוך שימוש בשיטה‬
‫המבוססת על תחום משתנה‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
203225
‫מחסנית לתחמושית‬
‫פאב ייצור ויבוא ציוד תעשייתי בע"מ‬
AMMUNITION MAGAZINE
YEHUDA MELLER
10/01/2010
203232
APPARATUS AND SYSTEM FOR
USING RELAY STATION IN A TDD
WIRELESS NETWORK
ALVARION LTD.
10/01/2010
F41A )2010.01(
H04B )2010.01(
‫מכשיר ומערכת לשימוש בתחנת ממסר‬
TDD ‫ברשת אלחוטית מסוג‬
‫אלווריון בע"מ‬
203233
LASER THREAT WARNING SYSTEM
AND METHOD
ELBIT SYSTEMS LTD.
F41A )2010.01(
‫שיטה ומערכת התרעת איום לייזר‬
‫אלביט מערכות בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
01/01/2004
203335
SYSTEM AND METHOD FOR
ENHANCING THE PAYLOAD
CAPACITY, CARRIAGE EFFICIENCY,
AND ADAPTIVE FLEXIBILITY OF
EXTERNAL STORES MOUNTED ON
AN AERIAL VEHICLE
NIR PADAN
28/01/2010
07/10/2008
‫מערכת ושיטה לנישאה יעילה של מטענים‬
‫חיצוניים על פלטפורמות אוויריות‬
‫ניר פדן‬
203568
RADIO RESOURCE MANAGEMENT
METHODS OF CELLULAR
LTE/WiMAX MULTI - HOP RELAYS
NETWORK IN WHICH THE RELAY
ARE MOBILE
BENJAMIN GILOH AND IQITEC TLD
H04Q )2010.01(
‫שיטה לניהול משאבי רדיו של רשת‬
‫תקשורת ניידת המתבססת על טכנולוגיה‬
‫) בשיטת‬LTE WiMAX,( 4 ‫סלולארית דור‬
‫ריבוי נתיבים בעזרת ממסרים ניידים‬
IOITEC ‫בנימין גילה חברת‬
204755
A SYSTEM AND METHODS FOR
MEASURING GENERAL
TRANSLATION ACTIVITY IN VIABLE
CELLS
ANIMA CELL METROLOGY, INC.
US
60/978420
09/10/2007
61/086165
05/08/2008
US
PCT/IL/2008/001328
WO/2009/047760
B64D )2010.01(
C12Q )2010.01(
‫מערכת ושיטה למדידת פעילוית התרגום‬
‫בתאים חיים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
13/11/2008
205701
INSTANT WIN LOTTERY TICKET
WITH FULL COLOUR SECURITY
AREA AND METHOD OF
MANUFACTURE
BLACK & WHITE PAPER MFG, AB
US
60/996323
13/11/2007
PCT/CA/2008/001992
WO/2009/062297
12/11/2008
‫כרטיס הגרלה ולזכייה מיידית בעל איזור‬
‫בטחון בצבע מלא ושיטת ייצור‬
205703
SIMULATING PATIENT SPECIFIC
OUTCOMES
ENTELOS, INC.
US
60/987412
13/11/2007
61/029293
15/02/2008
US
PCT/US/2008/083286
WO/2009/064817
17/11/2008
12/11/2008
A01N )2010.01(
‫תכשירים ושיטות לטיפול בקדחת חזירים‬
205705
ANTI-INFLUENZA ANTIBODIES,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
THERACLONE SCIENCES, INC.
US
60/987355
12/11/2007
60/987353
12/11/2007
US
61/053840
16/05/2008
US
61/095208
08/09/2008
US
G06F )2010.01(
‫הדמית תוצאות של פציינטים מסוימים‬
205704
COMPOSITIONS AND METHODS FOR
TREATING PURPURA
VICEPT THERAPEUTICS, INC.
US
60/988564
16/11/2007
PCT/US/2008/083774
WO/2009/065116
B42D )2010.01(
C07K )2010.01(
‫ תכשירים המכילים‬,‫נוגדנים נגד שפעת‬
‫אותם ושימושים בהם‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PCT/US/2008/083265
WO/2009/064805
10/11/2008
205709
METHOD AND SYSTEM FOR
CONNECTING SOLAR CELLS OR
SLICES IN A PANEL SYSTEM
TIGO ENERGY, INC.
US
61/003091
14/11/2007
12/253868
17/10/2008
US
PCT/US/2008/082935
WO/2009/064683
13/11/2008
205710
EQUILIBRATIVE NUCLEOSIDE
TRANSPORTER ENT1 INHIBITORS
JANSSEN PHARMACEUTICA, N.V.
EP
07120630.4 14/11/2007
PCT/EP/2008/065438
WO/2009/062990
12/11/2008
205711
COMPOSITIONS FOR THE
TREATMENT GASTROINTESTINAL
INFLAMMATION
MERITAGE PHARMA, INC
US
60/987720
13/11/2007
61/012012
06/12/2007
US
61/015998
21/12/2007
US
61.019818
08/01/2008
US
61/034941
07/03/2008
US
61/035348
10/03/2008
US
61/054103
16/05/2008
US
61/054104
16/05/2008
US
61/054105
16/05/2008
US
61/054106
16/05/2008
US
H01L )2010.01(
‫שיטה ומערכת לחיבור תאים סולרים או‬
‫פלחים במערכת לוח‬
C07D )2010.01(
‫ בשווי‬ENT1 ‫מעכבי מעביר נוקלאוזיד‬
‫משקל‬
A61K )2010.01(
‫תכשירים לטיפול בדלקת של הקיבה‬
‫והמעיים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
61/054107
US
61/090568
US
PCT/US/2008/083288
WO/2009/064819
17/10/2008
16/05/2008
20/08/2008
205712
ROLLS OF MATERIAL PROVIDING
ONE-HANDED DISPENSING OF
SHEETS OF PRE-DETERMINED
LENGHT
KIMBERLY-CLARK WORLDWIDE,
INC.
US
12/001966
13/12/2007
PCT/IB/2008/054289
WO/2009/074899
13/01/2009
205713
AFUCOSYLATED ANTIBODIES
AGAINST CCR5 AND THEIR USE
F. HOFFMANN-LA ROCHE AG
US
61/011348
15/01/2008
PCT/EP/2009/000133
WO/2009/090032
07/11/2008
205714
DEVICE FOR MEASURING THE
DEFECTS OF AN IMAGING
INSTRUMENT WITH TWO OPTOELECTRONIC SENSORS
THALES
FR
0707967
13/11/2007
PCT/EP/2008/065133
WO/2009/062890
A47K )2010.01(
‫גלילי חומר המספקים חלוקה ביד אחת‬
‫של יריעות באורך שנקבע מראש‬
C07K )2010.01(
CCR5 ‫נוגדנים אפוקוסילאטים נגד‬
‫והשימוש בהם‬
G02B )2010.01(
‫התקן למדידת הפגמים במכשיר הדמייה‬
–‫באמצעות שימוש בשני גלאים אופטו‬
‫אלקטרוניים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
12/11/2008
205716
FORMULATIONS FOR TACIIMMUNOGLOBULIN FUSION
PROTEINS
ARES TRADING S.A.
EP
07120489.5 12/11/2007
07120490.3
12/11/2007
EP
61/003028
14/11/2007
US
61/002988
14/11/2007
US
61/072038
27/03/2008
US
08005923.1
27/03/2008
EP
PCT/EP/2008/065395
WO/2009/062960
10/11/2008
11/11/2008
–TACI ‫פורמולציות לחלבונים מחוברים‬
‫אימונוגלובולין‬
205717
TACI-IMMUNOGLOBULIN FUSION
PROTEINS FOR TREATMENT OF
OPTIC NEURITIS
ARES TRADING S.A.
EP
07120490.3 12/11/2007
61/002988
14/11/2007
US
PCT/EP/2008/065252
WO/2009/062916
A61K )2010.01(
‫ אימונוגלובין מחוברים טיפול‬TACI ‫חלבוני‬
‫בניאוריטיס אופטי‬
205718
TACI-IMMUNOGLOBULIN FUSION
PROTEINS FOR TREATMENT OF
RELAPSING MULTIPLE SCLEROSIS
ARES TRADING S.A.
EP
07120489.5 12/11/2007
61/003028
14/11/2007
US
PCT/EP/2008/065282
WO/2009/062926
15/11/2007
A61K )2010.01(
205719
A61K )2010.01(
‫ אימונו גלובולין מחוברים‬TACI ‫חלבוני‬
‫לשימוש בטרשת נפוצה‬
C07D )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
‫תרכובות אנאנטיומריקליות מעושרות‬
‫באימידאזואזפינאן‬
ENANTIOMERICALLY ENRICHED
IMIDAZOAZEPINONE COMPOUNDS
EISAI R&D MANAGEMENT CO., LTD.
PCT/US/2007/024011
WO/2009/064274
17/11/2008
205720
USE OF NITRITE SALTS IN CHRONIC
ISCHEMIA
THE UAB RESEARCH FOUNDATION
US
61/003150
15/11/2007
PCT/US/2008/083830
WO/2009/065142
13/11/2008
‫שימוש במלחי ניתריט באיסכמיה כרונית‬
205721
METHODS OF MODULATING
PRODUCTION OF
PHENYLPROPANOID COMPOUNDS
IN PLANTS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD
US
60/987616
13/11/2007
PCT/IL/2008/001490
WO/2009/063460
13/11/2008
205726
PHARMACEUTICAL COMPOSITIONS
VIFOR (INTERNATIONAL) AG.
EP
07120837.5 16/11/2007
PCT/EP/2008/065444
WO/2009/062993
A61K )2010.01(
C12N )2010.01(
‫שיטות לבקרה על ייצור תרכובות‬
‫פנילפרואנואידיות בצמחים‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
A61K )2010.01(
‫תכשירי רוקחות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
14/11/2008
205728
COMMUNICATION APPARATUS,
COMMUNICATION METHOD, AND
INTEGRATED CIRCUIT
PANASONIC CORPORATION
2007JP
14/11/2007
295684
PCT/JP/2008/071165
WO/2009/064027
14/11/2007
H04L )2010.01(
‫ שיטת תקשורת ומעגל‬,‫מערכת תקשורת‬
‫משולב‬
205730
METHODS FOR TREATING OBESITY
AND OBESITY RELATED DISEASES
AND DISORDERS
AMYLIN PHARMACEUTICALS, INC.
A61K )2010.01(
–‫שיטות לטיפול בהשמנה ובמחלות ואי‬
‫סדרים הקשורים להשמנה‬
PCT/US/2007/084733
WO/2009/064298
205731
29/10/2008
METERING DEVICE FOR INHALING A
POWDERY SUBSTANCE
SSIEGFRIED GENERICS
INTERNATIONAL AG
DE
102007056263.4 22/11/2007
PCT/EP/2008/064652
WO/2009/065707
03/12/2008
‫התקן מדידה לשאיפת חומר אבקתי‬
205732
VANE TYPE FLOW METER WITH
TWO OR MORE MEASURING
RANGES
AQUA DIGITAL LTD.
US
60/996721
03/12/2007
61/129470
30/06/2008
US
PCT/IL/2008/001568
A61M )2010.01(
G01F )2010.01(
‫מד זרימה עם שניים או יותר טווחי מדידה‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/072117
23/12/2008
205733
‫מכייל לבוחן אימוני‬
CALIBRATOR FOR IMMUNOASSAYS
ONCIMMUNE LIMITED
GB
0725239.8
24/12/2007
61/016689
26/12/2007
US
PCT/GB/2008/004260
WO/2009/081165
27/11/2008
205734
AMINO ACID SEQUENCES DIRECTED
AGAINST HETERODIMERIC
CYTOKINES AND/OR THEIR
RECEPTORS AND POLYPEPTIDES
COMPRISING THE SAME
ABLYNX N.V.
US
61/004332
27/11/2007
61/005265
04/12/2007
US
61/005324
04/12/2007
US
61/005331
04/12/2007
US
PCT/EP/2008/066365
WO/2009/068627
12/12/2008
C07K )2010.01(
‫רצפי חומצה אמינית המכוונים נגד‬
‫או קולטניהם‬/‫ציטוקינים הטרודימרים ו‬
‫ופוליפפטידים המכילים אותם‬
205735
SYSTEM AND METHOD FOR
REGENERATING AN ABSORBENT
SOLUTION
ALSTOM TECHNOLOGY LTD.
US
61/013369
13/12/2007
12/277935
25/11/2008
US
PCT/US/2008/086512
WO/2009/076575
G01N )2010.01(
B01D )2010.01(
‫מערכת ושיטה לייצור מחדש של תמיסה‬
‫סופגת‬
November 30, 2010-‫כג' בכסלו התשע"א‬
205736
20/11/2008
DEVICE AND METHOD FOR
PRODUCING A REINFORCED FOAM
MATERIAL
EVONIK ROHM GMBH
DE
102007055684.7 21/11/2007
61/004004
21/11/2007
US
PCT/EP/2008/065923
WO/2009/065896
01/12/2008
‫מערכת ושיטה לייצור חומר קצפי‬
‫מחוזק‬
205737
C02F )2010.01(
SYSTEMS AND METHODS FOR
WATER TREATMENT
SIEMENS WATER TECHNOLOGIES
CORP.
US
60/991316
30/11/2007
PCT/US/2008/013286
WO/2009/073175
‫מערכות ושיטות לטיפול במים‬
205739
20/11/2008
B29C )2010.01(
METHOD AND DEVICE FOR
DETECTING WHETHER A VEHICLE HAS
EXCEEDED A SPEED LIMIT
G08G )2010.01(
‫שיטה והתקן לגילוי האם כלי רכב עבר‬
‫הגבלת המהירות‬
SIEMENS AKTIENGESELLSCHAFT
DE
102007059346.7 10/12/2007
PCT/EP/2008/065898
WO/2009/074436
12/11/2008
205740
CORTICOSTEROID COMPOSITIONS
MERITAGE PHARMA, INC
US
60/987720
13/11/2007
61/012012
06/12/2007
US
61/015998
21/12/2007
US
61/019818
08/01/2008
US
A61K )2010.01(
‫תכשירי קורטיקוסטירואיד‬
November 30, 2010-‫כג' בכסלו התשע"א‬
61/034941
US
61/035348
US
61/054103
US
61/054104
US
61/054105
US
61/054106
US
61/054107
US
61/090568
US
PCT/US/2008/012780
WO/2009/064457
28/11/2008
07/03/2008
10/03/2008
16/05/2008
16/05/2008
16/05/2008
16/05/2008
16/05/2008
20/08/2008
205741
NEW THERAPEUTIC APPROACHES
FOR TREATING CMT AND RELATED
DISORDERS
PHARNEXT,
EP
07301614.9 30/11/2007
60/991800
03/12/2007
US
PCT/EP/2008/066468
WO/2009/068668
09/12/2008
‫ ואי‬CMT–‫גישות רפואיות חדשות לטיפול ב‬
‫סדרים הקשורים לכך‬
205742
4-(4-CYANO-2-THIOARYL)
DIHYDROPYRIMIDINONES AND USE
THEREOF
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
DE
102007061766.8 20/12/2007
102008022521.5
07/05/2008
DE
102008052013.6
17/10/2008
DE
PCT/EP/2008/010411
WO/2009/080199
09/12/2008
A61K )2010.01(
205743
C07D )2010.01(
–2–‫–ציאנו‬4(–4
‫תיאואריל)דיהידרופירימידינונים והשימוש‬
‫בהם‬
B01D )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
SYSTEM AND METHOD FOR
REMOVAL OF AN ACIDIC
COMPONENT FROM A PROCESS
STREAM
ALSTOM TECHNOLOGY LTD.
US
61/013376
13/12/2007
12/269352
12/11/2008
US
PCT/US/2008/086000
WO/2009/076326
21/11/2008
‫מערכת ושיטה להוצאת רכיב חומצי מזרם‬
‫תהליך‬
205744
PYRIDYLMETHYL-SULFONAMIDE
COMPOUNDS
BASF SE
EP
07122415.8 05/12/2007
08102193.3
29/02/2008
EP
PCT/EP/2008/065958
WO/2009/071448
16/12/2008
‫תרכובות פירידילמתיל–סולפונאמיד‬
205745
METHOD FOR THE PRODUCTION OF
2-FLUOROACYL-3-AMINO-ACRYLIC
ACID DERIVATIVES
C07D )2010.01(
C07C )2010.01(
–3–‫–פלואורו אציל‬2 ‫שיטה להכנת תולדות‬
‫אמינו–חומצה אקרילית‬
BAYER CROPSCIENCE AG
EP
07150357.7 21/12/2007
PCT/EP/2008/010689
WO/2009/083134
03/11/2008
205746
INHIBITORS OF HUMAN
IMMUNODEFICIENCY VIRUS
REPLICATION
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
60/988342
15/11/2007
PCT/CA/2008/001935
C07D )2010.01(
‫מעכבי שכפול נגיף האיידס‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/062288
12/11/2008
205747
INHIBITORS OF HUMAN
PHOSPHATIDYL-INOSITOL 3-KINASE
DELTA
ICOS CORPORATION
US
60/987723
13/11/2007
PCT/US/2008/083262
WO/2009/064802
26/11/2008
14/11/2008
A61K )2010.01(
–4 ‫אנטגוניסטים מותאמים לקולטן מוטאין‬
IL
205750
BIVALENT, BISPECIFIC ANTIBODIES
F. HOFFMANN-LA ROCHE AG
EP
07024866.1 21/12/2007
PCT/EP/2008/010705
G01N )2010.01(
‫ וטיפול נגד היווצרות כלי‬VEGF ‫ריבוי צורות‬
‫דם‬
205749
MODIFIED IL-4 MUTEIN RECEPTOR
ANTAGONISTS
AEROVANCE, INC.
US
11/940217
14/11/2007
PCT/US/2008/083589
WO/2009/065007
16/12/2008
‫–קינאז‬3–‫מעכבי פוספתידיל–אינוסיטול‬
‫דלתא אנושי‬
205748
VEGF POLYMORPHISMS AND ANTIANGIOGENESIS THERAPY
SLEDGE, GEORGE W. OF
US
60/991616
30/11/2007
61/038699
21/03/2008
US
PCT/US/2008/084933
WO/2009/073540
C07D )2010.01(
C07K )2010.01(
‫נוגדנים ביספציפיים ביוולנטים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/080254
20/11/2008
205751
AMINOTHIAZOLE DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
07122019.8 30/11/2007
PCT/EP/2008/065910
WO/2009/068467
17/12/2008
205752
OCTAHYDROQUINOLIZINES FOR
ANTIDIABETIC TREATMENT
55PHARMA DRUG DISCOVERY &
DEVELOPMENT AG
EP
07450235.2 19/12/2007
AT
A1315/2008 25/08/2008
PCT/AT/2008/000458
WO/2009/076693
26/11/2008
205753
ISOXAZOLO-PYRIDAZINE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
07122293.9 04/12/2007
PCT/EP/2008/066226
WO/2009/071477
28/12/2007
205754
SECURE MOBILE TELEPHONY
KOOLSPAN, INC.
US
60/987709
13/11/2007
11/951202
05/12/2007
US
PCT/US/2007/026441
C07D )2010.01(
‫תולדות אמינותיאזול‬
C07D )2010.01(
–‫אוקטהידרוקווינוליזינים לטיפול אנטי‬
‫סכרתי‬
C07D )2010.01(
‫תולדות איזוקסאזולו–פירידזין‬
H04M )2010.01(
‫מערכת טלפונים ניידת מאובטחת‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/064279
25/11/2008
205755
ISOXAZOLO-PYRAZINE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
07122271.5 04/12/2007
PCT/EP/2008/066127
WO/2009/071464
18/11/2008
205756
POLYMORPHS OF A C-MET/HGFR
INHIBITOR
PFIZER INC.
US
60/991169
29/11/2007
PCT/IB/2008/003170
WO/2009/068955
18/12/2008
205758
BIS-(SULFONYLAMINO)
DERIVATIVES FOR USE IN THERAPY
ASTRAZENECA AB
US
61/015287
20/12/2007
PCT/SE/2008/051500
WO/2009/082347
26/11/2008
205759
ISOXAZOLO-PYRIDINE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
07122240.0 04/12/2007
PCT/EP/2008/066225
WO/2009/071476
C07D )2010.01(
‫תולדות איזוקסאזולו–פיראזין‬
C07D )2010.01(
HGFR/MET–C ‫פולימורפים של מעכב‬
C07D )2010.01(
‫תולדות ביס–(סולפונילאמינו)לשימוש‬
‫בטיפול‬
C07D )2010.01(
‫תולדות איזוקסאזולו–פירידין‬
November 30, 2010-‫כג' בכסלו התשע"א‬
14/11/2008
205761
NOVEL INTERMEDIATE FOR
HALICHONDRIN B ANALOG
SYNTHESIS AND NOVEL
DESULFONYLATION REACTION
USED FOR THE INTERMEDIATE
EISAI R&D MANAGEMENT CO., LTD.
US
60/988496
16/11/2007
2007-298074 16/11/2007
JP
PCT/JP/2008/071167
WO/2009/064029
05/11/2008
‫תוצרביניים חדש עבור סינתזת אנלוג של‬
‫ וריאקציה חדשה של הוצאת‬B ‫הליקונדרין‬
‫קבוצות סולפוניות לשימוש עבור תוצר‬
‫הביניים‬
205762
APPARATUS, SYSTEM AND METHOD
FOR AUTOMATED CORONARY
ARTERY DISEASE TESTING AND
ANALYSIS
SPIROCOR LTD
US
11/984251
15/11/2007
PCT/IL/2008/001455
WO/2009/063451
20/11/2008
G06F )2010.01(
‫ מערכת ושיטה לבחינה ואנליזה‬,‫התקן‬
‫אוטומטית של מחלות כלי דם כליליים‬
‫ספיירוקור בע"מ‬
205763
BIARYL SUBSTITUTED
AZABICYCLIC ALKANE
DERIVATIVES AS NICOTINIC
ACETYLCHOLINE RECEPTOR
ACTIVITY MODULATORS
ABBOTT LABORATORIES
US
60/989538
21/11/2007
PCT/US/2008/084148
WO/2009/067579
C07D )2010.01(
C07D )2010.01(
‫נגזרות אלקאן אזאביציקלי מותמר ביאריל‬
‫כמודולטורים של פעילות קולטן‬
‫אצטילכולין ניקוטיני‬
November 30, 2010-‫כג' בכסלו התשע"א‬
20/11/2008
205764
NEW VITAMIN D RECEPTOR
ACTIVATORS AND METHODS OF
MAKING
ABBOTT LABORATORIES
US
60/989167
20/11/2007
12/205998
08/09/2008
US
PCT/US/2008/084142
WO/2009/067578
27/11/2008
‫ חדשים ושיטות‬D ‫מפעילי קולטן ויטמין‬
‫לייצורם‬
205766
PREPARATION OF NANOPARTICLE
MATERIAL
NANOCO TECHNOLOGIES LIMITED
US
60/991510
30/11/2007
0723539.3
01/12/2007
GB
PCT/GB/2008/003958
WO/2009/068878
14/11/2008
205767
A61L )2010.01(
‫מכשיר ושיטה לציפוי אוטומטי‬
205768
USE OF ANTI CD24 ANTIBODIES FOR
TREATING CANCER
THE MEDICAL RESEARCH,
INFRASTRUCTURE, AND HEALTH
SERVICES FUND OF THE TEL-AVIV
MEDICAL CENTER
US
60/996383
14/11/2007
H01L )2010.01(
‫הכנת חומר המכיל ננו–חלקיקים‬
AUTOMATED COATING APPARATUS
AND METHOD
BIOSENSORS INTERNATIONAL
GROUP
US
60/987963
14/11/2007
PCT/US/2008/083700
WO/2009/065087
13/11/2008
C07C )2010.01(
A61K )2010.01(
‫ לטיפול‬CD24 ‫שימוש בנוגדנים כנגד‬
‫בסרטן‬
‫קרן מחקרים ופיתוח תשתיות שליד המרכז‬
‫הרפואי תל אביב ע"ש סוראסקי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PCT/IL/2008/001491
WO/2009/063461
13/11/2008
205769
PICO LITER WELL HOLDING DEVICE
AND METHOD OF MAKING THE
SAME
SENG ENTERPRISES LTD.
US
11/940996
15/11/2007
61/006130
26/12/2007
US
PCT/IL/2008/001492
WO/2009/063462
13/11/2008
‫מתקן לגומחות פיקו–ליטר ושיטה לייצורו‬
205770
FOOD PRODUCTS COMPRISING
SESAME PASTE
OPTIMUM-SYSTEMS ENGINEERING
LTD
US
60/987645
13/11/2007
PCT/IL/2008/001488
WO/2009/063458
27/11/2008
205773
ANTIBODIES AGAINST A CANCERASSOCIATED EPITOPE OF VARIANT
NFKBIB AND USES THEREOF
VIVENTIA BIOTECH INC
US
60/990494
27/11/2007
PCT/CA/2008/002076
WO/2009/067800
13/11/2008
C12M )2010.01(
205775
A23L )2010.01(
‫מוצרי מזון המורכבים מממרח שומשום‬
C07K )2010.01(
‫ הקשור לסרטן‬EPITOPE ‫נוגדנים נגד‬
‫ ושימושיהם‬NFKBIB ‫מנגזרת‬
H04W )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
MOBILE TERMINAL HAVING "IN
CASE OF EMERGENCY" STATE AND
METHOD FOR ENTERING SUCH
STATE
TELEFONAKTIEBOLAGET LM
ERICSSON (PUBL)
US
60/987837
14/11/2007
PCT/EP/2008/065471
WO/2009/063007
14/11/2008
"‫מסוף נייד בעל מצב "במקרה חירום‬
‫ושיטה להכנסת מצב כאמור‬
205776
MORPHOLINO COMPOUNDS AND
METHODS OF PRODUCING
MORPHOLINO OLIGOMERS
AVI BIOPHARMA, INC.
US
60/988200
15/11/2007
60/988192
15/11/2007
US
PCT/US/2008/012804
WO/2009/064471
13/11/2007
C07D )2010.01(
‫תרכובות מורפולינו ושיטות לייצור‬
‫מורפולינו אוליגומרים‬
205777
MEDICAL SYSTEM, APPARATUS
AND METHOD
ORIDION MEDICAL (1987)LTD.
A61B )2010.01(
‫ מכשיר ושיטה‬,‫מערכת רפואית‬
‫ ) בע"מ‬1987( ‫אורידיון מדיקל‬
PCT/IL/2007/001393
WO/2009/063443
30/06/2008
205778
MEDICAL SYSTEM, APPARATUS AND
METHOD
ORIDION MEDICAL (1987)LTD.
IL
PCT/IL/2007/001393 13/11/2007
61/071959
28/05/2008
US
PCT/IL/2008/000894
WO/2009/063446
G06F )2010.01(
‫ מכשיר ושיטה‬,‫מערכת רפואית‬
‫ ) בע"מ‬1987( ‫אורידיון מדיקל‬
November 30, 2010-‫כג' בכסלו התשע"א‬
03/12/2008
205780
FVIII PEPTIDES AND THEIR USE IN
TOLERISING HAEMOPHILIACS
APITOPE TECHNOLOGY (BRISTOL)
LIMITED
GB
0723712.6
04/12/2007
PCT/GB/2008/003996
WO/2009/071886
07/11/2008
205781
PREAMBLE DESIGN FOR A
WIRELESS SIGNAL
QUALCOMM INCORPORATED
US
60/988665
16/11/2007
60/988720
16/11/2007
US
61/025670
01/02/2008
US
61/028497
13/02/2008
US
61/047021
22/04/2008
US
12/260868
29/10/2008
US
PCT/US/2008/082866
WO/2009/064678
05/11/2008
205782
PREAMBLE DESIGN FOR A
WIRELESS SIGNAL
QUALCOMM INCORPORATED
US
60/988665
16/11/2007
60/988720
16/11/2007
US
61/025670
01/02/2008
US
61/028497
13/02/2008
US
61/047021
22/04/2008
US
12/260861
29/10/2008
US
PCT/US/2008/082523
WO/2009/064648
C07K )2010.01(
‫ ושימושם לביטול רגישות‬FVIII ‫פפטידי‬
‫של המופיליה‬
H04W )2010.01(
‫עיצוב הקדמה לאות אלחוטי‬
H04W )2010.01(
‫עיצוב הקדמה לאות אלחוטי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
14/11/2008
205783
USING IDENTIFIERS TO ESTABLISH
COMMUNICATION
QUALCOMM INCORPORATED
US
60/988646
16/11/2007
61/059654
06/06/2008
US
61/074114
19/06/2008
US
61/074935
23/06/2008
US
12/269676
12/11/2008
US
PCT/US/2008/083658
WO/2009/065053
03/12/2008
‫שימוש במזהים לבסס תקשורת‬
205784
SEED-PREFERRED GENE
PROMOTERS FROM THE CASTOR
PLANT
DOW GLOBAL TECHNOLOGIES INC.
US
60/992273
04/12/2007
PCT/US/2008/085426
WO/2009/073738
10/11/2008
SYSTEM AND METHOD FOR
SECURING FUEL SUPPLY CHAIN
DELIVERY PROCESS WITH A RFID
ELECTRONIC SEAL
C12N )2010.01(
‫קדמי גן מועדפי–גרעין מצמח הקיקיון‬
205785
A01G )2010.01(
‫מערכת לגידול צמחים‬
SYSTEM FOR GROWING PLANTS
GALLO, STEVEN, WILLIAM
US
11/939558
14/11/2007
PCT/CA/2008/001967
WO/2009/062291
16/11/2008
H04W )2010.01(
205786
G08B )2010.01(
‫מערכת ושיטה לאבטחת שרשרת אספקת‬
RFID ‫דלק עם אטם אלקטרוני‬
November 30, 2010-‫כג' בכסלו התשע"א‬
ORPAK SYSTEMS LTD
US
60/996415
PCT/IL/2008/001504
WO/2009/063471
‫אורפק מערכות בע"מ‬
16/11/2007
20/11/2008
205787
PUMPING UNIT FOR DELIVERY OF
LIQUID MEDIA FROM A VESSEL
ICECURE MEDICAL LTD
US
60/989744
21/11/2007
PCT/IL/2008/001526
WO/2009/066292
‫יחידת שאיבה לאספקת נוזל ממיכל‬
‫אייסקיור מדיקל בע"מ‬
205789
28/11/2008
A ROTARY ELECTRIC MACHINE AND
THE METHOD FOR ASSEMBLING IT
SPAL AUTOMOTIVE S.R.L.
IT
B02007A000791 30/11/2007
PCT/IB/2008/055011
WO/2009/069103
17/12/2008
205795
HEPATITIS C VIRUS ANTIBODIES
MEDICAL RESEARCH COUNCIL
TECHNOLOGY
US
61/006066
17/12/2007
PCT/IB/2008/003952
WO/2009/081285
14/11/2008
RF ABLATION DEVICE WITH JAMPREVENTING ELECTRICAL
COUPLING MEMBER
F04B )2010.01(
205796
H02K )2010.01(
‫מכונה חשמלית סיבובית ושיטה‬
‫להרכבתה‬
C07K )2010.01(
C ‫נוגדני ויחרוס צהבת‬
A61N )2010.01(
‫התקן הסרה ת"ר עם אלמנט קישור‬
‫חשמלי מונע מעצורים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
HALT MEDICAL, INC.
US
11/940289
PCT/US/2008/083634
WO/2009/065034
01/02/2008
14/11/2007
205797
METHOD AND APPARATUS FOR
RESOLVING BLINDED-NODE
PROBLEMS IN WIRELESS
NETWORKS
QUALCOMM INCORPORATED
US
11/955257
12/12/2007
PCT/US/2008/052820
WO/2009/075900
14/11/2008
‫שיטה והתקן ליישוב בעיות צומת מסונוור‬
‫ברשתות אלחוטיות‬
205798
ANCHORED RF ABLATION DEVICE
FOR THE DESTRUCTION OF TISSUE
MASSES
HALT MEDICAL, INC.
US
11/940294
14/11/2007
PCT/US/2008/083617
WO/2009/065025
05/12/2008
205800
HANDOVER FAILURE PROCEDURES
IN COMMUNICATION SYSTEMS
QUALCOMM INCORPORATED
US
60/992658
05/12/2007
12/328606
04/12/2008
US
PCT/US/2008/085689
WO/2009/076208
H04Q )2010.01(
A61F )2010.01(
‫התקן הסרה ת"ר מעוגן להשמדת גושי‬
‫רקמה‬
H04W )2010.01(
‫נוהלי כשל העברה במערכות תקשורת‬
November 30, 2010-‫כג' בכסלו התשע"א‬
05/12/2008
205801
USER EQUIPMENT CAPABILITY
UPDATE IN WIRELESS
COMMUNICATIONS
QUALCOMM INCORPORATED
US
60/992645
05/12/2007
12/327301
03/12/2008
US
PCT/US/2008/085708
WO/2009/076219
20/11/2007
H04W )2010.01(
‫עדכון יכולת ציוד משתמש בתקשורת‬
‫אלחוטית‬
205804
REMOVAL OF RESIDUAL CONCRETE
FROM READY MIXED CONCRETE
DRUMS
BLASTERS, LLC
B08B )2010.01(
‫הורדת שאריות בטון ממכלים של תערובת‬
‫בטון מוכנה‬
PCT/US/2007/085248
WO/2008/118218
205805
29/10/2008
PATCHOULOL ODORANT
FIRMENICH SA
IB
PCT/IB2007/054690
PCT/IB/2008/054491
WO/2009/066193
09/12/2008
C07C )2010.01(
‫פטצ'ולול ריחני‬
19/11/2007
205806
IMAGING DEVICE AND METHOD
SELEX GALILEO LTD
GB
0722643.4
19/11/2007
PCT/GB/2008/004052
WO/2009/066092
H04N )2010.01(
‫מכשיר הדמייה ושיטה‬
November 30, 2010-‫כג' בכסלו התשע"א‬
14/11/2008
205808
METHOD AND APPARATUS OF
TAKING AERIAL SURVEYS
INTERGRAPH SOFTWARE
TECHNOLOGIES COMPANY
US
60/987883
14/11/2007
PCT/US/2008/083582
WO/2009/065003
18/11/2008
G06T )2010.01(
‫שיטה ומכשיר לעריכת סקרים אוויריים‬
205809
CALCIUM MEDIATED EFFECTS OF
CORAL AND METHODS OF USE
THEREOF
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
60/996450
19/11/2007
PCT/IL/2008/001511
WO/2009/066283
13/12/2007
‫השפעת אלמוג מתווכות על ידי סידן‬
‫ושיטות לשימוש בהם‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
205810
A61B )2010.01(
‫חוסם עורקים דו כיווני‬
BI-DIRECTIONAL TOURNIQUET
PATRICIA E. THORPE
US
60/875,087
13/12/2006
60/901,715
13/02/2007
US
11/940225
14/11/2007
US
PCT/US/2007/087418
WO/2008/076820
13/12/2007
A61K )2010.01(
205812
A FRAGRANCE DISPENSING PUMP
HEAD
COLGATE-PALMOLIVE COMPANY
US
US2007/087351 13/12/2007
PCT/US/2007/087351
WO/2009/075687
A45D )2010.01(
‫ראש משאבה לאספקת ניחוח‬
November 30, 2010-‫כג' בכסלו התשע"א‬
20/11/2008
205816
DEHYDRATED AVOCADO IN PIECES
ERWIN HERMANN SCHLAGER RIEBL
CL
3320-2007
20/11/2007
PCT/IB/2008/054874
WO/2009/066259
02/09/2008
205818
FILM COATED TABLETS
CONTAINING DROSPIRENONE AS
ACTIVE AGENT AND A METHOD
FOR THE PREPARATION THEREOF
RICHTER GEDEON NYRT.
HU
P0700826
20/12/2007
PCT/HU/2008/000100
WO/2009/081216
23/12/2008
205819
TREATMENT OF COLON DISEASES
OR PREVENTION OF COLORECTAL
CARCINOMA WITH
IMIDAZOQUINOLINE DERIVATIVES
MEDA AB
US
61/006459
15/01/2008
PCT/EP/2008/011088
WO/2009/089900
24/04/2009
FIBER-REINFORCED RESIN PIPE
MITSUBISHI HEAVY INDUSTRIES,
LTD.
205820
A23L )2010.01(
‫אבוקדו מיובש בחתיכות‬
A61K )2010.01(
‫טבליות מצופות הכוללות דרוספירנון‬
‫כגורם פעיל ושיטה להכנתן‬
A61K )2010.01(
‫טיפול במחלות המעי הגס או מניעה של‬
‫סרטן כרכשתי–חלחולתי עם תולדות‬
‫אימידאזו קווניולין‬
F16L )2010.01(
‫צינור העשוי משרף המחוזק ע"י סיבים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
2008119302
PCT/JP/2009/058205
WO/2009/133825
JP
03/12/2008
30/04/2008
205821
METHOD AND COMPOSITIONS FOR
CUTANEOUS IMMUNISATION
DBV TECHNOLOGIES,
FR
0759505
03/12/2007
PCT/FR/2008/052198
WO/2009/080933
03/12/2008
205822
ALLERGEN DESENSITIZATION
METHOD
DBV TECHNOLOGIES,
FR
0759503
03/12/2007
61/084305
29/07/2008
US
PCT/FR/2008/052199
WO/2009/080934
20/11/2008
205823
ARTICLE AND METHOD OF
MANUFACTURING SAME
DOW CORNING CORPORATION
US
61/003726
20/11/2007
PCT/US/2008/012956
WO/2009/067230
20/11/2008
205825
ARTICLE COMPRISING FIBERS AND
A METHOD OF FORMING THE SAME
A61K )2010.01(
‫שיטה ותכשירים לחיסון דרך העור‬
A61K )2010.01(
‫שיטה להורדת רמת הרגישות לאלרגן‬
D04H )2010.01(
‫פריט ושיטה לייצורו‬
C08L )2010.01(
‫מוצר המכיל סיבים ושיטה ליצורו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
DOW CORNING CORPORATION
US
61/003793
20/11/2007
PCT/US/2008/012962
WO/2009/067232
14/11/2008
205829
BIDENTATE SECONDARY
PHOSPHINE OXIDE CHIRAL
LIGANDS FOR USE IN ASYMMETRIC
ADDITION REACTIONS
SOLVIAS AG
CH
1788/07
20/11/2007
PCT/EP/2008/065605
WO/2009/065783
14/11/2008
12/12/2008
‫ליגנדים כיראליים של בידנטאט שניוני‬
‫פוספין אוקסיד לשימוש בריאקציות חיבור‬
‫א–סימטריות‬
205830
BIDENTATE CHIRAL LIGANDS FOR
USE IN CATALYTIC ASYMMETRIC
ADDITION REACTIONS
SOLVIAS AG
CH
1789/07
20/11/2007
PCT/EP/2008/065607
WO/2009/065784
C07F )2010.01(
‫ליגנדים כיראליים של בידנטאט לשימוש‬
‫בריאקציות חיבור א–סימטריות קטליטיות‬
205831
KINESIN INHIBITORS AS CANCER
THERAPEUTICS
NOVARTIS AG
US
61/013966
14/12/2007
PCT/EP/2008/067412
WO/2009/077448
07/11/2008
C07F )2010.01(
205832
A61K )2010.01(
‫מעכבי קינזין כתרופות לסרטן‬
C07D )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
METHODS FOR PREPARING
CAPECITABINE AND BETAANOMER-RICH TRIALKYL
CARBONATE COMPOUND USED
THEREIN
HANMI PHARM. CO., LTD.
10-2007KR
19/11/2007
0118062
PCT/KR/2008/006565
WO/2009/066892
18/12/2008
205833
TIMING SIGNAL GENERATOR
PROVIDING SYNCHRONIZED
TIMING SIGNALS AT NON-INTEGER
CLOCK MULTIPLES ADJUSTABLE BY
MORE THAN ONE PERIOD
TERADYNE, INC.
US
61/018443
31/12/2007
PCT/US/2008/087363
WO/2009/088693
17/12/2008
G06F )2010.01(
‫מחולל אותות זמן לסינכרון במכפלות שעון‬
‫לא שלמות הניתן לכיוון ביותר מזמן מחזור‬
‫אחד‬
205834
METHOD AND APPARATUS FOR
SENDING AND RECEIVING RANDOM
ACCESS RESPONSE IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
61/014649
18/12/2007
12/243151
01/10/2008
US
PCT/US/2008/087083
WO/2009/079533
13/12/2008
‫שיטות להכנת קפציטבין ותרכובת קרבונט‬
‫טריאלקיל עתירת בטא–אנומר המשמשת‬
‫בשיטות אלו‬
H04W )2010.01(
‫שיטה והתקן לשידור וקליטת תגובת גישה‬
‫אקראית במערכת תקשורת אלחוטית‬
205835
G10L )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
FAST ALGORITHMS FOR
COMPUTATION OF 5-POINT DCT-II,
DCT-IV, AND DST-IV, AND
ARCHITECTURES
QUALCOMM INCORPORATED
US
61/013579
13/12/2007
61/016106
21/12/2007
US
61/039194
25/03/2008
US
12/334238
12/12/2008
US
PCT/US/2008/086739
WO/2009/076666
17/12/2008
205836
TREATMENT OF INTERSTITIAL
CYSTITIS
PFIZER LIMITED
US
61/014171
17/12/2007
61/061149
13/06/2008
US
PCT/IB/2008/055383
WO/2009/077993
19/12/2008
COMMUNICATION HANDOVER
MANAGEMENT
C07K )2010.01(
‫טיפול בדלקת בין–רקמתית של שלפוחית‬
‫השתן‬
205837
METHOD AND APPARATUS FOR
TRANSFER OF A MESSAGE ON A
COMMON CONTROL CHANNEL FOR
RANDOM ACCESS IN A WIRELESS
COMMUNICATION NETWORK
QUALCOMM INCORPORATED
US
61/015159
19/12/2007
12/337383
17/12/2008
US
PCT/US/2008/087815
WO/2009/086188
24/12/2008
–5 ‫אלגוריתמים מהירים לחישוב מבני‬
IV–DC –‫ ו‬,II–DCT ‫נקודות‬
H04W )2010.01(
‫שיטה והתקן להעברת מסר בערוץ בקרה‬
‫משותף לגישה אקראית ברשת תקשורת‬
‫אלחוטית‬
205838
H04W )2010.01(
‫ניהול העברת תקשורת‬
November 30, 2010-‫כג' בכסלו התשע"א‬
QUALCOMM INCORPORATED
US
61/016759
26/12/2007
12/341611
22/12/2008
US
PCT/US/2008/088336
WO/2009/086467
17/12/2008
205839
MULTIPLE CHUCK SCANNING
STAGE
KLA-TENCOR CORPORATION
US
11/958201
17/12/2007
PCT/US/2008/087195
WO/2009/079565
20/11/2008
‫בימת סריקה עם מלחציים רבים‬
205843
NOVEL IMMUNOREGULATORY
PEPTIDES, COMPOSITIONS AND
USES THEREOF
IMMUNOTECH DEVELOPMENTS INC
US
60/989280
20/11/2007
PCT/CA/2008/002037
WO/2009/065217
06/11/2008
23/11/2008
C07K )2010.01(
,‫פפטידים אימונו–רגולטורים חדשים‬
‫הרכבים ושימושים שלהם‬
205844
FOURIER TRANSFORM
DEFLECTOMETRY SYSTEM AND
METHOD
LAMBDA-X
EP
07121009.0 19/11/2007
PCT/EP/2008/065082
WO/2009/065740
H01L )2010.01(
G01N )2010.01(
‫מערכת דיפלקטרומטריה להתמרת פורייה‬
‫ושיטה‬
205848
C07H )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
NON-HYDROLYZABLE NUCLEOSIDE
DI-OR TRI-PHOSPHATE
DERIVATIVES AND USES THEREOF
BAR-ILAN UNIVERSITY
US
60/989888
23/11/2007
PCT/IL/2008/001535
WO/2009/066298
25/11/2008
‫אילן‬-‫אוניברסיטת בר‬
205849
NOVEL NAPHTHYRIDINE
DERIVATIVE MONOHYDRATE AND
METHOD FOR PRODUCING THE
SAME
TOYAMA CHEMICAL CO., LTD.
2007JP
26/11/2007
304736
PCT/JP/2008/071333
WO/2009/069589
19/12/2008
‫תולדות דיפוספאט וטריפוספאט‬
‫נוקלאוזידים עמידות להידרוליזה ושימושיהן‬
‫נגזרת חדשה של נאפת'הידרין מונוהידראט‬
‫ושיטה לייצורה‬
205855
STABLE LAQUINIMOD
PREPARATIONS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/008698
20/12/2007
PCT/US/2008/013890
WO/2009/082471
26/11/2008
A01N )2010.01(
‫תרכובות יציבות המכילות לאקוינימוד‬
‫טבע תעשיות פרמצבטיות בע"מ‬
205856
METHOD OF DELAYING THE ONSET
OF CLINICALLY DEFINITE
MULTIPLE SCLEROSIS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/004710
28/11/2007
61/005271
03/12/2007
US
61/007141
11/12/2007
US
C07D )2010.01(
A01N )2010.01(
‫שיטה לעיכוב הפריצה של טרשת נפוצה‬
‫מוגדרת קלינית‬
‫טבע תעשיות פרמצבטיות בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
61/192455
US
PCT/US/2008/013146
WO/2009/070298
01/12/2008
17/09/2008
205857
PROCESSES FOR PREPARATION OF
CRYSTALLINE TIGECYCLLINE
FORM II
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/004786
29/11/2007
PCT/US/2008/085156
WO/2009/070799
II ‫תהליכים להכנת טיגציקלין פורם‬
‫טבע תעשיות פרמצבטיות בע"מ‬
205858
15/11/2008
BEAM FORMING DEVICE
LIMO PATENTVERWALTUNG GMBH
&CO. KG
DE
102007057868.9 29/11/2007
PCT/EP/2008/009677
WO/2009/068192
21/11/2008
205859
G02B )2010.01(
‫מכשיר ליצירת קרן אור‬
A61L )2010.01(
‫התקן לחיטוי עצמי המשתמש בחלקי‬
‫פלזמה‬
SELF-STERILIZING DEVICE USING
PLASMA FIELDS
UNIVERSITY OF FLORIDA
RESEARCH FOUNDATION, INC.
US
60/989496
21/11/2007
PCT/US/2008/084378
WO/2009/067682
10/11/2008
C07C )2010.01(
205860
A61K )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
PHARMACEUTICAL COMPOSITIONS
CONTAINING BRADYKININ
ANTAGONISTS AND HYALURONIC
ACID, AND USES THEREOF
ISTITUTO LUSO FARMACO D'ITALIA
S.P.A.
IT
MI2007A002225 23/11/2007
PCT/EP/2008/009451
WO/2009/065507
205861
29/10/2008
DOSING DEVICE FOR THE
INHALATION OF A POWDER
SUBSTANCE
SSIEGFRIED GENERICS
INTERNATIONAL AG
DE
102007056263.4 22/11/2007
PCT/EP/2008/064661
WO/2009/065708
09/12/2008
205862
SYSTEM AND METHOD FOR
REGENERATION OF AN ABSORBENT
SOLUTION
ALSTOM TECHNOLOGY LTD.
US
61/013363
13/12/2007
12/269389
12/11/2008
US
PCT/US/2008/086002
WO/2009/076328
11/12/2008
‫תכשירי רוקחות המכילים אנטגוניסטים‬
,‫לבראדיקינין וחומצה הילורונית‬
‫ושימושיהם‬
205863
HETEROCYCLIC ANTIVIRAL
COMPOUNDS
F. HOFFMANN-LA ROCHE AG
US
61/016142
21/12/2007
PCT/EP/2008/067274
WO/2009/080534
A61M )2010.01(
‫התקן מינון עבור שאיפת חומר אבקתי‬
B01D )2010.01(
‫מערכת ושיטה לשחזור של תמיסה‬
‫סופחת‬
C07D )2010.01(
‫תרכובות הטרוציקליות אנטי ויראליות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
20/10/2008
205864
AUTOMATED ENUMERATION AND
CHARACTERIZATION OF
CIRCULATING MELANOMA CELLS
IN BLOOD
VERIDEX, LLC
US
61/004345
27/11/2007
PCT/US/2008/080436
WO/2009/070392
18/11/2008
15/12/2008
‫ספירה אוטומטית ואפיון של תאי מלנומה‬
‫המסתובבים בדם‬
205865
DEVICE AND METHOD FOR
AUTOMATICALLY BUILDING
APPLICATIONS FROM
SPECIFICATIONS AND FROM OFFTHE-SHELF COMPONENTS
SELECTED BY SEMANTIC ANALYSIS
ALCATEL LUCENT
EP
07301646.1 07/12/2007
PCT/EP/2008/065721
WO/2009/071440
G06F )2010.01(
‫התקן ושיטה לבניה אוטומטית של ישומים‬
‫מהוראות ורכיבים מהמדף הנבחרים‬
‫באנליזה סמנטית‬
205866
ANTIBODIES AGAINST HUMAN NKG2D
AND USES THEREOF
NOVO NORDISK A/S
EP
PCT/EP07/063979 14/12/2007
08163163.2
28/08/2008
EP
PCT/EP/2008/067499
WO/2009/077483
26/02/2008
G01N )2010.01(
205867
C07K )2010.01(
‫ ממקור אנושי‬NKG 20 ‫נוגדנים נגד‬
‫ושימושיהם‬
C22C )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
‫פלדת אל–חלד אוסטנטית דקה עמידה‬
‫לשיתוך‬
CORROSION RESISTANT IEAN
AUSTENITIC STAINLESS STEEL
ATI PROPERTIES, INC.
US
61/015338
20/12/2007
PCT/US/2008/054945
WO/2009/082501
20/02/2008
205868
‫פלדלת אל–חלד אוסטנטית בעלת ריכוז‬
‫נמוך של ניקל ואשר מכילה יסודות‬
‫מייצבים‬
AUSTENITIC STAINLESS STEEL LOW
IN NICKEL CONTAINING
STABILIZING ELEMENTS
ATI PROPERTIES, INC.
US
61/015264
PCT/US/2008/054396
WO/2009/082498
07/01/2009
C22C )2010.01(
20/12/2007
205869
‫גליקוזילציה בעופות‬
GLYCOSYLATION IN AVIANS
SYNAGEVA BIOPHARMA CORP.
US
61/010207
07/01/2008
PCT/US/2009/000058
WO/2009/088998
19/12/2008
205870
TREATMENT OF HEART DISEASE
USING B-BLOCKERS
BAYER ANIMAL HEALTH GMBH
US
61/016891
27/12/2007
PCT/EP/2008/010892
WO/2009/083177
01/12/2008
A01K )2010.01(
A61K )2010.01(
‫טיפול במחלת לב באמצעות חוסמי בתא‬
205872
C07C )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
PROCESS FOR THE PRODUCTION OF 2-[4-(3-OR 2FLUOROBENZYLOXY)BENZYLAMINO]PROPANAMIDES
WITH HIGH PURITY DEGREE
–2 ‫–או‬3(–4[–2 ‫תהליך להכנת‬
‫פלואורובנזילוקסי)בנזילאמינו]פרופאנאמידים‬
‫בעלי דרגת טוהר גבוהה‬
NEWRON PHARMACEUTICALS S.P.A.
EP
07023937.1
11/12/2007
PCT/EP/2008/066559
WO/2009/074478
10/12/2008
205873
NOVEL COMPOUNDS 010
ASTRAZENECA AB
US
61/012972
12/12/2007
PCT/GB/2008/051173
WO/2009/074829
05/12/2008
205874
PIPERAZINES AS ANTI-OBESITY
AGENTS
ASTRAZENECA AB
SE
0702696-6
05/12/2007
61/022983
23/01/2008
US
PCT/EP/2008/066877
WO/2009/071658
24/10/2008
205876
MODULAR DEVICE FOR MULTIAXIAL INSULATION AGAINST
VIBRATION AND IMPACTS, BASED
ON ELASTOMER
ASTRIUM SAS
FR
0708197
22/11/2007
PCT/FR/2008/051928
WO/2009/066045
C07D )2010.01(
010 ‫תרכובות חדשות‬
C07D )2010.01(
‫פיפראזינים כתרופות נגד השמנת יתר‬
F16F )2010.01(
‫מכשיר מודולרי לבידוד רב–צירי כנגד‬
‫ המבוסס על אלסטומר‬,‫רעידות ופגיעות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
01/12/2008
205878
‫שיטה ומכשיר להגנה מדיה סוף לקצה‬
‫ (אינטרנט מולטימדיה‬IMS ‫במערכת‬
)‫פרוטוקול תת–מערכת‬
METHOD AND APPARATUS FOR
END-TO-EDGE MEDIA PROTECTION
IN AN IMS SYSTEM
TELEFONAKTIEBOLAGET LM
ERICSSON (PUBL)
US
60/991014
29/11/2007
PCT/IB/2008/003288
WO/2009/068985
21/11/2008
205880
AMINOGLYCOSIDE ANALOGS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
ACHAOGEN, INC.
US
60/989645
21/11/2007
PCT/US/2008/084399
WO/2009/067692
20/11/2008
205881
205882
BIARYL PDE4 INHIBITORS FOR
TREATING PULMONARY AND
CARDIOVASCULAR DISORDERS
DECODE GENETICS EHF
US
60/989551
21/11/2007
C07H )2010.01(
‫ תכשירים המכילים‬,‫אנלוגי אמינוגליקוזידים‬
‫אותם ושימושים בהם‬
BIARYL PDE4 INHIBITORS FOR
TREATING INFLAMMATION
DECODE GENETICS EHF
US
60/989551
21/11/2008
PCT/US/2008/084193
WO/2009/067600
20/11/2008
H04L )2010.01(
C07D )2010.01(
‫ ביארילים לטיפול בניפוח‬PDE4 ‫מונעי‬
C07D )2010.01(
‫ ביארילים לטיפול בבעיות‬PDE 4 ‫מונעי‬
‫ראות ולב‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PCT/US/2008/084230
WO/2009/067621
20/11/2008
205883
SUBSTITTUED BENZOAZOLE PDE4
INHIBITORS FOR TREATING
PULMONARY AND
CARDIOVASCULARD DISORDERS
DECODE GENETICS EHF
US
60/989557
21/11/2007
PCT/US/2008/084199
WO/2009/067604
20/11/2008
18/11/2008
‫ בנזואזולים מותמרים לטיפול‬PDE4 ‫מונעי‬
‫ מחלות ולב ומחלות מערכת‬,‫בניפוח‬
‫עצבים מרכזית‬
205884
SUBSTITTUED BENZOAZOLE PDE4
INHIBITORS FOR TREATING
PULMONARY AND
CARDIOVASCULARD DISORDERS
DECODE GENETICS EHF
US
60/989557
21/11/2007
PCT/US/2008/084225
WO/2009/067618
C07D )2010.01(
‫ בנזואזולים מותמרים לטיפול‬PDE 4 ‫מונעי‬
‫ מחלות ולב ומחלות עצבים‬,‫בניפוח‬
‫מרכזית‬
205886
CONFIGURING AN ACCESS POINT OF
A FEMTO CELL
QUALCOMM INCORPORATED
US
60/989054
19/11/2007
60/989057
19/11/2007
US
61/025683
01/02/2008
US
12/272665
17/11/2008
US
PCT/US/2008/083927
WO/2009/067454
C07D )2010.01(
H04W )2010.01(
‫עיצוב נקודת גישה של תא פמטו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
18/11/2008
205887
CONFIGURING AN IDENTIFIER FOR
AN ACCESS POINT OF A FEMTO
CELL
QUALCOMM INCORPORATED
US
60/989054
19/11/2007
60/989057
19/11/2007
US
61/025683
01/02/2008
US
12/272672
17/11/2008
US
PCT/US/2008/083925
WO/2009/067452
27/11/2007
H04W )2010.01(
‫עיצוב מזהה לנקודת גישה של תא פמטו‬
205888
INITATING NATURAL PLANT FIBER,
PREPARATION METHOD THEREOF
AND THE FABRIC MADE OF IT
NOVEKO TRADING 2008 LLC
D01F )2010.01(
,‫ שיטה להכנתו‬,‫חיקוי סיבי צמח טבעיים‬
‫ואריג הנעשה ממנו‬
PCT/CN/2007/003339
WO/2009/067840
20/11/2008
205891
METHOD AND APPARATUS FOR
RECOVERING ENERGY FROM DRIVING
ENGINES
SCHWIENBACHER, CHRISTOPH
IT
BZ2007A000049 23/11/2007
PCT/IB/2008/003249
WO/2009/066171
27/11/2008
‫שיטה והתקן להפקת אנרגיה ממנועים‬
‫נהוגים‬
205893
INTERVERTEBRAL IMPLANT
HENNING KLOSS
DE
102007056993.0 27/11/2007
PCT/DE/2008/001994
F01K )2010.01(
A61F )2010.01(
‫שתל בין–חליתי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/068021
205894
21/11/2008
METHOD FOR METALLIZING A
POLYMER
DETLEF MILITZ
DE
102007056599.4 21/11/2007
PCT/EP/2008/065968
WO/2009/065924
205895
17/11/2008
2',4'-SUBSTITUTED NUCLEOSIDES AS
ANTIVIRAL AGENTS
PHARMASSET, INC.
US
60/989296
20/11/2007
12/271388
14/11/2008
US
PCT/US/2008/083787
WO/2009/067409
205896
27/01/2009
LIGHTING
LSI INDUSTRIES, INC.
US
12/040321
PCT/US/2009/032083
WO/2009/108436
D06M )2010.01(
‫שיטה לציפוי מתכתי של פולימר‬
C07H )2010.01(
‫' כתכשירים‬4,'2–‫נוקלאוסידים מוחלפים‬
‫קוטלי נגיפים‬
F21V )2010.01(
‫תאורה‬
29/02/2008
23/05/2010
FILLER APPARATUS FOR BAKED
GOODS KIT
YOSSEF GOTTLIEB
205901
A47J )2010.01(
‫קיט של מכשיר מילוי למוצרים אפויים‬
‫יוסף גוטליב‬
November 30, 2010-‫כג' בכסלו התשע"א‬
23/05/2010
205902
REFUELING FUEL-SAVING
APPARATUS AND METHOD
TAL KAIL
23/05/2010
‫מכשיר ושיטה לחסכון בדלק בעת תדלוק‬
‫טל קייל‬
205903
INTERNET SITES AND INTERNET
PAGES WITH AUTOMATIC FITTING
TO THE RESOLUTION OF SURFER'S
COMPUTER SCREEN RESOLUTION
MENAHEM SHARON
20/11/2008
205904
IMPROVED SPEAKER APPARATUS
AND METHODS USEFUL IN
CONJUNCTION THEREWITH
AUDIO PIXELS LTD
US
60/996513
21/11/2007
PCT/IL/2008/001524
WO/2009/066290
28/11/2008
B60K )2010.01(
205906
ANTIGEN-BINDING CONSTRUCTS
GLAXO GROUP LIMITED
US
60/991449
30/11/2007
61/027858
12/02/2008
US
G06F )2010.01(
‫אתרי אינטרנט ודפי אינטרנט בעלי‬
‫התאמה אוטומטית לרזולוציה של מסך‬
‫המחשב של הגולש‬
‫מנחם שרון‬
H04R )2010.01(
‫מערכת רמקולים משופרת ושיטות‬
‫שימושיות בצרופה‬
‫אודיו פיקסלס בע"מ‬
C07K )2010.01(
‫מבנים קושרי אנטיגן‬
November 30, 2010-‫כג' בכסלו התשע"א‬
61/046572
US
61/081191
US
61/084431
US
PCT/EP/2008/066438
WO/2009/068649
26/11/2008
21/04/2008
16/07/2008
29/07/2008
205907
14-3-3 ANTAGONISTS FOR THE
PREVENTION AND TREATMENT OF
ARTHRITIS
THE UNIVERSITY OF BRITISH
COLUMBIA
US
60/990520
27/11/2007
61/077123
30/06/2008
US
PCT/CA/2008/002154
WO/2009/067820
27/11/2008
‫ למניעה וטיפול‬3–3–14 ‫אנטגוניסטים‬
‫בדלקת מפרקים‬
205908
205909
METHODS OF TREATING NONALCOHOLIC STEATOHEPATITIS
(NASH) USING CYSTEAMINE
PRODUCTS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/991517
30/11/2007
61/085397
31/07/2008
US
PCT/US/2008/085064
WO/2009/070781
B05B )2010.01(
‫התקן חלוקה‬
A DISPENSING DEVICE
GLAXO GROUP LIMITED
GB
0723418.0
29/11/2007
0809770.1
29/05/2008
GB
PCT/GB/2008/003954
WO/2009/068877
28/11/2008
A61K )2010.01(
A01N )2010.01(
‫ באמצעות מוצרי‬NASH–‫שיטות לטיפול ב‬
‫ציסטאמין‬
November 30, 2010-‫כג' בכסלו התשע"א‬
24/11/2008
205910
PROMOTER ENHANCED CHILLED
AMMONIA BASED SYSTEM AND
METHOD FOR REMOVAL OF CO2
FROM FLUE GAS STREAM
ALSTOM TECHNOLOGY LTD.
US
60/992340
05/12/2007
12/272953
18/11/2008
US
PCT/US/2008/084457
WO/2009/073422
‫מערכת המבוססת על מקדם הגברת‬
–‫אמוניה מקוררת ושיטה להוצאת פחמן דו‬
‫חמצני מזרם גזי הנפלט מארובה‬
205911
11/12/2008
METHODS FOR THE INHIBITION OF
SCARRING
RENOVO LTD
GB
0724203.5
12/12/2007
PCT/GB/2008/004072
WO/2009/074793
11/12/2008
205912
INHIBITION OF SCARRING USING
TGF-BETA 3
RENOVO LTD
GB
0724204.3
12/12/2007
PCT/GB/2008/004078
WO/2009/074796
23/11/2007
205913
ELECTRONIC ARTICLE
SURVEILLANCE TAG
SENSORMATIC ELECTRONICS, LLC
B01D )2010.01(
A61K )2010.01(
‫שיטות לעיכוב צלקות‬
A61K )2010.01(
–‫עיכוב צלקות באמצעות שימוש ב‬
BETA–TGF3
E05B )2010.01(
‫תג אלקטרוני להשגחה על חפץ‬
PCT/US/2007/024352
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/067102
24/11/2008
205914
LIFTING ASSEMBLIES INCLUDING
TRAPEZOIDAL STRONG BACK BEAM
SYSTEMS
GLOBAL TRACK TECHNOLOGIES
PTY LTD
AU
2007906386 22/11/2007
2008903491
08/07/2008
AU
PCT/AU/2008/001731
WO/2009/065183
21/11/2008
‫הרכבי הרמה הכוללים מערכות טרפזיות‬
‫בעלות קורה אחורית חזקה‬
205915
APPARATUS AND METHODS FOR
ASSESSING AND MAINTAINING
SECURITY OF A COMPUTERIZED
SYSTEM UNDER DEVELOPMENT
WHITE CYBER KNIGHT LTD
21/11/2008
A61K )2010.01(
‫תכשירי טפנטדול‬
TAPENTADOL COMPOSITIONS
PROTECT PHARMACEUTICAL
CORPORATION
US
61/004029
23/11/2007
PCT/US/2008/084423
WO/2009/067703
23/05/2010
B66C )2010.01(
205916
G06F )2010.01(
‫התקן ושיטות להערכה ושימור בטיחותה‬
‫של מערכת ממוחשבת תחת פיתוח‬
‫וייט סייבר נייט בע"מ‬
205918
G01S )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
METHOD OF MULTI-TRANSMITTER
AND MULTI-PATH AOA-TDOA
LOCATION COMPRISING A SUBMETHOD FOR SYNCHRONIZING AND
EQUALIZING THE RECEIVING
STATIONS
THALES
FR
0708219
23/11/2007
PCT/EP/2008/066027
WO/2009/065943
25/11/2008
205919
INTERFERENCE MANAGEMENT IN A
WIRELESS COMMUNICATION
SYSTEM USING BEAM AND NULL
STEERING
QUALCOMM INCORPORATED
US
60/990541
27/11/2007
60/990547
27/11/2007
US
60/990513
27/11/2007
US
60/990564
27/11/2007
US
60/990570
27/11/2007
US
12/276894
24/11/2008
US
PCT/US/2008/084738
WO/2009/070606
24/11/2008
‫ רב–נתיבית‬TDOA–AOA ‫שיטה לאיתור‬
‫ורב–משדרית הכוללת תת–שיטה לסנכרון‬
‫והשוואת התחנות הקולטות‬
‫ניהול הפרעה במערכת תקשורת אלחוטית‬
‫המשתמשת בהיגוי גל והיגוי אפסי‬
205920
MAPPING METHOD IMPLEMENTING
A PASSIVE RADAR
THALES
FR
07/08213
23/11/2007
PCT/EP/2008/066079
WO/2009/065957
25/11/2008
H04W )2010.01(
205921
G01S )2010.01(
‫שיטת מיפוי המיישמת מכ"ם פסיבי‬
H04L )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
INTERFERENCE MANAGEMENT IN A
WIRELESS COMMUNICATION
SYSTEM USING FREQUENCY
SELECTIVE TRANSMISSION
QUALCOMM INCORPORATED
US
60/990541
27/11/2007
60/990547
27/11/2007
US
60/990459
27/11/2007
US
60/990513
27/11/2007
US
60/990564
27/11/2007
US
60/990570
27/11/2007
US
12/276906
24/11/2008
US
PCT/US/2008/084732
WO/2009/070602
25/11/2008
205922
INTERFACE MANAGEMENT IN A
WIRELESS COMMUNICATION
SYSTEM USING SUBFRAME TIME
REUSE
QUALCOMM INCORPORATED
US
60/990541
27/11/2007
60/990547
27/11/2007
US
990459'/60
27/11/2007
US
60/990513
27/11/2007
US
60/990564
27/11/2007
US
60/990570
27/11/2007
US
12/276882
24/11/2008
US
PCT/US/2008/084743
WO/2009/070610
29/10/2008
‫ניהול הפרעה במערכת תקשורת אלחוטית‬
‫המשתמשת בשידור בריר–תדר‬
‫ניהול ממשק במערכת תקשורת אלחוטית‬
–‫המשתמשת בשימוש חוזר של זמן תת‬
‫מסגרת‬
205923
SHELL DESIGNED FOR SECURING IN
A MORTAR AND MORTAR
DESIGNED FOR SUCH A SHELL
BAE SYSTEMS BOFORS AB
SE
0702645.3
30/11/2007
PCT/SE/2008/000612
WO/2009/070076
H04W )2010.01(
F42B )2010.01(
‫פגז המתוכנן לאבטחה במרגמה ומרגמה‬
‫המתוכננת לפגז כזה‬
November 30, 2010-‫כג' בכסלו התשע"א‬
23/11/2008
205924
USE OF HAPTOGLOBIN
GENOTYPING IN DIAGNOSIS AND
TREATMENT OF CARDIOVASCULAR
DISEASE
RAPPAPORT FAMILY INSTITUTE
FOR RESEARCH IN THE MEDICAL
SCIENCES
US
60/996552
23/11/2007
PCT/IL/2008/001536
WO/2009/066299
‫שימוש בגנוטיפיזציה של הפטוגלובין‬
‫לאבחון וטיפול במחלות קרדיו–ואסקולריות‬
‫המכון למחקר במדעי הרפואה ע"ש‬
‫משפחת רפפורט‬
205926
20/11/2008
C12M )2010.01(
G01N )2010.01(
‫מערכת לייזר מרובת חיישנים עבור‬
‫אנליזת מעקב סלקטיבית של חומר‬
‫אורגני‬
LASER MULTI-SENSOR SYSTEM FOR
THE SELECTIVE TRACE ANALYSIS OF
ORGANIC MATERIALS
EADS DEUTSCHLAND GMBH
DE
102007057374.1 27/11/2007
PCT/EP/2008/009814
WO/2009/068218
18/12/2008
205927
REAGENTS AND METHODS FOR THE
BETA-KETO AMIDE SYNTHESIS OF A
SYNTHETIC PRECURSOR TO
IMMUNOLOGICAL ADJUVANT E6020
EISAI R&D MANAGEMENT CO., LTD.
US
61/014648
18/12/2007
PCT/US/2008/087435
WO/2009/079627
24/05/2010
PLASTIC SOLAR PANEL
C07C )2010.01(
‫ריאקצית חומר כימי ושיטה עבור הסינטזה‬
E6020 ‫אמיד בטא–קאטו של אדג'ובאנט‬
‫אימונולוגי סינטטי קודם‬
205928
F24J )2010.01(
‫קולט שמש מפלסטיק‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫ברוך זיסר‬
BARUCH ZISER
24/05/2010
205929
HAMMER MECHANISM FOR
INSERTING A POLE TO THE GROUND
YUVAL MOSCOVICH
24/05/2010
19/12/2008
‫מנגנון לתקיעת מוט באדמה‬/‫פטיש‬
‫פרי עגור‬
205930
APPARATUS FOR COOLING AND
CARBONATING BEVERAGE CANS
AND BOTTLES
PAVEL LERNER
B65D )2010.01(
‫מיתקן לקירור ולהגזה של פחיות ובקבוקי‬
‫משקה‬
‫פאבל לרנר‬
205931
PHARMACEUTICAL COMPOSITION
NOVARTIS AG
EP
07150347.8 21/12/2007
PCT/EP/2008/068051
WO/2009/080762
02/12/2008
F21S )2010.01(
205932
A61K )2010.01(
‫הרכב רוקחי‬
C07K )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
INSULINTROPIC PEPTIDE
SYNTHESIS USING SOLID AND
SOLUTION PHASE COMBINATION
TECHNIQUES
F. HOFFMANN-LA ROCHE AG
US
61/007238
11/12/2007
PCT/EP/2008/066585
WO/2009/074483
02/12/2008
‫סינטזת פפטיד אינסולינוטרופי על ידי‬
‫שילוב טכניקות מוצק ופאזת תמיסה‬
205933
SYSTEM AND METHOD FOR
PRODUCING BEADS
DSM IP ASSETS B.V.
DK
PA200701722 03/12/2007
PCT/EP/2008/066659
WO/2009/071560
19/12/2008
‫מערכת ושיטה לייצור בידים‬
205934
TREATMENT OF BANANA AND
POTATO PLANTS WITH A NEW
ANTIFUNGAL COMPOSITION
DSM IP ASSETS B.V.
EP
07123685.5 19/12/2007
PCT/EP/2008/067975
WO/2009/077613
27/11/2008
A01N )2010.01(
‫טיפול בצמחי בננה ותפוח אדמה עם‬
‫תכשיר אנטי–פטרייתי‬
205935
ALGINATE BIOMATERIALS FOR THE
TREATMENT OF HEPATIC
DISORDERS
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD.
IL
187707
27/11/2007
PCT/IL/2008/001552
WO/2009/069131
B01J )2010.01(
A61K )2010.01(
‫ביו–חומרים של אלגינט לטיפול בהפרעות‬
‫כבד‬
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
25/11/2008
205936
RECOMBINANTL Y MODIFIED
PLASMIN
TALECRIS BIOTHERAPEUTICS, INC.
US
60/991148
29/11/2007
PCT/US/2008/084645
WO/2009/073471
30/11/2008
27/11/2008
‫פלסמין מותאם רקומביננטית‬
205937
METHOD AND APPARATUS FOR
MAINTAINING A COHERENT
COMBINED BEAM DURING
ARBITRARY STEERING
RAYTHEON COMPANY
US
60/991403
30/11/2007
PCT/US/2008/013242
WO/2009/073158
205938
205939
COMPOSITIONS AND METHODS FOR
TREATING LYSOSOMAL DISORDERS
THE HOSPITAL FOR SICK CHILDREN
US
60/991136
29/11/2007
61/095825
10/09/2008
US
PCT/US/2008/085039
G02B )2010.01(
‫שיטה והתקן לשמירת גל משולב קוהרנטי‬
‫בזמן היגוי אקראי‬
PURIFICATION OF FATTY
MATERIALS SUCH AS OILS
GRACE GMBH & CO. KG
US
61/004353
27/11/2007
PCT/EP/2008/010048
WO/2009/068277
26/11/2008
C12N )2010.01(
C10G )2010.01(
‫טיהור חומרים שומניים כמו שמנים‬
A61K )2010.01(
‫תכשירים ושיטות לטיפול בהפרעות‬
‫ליזוזומיות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/073564
25/11/2007
205940
IMPROVED ENDOSCOPIC BITE
BLOCK
ORIDION MEDICAL LTD.
A61M )2010.01(
‫מנשך משופר לאנדוסקופיה‬
‫אורידיון מדיקל בע"מ‬
PCT/IL/2007/001451
WO/2009/066277
26/11/2008
205942
LARGE AREA AREA DYE CELLS,
AND METHOD OF PRODUCTION
THEREOF
3G SOLAR LTD
US
60/990307
27/11/2007
PCT/IL/2008/001550
WO/2009/069129
25/05/2010
,‫תאי שמש על בסיס צבע בעלי שטח גדול‬
‫ושיטה לייצורן‬
205943
A COUNCRETE PLATE, METHOD FOR
MANUFACTURING THEREOF AND
FOR CONNECTING CONCRETE
PLATES
VADIM SHENKAR
26/11/2008
B29C )2010.01(
205944
‫ג'י סולאר בע"מ‬3
E04B )2010.01(
‫ שיטה לייצורה ולחיבור‬,‫טבלת ביטון‬
‫טבלות ביטון‬
‫וודים שנקר‬
C12N )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
LNA OLIGOMER ANDROGEN
RECEPTOR ANTAGONISTS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
SANTARIS PHARMA A/S
US
60/990125
26/11/2007
PCT/DK/2008/000417
WO/2009/068033
25/03/2002
‫ אוליגומר אנטאגוניסטי קולטן‬LNA
‫ תכשירים המכילים אותו‬,‫האנדרוגן‬
‫ושימושים בו‬
205945
158P3D2 POLYNUCLEOTIDES FOR
USE AS A DIAGNOSTIC AND
THERAPEUTIC
AGENSYS, INC.
US
60/283112
10/04/2001
60/286630
25/04/2001
US
PCT/US/2002/009403
WO/2002/083928
02/04/2003
‫ פולינוקליאוטידים לשימוש‬D3 P8 5 1 2
‫דיאנוסטי ורפואי‬
205946
SYSTEM FOR EFFICIENT RECOVERY
OF NODE B BUFFERED DATA
FOLLOWING SERVING HIGH SPEED
DOWNLINK SHARED CHANNEL
CELL CHANGE
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/370740
05/04/2002
10/334489
30/12/2002
US
PCT/US/2003/010037
WO/2003/087978
28/11/2008
C12Q )2009.01(
H04J )2010.01(
‫מערכת לשיחרור יעיל של מידע בעקבות‬
DSCH–HS–‫שינוי ב‬
205947
PHOSPHONIC ACID DERIVATIVES AND
THEIR USE AS P2Y12 RECEPTOR
ANTAGONISTS
ACTELION PHARMACEUTICALS LTD.
C07F )2010.01(
‫תולדות חומצה פוספונית ושימושיהן‬
Y2P12 ‫כאנטאגוניסטים של קולטן‬
November 30, 2010-‫כג' בכסלו התשע"א‬
IB
PCT/IB07/054850
PCT/IB/2008/055002
WO/2009/069100
26/11/2008
29/11/2007
205948
14-3-3 ETA ANTIBODIES AND USES
THEREOF FOR THE DIAGNOSIS AND
TREATMENT OF ARTHRITIS
THE UNIVERSITY OF BRITISH
COLUMBIA
US
60/990520
27/11/2007
61/077123
30/06/2008
US
PCT/CA/2008/002094
WO/2009/067811
10/12/2008
09/12/2008
‫ ושימושים שלהם‬ETA 14–3–3 ‫נוגדים‬
‫לאבחון וטיפול של דלקת פרקים‬
205949
3-CARBOXYPROPYLAMINOTETRALIN DERIVATIVES
AND RELATED COMPOUNDS AS MU
OPIOID RECEPTOR ANTAGONISTS
THERAVANCE, INC.
US
61/007220
11/12/2007
61/049219
30/04/2008
US
PCT/US/2008/086171
WO/2009/076408
C07C )2010.01(
‫–קרבוקסיפרופיל–אמינוטטראלין‬3 ‫תולדות‬
‫ותרכובות קרובות כאנטגוניסטים של‬
‫ אופיאוד‬MU ‫קולטן‬
205950
SYSTEM AND METHOD FOR
REGENERATION OF AN ABSORBENT
SOLUTION
ALSTOM TECHNOLOGY LTD.
US
61/013384
13/12/2007
12/274585
20/11/2008
US
PCT/US/2008/086001
WO/2009/076327
C07K )2010.01(
B01D )2010.01(
‫מערכת ושיטה ליצור מחדש של תמיסה‬
‫סופחת‬
November 30, 2010-‫כג' בכסלו התשע"א‬
04/12/2008
205951
METHOD OF INHIBITION OF
LEUKEMIC STEM CELLS
UNIVERSITY HEALTH NETWORK
US
60/996819
06/12/2007
PCT/AU/2008/001797
WO/2009/070844
02/12/2008
205952
PROTEASE VARIANTS FOR
PHARMACEUTICAL USE
SOLVAY PHARMACEUTICALS GMBH
EP
07122243.4 04/12/2007
PCT/EP/2008/066646
WO/2009/071550
04/12/2008
205953
VACCINE
GLAXOSMITHKLINE BIOLOGICALS
S.A.
US
60/992802
06/12/2007
PCT/EP/2008/066762
WO/2009/071613
08/12/2008
205954
INTERMEDIATES AND METHODS
FOR MAKING ZEARALENONE
MACROLIDE ANALOGS
EISAI R&D MANAGEMENT CO., LTD.
US
61/012408
07/12/2007
61/012409
07/12/2007
US
61/012411
07/12/2007
US
61/080048
11/07/2008
US
A61K )2010.01(
‫שיטה לעיכוב תאי גזע לוקמים‬
C12N )2010.01(
‫גרסאות פרוטאז לשימוש רוקחי‬
C12N )2010.01(
‫חיסון‬
C07D )2010.01(
‫חומר ביניים ושיטות להכנת אנלוגים‬
‫מקרולידים של זארלנון‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PCT/US/2008/013498
WO/2009/075818
17/12/2008
205955
AN ARTIFICIAL DIELECTRIC
MATERIAL AND A METHOD OF
MANUFACTURING THE SAME
MATSING PTE. LTD
H01Q )2010.01(
‫חומר דיאלקטרי מלאכותי ושיטה לייצורו‬
PCT/SG/2007/000430
WO/2009/078807
26/11/2008
205956
A TELECOMMUNICATIONS
NETWORK AND
TELECOMMUNICATIONS DEVICE
COMPLIANT PHONES LIMITED
GB
0723298.6
28/11/2007
PCT/GB/2008/003929
WO/2009/068861
25/10/2004
24/11/2008
‫רשת תקשורת והתקן תקשורת‬
205957
IMMUNOGENIC COMPOSITION AND
METHOD OF DEVELOPING A
VACCINE BASED ON PORTIONS OF
THE HIV MATRIX PROTEIN
NMK RESEARCH, LLC
US
60/513827
23/10/2003
PCT/US/2004/035212
WO/2005/040365
H04M )2010.01(
A61K )2010.01(
‫הרכב אימונוגני ושיטה לפיתוח תרכיב על‬
HIV ‫בסיס חלקי חלבון המטריקס של‬
205959
A61K )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
POLYSACCHARIDE GEL
FORMULATION
ALLERGAN, INC.
US
60/991473
12/276167
US
PCT/US/2008/084515
WO/2009/073437
11/12/2008
‫פורמולצית ג'ל פוליסכריד‬
30/11/2007
21/11/2008
205960
IMPLANTABLE DRUG DELIVERY
DEVICE AND METHODS FOR
TREATMENT OF THE BLADDER AND
OTHER BODY VESICLES OR LUMENS
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY
US
61/007177
11/12/2007
61/084927
30/07/2008
US
PCT/US/2008/086467
WO/2009/076547
03/12/2008
‫התקן מתן תרופה הניתן להשתלה ושיטות‬
‫טיפול בשלפוחית השתן ושלפוחיות וחללי‬
‫הגוף אחרים‬
205961
MEDICAL USE OF 3-(2,2,2TRIMETHYLHYDRAZINIUM)
PROPIONATE HYDROGEN
FUMARATE AND DIHYDROGEN
PHOSPHATE
GRINDEKS, A. JOINT STOCK
COMPANY
EP
07122272.3 04/12/2007
07122273.1
04/12/2007
EP
PCT/EP/2008/066711
WO/2009/071585
03/12/2008
A61M )2010.01(
A61K )2010.01(
–2,2,2(–3 ‫שימוש רפואי של‬
‫טרימתילהידרוזיניום) פרופיונט מימן‬
‫פומרט ודימימן פוספט‬
205962
A61P )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
3-(2,2,2TRIMETHLHYDRAZINIUM)PROPIONATE
SALTS FOR TREATING ISCHEMIC HEART
DISEASE
GRINDEKS, A JOINT STOCK COMPANY
EP
07122359.8
05/12/2007
07122360.6
05/12/2007
EP
PCT/EP/2008/066712
WO/2009/071586
04/12/2008
205963
TOSYLATE SALT OF TRANS-NISOBUTYL-3-FLUORO-3-[3-FLUORO4-(PYRROLIDIN-1-YL-METHYL)PHENYL]CYCLOBUT
ANECARBOXAMIDE
PFIZER INC
US
61/005696
07/12/2007
PCT/IB/2008/003392
WO/2009/071988
26/11/2008
–2,2,2(–3 ‫מלחי פרופיונט של‬
‫טרימתילהידרזיניום) לטיפול במחלת‬
‫לב איסכמית‬
–3–‫–איזובוטיל‬N–‫מלח טוסילט של טראנס‬
–)‫–איל–מתיל‬1–‫–(פירולידין‬4–‫פלורו‬
‫פניל]ציקלובוטאן‬
205964
INDOLES, DERIVATES AND
ANALOGS THEREOF AND USES
THEREOF
UNIVERSITY OF TENNESSEE
RESEARCH FOUNDATION
US
11/947668
29/11/2007
PCT/US/2008/084801
WO/2009/070645
11/12/2008
C07D )2010.01(
‫ ניגזרות ואנלוגים שלהם‬,‫אינדולים‬
‫ושימושם‬
205965
THERAPEUTIC USES OF COMPOUNDS
HAVING AFFINITY TO THE
SEROTONIN TRANSPORTER,
SEROTONIN RECEPTORS AND
NORADRENALIN TRANSPORTER
C07D )2010.01(
A61K )2010.01(
‫שימושים תרפיוטיים של תרכובות בעלות‬
‫ רצפטור‬,‫זיקה לטרנספורטר של סרוטונין‬
‫של סרוטונין וטרנספורטר של נוראדרנלין‬
November 30, 2010-‫כג' בכסלו התשע"א‬
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC.
DK
PA200701791 14/12/2007
DK
PA200701798 17/12/2007
PCT/DK/2008/050302
WO/2009/076962
28/11/2008
205966
OLIGOMER-TRICYCLIC
CONJUGATES, COMPOSITIONS
COMPRISING THE SAME AND USES
THEREOF
NEKTAR THERAPEUTICS
US
61/004483
28/11/2007
61/191635
10/09/2008
US
PCT/US/2008/013221
WO/2009/073154
28/11/2008
‫ תכשירים‬,‫מוצמדי אוליגומר–טריציקלי‬
‫המכילים אותם ושימושים בהם‬
205967
ANTIBIOTIC MACROCYCLE
COMPOUNDS AND METHODS OF
MANUFACTURE AND USE THEREOF
OPTIMER PHARMACEUTICALS, INC
US
60/996609
27/11/2007
PCT/US/2008/085056
WO/2009/070779
20/11/2008
A61K )2010.01(
A61K )2010.01(
,‫תרכובות אנטיביוטיקה מקרוציקלייות‬
‫ושיטות לייצור ושימושים בהן‬
205968
MIXED BUTYRIC FORMIC ESTERS OF
ACID POLYSACCHARIDES, AND THEIR
PREPARATION AND USE AS SKIN
COSMETICS
SIGEA S.R.L
IT
MI2007A002237 27/11/2007
PCT/EP/2008/009801
WO/2009/068215
C08B )2010.01(
‫אסטרים בוטירים פורמים מעורבים של‬
‫ הכנתם‬,‫פוליסכארידים חומציים‬
‫ושימוש בהם כחומרים קוסמטים לעור‬
November 30, 2010-‫כג' בכסלו התשע"א‬
205969
26/05/2010
‫כלי רכב מומר בעל מוביליות גבוהה‬
‫ותהליך המרה‬
CONVERTED HIGH MOBILITY
VEHICLE AND CONVERSION
METHOD THEREFOR
‫פלסן סאסא אגודה שיתופית חקלאית‬
‫בע"מ‬
PLASAN SASA AGRICULTURAL
COOPERATIVE SOCIETY LTED.
26/11/2008
205970
TARGETED RADIOTHERAPY
KATHOLIEKE UNIVERSITEIT
LEUVEN OF
GB
0723124.4
26/11/2007
PCT/BE/2008/000099
WO/2009/067767
26/11/2008
POWER SENSOR
SAFEWORKS, LLC
US
60/990194
PCT/US/2008/084961
WO/2009/070725
18/12/2008
B62D )2010.01(
205972
A61K )2010.01(
‫טיפול מכוון באמצעות חומר רדיואקטיבי‬
G01R )2010.01(
‫חיישן כח‬
26/11/2007
205973
METHODS AND SYSTEM FOR
REMOVING A MATERIAL FROM A
SAMPLE
NAWOTEC GMBH
US
61/016724
26/12/2007
H01J )2010.01(
‫שיטות ומערכות להסרת חומר מדגימה‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PCT/EP/2008/067909
WO/2009/080707
26/11/2008
205974
C07D )2010.01(
NOVEL COMPOUNDS AND
COMPOSITIONS AND METHODS OF
USE
ARDEA BIOSCIENCES, INC.
US
60/990574
27/11/2007
61/094388
04/09/2008
US
PCT/US/2008/084988
WO/2009/070740
‫תרכובות חדשות ותכשירים ושיטות‬
‫לשימוש‬
205975
05/12/2008
PHARMACEUTICAL COMPOSITION
FERRING INTERNATIONAL CENTER
SA
EP
07254754.0
07/12/2007
61/012197
07/12/2007
US
200810002285.7 08/01/2008
CN
PCT/IB/2008/003677
WO/2009/071993
08/12/2008
205976
ANTI-HUMAN IL-21 MONOCLONAL
ANTIBODIES
ZYMOGENETICS INC.
US
61/012329
07/12/2007
PCT/IB/2008/005011
WO/2010/055366
18/12/2008
205977
A61K )2010.01(
‫תכשיר רוקחות‬
C07K )2010.01(
‫ ממקור‬IL–21 ‫נוגדנים חד–שבטיים נוגדי‬
‫אנושי‬
C07D )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
‫–אנילינו אימידאזו פירידינים ושיטות‬5
‫לשימוש בהם‬
5-ANILINOIMIDAZOPYRIDINES AND
METHODS OF USE
GENENTECH, INC.
US
61\015129
19/12/2007
61/054014
16/05/2008
US
PCT/US/2008/087482
WO/2009/085983
08/12/2008
205980
C07D )2010.01(
CANNABINOID RECEPTOR
MODULATORS
7TM PHARMA A/S
GB
0724096.3
10/12/2007
0813350.6
21/07/2008
GB
PCT/GB/2008/004051
WO/2009/074782
‫מאפנני קולטן קנאבינואיד‬
205981
23/12/2008
15,16-METHYLENE-17-HYDROXY-19NOR-21-CARBOXYLIC ACID ?LACTONE DERIVATIVE , USE THEREOF,
AND MEDICAMENT CONTAINING SAID
DERIVATIVE
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
DE
102007063501.1 29/12/2007
PCT/EP/2008/011162
WO/2009/083269
08/12/2008
205983
INTERMEDIATES IN THE SYNTHESIS
OF ZEARALENONE MACROLIDE
ANALOGS
EISAI R&D MANAGEMENT CO., LTD.
US
61/012411
07/12/2007
61/012408
07/12/2007
US
C07J )2010.01(
–17–‫–מתילן‬16,15 ‫תולדות ?–לקטון של‬
‫–חומצה‬21–‫–נור‬19–‫הידרוקסי‬
‫ שימושיהן ותרופות‬,‫קרבוקסילית‬
‫המכילות תולדות אלו‬
C07D )2010.01(
‫חומרי ביניים בסינטזה של אנלוגים של‬
‫זאראלנון מאקרוליד‬
November 30, 2010-‫כג' בכסלו התשע"א‬
61/012409
US
61/080048
US
PCT/US/2008/013512
WO/2009/075823
03/03/2003
07/12/2007
11/07/2008
205985
HUMANIZED ANTI-CD74 ANTIBODY
AND COMPOSITION COMPRISING
SAME
IMMUNOMEDICS, INC.
US
60/360259
01/03/2002
PCT/GB/2003/000890
WO/2003/074567
26/11/2008
21/11/2008
‫ והרכבים‬CD74 ‫נוגדן הומני של אנטי‬
‫המכילים אותו‬
205986
COMPOSITIONS AND METHODS FOR
PRODUCING VASCULAR
OCCLUSION USING A SOLID-PHASE
PLATELET BINDING AGENT
IMBIOTECHNOLOGIES LTD.
US
60/990031
26/11/2007
61/031653
26/02/2008
US
61/093268
29/08/2008
US
PCT/CA/2008/002060
WO/2009/067791
A61K )2010.01(
‫תכשירים ושיטות לייצור חוסם כלי–דם‬
‫באמצעות שימוש בגורם קושר טסיות דם‬
‫בפאזה מוצקה‬
205987
BANK1 SPLICE VARIANT, ITS
PREPARATION AND USE
MERCK SERONO S.A.
EP
07121538.8 26/11/2007
61/004480
28/11/2007
US
PCT/EP/2008/065980
WO/2009/068481
C07K )2010.01(
C07K )2010.01(
‫ הכנתו‬,BANK1 ‫ספלייס ואריאנט של‬
‫והשימוש בו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
26/11/2008
205990
H04L )2010.01(
SYSTEM FOR AND METHOD OF
CRYPTOGRAPHIC PROVISIONING
KOOLSPAN, INC.
US
60/990145
26/11/2007
11/951202
05/12/2007
US
61/032196
28/02/2008
US
12/109883
25/04/2008
US
61/103111
06/10/2008
US
PCT/US/2008/084998
WO/2009/105139
26/11/2008
‫מערכת ושיטת משלוח מוצפנת‬
205991
SYSTEM FOR AND METHOD OF
AUTO-REGISTRATION WITH
CRYPTOGRAPHIC MODULES
KOOLSPAN, INC.
US
60/990145
26/11/2007
11/951202
05/12/2007
US
61/032196
28/02/2008
US
12/109883
25/04/2008
US
61/103111
06/10/2008
US
PCT/US/2008/085006
WO/2009/070752
24/07/2006
G06F )2010.01(
‫מערכת ושיטת רישום אוטומטית הכוללת‬
‫מודול הצפנה‬
205992
COMPOUNDS AND THEIR SALTS
SPECIFIC TO THE PPAR RECEPTORS
AND THE EGF RECEPTORS AND THEIR
USE IN THE PREPARATION OF
MEDICAMENTS
GIULIANI INTERNATIONAL LIMITED
IT
RM2005A000389 22/07/2005
PCT/IE/2006/000078
WO/2007/010516
C07C )2010.01(
–‫תרכובות ומלחיהן המיוחדות לקולטי‬
‫ ושימושן בהכנת‬EGF–‫ ולקולטי‬PPAR
‫תרופות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
26/11/2008
205993
ANTI-B7H4 MONOCLONAL
ANTIBODY-DRUG CONJUGATE AND
METHODS OF USE
BRISTOL-MYERS SQUIBB COMPANY
US
60/991693
30/11/2007
PCT/US/2008/084923
WO/2009/073533
25/11/2008
25/11/2008
‫צמד נוגדן חד–שבטי–תרופה ושיטת שימוש‬
205994
INTERFACE MANAGEMENT IN A
WIRELESS COMMUNICATION
SYSTEM USING OVERHEAD
CHANNEL POWER CONTROL
QUALCOMM INCORPORATED
US
60/990541
27/11/2007
60/990547
27/11/2007
US
60/990459
27/11/2007
US
60/990513
27/11/2007
US
60/990564
27/11/2007
US
60/990570
27/11/2007
US
12/276897
24/11/2008
US
PCT/US/2008/084741
WO/2009/070608
H04W )2010.01(
‫ניהול הפרעה במערכת תקשורת אלחוטית‬
‫המשתמש בבקרת כח ערוץ תקורה‬
205995
INTERFACE MANAGEMENT IN
WIRELESS COMMUNICATION
SYSTEM USING HYBRID TIME
REUSE
QUALCOMM INCORPORATED
US
60/990541
27/11/2007
60/990547
27/11/2007
US
60/990459
27/11/2007
US
60/990513
27/11/2007
US
60/990564
27/11/2007
US
60/990570
27/11/2007
US
A61K )2010.01(
H04W )2010.01(
‫ניהול ממשק במערכת תקשורת אלחוטית‬
‫המשתמש בשימוש חוזר של זמן היברידי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
12/276932
US
PCT/US/2008/084754
WO/2009/070618
16/12/2008
24/11/2008
205996
‫חומרים מבניים עם כמעט אפס פליטת‬
‫פחמן‬
STRUCTURAL MATERIALS WITH
NEARLY ZERO CARBON EMISSIONS
UNIVERSITY OF CENTRAL FLORIDA
RESEARCH FOUNDATION INC.
US
61/015418
20/12/2007
PCT/US/2008/013734
WO/2009/082442
25/11/2008
205997
INTERFERENCE MANAGEMENT IN A
WIRELESS COMMUNICATION
SYSTEM USING ADAPTIVE PATH
LOSS ADJUSTMENT
QUALCOMM INCORPORATED
US
60/990541
27/11/2007
60/990547
27/11/2007
US
60/990459
27/11/2007
US
60/990513
27/11/2007
US
60/990564
27/11/2007
US
60/990570
27/11/2007
US
12/276916
24/11/2008
US
PCT/US/2008/084749
WO/2009/070614
26/11/2008
H04W )2010.01(
‫ניהול הפרעה במערכת תקשורת אלחוטית‬
‫המשתמש בהתאמת אבדן נתיב מסתגלת‬
205998
COMPOSITIONS COMPRISING
NICOTINIC AGONISTS AND
METHODS OF USING SAME
NEURODERM LTD.
US
60/990161
26/11/2007
PCT/IL/2008/001546
WO/2009/069126
C04B )2010.01(
A61K )2010.01(
‫תכשירים הכוללים אגוניסטים ניקוטינים‬
‫ושיטות לשימושם‬
‫נוירודרם בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
08/04/2004
205999
‫ באופן הפיך‬PEG–‫תרופות המותמרות ב‬
REVERSIBLE PEGYLATED DRUGS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
60/460816
08/04/2003
PCT/IL/2004/000321
WO/2004/089280
30/11/2007
C07K )2010.01(
‫ידע חברה למחקר ופיתוח בע"מ‬
206000
PHARMACEUTICAL COMPOSITIONS
FOR TREATING DEPRESSION AND
ANXIETY
ZHANG ZUOGUANG
A61K )2010.01(
‫תרכובת פרמצבטית לטיפול בדיכאון‬
‫וחרדה‬
PCT/CN/2007/003386
WO/2009/070915
206001
18/11/2008
METHOD FOR PRODUCING RAISED
MARKING ON A GLASS OBJECT
HERAEUS QUARZGLAS GMBH & CO.
KG
DE
102007058360.7 03/12/2007
PCT/EP/2008/065724
WO/2009/071441
30/11/2008
206002
CLINICAL APPLICATIONS OF
NEUROPSYCHOLOGICAL PATTERN
ANALYSIS AND MODELING
ELMINDA LTD
US
60/990966
29/11/2007
C03C )2010.01(
‫שיטה ליצור סימון מוגבה על פריט‬
‫מזכוכית‬
G06E )2010.01(
‫יישומים קליניים של עיבוד תבניות‬
‫נוירופיזילוגיות‬
‫אלמינדה בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
61/058578
US
61/097880
US
PCT/IL/2008/001560
WO/2009/069136
30/11/2008
04/06/2008
18/09/2008
206003
SYSTEM AND METHOD FOR
NEURAL MODELING OF
NEUROPHYSIOLOGICAL DATA
ELMINDA LTD
US
60/990945
29/11/2007
PCT/IL/2008/001559
WO/2009/069135
26/11/2008
30/11/2008
‫מערכת ושיטה למידול נתונים‬
‫נוירופיזיולוגיים‬
‫אלמינדה בע"מ‬
206004
COMPOSITIONS COMPRISING
FIBROUS POLYPEPTIDES AND
POLYSACCHARIDES
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD
US
60/996581
26/11/2007
61/071968
28/05/2008
US
PCT/IL/2008/001542
WO/2009/069123
C07K )2010.01(
–‫תכשירים המכילים פפטידים סיביים ורב‬
‫סוכרים‬
206005
FUNCTIONAL ANALYSIS OF
NEUROPHYSIOLOGICAL DATA
ELMINDA LTD
US
60/990930
29/11/2007
PCT/IL/2008/001558
WO/2009/069134
G06F )2010.01(
‫קולפלנט בע"מ‬
A61B )2010.01(
‫ניתוח פונקציונאלי של נתונים‬
‫נוירופיזיולוגיים‬
‫אלמינדה בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
27/05/2010
206006
‫שמור מרחק‬
)‫(מהרכב שלפניך‬
‫זיו יגאל‬
KEEP DISTANCE SYSTEM (K.D.S)
ZIV IGEALL
27/05/2010
206007
PISTON INTERNAL COMBUSTION
ENGINE
OLGA LAPATIN
05/05/2004
F01C )2010.01(
‫מנוע הבוכנה שריפה פנימית‬
‫לפטין יפים‬
206009
USE OF EFFECTORS OF
GLUTAMINYL AND GLUTAMATE
CYCLASES
PROBIODRUG AG
US
60/468043
05/05/2003
60/468014
05/05/2003
US
60/512038
15/10/2003
US
PCT/EP/2004/004778
WO/2004/098625
01/12/2008
G08G )2010.01(
206010
CHELATING COMPOUND, AND
METHOD OF USE OF, POLY (2OCTSDECYL-BUTANEDIOATE)AND
CORRESPONDING ACID, POLY (2OCTADECYL-BUTANEDIOIC ACID)
JOSEPH LAURINO
US
11/998612
30/11/2007
A61K )2010.01(
‫שימוש במפעילי גלוטמיניל וגלוטמאט‬
‫ציקלאז‬
C08G )2010.01(
‫ ושיטה לשימוש בפולי‬,‫תרכובת סופחת‬
‫–אוקטדציל–בוטנדיואט)והחומצה‬2(
‫–אוקטדציל–חומצה‬2( ‫ פולי‬,‫המקבילה‬
)‫בוטנדיואית‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PCT/US/2008/085122
WO/2009/073601
27/11/2008
206011
‫מעורר חדש‬
NEW ADJUVANT
RAMOT AT TEL AVIV UNIVERSITY
LTD.
US
61/004418
27/11/2007
PCT/IL/2008/001551
WO/2009/069130
17/02/2006
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
206012
C07K )2010.01(
COLI –‫חלבונים וחומצות מ‬
‫ הקשור לזיהום דלקת‬ESCHERICHIA
‫קרום המוח והשימוש בהם‬
PROTEINS AND NUCLEIC ACIDS
FROM MENINGITIS/SEPSISASSOCIATED ESCHERICHIA COLI
NOVARTIS VACCINES AND
DIAGNOSTICS, INC.
US
60/654632
18/02/2005
60/712720
29/08/2005
US
PCT/US/2006/005913
WO/2006/089264
27/11/2008
A61K )2010.01(
206013
STAT 3 ‫פפטידי אפיטופ‬
STAT3 EPITOPE PEPTIDES
ONCOTHERAPY SCIENCE, INC.
US
60/990877
28/11/2007
PCT/JP/2008/003497
WO/2009/069302
26/11/2008
GENE EXPRESSION MARKERS FOR
INFLAMMATORY BOWEL DISEASE
C12N )2010.01(
206014
C12Q )2010.01(
‫סמנים לביטוי גני עבור מחלת מעיים‬
‫דלקתית‬
November 30, 2010-‫כג' בכסלו התשע"א‬
THE UNIVERSITY COURT OF THE
UNIVERSITY OF EDINBURGH OF OLD
COLLEGE
US
60/991203
29/11/2007
US
PCT/US08/064562 22/05/2008
61/192268
17/09/2008
US
PCT/US/2008/085045
WO/2009/073565
26/11/2008
206015
SOLARTURF: SOLAR ENERGY
HARVESTING ARTIFICIAL TURF
UNIVERSITY OF FLORIDA
RESEARCH FOUNDATION, INC.
US
60/990807
28/11/2007
PCT/US/2008/084917
WO/2009/070706
12/12/2008
H01L )2010.01(
‫דשא מלאכותי לאיסוף אנרגיה סולרית‬
206016
QUARTERNIZATION OF THE ADDITIVE
AMINO ALKYL METHACRYLATE
COPOLYMER E FOR IMPROVING
PERMEABILITY AND SOLUBILITY OF
PHARMACEUTICALS
EVONIK ROHM GMBH
DE
102007060175.3 13/12/2007
PCT/EP/2008/010585
WO/2009/074336
09/12/2008
206017
NONTOXIC POLYSILOXANE MATERIAL
FOR PRODUCING BIOLOGICALLY
RESORBABLE AND/OR BIOACTIVE
ARTICLES CONTAINING
POLYSILOXANE MATERIAL, ITS
PRODUCTION AND USE
A61K )2010.01(
‫קווטרניזציה של תוסף אמינואלקיל‬
‫ לשיפור‬E ‫מתאקרילט קופולימר‬
‫החדירות והמסיסות של תרופות‬
C03B )2010.01(
‫חומר פוליסילוקסאן בלתי רעיל לייצור‬
‫פריטים הנספגים מחדש באופן ביולוגי‬
‫או פעילים ביולוגית המכילים חומר‬/‫ו‬
‫ הכנתו ושימוש בו‬,‫פוליסילוקסאן‬
November 30, 2010-‫כג' בכסלו התשע"א‬
BAYER INNOVATION GMBH
DE
102007061874.5 19/12/2007
PCT/EP/2008/010412
WO/2009/077104
14/09/2006
206018
‫התקן למדידת משקל‬
‫לאניאדו שלמה‬
WEIGHT-MEASURING DEVICE
SHLOMO LANIADO
US
11/226438
15/09/2005
PCT/IL/2006/001076
WO/2007/032007
206019
23/12/2008
19-NOR-STEROID DERIVATIVES WITH
A 15a, 16a-METHYLENE GROUP AND A
SATURATED17,17-SPIROLACTONE
RING, USE THEREOF, AND
MEDICAMENTS CONTAINING SAID
DERIVATIVES
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
DE
102007063495.3 29/12/2007
PCT/EP/2008/011165
WO/2009/083272
09/07/2008
C07J )2010.01(
‫–נור–סטירואיד עם קבוצת‬19 ‫תולדות‬
–‫–ספירו‬17,17 ‫–מתילן וטבעת‬a15,a16
‫ השימוש בהן ותרופות‬,‫לקטון רוויה‬
‫המכילות אותן‬
206020
ADIPONECTIN RECEPTOR
FRAGMENTS AND METHODS OF USE
SIEMENS HEALTHCARE
DIAGNOSTICS INC.
US
60/991328
30/11/2007
PCT/US/2008/069500
WO/2009/070350
G01G )2009.01(
C12Q )2010.01(
‫קטעי קולטן אדיפונקטין ושיטות לשימוש‬
November 30, 2010-‫כג' בכסלו התשע"א‬
206021
19/12/2008
CRYSTALLINE FORM OF
AZELASTINE
ESTEVE QUIMICA, S.A.
EP
07382005.2 21/12/2007
61/030451
21/02/2008
US
PCT/EP/2008/067999
WO/2009/080744
‫צורה גבישית של אזלסטין‬
206022
25/11/2008
FLUID-TIGHT ROTATION-GUIDING
DEVICE
THALES
FR
0708290
27/11/2007
PCT/EP/2008/066160
WO/2009/068532
A ROBUST MULTIENZYME
PREPARATION FOR THE SYNTHESIS
OF FATTY ACIDS ALKYL ESTERS
TRANS BIODISEL LTD.
US
11/946121
PCT/IL/2008/001497
WO/2009/069116
F16C )2010.01(
‫התקן מנחה סיבוב עבור נוזלים‬
206023
13/11/2008
C07D )2010.01(
C12P )2010.01(
‫תכשיר בעל עמידות גבוהה המכיל מספר‬
‫אנזימים לשימוש בייצור אסטרים אלקיליים‬
‫של חומצות שומן‬
‫דיזל בע"מ‬-‫טרנס ביו‬
28/11/2007
27/05/2010
HANDHELD TITRATION DEVICE
RED SEA FISH PHARM LTD.
206024
A61B )2010.01(
‫התקן לטיטור מוחזק ביד‬
‫רד סי פיש פארם בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
29/06/2007
206025
SOLVENT-FREE FUNGICIDAL
COMPOSITIONS COMPRISING AT
LEAST OF ONE STROBILURIN
FUNGICIDE AND PROCESSES FOR
ITS PREPARATION
UNILEVER PLC,
GB
0613925.7
13/07/2006
PCT/EP/2007/056562
WO/2008/006714
23/01/2009
‫תכשיר קוטל פטריות ללא ממיס המכיל‬
‫לפחות קוטל פטריות סטרובילורין אחד‬
‫ותהליכים להכנתו‬
206026
206027
UPLINK CARRIER HANDOFF AND
METHOD FOR PATH LOSS BASED
TRIGGERING OF UPLINK CARRIER
HANDOFF
ALCATEL-LUCENT USA INC.
US
12/000967
19/12/2007
PCT/US/2008/013702
WO/2009/085128
03/12/2008
H04W )2010.01(
‫העברת נשא אפ–לינק ושיטה עבור אובדן‬
–‫נתיב המבוססת על גירוי העברת נשא אפ‬
‫לינק‬
206028
IMMUNOTHERAPEUTIC METHOD
FOR INCREASING GROUNDUNT
TOLERANCE IN A SUBJECT
DBV TECHNOLOGIES,
FR
0759503
03/12/2007
C07D )2010.01(
‫תולדות פתלזינון‬
PHTHALAZINONE DERIVATIVES
ASTRAZENECA AB
US
61/022900
23/01/2008
61/142413
05/01/2009
US
PCT/GB/2009/000181
WO/2009/093032
15/12/2008
A61K )2010.01(
A61K )2010.01(
‫שיטה חיסונית–רפואית להגברת סבילות‬
‫לבוטנים באדם‬
November 30, 2010-‫כג' בכסלו התשע"א‬
61/084305
US
PCT/EP/2008/066737
WO/2009/071599
12/12/2008
29/07/2008
206029
POLYPEPTIDES WITH ENHANCED
ANTI-INFLAMMATORY AND
DECREASED CYTOTOXIC
PROPERTIES AND RELATING
METHODS
THE ROCKEFELLER UNIVERSITY
US
11/957015
14/12/2007
PCT/US/2008/086622
WO/2009/079382
22/12/2008
‫פוליפפטידים עם תכונות אנטי–דלקתיות‬
‫מוגברות ותכונות ציטוטוקסיות מופחתות‬
‫ושיטות קשורות‬
206030
CROSS -LINKED HYDROGEL
CONTAINING AN ACTIVE
SUBSTANCE
ENCECOR AB
SE
0702904-4
21/12/2007
PCT/SE/2008/051550
WO/2009/082354
01/07/2005
TOPICAL ANTIVIRAL
FORMULATIONS
GILEAD SCIENCES, INC.
US
60/586839
PCT/US/2005/023492
WO/2006/017044
26/11/2008
A61K )2010.01(
206031
A61K )2010.01(
‫הידרוג'ל מצולב המכיל חומר פעיל‬
A61K )2010.01(
‫הרכבים מקומיים אנטי וירליים‬
09/07/2004
206032
C07D )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
STABLE CRYSTALLINE SALT OF (R)3-FLUOROPHENYL-3,4,5TRIFLUOROBENZYLCARBAMIC
ACID 1-AZABICIYCLO [2.2.2]OCT-3YL ESTER
LABORATORIOS SALVAT, S.A.
EP
07384038.1 28/11/2007
PCT/EP/2008/010012
WO/2009/068253
02/08/2005
‫–אזאביציקלו‬1 ‫מלח גבישי יציב של אסטר‬
–R)–3( ‫–איל של חומצה‬3–‫]אוקט‬2,2,2[
–5,4,3‫פלואורופניל‬
‫טריפלואורובנזילקרבאמית‬
206034
ION FILTER FOR USE IN A
SPECTROMETER AND A
SPECTROMETER USING SUCH A
FILTER
OWLSTONE LTD
GB
0417184.9
02/08/2004
0500812.3
17/01/2005
GB
PCT/GB/2005/050124
WO/2006/013396
04/12/2008
01/12/2008
‫מסנן יונים לשימוש בספקטרומטר‬
‫וספקטרומטר המשתמש במסנן כאמור‬
206035
ASSAY FOR DETECTING
CIRCULATING FREE NUCLEIC ACIDS
MOR RESEARCH APPLICATIONS
LTD.
US
60/996900
10/12/2007
PCT/IL/2008/001584
WO/2009/074983
C12Q )2010.01(
‫בדיקה לזיהוי של חומצות גרעיניות בין תאי‬
‫נעות חופשיות‬
206036
ANTIBODIES TO THE PcrV ANTIGEN
OF PSEUDOMONAS AERUGINOSA
AND USES THEREOF
KALOBIOS PHARMACEUTICALS ,
INC.
US
60/991679
30/11/2007
H01J )2010.01(
‫מור יישום מחקרים בע"מ‬
C07K )2010.01(
‫ של‬PcrV ‫נוגדנים נגד אנטיגן של אנטיגן‬
‫פוידומונוס ארוגינוזה ושימושים בהם‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PCT/US/2008/085196
WO/2009/073631
12/12/2008
206037
C07D )2010.01(
CARBOXYL-OR HYDROXYLSUBSTITUTED BENZIMIDAZOLE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
07150351.0 21/12/2007
PCT/EP/2008/067399
WO/2009/080555
13/01/2009
‫תולדות בנזימידאזול מותמרות עם‬
‫הידרוקסיל או קרבוקסיל‬
206038
C07D )2010.01(
–‫אנטאגוניסט לרצפטור אופיואידי קאפא‬
‫בררן‬
KAPPA SELECTIVE OPIOID
RECEPTOR ANTAGONIST
ELI LILLY AND COMPANY
EP
08380012.8 22/01/2008
61/039121
25/03/2008
US
PCT/US/2009/030811
WO/2009/094260
206039
C07D )2010.01(
PHARMACEUTICALLY ACCEPTABLE SALTS OF
METHYL (3-{[[3-(6-AMINO-2-BUTOXY-8-OXO-7,
8-DIHYDRO-9H-PURIN-9-YL)PROPYL](3MORPHOLIN-4YLPROPYL)AMINO]METHYL}PHENYL)ACETATE
AND THEIR USE IN THERAPY
‫מלחים תואמים פארמצבטית של‬
–2–‫–אמינו‬6(–3[[{–3( ‫מתיל‬
–‫–דיהידרו‬8,7–‫–אוקסו‬8–‫בוטוקסי‬
–3(]‫–יל)פרופיל‬9–‫–פורינ‬H9
–4–‫מורפולינ‬
‫ילפרופיל)אמינו]מתיל}פניל)אצטאט‬
‫ושימושם בטיפול‬
16/12/2008
DAINIPPON SUMITOMO PHARMA CO., LTD.
US
61/014164
17/12/2007
PCT/SE/2008/051465
WO/2009/078798
November 30, 2010-‫כג' בכסלו התשע"א‬
18/12/2008
206040
A01N )2010.01(
‫תרכובות קוטלות חיידקים‬
INSECTICIDAL COMPOUNDS
SYNGENTA PARTICIPATIONS AG
GB
0724757.0
19/12/2007
0808471.7
09/05/2008
GB
PCT/EP/2008/010863
WO/2009/077197
18/12/2008
206041
DESENSITISATION BY COATING OF
CRYSTALS OF EXPLOSIVE
ENERGETIC SUBSTANCES, COATED
CRYSTALS OF SUCH SUBSTANCES,
AND ENERGETIC MATERIALS
SNPE MATERIAUX ENERGETIQUES
FR
0760036
19/12/2007
PCT/FR/2008/052353
WO/2009/081048
‫הורדת רגישות על ידי ציפוי קריסטלים של‬
‫ ציפוי קריסטלים‬,‫חומרים אנרגטיים נפיצים‬
‫ וחומרים אנרגטיים‬,‫של חומרים אלו‬
206042
10/11/2008
CCD PIXEL ELEMENT WITH
GEOMETRY CAPABLE OF IMPROVING
RESOLUTION
CHANGCHUN INSTITUTE OF OPTICS,
FINE MECHANICS AND PHYSICS,
CHINESE ACADEMY OF SCIENCES
CN
200810050583.3 10/04/2008
PCT/CN/2008/001865
WO/2009/124427
20/11/2008
B01J )2010.01(
206043
USE OF ESSENTIAL OIL
COMPOUNDS AS HISTOMONASTAT
H01L )2010.01(
‫רכיב נקודתי מצומד נושא מטען חשמלי‬
‫בעל גאומטריה המסוגלת לשפר‬
‫רזולוציה‬
A23K )2010.01(
‫שימוש בתרכובות שמן חיוניות‬
‫כהיסטומונוסטאט‬
November 30, 2010-‫כג' בכסלו התשע"א‬
DSM IP ASSETS B.V.
EP
07023954.6
PCT/EP/2008/009816
WO/2009/074214
16/01/2009
11/12/2007
206044
ISOXAZOLE DERIVATIVES AS
MODULATORS OF 11-BETAHYDROXYSTEROID
DEHYDROGENASE TYPE 1
BIOVITRUM AB
SE
0800108-3
17/01/2008
PCT/EP/2009/050485
WO/2009/090239
18/12/2008
–11 ‫תולדות איזוקסאזול כמאפננים של‬
1 ‫בטא–הידרוקסיסטרואיד דהידרוגנאז סוג‬
206045
CARBAMOYL COMPOUNDS AS
DGAT1 INHIBITORS 190
ASTRAZENECA AB
US
61/015397
20/12/2007
PCT/GB/2008/051199
WO/2009/081195
13/11/2008
206048
PROTEIN AGGREGATION
PREDICTION SYSTEMS
CAMBRIDGE ENTERPRISE LIMITED.
AE
0723288.7
28/11/2007
PCT/GB/2008/051055
WO/2009/068900
26/11/2008
C07D )2010.01(
206049
C07D )2010.01(
DGAT 1901 ‫תרכובות קרבמויל כמעכבי‬
G06F )2010.01(
‫מערכות לחיזוי צבירת חלבונים‬
H04B )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
TRANSBODY COMMUNICATION
SYSTEMS EMPLOYING
COMMUNICATION CHANNELS
PROTEUS BIOMEDICAL, INC.
US
60/990562
27/11/2007
60/990567
27/11/2007
US
60/990572
27/11/2007
US
PCT/US/2008/085048
WO/2009/070773
07/12/2004
‫מערכות תקשורת טרנס–גוף המשתמשות‬
‫בערוצי תקשורת‬
206050
OXAZOLE DERIVATIVES OF
TETRACYCLINES
WYETH LLC
US
60/527928
12/08/2003
60/584823
01/07/2004
US
PCT/US/2004/040850
WO/2005/056538
10/12/2008
27/11/2008
‫נגזרות אוקסאזול של טטרציקלינים‬
206051
METHODS OF DIAGNOSING CANCER
THE MEDICAL RESEARCH,
INFRASTRUCTURE, AND HEALTH
SERVICES FUND OF THE TEL-AVIV
MEDICAL CENTER
US
60/996881
10/12/2007
PCT/IL/2008/001604
WO/2009/074988
G01N )2010.01(
‫שיטות לאבחון סרטן‬
‫קרן מחקרים ופיתוח תשתיות שליד המרכז‬
‫הרפואי תל אביב ע"ש סוראסקי‬
206052
METHODS FOR THE TREATMENT OF
RADIATION OR CHEMOTHERAPYINDUCED TISSUE DAMAGE
HADASIT MEDICAL RESEARCH
SERVICES AND DEVELOPMENT LTD
US
60/990631
28/11/2007
PCT/IL/2008/001556
C07D )2010.01(
A61K )2010.01(
‫שיטות לטיפול בנזק רקמתי המושרה ע"י‬
‫כימותרפיה או הקרנות‬
‫הדסית שירותי מחקר רפואי ופיתוח בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/069133
10/04/2006
206053
PEPTIDE-PEG RESIN CONJUGATES
LONZA AG
EP
05007694.2 08/04/2005
05010051.0
09/05/2005
EP
60/699861
18/07/2005
US
PCT/EP/2006/003256
WO/2006/108594
07/06/2004
206054
PESTICIDAL COMPOSITION AND
METHOD FOR SEED TREATMENT
SYNGENTA PARTICIPATIONS AG
US
60/553462
16/03/2004
PCT/EP/2004/006110
WO/2005/094155
17/11/2004
206055
INHIBITORS OF THE MUTANT FORM
OF KIT
NOVARTIS AG
US
60/520714
18/11/2003
PCT/EP/2004/013045
WO/2005/049032
24/11/2008
206057
BIOCOMPATIBLE BIODEGRADABLE
FUMAGILLIN ANALOG
CONJUGATES
MERSANA THERAPEUTICS, INC.
US
61/004582
28/11/2007
C07K )2010.01(
PEG–‫קוניוגנטים של שרף פפטיד‬
A01N )2010.01(
‫תכשיר קוטל מזיקים ושיטה לטיפול זרע‬
A61K )2010.01(
‫מעכבים בעלי צורה מוטנטית של ערכה‬
A61K )2010.01(
‫קוניוגטים אנלוגיים של פומגילין בעלי‬
‫התאמה ביולוגית ומתכלים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PCT/US/2008/084539
WO/2009/073445
30/05/2010
206058
‫מנוף חדש‬
‫חיים גולדנבלום‬
NEW LEVER
HAIM GOLDENBLUM
30/05/2010
206059
ADAPTER FOR HOT WATER
STORAGE TANK AND METHOD OF
USE THEREOF
SHMUEL BEN-ISHAI
26/11/2008
CONTROLLER FOR A HYDRAULIC
DRIVE SYSTEM
F24J )2010.01(
‫מתאם עבור דוד מים חמים ושיטת שימוש‬
‫בו‬
‫ישי‬-‫שמואל בן‬
206060
CONJUGATES OF ANTI-RG-1
ANTIBODIES, COMPOSITIONS
COMPRISING THE SAME AND USES
THEREOF
BRISTOL-MYERS SQUIBB COMPANY
US
60/991690
30/11/2007
PCT/US/2008/084899
WO/2009/073524
30/05/2010
B66C )2010.01(
206061
A61K )2010.01(
‫ תכשירים‬,RG–1 ‫מוצמדי נוגדנים נגד‬
‫המכילים אותם ושימושים בהם‬
B60P )2010.01(
‫בקר למערכת הנעה הידרולי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
ISRAEL AEROSPACE INDUSTRIES
LTD.
16/12/2008
‫התעשייה האוירית לישראל בע"מ‬
206062
(AZA) INDOLE DERIVATIVE
SUBSTITUTED IN POSITION 5,
PHARMACEUTICAL COMPOSITION
COMPRISING IT, INTERMEDIATE
COMPOUNDS AND PREPARATION
PROCESS THEREOF
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.p.A.
EP
07425830.2 28/12/2007
PCT/EP/2008/067622
WO/2009/083436
20/11/2008
12/12/2008
‫תולדת (אזא) אינדול מותמרת בעמדה‬
,‫ תכשיר רוקחות המכיל אותה‬,‫חמש‬
‫תרכובות ביניים ותהליך להכנתה‬
206063
AROMATIC ISOMERIZATION
CATALYST AND A PROCESS OF USE
THEREOF
UOP LLC
US
11/954296
12/12/2007
PCT/US/2008/084106
WO/2009/076024
B01J )2010.01(
‫זרז איזומריזציה ארומטית ותהליך לשימוש‬
‫בו‬
206064
ARCHING METALLIC PROFILES IN
CONTINUOUS IN-LINE PROCESS
ALLIED TUBE & CONDUIT
CORPORATION
US
61/012929
12/12/2007
PCT/US/2008/086655
WO/2009/076625
C07D )2010.01(
B21B )2010.01(
‫יצירת פרופילים מתכתיים בצורת קשת‬
‫בתהליך מתמשך‬
November 30, 2010-‫כג' בכסלו התשע"א‬
22/12/2008
206065
ASYNCHRONOUS MULTI-LEVEL
UNDO SUPPORT IN JAVASCRIPT
GRID
M.I.C. INDUSTRIES, INC.
US
11/971206
08/01/2008
PCT/US/2008/087925
WO/2009/088727
16/01/2008
‫תמיכה בביטול אסינכרוני מרובה רמות‬
JAVASCRIPT ‫ברשת‬
206066
POULTRY DE-FEATHERING
APPARATUS AND METHODS
CONAWAY DEVELOPMENT
INDUSTRIES, INC
US
60/991688
30/11/2007
PCT/US/2008/051242
WO/2009/073239
27/11/2008
COMPACT IMAGE INTENSIFIER
TUBE AND NIGHT VISION SYSTEM
FITTED WITH SUCH A TUBE
A22C )2010.01(
‫מערכת למריטת נוצות בעופות ושיטות‬
206067
METHOD FOR SECURING A BIDIRECTIONAL COMMUNICATION
CHANNEL AND DEVICE FOR
IMPLEMENTING SAID METHOD
THALES
FR
0708397
30/11/2007
PCT/EP/2008/066316
WO/2009/068603
12/12/2009
G06F )2010.01(
H04L )2010.01(
‫שיטה להבטחת ערוץ תקשורת דו–כיווני‬
‫והתקן ליישום השיטה‬
206068
H01J )2010.01(
‫שפופרת מגביר תמונה קומפקטית‬
‫ומערכת ראיית לילה מצוידת בשפופרת כזו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PHOTONIS FRANCE
FR
0759826
PCT/EP/2008/067453
WO/2009/074682
18/12/2008
13/12/2007
206069
PHENYL ACETIC ACID DERIVATIVES
AS INFLAMMATION MODULATORS
AMGEN INC.
US
61/008433
19/12/2007
PCT/US/2008/013833
WO/2009/085177
18/12/2008
‫נגזרות חומצה פנילאצטית כמאפנני דלקת‬
206070
FUSED PYRIDINE, PYRIMIDINE AND
TRIAZINE COMPOUNDS AS CELL
CYCLE INHIBITORS
AMGEN INC.
US
61/008429
19/12/2007
PCT/US/2008/013849
WO/2009/085185
24/11/2008
04/12/2008
C07D )2010.01(
‫ פירימידין וטריאזין‬,‫תרכובות פירידין‬
‫מאוחות כמעכבי מחזור התא‬
206071
PROCESS FOR INCREASING PURITY
OF SOLID BROMINATED FLAME
RETARDANTS DURING
PREPARATION
ALBEMARLE CORPORATION
US
61/012139
07/12/2007
PCT/US/2008/084546
WO/2009/076056
C07C )2010.01(
C07C )2010.01(
‫תהליך להגברת דרגת הניקיון של מעכבי‬
‫בערה ברומיים מוצקים בעת הכנתם‬
206072
C12Q )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
NOVEL METHOD FOR GENERATING
AND SCREENING AN ANTIBODY
LIBRARY
PIERRE FABRE MEDICAMENT
FR
0708444
04/12/2007
PCT/EP/2008/066804
WO/2009/080461
04/12/2008
206073
MEQUITAZINE FOR TREATING OR
PREVENTING PATHOLOGIES
INVOLVING HISTAMINE H4
RECEPTORS
PIERRE FABRE MEDICAMENT
FR
0759538
04/12/2007
0854144
23/06/2008
FR
PCT/EP/2008/066787
WO/2009/071625
04/12/2008
206074
A METHOD FOR SECURE
TRANSACTIONS
ACCUMULATE AB
SE
0702686-7
04/12/2007
PCT/SE/2008/051403
WO/2009/072977
26/11/2008
206075
AUTOMATIC GENERATION OF
PROTOCOL FOR PCMR IMAGING
VASSOL INC
US
60/991374
30/11/2007
61/077266
01/07/2008
US
12/277889
25/11/2008
US
PCT/US/2008/013151
WO/2009/070300
‫שיטה חדשה ליצירה ומיון ספריה של‬
‫נוגדנים‬
A61K )2010.01(
‫מקויטזין לטיפול או מניעת פתולוגיות‬
H4 ‫הקשורות לרצפטורים של היסטמין‬
G06Q )2010.01(
‫שיטה לעסקות בטוחות‬
A61B )2010.01(
‫ייצור אוטומטי של פרוטוקולים עבור‬
PCMR ‫הדמיה בשיטת‬
November 30, 2010-‫כג' בכסלו התשע"א‬
26/11/2008
206076
A CLOSED THERMODYNAMIC
SYSTEM FOR PRODUCING ELECTRIC
POWER
BEN LOLO, GILBERT GAL
US
60/996667
29/11/2007
PCT/IL/2008/001548
WO/2009/069128
02/03/2003
‫מערכת תרמודינמית סגורה לייצור כח‬
‫חשמלי‬
‫בן לולו ג'ילברט גל‬
206078
206079
MICRORNA EXPRESSION PROFILING
AND TARGETING IN PERIPHERAL
BLOOD IN LUNG CANCER
OSURF (OHIO STATE UNIVERSITY
RESEARCH FOUNDATION)
US
61/004863
30/11/2007
PCT/US/2008/084821
WO/2009/070653
13/02/2009
PHARMACEUTICAL COMPOSITION
FOR USE IN THE TREATMENT
AND/OR THE PREVENTION OF
OSTEOARTICULAR DISEASES
BONE THERAPEUTICS
C12Q )2009.01(
‫מטרה מסומנת‬
A LABELED TARGET
ENZO LIFE SCIENCES, INC.
US
10/096075
12/03/2002
26/11/2008
F01K )2010.01(
C12Q )2009.01(
‫ וכיוונון בדם‬RNA–‫פרופיל ביטוי של מיקרו‬
‫היקפי בסרטן ריאות‬
206080
A61K )2010.01(
‫או למניעת‬/‫תרכובות פרמצבטיות לטיפול ו‬
‫מחלות אוסטאורקולריות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
EP
08101682.6
08158285.0
EP
PCT/EP/2009/051739
WO/2009/101194
28/11/2008
15/02/2008
13/06/2008
206081
PROTEIN FORMULATIONS AND
METHODS OF MAKING SAME
ABBOTT LABORATORIES
US
61/004992
30/11/2007
PCT/US/2008/085066
WO/2009/073569
30/11/2007
206082
PHARMACEUTICAL COMPOSITIONS
WITH A MECHANISM OF MULTITARGET RECEPTOR RETROACTION
FOR TREATING DEPRESSION
ZUOGUANG ZHANG
A61K )2010.01(
‫פורמולציות חלבונים ושיטות להכנתן‬
A61K )2010.01(
‫הרכבים רוקחיים עם מנגנון של פעולה‬
‫למפרע של קולטן רב–מטרתי לטיפול‬
‫בדכאון‬
PCT/CN/2007/003400
WO/2009/070924
25/11/2008
206084
ARYL AND HETEROARYL FUSED
IMIDAZO [1,5-A] PYRAZINES AS
INHIBITORS OF
PHOSPHODIESTERASE 10
WYETH
US
61/004844
30/11/2007
PCT/US/2008/084689
WO/2009/070584
C07D )2010.01(
–5,1[ ‫אריל והטרואריל אימידאזו‬
‫]פיראזינים מאוחים כמעכבי‬A
10 ‫פוספודיאסטראז‬
November 30, 2010-‫כג' בכסלו התשע"א‬
12/12/2008
206085
PROCESS FOR PRODUCING OF
PYRAZOLINONE DERIVATIVE
SUMITOMO CHEMICAL COMPANY,
LIMITED
JP
2007323130 14/12/2007
PCT/JP/2008/073140
WO/2009/078475
18/12/2008
12/12/2008
‫תהליך עבור הייצור של נגזרת פיראזולינאן‬
206086
CORROSION RESISTANT STEEL FOR
MARINE APPLICATIONS
ARCELORMITTAL COMMERCIAL
RPS S.A.R.L.
EP
07150370
21/12/2007
PCT/EP/2008/067922
WO/2009/080714
206087
C07D )2010.01(
‫אינדולים ושימושם הרפואי‬
206088
USED CAPSULE OR POD
RECEPTACLE FOR LIQUID FOOD OR
BEVERAGE MACHINES
NESTEC S.A.
US
07123009.8 12/12/2007
08155753.0
07/05/2008
US
C22C )2010.01(
‫ברזל עמיד בפני קורוזיה עבור שימוש ימי‬
INDOLES AND THEIR THERAPEUTIC
USE
PULMAGEN THERAPEUTICS
(ASTHMA) LIMITED
GB
0724429.6
14/12/2007
0806083.2
03/04/2008
GB
0814910.6
14/08/2008
GB
PCT/GB/2008/004107
WO/2009/077728
09/12/2008
C07D )2010.01(
A47J )2010.01(
‫קפליה משומשת או תרמיל עבור מזון נוזלי‬
‫או מכונות למשקאות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PCT/EP/2008/067083
WO/2009/074559
31/05/2010
206089
‫גל חום‬
‫ברוך זיסר‬
HOT WAVE
BARUCH ZISER
05/12/2008
206090
METHODS FOR DELIVERING siRNA
VIA IONTOPHORESIS
EYEGATE PHARMA S.A.S.
US
61/005635
05/12/2007
61/047972
25/04/2008
US
PCT/US/2008/085709
WO/2009/076220
19/12/2005
206091
STILBENE DERIVATIVES AND THEIR
USE FOR BINDING AND IMAGING
AMYLOID PLAQUES
THE TRUSTEES OF THE UNIVERSITY
OF PENNSYLVANIA
US
60/636696
17/12/2004
60/686395
02/06/2005
US
PCT/US/2005/045682
WO/2006/066104
09/12/2008
MOBILE DEVICE MANAGEMENT
SCHEDULING
F24H )2010.01(
206092
A61N )2010.01(
‫ באמצעות‬siRNA ‫שיטה להעברת‬
‫יונטורפורזה‬
A61K )2010.01(
‫תולדות סטילבן והשימוש בהם לקשור‬
‫ולשיקוף רבדי אמילואיד‬
H04W )2010.01(
‫ניהול לוח זמנים של התקן נייד‬
November 30, 2010-‫כג' בכסלו התשע"א‬
MICROSOFT CORPORATION
US
11/971909
10/01/2008
PCT/US/2008/086084
WO/2009/088617
11/12/2008
206093
ARCHITECTURE FOR ONLINE
COMMUNAL AND CONNECTED
EXPERIENCES
MICROSOFT CORPORATION
US
12/013324
11/01/2008
PCT/US/2008/086385
WO/2009/088637
24/12/2008
19/12/2008
‫ארכיטקטורה עבור שיתופי קבצים מקוון‬
‫והתנסויות קשורות‬
206094
MULTI-CLIENT COLLABORATION
TO ACCESS AND UPDATE
STRUCTURED DATA ELEMENTS
MICROSOFT CORPORATION
US
12/014727
15/01/2008
PCT/US/2008/088347
WO/2009/091488
206095
206096
ORGANIC COMPOUNDS
INTRA-CELLULAR THERAPIES, INC.
G06F )2010.01(
‫שיתוף פעולה רב משתתפים לגישה ועדכון‬
‫יסודות מידע מובנים‬
CHEMICALLY MODIFIED FACTOR IX
BAXTER INTERNATIONAL INC.
US
61/009263
27/12/2007
PCT/EP/2008/010925
WO/2009/083187
06/12/2008
G06F )2010.01(
C12N )2010.01(
‫ מתואם מבחינה כימית‬IX ‫פקטור‬
C07D )2010.01(
‫תרכובות אורגניות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
US
61/012040
PCT/US/2008/013411
WO/2009/075784
06/12/2008
06/12/2007
206097
‫תרכובות אורגניות‬
ORGANIC COMPOUNDS
INTRA-CELLULAR THERAPIES, INC.
US
61/012045
06/12/2007
PCT/US/2008/013410
WO/2009/073210
16/12/2008
206098
AGGLOMERATED ZEOLITIC
ABSORBENTS, METHOD OF
PREPARING THEM AND USES
THEREOF
INSTITUT FRANCAIS DU PETROLE
FR
0760088
20/12/2007
PCT/FR/2008/052316
WO/2009/081023
16/12/2008
11/12/2008
B01J )2010.01(
,‫חומרים סופחים זאוליטים בצורת צברים‬
‫שיטה להכנתם ושימושים בהם‬
206099
AGGLOMERATED ZEOLITIC
ABSORBENTS, METHOD OF
PREPARING THEM AND USES
THEREOF
INSTITUT FRANCAIS DU PETROLE
FR
0760098
20/12/2007
PCT/FR/2008/052317
WO/2009/081024
A01N )2010.01(
B01J )2010.01(
,‫חומרים סופחים זאוליטים בצורת צברים‬
‫שיטה להכנתם ושימושים בהם‬
206100
C07D )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
PROCESS FOR THE PREPARATION
OF MACROCYCLE
F. HOFFMANN-LA ROCHE AG
EP
07150287.6 21/12/2007
PCT/EP/2008/067309
WO/2009/080542
31/05/2010
‫תהליך להכנת חומר מקרוציקלי‬
206101
ANOMALY DETECTION IN IMAGING
APPLICATIONS
D.V.P. TECHNOLOGIES LTD.
07/01/2009
11/12/2008
‫זיהוי אנומליות באפליקציות הדמיה‬
‫ טכנולוגיות בע"מ‬.‫פי‬.‫וי‬.‫די‬
206102
CRYSTALLINE (R)-2-(4CYCLOPROPANESULPHONYLPHENYL)-N-PYRAZIN-2-YL-3(TETRAHYDROPYRAN-4-YL)PROPIONAMIDE
ELI LILLY AND COMPANY
US
61/021133
15/01/2008
PCT/US/2009/030241
WO/2009/091634
A61K )2010.01(
–R)–2–(4( ‫קריסטלין‬
–‫–פיראזינ‬N–)‫ציקלופרופאנסולפוניל–פניל‬
)‫–יל‬4–‫–(טטראהידרופיראנ‬3–‫–יל‬2
‫פרופיאונאמיד‬
206103
ANTIBODY FORMULATION
F. HOFFMANN-LA ROCHE AG
EP
07150335.3 21/12/2007
PCT/EP/2008/067293
WO/2009/080541
G06T )2010.01(
A61K )2010.01(
‫פורמולציה של נוגדנים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
10/12/2008
206104
‫אמינותיאזולים ושימושם‬
AMINOTHIAZOLES AND THEIR USES
NOVARTIS AG
US
61/013122
12/12/2007
61/024709
30/01/2008
US
PCT/EP/2008/067220
WO/2009/074605
08/12/2008
206105
TETRAZOLE-SUBSTITUTED
ARYLAMIDE DERIVATIVES AND
THEIR USE AS P2X3 AND/OR P2X2/3
PURINERGIC RECEPTOR
ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
US
61/007891
17/12/2007
PCT/EP/2008/067017
WO/2009/077371
01/12/2008
206106
206107
ALPHA-AMINOAMIDE DERIVATIVES
USEFUL IN THE TREATMENT OF
PSYCHIATRIC DISORDERS
NEWRON PHARMACEUTICALS S.P.A.
EP
07024584.0 19/12/2007
PCT/EP/2008/066884
C07D )2010.01(
‫תולדות ארילאמיד מותמר טטראזול‬
‫ושימושן כאנטגוניסטים לרצפטור פורינרגי‬
X2P2 /3 ‫או‬/‫ ו‬X2P3
EXTRUSION PROCESS FOR
GRAFTING RUBBERS
DSM IP ASSETS B.V.
EP
07024052.8 12/12/2007
61/013359
13/12/2007
US
PCT/EP/2008/066534
WO/2009/074477
05/12/2008
C07D )2010.01(
C08F )2010.01(
‫תהליך אקסטרוזיה להרכבת גומי‬
A61K )2010.01(
‫תולדות אלפא–אמינואמיד השימושיות‬
‫בטיפול בהפרעות פסיכיאטריות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/080470
16/12/2008
206108
BIVALENT, BISPECIFIC ANTIBODIES
F. HOFFMANN-LA ROCHE AG
EP
07024865.3 21/12/2007
PCT/EP/2008/010704
WO/2009/080253
25/05/2005
206109
CINNAMIDE COMPOUND
EISAI R&D MANAGEMENT CO., LTD.
2004JP
26/05/2004
155790
2004-310909 26/10/2004
JP
PCT/JP/2005/009537
WO/2005/115990
12/12/2008
206110
COMPOSITION FOR HUMAN AND/OR
ANIMAL NUTRITION, USES
THEREOF AND YEASTS
UNIVERSITE DU DROIT ET DE LA
SANTE DE LILLE 2
FR
0760377
26/12/2007
0801342
12/03/2008
FR
PCT/FR/2008/001729
WO/2009/103884
31/01/2003
206111
C07K )2010.01(
‫נוגדנים דו–ערכיים דו–סגוליים‬
C07D )2010.01(
‫תרכובת צינאמיד‬
C12N )2010.01(
,‫או חייתית‬/‫תכשיר לתזונה אנושית ו‬
‫שימושים שלו ושמרים‬
G06F )2009.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
SYSTEM AND METHOD FOR
PROVIDING MESSAGES ON A
WIRELESS DEVICE CONNECTING TO
AN APPLICATION SERVER
QUALCOMM INCORPORATED
US
10/061642
31/01/2002
PCT/US/2003/002894
WO/2003/065596
04/12/2008
206112
METHODS AND APPARATUS FOR
ANALYZING SAMPLES AND
COLLECTING SAMPLE FRACTIONS
ALLTECH ASSOCIATES, INC.
US
61/005590
05/12/2007
PCT/US/2008/013359
WO/2009/075764
15/04/2005
‫מערכת ושיטה לאספקת הודעות בהתקן‬
‫אלחוטי המתחבר לשרתי יישומים‬
‫שיטות והתקן לניתוח דגימת ואיסוף חלקי‬
‫דגימה‬
206113
COMPOSITIONS AND PROCESSES
FOR REDUCING NOX EMISSIONS
DURING FLUID CATALYTIC
CRACKING
W.R. GRACE & CO. CONN
US
10/824913
15/04/2004
10/909709
02/08/2004
US
PCT/US/2005/012982
WO/2005/099898
23/08/2001
206114
ORALLY ADMINISTERED PEPTIDES
TO AMELIORATE
ATHEROSCLEROSIS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
09/645454
24/08/2000
PCT/US/2001/026497
G01N )2010.01(
B01J )2010.01(
NOX ‫הרכבים ותהליכים לחיזור פליטות‬
‫במהלך פיצוח קטליטי של נוזל‬
C07K )2010.01(
‫פפטידים הנותנים דרך הפה לטיפול‬
‫בהסתיידות עורקים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2002/015923
16/05/2003
206115
STUB HAVING AN OPTICAL FIBER
STRATOS INTERNATIONAL, INC.
US
10/151,362
20/05/2002
PCT/US/2003/015803
WO/2003/100482
17/12/2008
206116
RESUSCITATION FLUID
CUTHBERT, O. SIMPKINS
US
61/016443
22/12/2007
61/064639
18/03/2008
US
PCT/US/2008/013781
WO/2009/082449
03/12/2008
206117
TRANSGENIC PLANTS HAVING
ALTERED LEVELS OF AROMATIC
AMINO ACIDS AND METABOLITES
DERIVED THEREFROM
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
60/992106
04/12/2007
61/095638
10/09/2008
US
PCT/IL/2008/001569
WO/2009/072118
20/05/2004
206118
G02B )2010.01(
‫גדם בעל סיב אופטי‬
A61K )2010.01(
‫נוזל החיאה‬
C12N )2010.01(
‫צמחים טרנסגנים עם תכולה שונה של‬
‫חומצות אמינו ארומאטיות ושל חמרים‬
‫הנוצרים מהן‬
‫ידע חברה למחקר ופיתוח בע"מ‬
C12N )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
METHODS OF INCREASING ABIOTIC
STRESS TOLERANCE AND/OR
BIOMASS IN PLANTS AND PLANTS
GENERATED THEREBY
EVOGENE LTD.
US
60/472433
22/05/2003
PCT/IL/2004/000431
WO/2004/104162
01/06/2010
206119
206120
SPIGOT FOR CONTROLLING FLOW
RATE OF LIQUIDS
MOSHE BUHBUT
25/02/2004
B65D )2010.01(
F16K )2010.01(
‫ברז לשליטה בקצב זרמית נוזלים‬
‫משה בוחבוט‬
206121
FEEDBACK LOOP FOR SPAM
PREVENTION
MICROSOFT CORPORATION
US
10/378463
03/03/2003
PCT/US/2004/005501
WO/2004/079514
13/05/2002
‫אבוג'ן בע"מ‬
‫צידנית מודולארית‬
‫דרור עטיה‬
MODULAR PICNIC COOLER
DROR ATUYA
01/06/2010
‫צמחים ושיטות להעלאת עמידות של‬
‫או להעלאת‬/‫צמחים לעקה אביוטית ו‬
‫ביומסה של הצמחים‬
206122
H04L )2010.01(
‫לולאת משוב למניעת הצפת רשת‬
‫האינטרנט בדואר אלקטרוני בלתי רצוי‬
H04J )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
PHYSICAL CHANNEL
CONFIGURATION SIGNALING
PROCEDURES
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/290717
14/05/2001
10/029651
21/12/2001
US
PCT/US/2002/014955
WO/2002/093787
27/01/1999
‫הליכי איתות הקשורים בקונפיגורציה של‬
‫תעלה פיזיקלית‬
206123
CANCELLATION OF PILOT AND
UNWANTED TRAFFIC SIGNALS IN A
CDMA SYSTEM
INTERDIGITAL TECHNOLOGY
CORPORATION
US
09/175174
20/10/1998
PCT/US/1999/001883
WO/2000/024135
23/12/2008
206124
A SLOW RELEASE FORMULATION
BASED ON AN ASSOCIATION OF
GLYCOGEN AND ALGINATE
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.p.A.
EP
07425828.6 28/12/2007
PCT/EP/2008/068256
WO/2009/083561
19/12/2008
206125
AZAINDOLIZINES AND METHODS OF
USE
GENENTECH, INC.
US
61/015942
21/12/2007
PCT/US/2008/087626
H04B )2009.01(
‫ביטול של אותות לא רצויים במערכת‬
CDMA
A61K )2010.01(
‫הרכב המשתחרר באיטיות המבוסס על‬
‫אסוסיאציה של גליקוגן ואלגינאט‬
C07D )2010.01(
‫אזא אינדוליזינים ושיטות לשימוש בהם‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2009/082687
19/12/2008
206126
THERAPY OF RITUXIMABREFRACTORY RHEUMATOID
ARTHRITIS PATIENTS
GENENTECH, INC.
US
61/016281
21/12/2007
PCT/US/2008/087629
WO/2009/086072
12/12/2008
206127
AZOLYLMETHYLOXIRANES, USE
THEREOF AND AGENTS
CONTAINING THE SAME
BASF SE
EP
07123700.2 19/12/2007
PCT/EP/2008/067394
WO/2009/077443
06/11/2008
206128
USE OF 4-OXOBUTANOIC ACID
DERIVATIVES IN THE TREATMENT
OF PATHOLOGIES ASSOCIATED
WITH IMMUNOLOGICAL DISORDERS
MERCK PATENT GMBH
EP
07291449.2 03/12/2007
PCT/EP/2008/009384
WO/2009/071161
03/12/2003
PRION PROTEIN LIGAND
206129
A61K )2010.01(
‫תרופה לחולי דלקת מפרקים שגרונית‬
‫העמידה לריטוקסימאב‬
A01N )2010.01(
‫ שימוש בהם‬,‫אזולילמתיל אוקסיראנים‬
‫וגורמים המכילים אותם‬
A61K )2010.01(
–4 ‫שימוש בנגזרות של חומצה‬
‫אוקסובוטנואית לטיפול בפתלוגיות‬
‫הקשורות לליקויי חסינות‬
G01N )2009.01(
‫ליגנד של חלבוני פריון‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PATHOGEN REMOVAL AND
DIAGNOSTIC TECHNOLOGIES INC.
US
60/430423
03/12/2002
PCT/US/2003/038343
WO/2004/050851
13/01/2006
206130
BENDAMUSTINE PHARMACEUTICAL
COMPOSITIONS FOR
LYOPHILISATION
CEPHALON, INC.
US
60/644354
14/01/2005
11/330868
12/01/2006
US
PCT/US/2006/001308
WO/2006/076620
19/12/2008
206131
HERBICIDAL PYRIDAZINONE
DERIVATIVES
E.I. DU PONT DE NEMOURS AND
COMPANY
US
61/008861
21/12/2007
PCT/US/2008/087577
WO/2009/086041
29/10/2008
206132
STABLE NUTRITIONAL POWDER
ABBOTT LABORATORIES
US
61/015318
20/12/2007
PCT/US/2008/081596
WO/2009/085388
10/04/2006
206133
A61K )2010.01(
‫תכשירים פרמצבטיים בנדאמוסטין עבור‬
‫ליאופיליסשון‬
C07D )2010.01(
‫נגזרות פיראיזינון קוטלות עשבים‬
A23L )2010.01(
‫אבקה תזונתית יציבה‬
A61B )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
MOLECULES AND METHODS OF
USING SAME FOR TREATING MCP1/CCR2 ASSOCIATED DISEASES
RAPPAPORT FAMILY INSTITUTE
FOR RESEARCH IN THE MEDICAL
SCIENCES
US
60/671476
15/04/2005
PCT/IL/2006/000454
WO/2006/109301
11/12/2008
206134
METHOD AND APPARATUS FOR
SEALING AN OPENING IN THE SIDE
WALL OF A BODY LUMEN
CORNELL UNIVERSITY
US
61/007189
11/12/2007
PCT/US/2008/086393
WO/2009/076515
02/06/2010
206135
‫מכון רפפורט המכון למחקר במדעי‬
‫הרפואה ע"ש משפחת רפפורט‬
A61F )2010.01(
‫שיטה ומכשיר לאיטום פתח בדופן צדדי‬
‫של חלל גוף‬
F41A )2010.01(
‫מערכת נשק אל–הרג‬
‫דוד כהן‬
A NON-LETHAL WEAPON SYSTEM
DAVID COHEN
09/01/2009
‫מולקולות ושיטות לטיפול במחלות‬
CCR/1–MCP2–‫הקשורות ב‬
206136
RASAGILINE FORMULATIONS,
THEIR PREPARATION AND USE
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/010860
11/01/2008
PCT/US/2009/000134
WO/2009/089049
A01N )2010.01(
,‫תרכובות פרמצבטיות של ראסג'ילין‬
‫דרכים להכנתן ושימושיהן‬
‫טבע תעשיות פרמצבטיות בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
15/12/2008
206138
PHARMACEUTICAL COMPOSITIONS
KARO BIO AB
GB
0724478.3
14/12/2007
PCT/EP/2008/010636
WO/2009/077147
02/06/2010
206140
SCOURING PAD FOR DISH WASHING
IN SATURDAY "SHABAT DAY"
DANIEL DALOYA
03/12/2007
206141
VEHICLE ADAPTED FOR DISABLED
PEOPLE
BERNER FACHHOCHSCHULE FUR
TECHNIK UND INFORMATIK
A61K )2010.01(
‫תכשירים רוקחיים‬
A47J )2010.01(
‫כרית לשטיפת כלים בשבת‬
‫דניאל דלויה‬
B60W )2010.01(
‫רכב המותאם לאנשים מוגבלי תנועה‬
PCT/EP/2007/063140
WO/2009/071113
02/06/2010
206143
COHERENT OPTICAL AMPLIFIER
CIVAN ADVANCED TECHNOLOGIES
LTD
G02F )2010.01(
‫מגבר אופטי קוהרנטי‬
‫סיון טכנולוגיות מתקדמות בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
03/06/2010
206149
ARTICLE FOR ROUNDING CORNERS
AND INTERSECTIONS OF FACES
MILIK BIGGER
03/06/2010
‫אביזר (פריט) המעגל פינות ומפגשים של‬
‫פאות‬
‫מיליק ביגר‬
206150
ELECTRIC APPARATUS TO LIGHT
THE TOBACCO OF A WATER PIPE
AVI BALULU
03/06/2010
A24F )2010.01(
‫אביזר חשמלי להבערת הטבק בנרגילה‬
‫אבי בלולו‬
206152
ORGANIC PHASE COMPOSITIONS,
METHODS FOR SEPARATING HCL
FROM A CARBOHYDRATE
UTILIZING THE SAME, LIGNIN
COMPOSITIONS AND METHODS FOR
PRODUCING THE SAME
HCL CLEANTECH LTD.
03/06/2010
E04B )2010.01(
‫ תהליכים‬,‫תכשירים בפזה אורגנית‬
‫להפרדת חומצה הידרוכלורית מסוכר‬
‫ תכשירי ליגנין ושיטות‬,‫המשתמשים בהם‬
‫להכנתם‬
206154
POOL CLEANING ROBOT
MAYTRONICS LTD.
US
61/184115
04/06/2009
C07H )2010.01(
‫אייץ ס' אל קלינטג בע"מ‬
B08B )2010.01(
‫רובוט לניקוי בריכות‬
‫מיטרוניקס בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
28/02/2005
206183
OBJECT EXAMINATION BY
DETECTION OF DELAYDE
NEUTRONS
VARIAN MEDICAL SYSTEMS, INC.
US
60/549093
01/03/2004
60/568541
05/05/2004
US
PCT/US/2005/006808
WO/2005/084351
06/06/2010
206186
206208
MODULATED SATURABLE
ABSORBER CONTROLLED LASER
RAYTHEON COMPANY
US
10/820613
08/04/2004
PCT/US/2005/010722
WO/2005/101594
07/06/2010
HAIR BRUSH WHICH CONTAINS A
BUILY IN HAIR SPRAY FOR EASY
AND EFFICIENT USAGE
BUARON ORLY
‫בחינת עצמים על ידי גילוי ניוטרונים‬
‫מושהים‬
A61H )2010.01(
‫כרית (שמנופחת) למים‬
‫דמיטרי זלצר‬
AIR-CUSHION FOR WATER
DMITRY ZELTSER
30/03/2005
G01V )2010.01(
206217
H01S )2010.01(
‫לייזר מותאם בעל יכולת רוויה מבוקרת‬
A45D )2010.01(
‫מברשת שיער משולבת עם מיכל קיבול‬
‫לנוזלי סיכה ומנגנון לחצן התזה בעת‬
‫הסירוק‬
‫אורלי בוארון‬
November 30, 2010-‫כג' בכסלו התשע"א‬
07/06/2010
206218
ASSSEMBLING FOR PROFOUND
SEWAGE PURIFICATION AREA OF
TECHNOLOGY
YAKOV PEYMER
13/09/2001
‫מתקן לטהור בוצה‬
‫נטליה יביבסקי‬
206229
HUMAN COAGULATION FACTOR VII
VARIANTS
NOVO NORDISK HEALTH CARE AG
DK
PA200001361 13/09/2000
60/236455
29/09/2000
US
PCT/DK/2001/000596
WO/2002/022776
07/06/2010
206232
SYSTEM AND METHOD FOR
PLANNING OF DEMAND FOR POWER
ON AN ELECTRICAL POWER
NETWORK
IZIDOR LIBERMAN
08/06/2010
B01D )2010.01(
206238
C07K )2009.01(
VII ‫גרסאות משתנות של גורם קרישה‬
‫ממקור אנושי‬
H01R )2010.01(
‫מערכת ושיטה לתכנון צריכת חשמל‬
‫ברשת אספקת חשמל‬
‫איזידור ליברמן‬
B60R )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
A VEHICULAR ANTI-THEFT SYSTEM
AND METHOD
YANIV MIZRAHI
08/06/2010
‫יניב מזרחי‬
206239
SEISMOPANEL METHOD- USE OF
PANEL SYSTEM FOR
STRENGTHENING STRUCTURES
WALLS AGAINST EARTHQUAKES
AND OTHER OUTSIDE FORCES
RONEN MAOZ
08/06/2010
‫מכשיר ושיטה נגד גניבת רכב‬
‫שיטת סיסמופנל–שימוש במערכת פלטות‬
‫לחיזוק קירות מבנים כנגד תזוזות קרקע‬
‫ושאר כוחות חיצוניים‬
‫רונן מעוז‬
206242
METHOD AND SYSTEM FOR SAVING
WATER
MAURICE ALIMAN
06/12/2002
E02D )2010.01(
206243
ANTIBODY SPECIFICALLY BINDING
A 193P1E1B PROTEIN
AGENSYS, INC.
US
10/013312
07/12/2001
PCT/US/2002/039274
WO/2003/050255
F24H )2010.01(
‫שיטה ומערכת לחיסכון במים‬
‫מוריס אלימן‬
C07K )2010.01(
‫ באופן‬B1E1P193 ‫נוגדן שקושר חלבון‬
‫ספציפי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
03/01/2003
206251
METHOD AND APPARATUS FOR
CONTROLLING COMMUNICATIONS
OF DATA FROM MULTIPLE BASE
STATIONS TO A MOBILE STATION
IN A COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
60/346987
08/01/2002
60/359005
20/02/2002
US
10/274343
18/10/2002
US
PCT/US/2003/000136
WO/2003/059002
08/06/2010
‫שיטה ומכשיר לבקרת תקשורת נתונים‬
‫מתחנות מוצא מרובות לתחנה ניידת‬
‫במערכת תקשורת‬
206255
206257
206259
AN ANTISENSE OLIGONUCLEOTIDE
TARGETED TO INSULIN-LIKE
GROWTH FACTOR BINDING
PROTEIN 5
ISIS PHARMACEUTICALS, INC.
US
09/975123
09/10/2001
PCT/US/2002/032060
G06F )2010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
07/10/2002
G08B )2010.01(
‫אביזר אבטחה‬
‫ימין שוקרון‬
SECURITY TOKEN DEVICE
YAMIN SHUKRUN
09/06/2010
H04L )2009.01(
C12N )2010.01(
‫אוליקונוקליאוטיד של הסיב הנגדי המכוון‬
‫ של פקטור גדילה‬5 ‫לחלבון קושר מספר‬
‫דמוי איסולין‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WO/2003/030826
07/10/2002
206260
AN ANTISENSE OLIGONUCLEOTIDE
TARGETED TO INSULIN-LIKE
GROWTH FACTOR BINDING
PROTEIN 5
ISIS PHARMACEUTICALS, INC.
US
09/975123
09/10/2001
PCT/US/2002/032060
WO/2003/030826
07/10/2002
20/07/1998
‫אוליקונוקליאוטיד של הסיב הנגדי המכוון‬
‫ של פקטור גדילה‬5 ‫לחלבון קושר מספר‬
‫דמוי אינסולין‬
206261
AN ANTISENSE OLIGONUCLEOTIDE
TARGETED TO INSULIN-LIKE
GROWTH FACTOR BINDING
PROTEIN 5
ISIS PHARMACEUTICALS, INC.
US
975123
09/10/2001
PCT/US/2002/032060
WO/2003/030826
CUTTING INSERT AND MILLING
TOOL
C12N )2010.01(
‫אוליקונוקליאוטיד של הסיב הנגדי המכוון‬
‫ של פקטור גדילה‬5 ‫לחלבון קושר מספר‬
‫דמוי אינסולין‬
206271
PERSONALIZED INTERNET
INTERACTION
EASYNET ACCESS INC.
IL
123129
30/01/1998
09/06/2010
C12N )2010.01(
206272
G06F )2009.01(
‫אינטרקציות אינטרנט אישיות‬
B23C )2010.01(
‫שימת חיתוך וכרסום‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫ישקר בע"מ‬
ISCAR LTD.
09/06/2010
206274
MUSICAL INSTRUMENT
SPRINGLIMBA
DANIEL MAYZEL
10/06/2010
‫כלי נגינה קפיצלימבה‬
‫דניאל מייזל‬
206283
CUTTING TOOL AND NOZZLE
THEREFOR
ISCAR LTD.
30/05/2006
G10B )2010.01(
B23C )2010.01(
‫כלי חיתוך ופיה עבורו‬
‫ישקר בע"מ‬
206289
COMBINATIONS COMPRISING (A) 4[3,5-BIS-(2-HYDROXYPHENYL)[1,2,4]-TRIAZOL -1-YL]BENZOIC
ACID AND (B) AN INTERFERON
AND/OR A NUCLEOSIDE ANTIMETABOLIT AND USE THEREOF
FOR THE PREPARATION OF
MEDICAMENTS FOR TREATING
CHRONIC HEPATITIS C
NOVARTIS AG
US
60/685848
31/05/2005
60/692808
22/06/2005
US
60/746786
09/05/2006
US
PCT/US/2006/020677
WO/2006/130532
A61K )2010.01(
–‫–ביס‬5,3[–4 ‫תכשיר המכילים (א) חומצה‬
]‫–יל‬1– ‫]–טריאזול‬4,2,1[–)‫–הידרוקסיפניל‬2(
‫או נוקלאוזיד‬/‫בנזואית ו–(ב) אינטרפרון ו‬
‫ ושימוש בהם להכנת‬,‫אנטי–מטבוליט‬
‫ כרונית‬C ‫תרופות לטיפול בצהבת‬
November 30, 2010-‫כג' בכסלו התשע"א‬
05/11/2002
206316
CLOSED AUTOMATED SYSTEM FOR
TISSUE BASED THERAPY, DOSING
AND ADMINISTRATION USING
SAME
MEDGENICS INC.
US
60/330959
05/11/2001
60/393745
08/07/2002
US
60/393746
08/07/2002
US
PCT/IL/2002/000879
WO/2003/049626
13/06/2010
206320
SUSPENSION SYSTEM FOR HUMMER
VEHICLE
ASFIR LTD.
13/06/2010
206322
‫ לטיפולים‬,‫מערכת אוטומטית סגורה‬
‫ מתן וכמות של‬,‫המבוססים על רקמה‬
‫אותם טיפולים‬
B60G )2010.01(
‫מערכת מתלים לכלי רכב מסוג האמר‬
‫אספיר בע"מ‬
A47J )2010.01(
‫מכשיר מחבת חשמלי‬
AN ELECTRIC PAN APPARATUS
JOSEPH HAIM IMPORT AND
MARKETING LTD
25/06/2004
A61B )2010.01(
‫יוסף חיים יבוא ושיווק בע"מ‬
206336
PRODRUGS OF 9 - AMINOMETHYL
TETRACYCLINE COMPOUNDS
PARATEK PHARMACEUTICALS, INC.
C07C )2010.01(
‫–אמינומתיל‬9 ‫קדם–תרופות מתרכובות‬
‫טטראציקליניות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
US
60/486017
60/525287
US
60/530123
US
60/566150
US
PCT/US/2004/020305
WO/2005/009944
09/07/2003
25/11/2003
16/12/2003
27/04/2004
14/06/2010
206348
PARQUET BOARD FOR VARIOUS
USES
LINE PARQUET LTD
14/06/2010
‫לוח פרקט למגוון שימושים‬
‫ליין פרקט בע"מ‬
206349
206350
HOLDER FOR EMPTY PLASTIC
BOTTLES
RAZ FELDMAN
08/01/2009
F16K )2010.01(
‫שסתום ביוב אל–חוזר‬
‫חוסאם קוסטה קסיס‬
NON-RETURN SEWAGE BARRIER
HOSAM COSTA KASSIS
14/06/2010
E04F )2010.01(
B65D )2010.01(
‫מחזיק לבקבוקים ריקים מפלסטיק‬
‫רז פלדמן‬
206351
A45D )2010.01(
November 30, 2010-‫כג' בכסלו התשע"א‬
A HAIR REMOVAL APPARATUS FOR
PERSONAL USE AND THE METHOD
OF USING SAME
SYNERON MEDICAL LTD
US
61/021723
17/01/2008
PCT/IL/2009/000033
WO/2009/090632
14/12/2008
206352
A DEVICE, APPARATUS, AND
METHOD OF ADIPOSE TISSUE
TREATMENT
SYNERON MEDICAL LTD
US
61/023194
24/01/2008
PCT/IL/2008/001612
WO/2009/093230
14/06/2010
206362
SYSTEM AND METHOD FOR
PERFORMING TENDERS
CHEN AVITAN TENDERS LTD
14/06/2010
‫מכשיר הסרת שיער לשימוש אישי‬
‫סינרון מדיקל בע"מ‬
A61B )2010.01(
‫מכשיר ושיטה לטיפול ברקמת שומן‬
‫סינרון מדיקל בע"מ‬
G07B )2010.01(
‫מערכת ושיטה לניהול מכרזים‬
‫חן אביטן מכרזים בע"מ‬
206369
IMPROVEMENTS APPLIED TO BAND
FOR PROTECTION OF VEHICULAR
WHEELS AND TIRES
ALEXANDRE SCHUNN VIANNA
B60C )2010.01(
‫שיפורים המיושמים לרצועה להגנה של‬
‫גלגלים וצמיגים של כלי רכב‬
November 30, 2010-‫כג' בכסלו התשע"א‬
15/06/2010
206376
NIGHT FIRING SIMULATOR (NFS)SPARKER
YOAV PAZ
15/06/2010
‫מדמה ירי לילה אלקטרוני–רשפון‬
‫יואב פז‬
206377
METHOD AND PROCESS FOR THE
GASIFICATION AND REMOVAL OF
POLLUTANTS FROM COAL FOR
EXISTING AND FUTURE POWER
BOILERS' FLUE
VICTOR DE BOTTON
20/10/2004
ORGANIC PHASE COMPOSITIONS,
LIGNIN COMPOSITIONS AND
METHODS FOR PRODUCING THE
SAME
HCL CLEANTECH LTD.
B01D )2010.01(
‫שיטה ותהליך לגזיפיקציה של פחם‬
‫והסרת המזהמים מפליטות של דודי כח‬
‫קיימים ועתידיים‬
‫ויקטור דה בוטון‬
206387
METHOD OF INTERCONNECTING
TWO ELEMENTS BONDED
TOGETHER
ZIPTRONIX, INC.
US
10/688910
21/10/2003
PCT/US/2004/032312
WO/2005/043584
15/06/2010
F41J )2010.01(
H01L )2009.01(
‫שיטה לחיבור בין שני אלמנטים הקשורים‬
‫יחד‬
206388
C01B )2010.01(
‫ תכשירי ליגנין‬,‫תכשירים בפזה אורגנית‬
‫ושיטות להכנתם‬
‫אייץ ס' אל קלינטג בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫כג' בכסלו התשע"א‪November 30, 2010-‬‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.
- ‫ לחוק הפטנטים תשכ"ז‬26 ‫הודעה לפי סעיף‬
1976
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬17 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬30 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬57 ‫הפטנטים בדרך הקבועה בתקנה‬
.1968 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
‫ בקשות הפטנטים שפורסמו ביומן‬:‫**הערה‬
‫זה סווגו בהתאם לגרסת הסיווג הבינלאומי‬
‫שהייתה בתוקף בעת הכנת הבקשות‬
.‫לפרסום‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
122106
‫שיטות ואלגוריתמים עבור זיהוי ואישור‬
]54[
METHOD AND ALGORITHMS
FOR IDENTIFICATION AND
VALIDATION
]22[
]51[
]71[
]74[
04.11.1997
Int. Cl.(2010.01) H04L 09//00
ENCOTONE LTD.
‫ הרצליה פיתוח‬,‫אנקוטון בע"מ‬
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
An identification method for a multitude of to-be-identified entites against a central
identification entity, the said identification arbitrated by an independent arbitrator
entity, characterized by the steps of:
the independent arbitrator entity characterizing specific algorithms for each, and
distributing the said algorithms to each of the to-identified entites;
the central identification entity distributing one reversible algorithm
(F_SYSssn) for all and to all of the to-be-identified entites;
and for each identification operation, the to-be-identified entity;
applies the independent arbitrator entity's algorithm to a
challenge (Ch) selected by the central dentification entity for such identification
operation computing a first result, and then
applies the central identification entity's reversible algorithm to the said challenge, to
its identification data and to the said first result computing a second result referred to
as a cipher,
and the to-be-identified entity transmits the said second result to the central
identification entity;
whereas
the central identification entity applies the reverse F'_SYSssn of the reversible
algorithm to the received second result, computing a presumed challenge (Ch'), a
presumed the to-be-identified entity's identification data (C_ID), and a presumed first
result (RI');
and hereas the central identification entity compares the challenge previously sent to
the said presumed challenge, and if they are identical,
the central identification entity sends to the independent arbitrator entity the presumed
first result, together with the to-be-identified presumed entity identification data or
other identification data of such entity, and the said challenge,
whereas the arbitrator entity retrieves the specific aalgorithm sent by it said the to-beidentified entity and applies the said specific algorithm to challenge computing the
true first result, and compares such true first sult with the presumed first result, and, if
eventually are identical, the arbitrator entity corroborates the veracity of the
identification to the central identification entity;
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
and whereas the centrl identificationentity having received the corroboration from the
arbitrator entity, accepts the presumed identification data as true identification data
corresponding the to-be-identified entity.
__________________
]11[]21[
132184
‫שיטה לייצור תא צמח ששונה בעל ייצור‬
)QPRTase( ‫קוינוליט פוספוריבוזיל טרנספרז‬
‫מופחת; כמו גם צמח טרנסגני ומוצר טבק מזה‬
]54[
METHOD OF PRODUCING A
TRANSFORMED PLANT CELL
HAVING REDUCED QUINOLATE
PHOSPHORIBOSYL
TRANSFERASE (QPRTASE)
PRODUCTION AS WELL AS
TRANSGENIC PLANT AND
TOBACCO PRODUCT THEREOF
]22[
]31[
]51[
]71[
10.06.1998
049471
]32[ 12.06.1997
]33[ US
Int. Cl.(2010.01) A01H 01//00, 05//00, C12N 09//10, 15//29, 15//54, 15//82
NORTH CAROLINA STATE
UNIVERSITY, U.S.A.
WO/1998/056923
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
]87[
]74[
]57[
DNA encoding a plant quinolate phosphoribosyl transferase (QPRTase) enzyme, and
constructs comprising such DNA are provided. Methods of altering quinolate
phosphoribosyl transferase expression are provided.
The applications for division
from this application have
not yet been published
,192232
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
133056
‫פוליפפטיד המכיל חלק אימונוגני של אנטיגן‬
‫טובורקולוסיס ואריאנט שלו ותכשירי רוקחות‬.‫מ‬
‫חיסונים וערכות המכילות אותו‬
]54[
POLYPEPTIDE CONTAINING AN
IMMUNOGENIC PORTION OF AN
M. TUBERCULOSIS ANTIGEN, A
VARIANT THEREOF AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
SAME
]22[
]31[
20.05.1998
08/859381
]32[ 20.05.1997
]33[ US
09/073010
05.05.1998
US
Int. Cl.(2008.04) A61K 39/04, 48/00, C07K 14/35, C12N 01/21, C12N 15/31
CORIXA CORPORATION, U.S.A.
WO/1998/053075
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]51[
]71[
]87[
]74[
]57[
Compounds and methods for inducing protective immunity against tuberculosis are
disclosed. The compounds provided include polypeptides that contain at least one
immunogenic portion of one or more M. tuberculosis proteins and DNA molecules
encoding such polypeptides. Such compounds may be formulated into vaccines and/or
pharmaceutical compositions for immunization against M. tuberculosis infection, or
may be used for the diagnosis of tuberculosis.
The applications for division
from this application have
not yet been published
,193595,193594,193593
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
METHODS OF PRODUCING
DROUGHT TOLERANT PLANTS,
DROUGHT TOLERANT
TRANSGENIC PLANTS
PRODUCED THEREBY AND
TRANSGENIC SEEDS
OBTAINABLE BY SAID PLANTS
134267
‫ צמחים‬,‫שיטות להכנת צמחים עמידי בצורת‬
‫טרנסגניים עמידי בצורת הנוצרים בשיטות אלו‬
‫וזרעים הנוצרים על ידי צמחים אלו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
29.07.1998
60/054474
]32[ 01.08.1997
]33[ US
Int. Cl.(2010.01) A01H 05//00, 05//10, C12N 09//10, 15//113, 15//29, 15//82
PERFORMANCE PLANTS, INC.,
CANADA
WO/1999/006580
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The novel constructs and methods of this invention improve tolerance in plants to
environmental stresses and senescence. Nucleic acids encoding a plant farnesyl
transferase are described, as are transgenic plants and seeds incorporating these nucleic
acids and proteins. Also provided are inhibitors of naturally-occurring farnesyl
transferase which, when expressed, will enhance drought tolerance in the plants,
improve resistance to senescence and modify growth habit.
__________________
]11[]21[
135647
‫שיטות ומערכות לחתימת מפתח ציבורי‬
]54[
PUBLIC-KEY SIGNATURE
METHODS AND SYSTEMS
]22[
]31[
]51[
]71[
]72[
13.04.2000
99401048.6
]32[ 29.04.1999
]33[ EP
Int. Cl.(2010.01) G09C 01//00, H04L 09//28, 09//30, 09//32
NDS LIMITED, UNITED KINGDOM
AVIAD KIPNIS, JACQUES
PATARIN, LOUIS GOUBIN
SANFORD T.COLB & CO.,
P.O.B. 2273,
]74[
‫אביעד קיפניס‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]57[
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A digital signature cryptographic method, performed by a processor, comprising:
supplying set S1 of k polygonal functions as a public-key, the set S1 including the
function P1(x1,…,xn+v,y1,…,yk), where k, v, and n are integers, x1,…,xn+v are n+v
variables of a first type, ,y1,…,yk are k variables of a second type, and the set S 1 is
obtained by applying a secret key operation on a set S2 of k polynomial functions
P'1(a1,…,an+v, y1,…,yk),… P'k (a1,…,an+v, ,y1,…,yk) where a1,…,an+v are n+v variables
which include a set of n "oil" variables a1,…,an, and a set of v "vinegar" variables
an+1,…,an+v;
providing a message to be signed;
applying a hash function on the message to produce a series of k values b 1,…,bk;
substituting the series of k values b1,…,bk for the variables y1,…,yk of the set S2
respectively to produce a set S3 of k polynomial functions
P''1(a1,…,ann+v),…,P''k(a1,…,ann+v);
selecting v values a'n+1,…,a'nn+vfor the v "vinegar" variables an+1,…,a n+v;
solving a set of equations P''1(a1,…,ana'n+1,…,a'n+v)=o,…,P;k a1,…,ana'n+1,…,a'n+v)=0 to
obtain a solution for a'1,…,a'n; and
applying the secret key operation to transform a'1,…,a'n+v to a digital signature
e1,…,enn+v.
__________________
]11[]21[
137019
– 8 – )‫ (אמינו מותמר‬4 –‫ – דימתיל‬7,2 ‫נגזרי‬
‫] טריאזין ותכשירי‬A–5,1 [ ‫ארילפיראזולו‬
‫רוקחות המכילים אותם‬
]54[
2,7 - DIMETHYL - 4 (SUBSTITUTED AMINO) - 8 ARYLPYRAZOLO [1,5-A]
TRIAZINE DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]22[
]31[
28.01.1999
09/015002
]32[ 28.01.1998
]33[ US
09/014734
28.01.1998
US
09/015001
28.01.1998
US
Int. Cl.(2008.04) A61K 31/53, A61P 1/00, 15/00, 21/00, 25/00, 29/00, 3/10, 31/18,
9/00, C07D 487/04, C12P 17/18
127871
DUPONT PHARMACEUTICALS
COMPANY, U.S.A.
WO/1999/038868
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]51[
]61[
]71[
]87[
]74[
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
P.O.B. 2273,
REHOVOT 76122
]57[
Corticotropin releasing factor (CRF) antagonists of formula (I) or (II) and their use in
treating anxiety, depression, and other psychiatric, neurological disorders as well as
treatment of immunological, cardiovascular or heart-related diseases and colonic
hypersensitivity associated with psychopathological disturbance and stress.
__________________
]11[]21[
137848
‫ מלחיה‬,‫ – חומצה פרופיונית‬3 – ‫אינדול‬
‫ואסטריה לשימוש כתרופות‬
]54[
INDOLE-3-PROPIONIC ACIDS
AND SALTS AND ESTERS
THEREOF FOR USE AS
MEDICAMENTS
]22[
]31[
23.02.1999
60/075555
]32[ 23.02.1998
]33[ US
60/112565
16.12.1998
US
Int. Cl.(2010.01) A61K 31//405, A61P 25//00, C07D 20/9/18
NEW YORK UNIVERSITY, U.S.A.
SOUTH ALABAMA MEDICAL
SCIENCE FOUNDATION, U.S.A.
WO/1999/042102
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The cytotoxic effects of amyloid beta protein on cells are prevented by contacting the
cells with an effective amount of an indole-3-propionic acid or a salt or ester thereof.
Furthermore, a fibrillogenic disease can be treated in a human subject by administering
to the human subject an amount of an indole-3-propionic acid or a salt or ester thereof
effective to prevent or reverse fibrillogenesis. Oxidation in a biological sample can be
decreased by contacting the biological sample with an effective amount of an indole-3propionic acid or a salt or ester thereof. Additionally, diseases or other conditions
where free radicals and/or oxidative stress play a role can be treated by administering
an effective amount of an indole-3-propionic acid or a salt or ester thereof.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
138469
‫מעקבי קזפאז ותכשירי רוקחות המכילים אותן‬
]54[
CASPASE INHIBITORS AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
]51[
19.03.1999
60/078770
]32[ 19.03.1998
]33[ US
Int. Cl.(2010.01) A61K 31//47, 38//03, 38//04, A61P 01//00, 01//04, 01//16, 01//18,
03//10, 05//00, 05//14, 05//48, 05//50, 07//00, 07//06, 09//00, 09//10, 11//00, 11//06,
13//00, 13//12, 17//00, 17//06, 17//14, 19//00, 19//02, 19//10, 21//00, 21//04, 25//00,
25//16, 25//28, 25//32, 29//00, 31//00, 31//04, 31//12, 31//18, 35//00, 35//02, 35//04,
37//00, 37//06, C07D 20/7/273, 40/1/12, C07K 05//02, 05//023, 05//06
VERTEX PHARMACEUTICALS
INCORPORATED, U.S.A.
WO/1999/047545
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]71[
]87[
]74[
]57[
The present invention relates to novel classes of compounds which are caspase
inhibitors, in particular interleukin-1β converting enzyme ("ICE") inhibitors. This
invention also relates to pharmaceutical compositions comprising these compounds.
The compounds and pharmaceutical compositions of this invention are particularly
well suited for inhibiting caspase activity and consequently, may be advantageously
used as agents against interleukin-1- ("IL-1"), apoptosis-, interferon-γ inducing factor(IGIF), or interferon-γ- ("IFN-γ") mediated diseases, including inflammatory diseases,
autoimmune diseases, destructive bone disorders, proliferative disorders, infectious
diseases, and degenerative diseases. This invention also relates to methods for
inhibiting caspase activity and decreasing IGIF production and IFN-γ production and
methods for treating interleukin-1, apoptosis-, and interferon-γ- mediated diseases
November 30, 2010-‫כג' בכסלו התשע"א‬
using the compounds and compositions of this invention. This invention also relates to
methods of preparing the compounds of this invention.
,206621
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
139051
‫תהליך לייצור תערובות יונומר וקרומי תערובות‬
‫יונומר‬
]54[
PROCESS FOR THE
MANUFACTURE OF IONOMER
BLENDS AND IONOMER BLEND
MEMBRANES
]22[
]31[
]51[
]71[
16.04.1999
19817374.1
]32[ 18.04.1998
]33[ DE
Int. Cl.(2009.01) B01D 71/62, C08L 79/04, 79/06, H01M 08/10
THOMAS HAERING, GERMANY
RIMA HAERING, GERMANY
]87[
]74[
WO/1999/054407
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]57[
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
The invention relates to novel compatible binary and tertiary cation exchange polymer
and anion exchange polymer acid base blend membranes.
__________________
]11[]21[
]54[
USE OF A G PROTEIN-COUPLED
RECEPTOR TO SCREEN
CANDIDATE COMPOUNDS AS
PHARMACETICAL AGENTS
142538
‫ לסנן‬G – ‫השימוש בקולטני מזווג לחלבון‬
‫תרכובות – מועמדות כגורם תרופתי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
13.10.1999
60/109213
]32[ 20.11.1998
]33[ US
60/120416
16.02.1999
US
60/121852
26.02.1999
US
60/123946
12.03.1999
US
60/123949
12.03.1999
US
60/136436
28.05.1999
US
60/137127
28.05.1999
US
60/137131
28.05.1999
US
60/136437
28.05.1999
US
60/136439
28.05.1999
US
60/136567
28.05.1999
US
60/141448
29.06.1999
US
60/157280
29.09.1999
US
60/156653
29.09.1999
US
60/156633
29.09.1999
US
60/156555
29.09.1999
US
60/157280
01.10.1999
US
60/157294
01.10.1999
US
60/157281
01.10.1999
US
60/157293
01.10.1999
US
60/157282
01.10.1999
US
417044
12.10.1999
US
416760
12.10.1999
US
Int. Cl.(2010.01) A61K 48//00, C07K 14//705, G01N 33//566
ARENA PHARMACEUTICALS, INC.,
U.S.A.
WO/2000/031258
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention disclosed in this patent document relates to transmembrane receptors,
more particularly to endogenous, human orphan G protein-coupled receptors.
The applications for division
from this application have
not yet been published
,205658,205657,205656
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
PATH DISCOVERY IN A
144709
‫גילוי נתיב בארכיטקטורת ניהול רשת מפוזר‬
November 30, 2010-‫כג' בכסלו התשע"א‬
DISTRIBUTED NETWORK
MANAGEMENT ARCHITECTURE
]22[
]31[
]51[
]71[
]74[
]57[
02.08.2001
60/222660
]32[ 03.08.2000
]33[
Int. Cl.(2010.01) H04L 12//24, 12//56, 29//06
CISCO TECHNOLOGY, INC., U.S.A.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method of determining the path that a network message would take among network
devices in a computer network the method comprising:
providing a plurality of device components to model a physical computer network,
wherein each of said device components model an aspect of a network device of said
physical computer network;
simulating sending a network message within said model of said computer network
from a source device component modeling one of said network devices of said
physical network to a destination device component along a device component path,
wherein said simulated message only traverses any of said devices which model said
network devices of said physical computer network; and
recording the device components traversed by said simulated message within said
model of said physical computer network, thereby determining said path that said
network message would take among said netwok devices in said physical computer
network as well as the validity of the path;
wherein each of said device components is configured to use message passing to
independently and directly communicate with any neighboring or adjacent one of said
device components, and wherein each of said device components receiving said
simulated message is configured to decide to which other of said device components
would a real message with the same characteristics as said simulated message be
forwarded.
__________________
]11[]21[
]54[
MORPHOLINE DERIVATIVES,
METHODS FOR THE
PRODUCTION THEREOF AND
PHARMACEUTICAL
PREPARATIONS
CONTAINING SAID
DERIVATIVES
145041
‫ ותרכובות‬,‫ שיטה לייצורן‬, ‫נגזרות מורפילין‬
‫פרמצבטיות המכילות את הנגזרות האמורות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
21.03.2000
99/03854
]32[ 25.03.1999
]33[ FR
Int. Cl.(2010.01) A61K 31//5375, A61P 25//00, C07D 26/5/30, 41/3/00
SANOFI AVENTIS, FRANCE
WO/2000/058292
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention relates to compounds of formula (I) and the salts thereof with mineral or
organic acids, the solvates and/or hydrates thereof, exhibiting a strong affinity and high
degree of selectivity with respect to human NK1 receptors of substance P. The
invention also relates to a method for the production of said derivatives, intermediate
compounds of formulae (IV), (VI) and (VIII) used in the production thereof,
pharmaceutical compositions containing said derivatives and the use thereof in the
production of medicaments in the treatment of all pathologies where substance P
and/or human NK1 receptors are involved.
__________________
]11[]21[
145538
‫שיטה להענקת עמידות או סבילות כנגד‬
‫ טוספווירוס וקוקומווירוס‬,‫ פוטיוירוס‬,‫פורווירוס‬
‫לתאי צמח‬
]54[
METHOD FOR CONFERRING
RESISTANCE OR TOLERANCE
AGAINST FUROVIRUS,
POTYVIRUS, TOSPOVIRUS AND
CUCOMOVIRUS TO PLANT
CELLS
]22[
]31[
]51[
]71[
08.05.2000
09/309038
]32[ 10.05.1999
]33[ US
Int. Cl.(2010.01) A01H 05//00, C12N 15//63, 15//82
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/2000/068374
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
]57[
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
The present invention relates to methods to alter the expression of a viral gene in a cell
November 30, 2010-‫כג' בכסלו התשע"א‬
using sense and antisense RNA fragments of the gene. The sense and antisense RNA
fragments are capable of pairing and forming a double-stranded RNA molecule,
thereby altering the expression of the gene. The present invention also relates to cells,
plants or animals, their progeny and seeds derived thereof, obtained using a method of
the present invention. Preferably, such cells, plants or animals are resistant or tolerant
to viruses.
__________________
]11[]21[
145675
‫גורמי גדילה תאיים משתנים של כלי דם‬
‫אנדותליים ושימוש בהם‬
]54[
VASCULAR ENDOTHELIAL CELL
GROWTH FACTOR VARIANTS
AND USES THEREOF
]22[
]31[
10.04.2000
60/129788
]32[ 16.04.1999
]33[ US
60/184235
23.02.2000
US
Int. Cl.(2010.01) A61K 38//18, C07K 14//475, C12N 15//12
GENENTECH, INC., U.S.A.
WO/2000/063380
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides VEGF variants having at least a single amino acid
mutation in the native VEGF sequence and selective binding affinity for either the
KDR receptor or the FLT-1 receptor. Methods of making the VEGF variants and
methods of using the VEGF variants are also provided.
__________________
]11[]21[
]54[
COMPOSITION FOR INHIBITING
GROWTH OF A PROSTATE
CANCER COMPRISING AN
ANTIBODY AS ACTIVE
145775
‫תכשיר רוקחי לעיכוב גידול סרטן הערמונית‬
‫המכיל נוגדן כחומר פעיל‬
November 30, 2010-‫כג' בכסלו התשע"א‬
INGREDIENT
]22[
]31[
]51[
]71[
]87[
]74[
]57[
12.04.2000
60/128858
]32[ 12.04.1999
]33[ US
Int. Cl.(2010.01) A61K 38//17, 48//00, C07K 16//18
AGENSYS, INC., U.S.A.
WO/2000/061746
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A prostate tumor associated gene (designated 24P4C12) and its encoded protein is
described. 24P4C12 is highly expressed in prostate tissue xenografts, providing
evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a
diagnostic and/or therapeutic target for prostate and other cancers.
The applications for division
from this application have
not yet been published
,206604
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
PHARMACEUTICAL
COMPOSITIONS FOR TREATING
AMYLOID DISEASES
]22[
]31[
]51[
]71[
01.06.2000
60/137010
]32[ 01.06.1999
Int. Cl.(2010.01) A61K 39//00
ELAN PHARMA INTERNATIONAL
LTD., IRELAND
WO/2000/072876
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
]57[
146563
‫תכשירי רוקחות לטפול במחלות עמיליודיות‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
Disclosed are pharmaceutical compositions and methods for preventing or treating a
number of amyloid diseases, including Alzheimer's disease, prion diseases, familial
amyloid neuropathies and the like. The pharmaceutical compositions include
immunologically reactive amounts of amyloid fibril components, particularly fibrilforming peptides or proteins. Also disclosed are therapeutic compositions and methods
November 30, 2010-‫כג' בכסלו התשע"א‬
which use immune reagents that react with such fibril components.
,207166
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
DEVICE FOR BLOOD SAMPLING
UNDER VACUUM CONDITIONS
]22[
]51[
]71[
23.07.2002
Int. Cl.(2009.01) A61B 05/00, 05/15
SHAHAL TELEMEDICINE
INTERNATIONAL LTD.
]72[
]87[
]74[
YORAM ALROY
WO/2003/045241
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
146776
‫מכשיר לדגימת דם בתנאי ואקום‬
-‫ תל‬,‫שחל טלמדיסין אינטרנשיונל בע"מ‬
‫אביב‬
‫יורם אלרואי‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A blood extraction device (100) and method for withdrawing a controlled number of
drops of blood from a patient, in whom there is created an incision of such dimension
that blood does not freely flow therefrom. A release unit (160) urges drops of blood to
flow from the incision, for example by applying a vacuum, and a disabling unit (145,
146, 170) is coupled to the incision unit for disabling the release unit when a
predetermined number of drops of blood have been withdrawn.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
150551
‫ בטא‬1 – ‫נוגדן רקומביננטי נגד אינטרלאוקין‬
,‫ תרכובות פרמצבטיות הכוללות אותו‬,‫אנושי‬
‫ תהליך‬,‫קונסטרוקט של דנא המקודד אותו‬
‫להכנתו ושימושיו בהכנת תרופה‬
]54[
RECOMBINANT ANTIBODY TO
HUMAN INTERLEUKIN-1 BETA,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME , DNA CONSTRUCT
ENCODING THE SAME, A
PROCESS FOR ITS PRODUCTION
AND USES THEREOF IN THE
PREPARATION OF A
MEDICAMENT
]22[
]31[
]51[
]71[
]87[
]74[
19.01.2001
0001448.0
]32[ 21.01.2000
]33[ GB
Int. Cl.(2010.01) A61K 39//395, A61P 37//02, C07K 16//24, C12N 15//13
NOVARTIS AG, SWITZERLAND
WO/2001/053353
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]57[
An IL-1β binding molecule, in particular an antibody to human IL-1β, especially a
human antibody to human IL-1β is provided, wherein the CDRs of the heavy and light
chains have amino acid sequences as defined, for use in the treatment of an IL-1
mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory
arthritides.
__________________
]11[]21[
150571
‫חלבונים כימריים חדשים ושיטות המנצלות‬
‫אותם‬
]54[
CHIMERIC PROTEINS AND
METHODS FOR USING THE
SAME
]22[
]31[
]51[
03.01.2001
60/174258
]32[ 03.01.2000
]33[ US
Int. Cl.(2010.01) A61K 38//19, C07K 14//705, C12N 15//09
November 30, 2010-‫כג' בכסלו התשע"א‬
]71[
]72[
]87[
]74[
]57[
TR ASSOCIATES, L.L.C., U.S.A.
MARK L, TYKOCINSKI, JUI-HAN
HUANG
WO/2001/049318
EDWARD LANGER,
MERKAZ GERON H. 312
P.O.B. 410,
RAANANNA 43103
,‫אדוארד לנגר‬
‫רעננה‬410 .‫ד‬.‫ ת‬,
Novel chimeric proteins are disclosed. The proteins comprise at least two portions. The
first portion binds to a first cell and decreases the cell's ability to send a trans signal to
a second cell; the second portion sends its own trans signal to the second cell. Methods
for making and using these proteins in the treatment of cancer, viral infections,
autoimmune and alloimmune diseases are also disclosed, as are pharmaceutical
formulations comprising the novel chimeric proteins and genes. Either the proteins
themselves or a genetic sequence encoding the protein can be administered. Other
methods are also disclosed in which two molecular components result in decrement of
a first trans signal from a first cell and the conferring of a second trans signal to a
second cell.
__________________
]11[]21[
]54[
COUPLING DEVICE WITH
GALVANIC INSULATION
ENSURING VISUALLY
DISPLAYED SWITCHING OFF
]22[
]31[
]51[
]71[
]87[
]74[
05.02.2001
00/01558
]32[ 07.02.2000
Int. Cl.(2010.01) H01F 38//14
EDELCOM, FRANCE
WO/2001/057891
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
151002
‫התקן צימוד עם בידוד גלווני המאפשר תצוגה‬
‫חזיתית של סגירה‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention concerns a so-called galvanic insulation device for coupling two
electrical circuits used both for transporting direct or low frequency current and for
transmitting medium or high frequency signals. Said device comprises two primary
November 30, 2010-‫כג' בכסלו התשע"א‬
and/or secondary coupling circuits (E1, E2), separated from each other by an
electrically insulating material (R) through which the coupling is produced, such that it
is possible to visually ascertain the physical separation of the two circuits (E1, E2).
__________________
]11[]21[
152283
‫מלואה שעוצב בצד הנגדי‬
]54[
REVERSE MOLDED PANEL
]22[
]31[
09.01.2001
60/198709
]32[ 20.04.2000
]33[ US
09/742840
21.12.2000
US
Int. Cl.(2010.01) B27N 03//08, B44C 05//04, E04F 13//10
MASONITE CORPORATION, U.S.A.
WO/2001/081055
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]51[
]71[
]87[
]74[
]57[
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
A reverse molded fiberboard panel (12); a wainscot kit comprising a plurality of
differently sized reverse molded panels (12), and a planar finishing or spacer panel,
adapted to completely cover any size wall between a wall base board and a wall chair
rail; and a method of reverse molding a loose cellulosic mat, in a single pressing step,
to provide one or more relatively high density, raised panels (12) without requiring
preliminary pressing, or other pre-shaping step, such as scalping. The reverse-molded
panels (12) are molded in a conventional, multi-opening fiberboard press, in a single
pressing step process, while achieving excellent transfer of mold detail (embossing
fidelity) without visually noticeable fiber fracture.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
152391
‫ניקוי באמצעות וירוס של תאים גידוליים‬
‫מתכשירים תאיים מעורבבים‬
]54[
VIRUS CLEARANCE OF
NEOPLASTIC CELLS FROM
MIXED CELLULAR
COMPOSITIONS
]22[
]31[
01.05.2001
60/201990
]32[ 03.05.2000
]33[ US
60/205389
19.05.2000
US
60/268054
13.02.2001
US
60/276782
16.03.2001
US
Int. Cl.(2009.01) A61K 35/76, 48/00, C12N 05/06, 15/861
ONCOLYTICS BIOTECH INC.,
CANADA
WO/2001/083710
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a method for removing neoplastic cells from a mixed
cellular composition, which is outside of a living organism, by using a virus which
selectively infect and kill neoplastic cell. A variety of viruses can be used in this
method to remove neoplastic cells for different purposes, for example, to purge
hematopoietic stem cells prior to transplantation. Also provided are compositions
prepared according to this method, and kits comprising a combination of viruses which
are useful in this invention.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
152651
‫תכשירים סינרגיסטים המכילים תולדות‬
‫ – דיאון ואגוניסט או אנטגוניסט‬4, 2 – ‫פירולידין‬
‫ תהליך להכנתם‬,‫של קולטן אצטיל כולין‬
‫והשימוש בהם להדברת מזיקים‬
]54[
SYNERGISTIC COMPOSITIONS
COMPRISING PYRROLIDINE-2,4DIONE DERIVATIVES AND AN
AGONIST OR ANTAGONIST OF
THE ACETYLCHOLINE
RECEPTOR, PROCESS FOR
THEIR PREPARATION AND
THEIR USE FOR CONTROLLING
ANIMAL PESTS
]22[
]31[
]51[
07.05.2001
10024934.5
]32[ 19.05.2000
]33[ DE
Int. Cl.(2010.01) A01N 43//72, C07D 20/7/38, 21/3/36, 23/3/20, 27/7/28, 27/9/06,
30/7/14, 40/1/06, 40/5/06, 41/3/06, 41/3/12, 41/7/06, C07F 09//16
BAYER CROPSCIENCE AG,
GERMANY
WO/2001/089300
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]71[
]87[
]74[
]57[
The invention relates to insecticidal mixtures containing compounds of formula (I), in
which W, X, Y, Z, A, B, D and G have the cited meanings, and agonists or antagonists
of nicotinergic acetylcholine receptors for protecting plants from infestation.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
152804
‫שיטות לקיפול מחדש לחלבונים המכילים‬
‫סיסטייאינים חופשיים‬
]54[
METHODS FOR REFOLDING
PROTEINS CONTAINING FREE
CYSTEINE RESIDUES
]22[
]31[
]51[
16.05.2001
60/204617
]32[ 16.05.2000
]33[ US
Int. Cl.(2010.01) A61K 47//48, C07K 01//02, 01//113, 14//435, 14//505, 14//515,
14//535, 14//54, 14//56, 14//61, 14//78, C12P 21//02
BOLDER BIOTECHNOLOGY, INC.,
U.S.A.
WO/2001/087925
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
]71[
]87[
]74[
]57[
The present invention relates to novel methods for making and refolding insoluble or
aggregated proteins having free cysteines in which a host cell expressing the protein is
exposed to a cysteine blocking agent. The soluble, refolded proteins produced by the
novel methods can then be modified to increase their effectiveness. Such modifications
include attaching a PEG moiety to form PEGylated proteins.
__________________
]11[]21[
]54[
SUBSTITUTED
152872
‫נגזרי פירולפירידינון מותמרים לשימוש כמעכבי‬
‫פוספודיאסטראז‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PYRROLOPYRIDINONE
DERIVATIVES USEFUL AS
PHOSPHODIESTERASE
INHIBITORS
]22[
]31[
]51[
]71[
]87[
]74[
]57[
03.05.2001
60/204646
]32[ 17.05.2000
]33[ US
Int. Cl.(2010.01) A61K 31//437, A61P 15//00, C07D 47/1/04, 47/1/14
ORTHO-MCNEIL
PHARMACEUTICAL, INC., U.S.A.
WO/2001/087882
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The invention relates to novel pyrrolopyridinone derivatives of the fomula (I) or (II):
pharmaceutical compositions containing the compounds and their use for the treatment
of sexual dysfuntion.
__________________
]11[]21[
153567
‫נוגדנים בעלי ספציפיות דואלית המקשר שני‬
‫פרוטאינים שונים בעלי מבנה דומה ושיטה‬
‫להשגתו‬
]54[
DUAL SPECIFICITY ANTIBODY
WHICH BINDS TWO DIFFERENT
BUT STRUCTURALLY RELATED
PROTEINS AND METHOD OF
OBTAINING THE SAME
]22[
]31[
]51[
28.06.2001
60/215379
]32[ 29.06.2000
]33[ US
Int. Cl.(2009.01) A01K 67/027, A61K 39/395, 51/10, A61P 37/06, C07K 14/545,
16/24, C12N 15/63, G01N 33/577, 33/68
ABBOTT LABORATORIES, U.S.A.
WO/2002/002773
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
]71[
]87[
]74[
November 30, 2010-‫כג' בכסלו התשע"א‬
TEL AVIV 62038
]57[
Antibodies having dual specificity for two different but structurally related antigens
are provided. The antibodies can be, for example, entirely human antibodies,
recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual
specificity for IL-1α and IL-1β and neutralize IL-1α and IL-1β activity in vitroand in
vivo. An antibody of the invention can be a full-length antibody or an antigen-binding
portion thereof. Methods of making and methods of using the antibodies of the
invention are also provided. The antibodies, or antibody portions, of the invention are
useful for detecting two different but structurally related antigens (e.g., IL-1α and IL1β) and for inhibiting the activity of the antigens, (e.g., in a human subject suffering
from a disorder in which IL-1α and/or IL-1β activity is detrimental.
The applications for division
from this application have
not yet been published
,203955
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
153576
]54[
DNA VACCINES ENCODING HIV
ACCESSORY PROTEINS
]22[
]31[
]51[
]71[
12.07.2001
60/218192
]32[ 14.07.2000
]33[ US
Int. Cl.(2010.01) A61K 39//12, C07K 14//15, 14//16, C12N 15//49
THE TRUSTEES OF THE
UNIVERSITY OF PENNSYLVANIA,
U.S.A.
WO/2002/006303
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]87[
]74[
]57[
HIV ‫תרכיבי דנ"א המקדדים חלבוני עזר של‬
Improved vaccines and methods of using the same are disclosed. Immunosuppressive
compositions for treating individuals who have autoimmune diseases or transplants
and methods of using the same are disclosed.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
SYSTEM AND METHOD FOR
PRE-ENCRYPTION OF
TRANSMITTED CONTENT
]22[
]31[
10.08.2001
0019879.6
]32[ 11.08.2000
0114235.5
11.06.2001
60/298958
18.06.2001
Int. Cl.(2010.01) H04N 01//00
NDS LIMITED, UNITED KINGDOM
NIGEL STEPHEN DALLARD, NIGEL
SMITH, DAVID SAMUEL CHECHIK
WO/2002/015578
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]51[
]71[
]72[
]87[
]74[
]57[
153945
‫מערכת ושיטה לטרום הצפנה של תוכן מועבר‬
]33[
GB
GB
US
‫דוד שמואל צ'צ'יק‬
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
‫רמת גן‬
A system and a method for the creation and transmission of 'pre-encrypted' digital
content, which is encrypted before being placed on a distributed media transmission
server. Preferably a plurality of such servers are used, for example in order to be able
to place such a media transmission server in physical proximity to the end user client,
whether in terms of geographical proximity or proximity through the network. Use of a
plurality of transmission servers also optionally enables the media content to be
transmitted flexibly, according to the request of the end user through the end user
client.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
‫‪154023‬‬
‫גדר היקפית עם מערכות ערור רעש‬
‫מגל מערכות בטחון בע"מ‪ ,‬יהוד‬
‫ד"ר וב ושות'‪,‬‬
‫רח' פקריס ‪2‬‬
‫‪ ,‬ת‪.‬ד‪2189 .‬רחובות‬
‫[‪]11[]21‬‬
‫‪PERIMETER FENCE WITH‬‬
‫‪NOISE INDUCING SYSTEMS‬‬
‫[‪]54‬‬
‫‪19.01.2003‬‬
‫‪Int. Cl.(2010.01) E04H 17//02, 17//24, G08B 13//12‬‬
‫‪MAGAL SECURITY SYSTEMS‬‬
‫‪LTD.‬‬
‫‪WEBB & CO.,‬‬
‫‪2 PEKERIS ST., P.O.B. 2189,‬‬
‫‪REHOVOT 76121‬‬
‫[‪]22‬‬
‫[‪]51‬‬
‫[‪]71‬‬
‫גדר היקפית ‪ 10‬אשר כוללת‪-‬‬
‫מספר עמודים ‪ 20‬ממוקמים במרווח זה מזה ‪ ,‬ו‬
‫אמצעי לגידור סטנדרטי ‪ 30‬פרוס לאורך העמודים הנ"ל ורתום אליהם‪ ,‬ו‬
‫אמצעי חישה לגלוי זעזועים ‪ 40‬באמצעי הגידור הנ"ל מותקן על‪-‬גבי אמצעי הגידור‬
‫הנ"ל‪ ,‬ו‬
‫כאשר הגדר ההיקפית הנ"ל מתאפיינת בכך שהיא כוללת בנוסף‪-‬‬
‫אמצעי לערור רעשי‪ 60 ,50 ,‬אחד לפחות‪ ,‬אשר מקושר לאמצעי הגידור הנ"ל‪ ,‬וכולל‪-‬‬
‫אמצעי גידור בר‪-‬מתיחה ‪ 61 ,51‬בין עמודים‪.‬‬
‫[‪]74‬‬
‫[‪]57‬‬
‫__________________‬
‫‪154305‬‬
‫נגזרות פנילאלאנין‪ ,‬תכשירים רפואיות מכילים‬
‫אותם ושיטות להכנתם‬
‫כג' בכסלו התשע"א‪November 30, 2010-‬‬
‫[‪]11[]21‬‬
‫‪PHENYLALANINE DERIVATIVES,‬‬
‫‪PHARMACEUTICAL‬‬
‫‪COMPOSITIONS COMPRISING‬‬
‫‪SAME AND METHODS OF‬‬
‫‪PREPARATION‬‬
‫[‪]54‬‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
27.08.2001
60/229128
]32[ 31.08.2000
]33[ US
Int. Cl.(2010.01) A61K 31//166, A61P 43//00, C07C 23/3/87
MITSUBISHI TANABE PHARMA
CORPORATION, JAPAN
WO/2002/018320
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a phenylalanine derivative of Formula (I) wherein X1
is a halogen atom, X2 is a halogen atom, Q is a CH2R- is a carboxyl group which may
be esterified; or a pharmaceutically acceptable salt thereof.
__________________
]11[]21[
154591
]54[
METHOD AND APPARATUS FOR
USING SATELLITE STATUS
INFORMATION IN SATELLITE
POSITIONING SYSTEMS
]22[
]31[
24.08.2001
60/228258
]32[ 25.08.2000
]33[
09/938076
23.08.2001
Int. Cl.(2010.01) G01S 01//00, 05//00, 05//14
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/018968
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
‫שיטה ומתקן לשימוש במידע סטטוס לוויין‬
‫במערכות מיקום לוויין‬
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Methods and apparatuses for removing the effects of cross-correlation on a satellite
November 30, 2010-‫כג' בכסלו התשע"א‬
positioning system's calculation of position are disclosed. The method includes
receiving the SPS signals from in view SPS satellites and determining whether a first
measurement, corresponding to a first SPS satellite which has been indicated to be a
healthy satellite, is to be removed from a set of measurements to be used to solve for a
position of a mobile SPS receiver. Determining includes testing the first measurement
is derived from the SPS signals. In one embodiment, the signals from the first SPS
satellite may be weaker than the signals from the second SPS satellite, which has been
indicated to be an unhealthy satellite.
__________________
]11[]21[
154608
‫תרכובות אימוניות היעילות למניעה או שיפור‬
‫של זיהום פנאומוניה המכיל לפחות שני חלבוני‬
‫סטרפטקוקוס פנאומוניה וייתכן שגם חלבון‬
‫המופילוס שפעתי‬
]54[
IMMUNOGENIC COMPOSITIONS
USEFUL FOR THE PREVENTION
OR AMELIORATION OF
PNEUMOCOCCAL INFECTION
COMPRISING AT LEAST TWO
STREPTOCOCCUS PNEUMONIAE
PROTEINS AND OPTIONALLY AN
HAEMOPHILUS INFLUENZAE
PROTEIN
]22[
]31[
]51[
]71[
12.09.2001
0022742.1
]32[ 15.09.2000
]33[ GB
Int. Cl.(2010.01) A61K 39//00, 39//09, 39//385, A61P 31//04
SMITHKLINE BEECHAM
BIOLOGICALS S.A., BELGIUM
WO/2002/022168
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
]57[
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
The present invention relates to a combination of 2 or more S pneumoniae proteins,
their manufacture and use in medicine as a vaccine. Such combinations are particularly
useful for the protection of infants and elderly against streptococcal infection.
The applications for division
from this application have
not yet been published
,206757
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
154622
‫חומצות גרעין המקודדות ופוליפפטידים קושרי‬
‫ וקטורים המכילים‬,R – BAFF –‫ ול‬BAFF
‫ שיטות להכנתם‬,‫ תאים המבטאים אותם‬,‫אותם‬
‫ותכשירים רוקחיים המכילים אותם‬
]54[
NUCLEIC ACIDS ENCODING
BAFF BINDING POLYPEPTIDES
AND BAFF-R, VECTOR
COMPRISING THEM, CELLS
EXPRESSING THEM, METHODS
FOR THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]22[
]31[
06.09.2001
60/233152
]32[ 18.09.2000
]33[ US
60/234140
21.09.2000
US
60/268499
13.02.2001
US
60/312185
14.08.2001
US
Int. Cl.(2010.01) A61K 38//17, C07K 14//715, 16//28, C12N 15//12
BIOGEN IDEC MA INC., U.S.A.
WO/2002/024909
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]51[
]71[
]87[
]74[
]57[
Disclosed are nucleic acids encoding BAFF-R polypeptides, as well as antibodies to
BAFF-R polypeptides and pharmaceutical compositions including same. Methods of
treating tumorigenic and autoimmune conditions using the nucleic acids, polypeptides,
antibodies and pharmaceutical compositions of this invention are also provided.
The applications for division
from this application have
,206414
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
not yet been published
__________________
]11[]21[
154705
‫ תהליכים להכנתם‬,‫פוליארילקרבוקסאמידים‬
‫ותכשירים רוקחיים הכוללים אותם‬
]54[
POLYARYLCARBOXAMIDE
COMPOUNDS, PROCESSES FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
SAME
]22[
]31[
]51[
27.08.2001
00203067.4
]32[ 04.09.2000
]33[ EP
Int. Cl.(2010.01) A61K 31//445, 31//4545, 31//495, 31//496, 31//551, A61P 03//06,
09//00, C07D 21/1/26, 21/1/34, 21/1/56, 21/1/70, 24/3/08, 29/5/14, 40/1/06, 40/1/12,
40/5/12, 40/9/12
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2002/020501
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]71[
]87[
]74[
]57[
Polyarylcarboxamide compounds of formula (I) are useful as lipid lowering agents.
__________________
]11[]21[
154777
]54[
USE OF IL-6 RECEPTOR/IL-6
CHIMERA FOR THE
MANUFACTURE OF A
MEDICAMENT FOR TREATING
HUNTINGTON'S DISEASE
]22[
]31[
]51[
10.09.2001
00120045.0
]32[ 14.09.2000
]33[ EP
Int. Cl.(2010.01) A61K 38//00, 38//20, 39//395, 47//42, 47//48, 48//00, A61P 25//14,
C07K 14//54, 19//00
‫ להכנת‬IL–6/IL–6 ‫שימוש בכימרה קולטן‬
‫תרופה לטיפול במחלת האנטינגטון‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]71[
]72[
]87[
]74[
]57[
ARES TRADING S.A.,
SWITZERLAND
DEGLON NICOLE, AEBISCHER
PATRICK, BENSADOUN JEANCHARLES
WO/2002/022149
INTERPHARM LABORATORIES
LTD.,
18 HAKISHON ST.,
P.O.B. 151,
YAVNE 81101
,‫אינטרפארם מעבדות בע"מ‬
18 ‫רחוב הקישון‬
‫יבנה‬151 .‫ד‬.‫ ת‬,
The invention relates to the use of an IL-6R/IL-6 chimera, a mutein, isoform, fused
protein, functional derivative, active fraction or circularly permutated derivative or a
salt thereof, for the manufacture of a medicament for the treatment and/or prevention
of Huntington's disease.
__________________
]11[]21[
155282
‫תכשירי חיסון לסרטן‬
]54[
CANCER VACCINES
]22[
]31[
16.10.2001
0025573.7
]32[ 18.10.2000
]33[ GB
0025574.5
18.10.2000
GB
690921
18.10.2000
US
Int. Cl.(2009.01) A61K 39/39, A61P 35/00, 37/04
GLAXOSMITHKLINE
BIOLOGICALS S.A., BELGIUM
WO/2002/032450
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides novel adjuvant formulations for use with cancer
antigens. The adjuvant comprises a saponin and a immunostimulatory oligonucleotide.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
MULTI-CHIP INTEGRATED
CIRCUIT CARRIER
]22[
]31[
]51[
]71[
19.10.2001
09/693068
]32[ 20.10.2000
Int. Cl.(2010.01) H05K 01//14
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2002/034018
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
]57[
155465
‫מצע למעגל משולב רב–שבבי‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
An integrated circuit carrier (70) includes a plurality of receiving zones. Each
receiving zone includes electrical contacts and each receiving zone is configured to
receive a particular type of integrated circuit (72, 74, 76). A plurality of island-defining
portions (16) is arranged about each receiving zone. Each island-defining portion (16)
has an electrical terminal electrically connected to one electrical contact of its
associated receiving zone. A rigidity reducing arrangement connects each islanddefining portion (16) to each of its neighbouring island-defining portions (16).
__________________
]11[]21[
]54[
PRINTED CARD BASED USER
INTERFACE SYSTEM
]22[
19.10.2001
155470
‫מערכת ממשק משתמש מבוססת על כרטיס‬
‫מודפס‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
09/693226
]32[ 20.10.2000
Int. Cl.(2010.01) G06K 07//12
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2002/035448
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]33[
US
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
An user interface (12) for reading data encoded in a fault tolerant digital form printed
in infrared ink on the face of a card (10) upon which may also be recorded a visual
representation is disclosed. The data may include text and/or images equivalent to
recording a book, newspaper, manual or a database.
__________________
]11[]21[
155648
‫תכשירים המכילים תולדות קטואנולים וקוטלי‬
‫ תהליך להכנתם ושימוש בהם לבקרה‬,‫רמשים‬
‫על מזיקים‬
]54[
COMPOSITIONS COMPRISING
COMBINATIONS OF KETOENOL
DERIVATIVES AND PESTICIDES,
PROCESS FOR THEIR
PREPARATION AND THEIR USE
FOR CONTROLLING ANIMAL
PESTS
]22[
]31[
]51[
29.10.2001
10055941.7
]32[ 10.11.2000
]33[ DE
Int. Cl.(2010.01) A01N 43//36, 43//38, 43//90, 53//02, 59//26, C07C 28/1/02, 30/9/67,
31/7/14, 33//24, 33/5/18, 69//017, 69//732, C07D 20/7/34, 20/7/38, 20/9/54, 23/1/14,
23/7/18, 23/9/42, 23/9/52, 23/9/70, 25/7/08, 26/3/14, 27/7/14, 33/3/12, 41/3/12, C07F
07//22, 09//28, C07H 17//08
BAYER CROPSCIENCE AG,
GERMANY
]71[
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
WO/2002/037963
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The novel active agent combinations consisting of certain cyclical keto-enols and the
active agents (1) to (29) listed in the description have excellent insecticidal and
acaricidal properties.
__________________
]11[]21[
156097
–‫תרכובות ביס–אריל אורתו–מותמרות ומטה‬
‫ השימוש בהן‬,‫ שיטה להכנתן‬,‫מותמרות‬
‫ ותכשירי רוקחות המכילים תרכובות‬,‫כתרופה‬
‫אלו‬
]54[
ORTHO-SUBSTITUTED AND
META-SUBSTITUTED BIS-ARYL
COMPOUNDS, METHOD FOR
THE PRODUCTION THEREOF,
THEIR USE AS MEDICAMENTS
AND PHARMACEUTICAL
PREPARATIONS CONTAINING
THESE COMPOUNDS
]22[
]31[
]51[
17.11.2001
10059418.2
]32[ 30.11.2000
]33[ DE
Int. Cl.(2010.01) A61K 31//166, 31//44, 31//4427, A61P 09//06, C07C 23/7/30, C07D
21/3/81, 21/3/82, 40/1/12
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2002/044137
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]71[
]87[
]74[
]57[
The invention relates to compounds of formula (I), wherein A1 to A8, R(1), R(2),
R(3), R(4), R(30) and R(31) have the meanings as cited in the patent claims. These
compounds are especially well-suited for use as novel antiarrhythmic active
substances, in particular, for the treatment and prophylaxis of atrial arrhythmias, e.g.
atrial fibrillations (AF) or atrial flutters.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
156264
,‫–און כמשפעלים של גלוקוקינאז‬1–‫איזוינדולין‬
‫תהליך להכנתם ותכשירי רוקחות שלהם‬
]54[
ISOINDOLIN-1-ONE
GLUCOKINASE ACTIVATORS,
PROCESS FOR THEIR
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS THEREOF
]22[
]31[
07.12.2001
60/255273
]32[ 13.12.2000
]33[ US
60/318715
13.09.2001
US
Int. Cl.(2010.01) A61K 31//427, 31//4439, 31//4709, 31//506, A61P 03//10, C07D
40/1/12, 40/3/12, 41/3/12, 41/7/12
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2002/048106
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Isoindolin-1-one-substituted propionamide glucokinase activators which increase
insulin secretion in the treatment of type II diabetes.
]51[
]71[
]87[
]74[
]57[
__________________
]11[]21[
]54[
ENHANCED MULTIPOINT LOCK
]22[
]51[
]71[
08.06.2003
Int. Cl.(2010.01) E05C 09//04
MUL-T-LOCK TECHNOLOGIES
LTD.
ADALBERT MATYKO, ALEX
ACKERMAN
DEKEL PATENT LTD.,
18 MENUHA VENEHALA ST.,
REHOVOT 76209
]72[
]74[
156342
‫מנעול רב–נקודתי משופר הניתן להארכה‬
‫ יבנה‬,‫מולטילוק טכנולוגיות בע"מ‬
‫ אלקס אקרמן‬,‫אדלברט מטיקו‬
,‫דקל פטנט בע"מ‬
27 ‫ חדר‬18 ‫מנוחה ונחלה‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]57[
‫רחובות‬
A multipoint lock comprising:
a locking mechanism adapted to selectively retract and extend at least one locking
element relative to an elongate housing, wherein said locking mechanism comprises
an arm pivotally attached to a lock actuator and constrained to travel in a channel
formed in a linkage device linked to said at least one locking element, wherein said
channel comprises at least two termini extending from and generally perpendicular to
said channel at which said arm is in a locked position and said at least one locking
element is at an extended position protruding out of said elongate housing, and
wherein said at least one locking element extends further out of said elongate housing,
with said arm at one of the termini than at another of the termini, wherein the termini
of said channel comprise an inner terminus, at least one intermediate terminus and an
outer terminus, said outer terminus being closer to an end of said elongate housing
than said inner terminus, and wherein said channel is a continuously straight channel
from said inner terminus to said outer terminus and said at least one intermediate
terminus is generally perpendicular to said continuously straight channel, and wherein
said arm is arranged for moving in said channel from said inner terminus to said at
least one intermediate terminus and to said outer terminus.
__________________
]11[]21[
]54[
MEDICAL IMAGING AND
NAVIGATION SYSTEM
]22[
]31[
12.02.2002
09/949160
]32[ 07.09.2001
09/782528
13.02.2002
Int. Cl.(2010.01) A61B 05//00
MEDIGUIDE LTD.
WO/2002/064011
]51[
]71[
]87[
157262
‫מערכת הדמייה וניווט רפואית‬
]33[
US
US
‫ חיפה‬,‫מדיגייד בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]74[
]57[
,'‫בורוכוב קורח ושות‬
‫מגדל כלל עתידים‬
‫אביב‬-‫תל‬58100 .‫ד‬.‫ ת‬,
BOROCHOV, KORAKH & CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
The three dimensional imaging system (100) includes, a main computer (102), a twodimentional image acquisition device (104), an ECG monitor (106), a medical
positioning system (MPS) (108), a frame grabber (110), a three dimensional image
reconstructor (112), an adaptive volumetric database (114), a superingposing processor
(116), a surgical tool (120), a plurality of MPS sensors (162(1)-162 (N), and a display
(130).
__________________
]11[]21[
]54[
POST-PARTUM MAMMALIAN
PLACENTA, ITS USE AND
PLACENTAL STEM CELLS
THEREFROM
]22[
]31[
13.02.2002
60/268560
]32[ 14.02.2001
004942
05.12.2001
Int. Cl.(2010.01) C12N 05//0735
ANTHROGENESIS CORPORATION,
U.S.A.
WO/2002/064755
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
157350
‫ שימוש ותאי‬,‫שליה ממקור אנושי שלאחר לידה‬
‫גזע ממנה‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides a method of extracting and recovering embryonic like
November 30, 2010-‫כג' בכסלו התשע"א‬
stem cells, including, but not limited to pluripotent or multipotent stem cells, from an
exsanguinated human placenta. A placenta is treated to move residual umbilical cord
blood by perfusing an exsanguinated placenta, preferably with an anticoagulant
solution, to flush out residual cells. The residual cells and perfusion liquid from the
exsanguinated placenta are collected, and the embryonic-like stem cells are separated
from the residual cells and perfusion liquid. The invention also provides a method of
utilizing the isolated and perfused placenta as a bioreactor in which to propagate
endogenous cells, including, but not limited to, embryonic-like stem cells. The
invention also provides methods for propagation of exogenous cells in a placental
bioreactor and collecting the propagated exogenous cells and bioactive molecules
therefrom.
The applications for division
from this application have
not yet been published
,207025,207024,201916
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
158289
‫ תהליך להכנתן‬,‫תולדות מרקפטואצטילאמיד‬
‫והשימוש בהן כתרופות לטיפול באי – ספיקת לב‬
‫ובלחץ דם גבוה‬
]54[
MERCAPTOACETYLAMIDE
DERIVATIVES, A PROCESS FOR
THEIR PREPARATION AND
THEIR USE AS MEDICAMENTS
FOR THE TREATMENT OF
HYPERTENSION AND CHF
]22[
]31[
03.04.2002
60/283305
]32[ 12.04.2001
]33[ US
0119305.1
08.08.2001
GB
Int. Cl.(2010.01) A61K 31//55, A61P 09//00, C07D 47/1/04
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2002/083671
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]51[
]71[
]87[
]74[
7 ‫רחוב שנקר‬
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]57[
This invention discloses and claims a series of mercaptoacetylamide derivatives of
formula (I). Also disclosed and claimed are pharmaceutical compositions incorporating
these compounds and processes for preparing said compounds. The use of said
compounds for inhibition of the enzymes angiotensin converting enzyme and neutral
endopeptidase, and for the treatment of hypertension and congestive heart failure are
also disclosed and claimed.
__________________
]11[]21[
158433
‫תכשיר נוגד גידול המכיל טולואן סולפונאמיד‬
‫ושיטה לשימושו‬
]54[
TOLUENE SULFONAMIDECONTAINING ANTI-TUMOR
COMPOSITION AND METHOD OF
USE THEREOF
]22[
]31[
]51[
]71[
16.04.2002
09/835908
]32[ 16.04.2001
]33[ US
Int. Cl.(2010.01) A61K 31//18, A61P 35//00, C07C 31/1/15
ROCKY S.H. SHIH, U.S.A.
PTS INTERNATIONAL INC., U.S.A.
LESTER WU, U.S.A.
]87[
]74[
WO/2002/083117
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]57[
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
The invention relates to composition which exhibit anti-tumor activity and which
comprise a toluene sulfonamide at a concentration not previously recognized as being
November 30, 2010-‫כג' בכסלו התשע"א‬
efficacious for this purpose. The compositions exhibit the ability to inhibit tumor
growth, shrink (i.e., necrotize) tumors, and prevent tumor formation in humans. The
invention also includes methods of making and using the compositions.
__________________
]11[]21[
158457
‫יונקים טרנסגניים שאינם פרימטים לשימוש‬
‫בניבוי התנהגות סבירה של תרופות במין נבחר‬
‫של פרימט‬
]54[
TRANSGENIC NON - PRIMATE
MAMMALS FOR USE IN
PREDICTING THE LIKELY
BEHAVIOR OF A DRUG IN A
SELECTED SPECIES OF
PRIMATE
]22[
]31[
]51[
18.04.2002
PR4467
]32[ 18.04.2001
]33[ AU
Int. Cl.(2010.01) A01K 67//00, C07K 14//47, 14//765, C12N 15//12, 15//85, G01N
33//68
GENE STREAM PTY LTD.,
AUSTRALIA
WO/2002/083897
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
‫רמת החייל‬
RAMAT HACHAYAL 69710
]71[
]87[
]74[
]57[
The present invention is directed to the production, breeding and use of transgenic
non-human animals such as mice in which specific genes or portions of genes have
been replaced by homologues from another animal to make the physiology of the
animals so modified more like that of the other animal with respect to drug
pharmacokinetics and metabolism. The invention also extends to the use of the
genetically modified non-human animals of the invention for pharmacological and/or
toxicological studies.
__________________
]11[]21[
]54[
ANTHRANILIC ACID AMIDES
158504
‫אמידים של חומצה אנתרנילית ותכשירי רוקחות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫מהם‬
AND PHARMACEUTICAL
PREPARATIONS THEREOF
]22[
]31[
]51[
]71[
]87[
]74[
]57[
13.04.2002
10121003.5
]32[ 28.04.2001
]33[ DE
Int. Cl.(2010.01) A61K 31//18, 31//341, 31//40, 31//415, 31//426, 31//44, A61P
09//06, C07C 31/1/08, 31/1/14, 31/1/21, 31/1/29, C07D 20/7/335, 20/9/14, 21/3/40,
21/3/62, 21/5/12, 23/1/12, 23/1/16, 23/3/61, 23/3/64, 23/5/14, 27/7/28, 30/7/52,
40/1/12, 40/5/12
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2002/088073
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to anthranilic acid amides, to a method for the production
thereof, to their use as a medicament, and to pharmaceutical preparations containing
these anthranilic acid amides. The anthranilic acid amides consist of compounds of
formula (I) in which R(1) to (R7) have the meanings as cited in the claims, act upon
the Kv1.5 potassium channel, and inhibit a potassium stream described as an 'ultrarapidly activating delayed rectifier' in the human cardiac atrium. The compounds are
therefore especially suited as novel antiarrhythmic active substances, particularly for
treating and preventing atrial arrhythmias, e.g. atrial fibrillation AF or atrial flutter.
__________________
]11[]21[
]54[
INTEGRATED SAMPLE TESTING
METER
]22[
02.04.2003
159051
‫מד בחינה משולב לדגימה‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
0207610.7
]32[ 02.04.2002
Int. Cl.(2010.01) A61B 05//00
LIFESCAN SCOTLAND LIMITED,
UNITED KINGDOM
WO/2003/082091
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
An integrated sample testing meter, for instance for measuring blood, comprising a
puncture means, a sensor and a test strip cartridge disposed in a single modular
housing. The test strip cartridge includes a stack of test strips suitable for performing
an electrochemical or photometric analysis of a blood sample. The integrated test
system automatically dispenses and positions a test strip and forms a puncture site.
Blood is transferred to the test strip from the puncture site and the sensor automatically
analyzes the blood sample after the test strip collects the sample from the puncture site.
__________________
]11[]21[
]54[
APPARATUS AND METHOD FOR
SPRAYING MAINTENANCE
ENHANCING MATERIAL ONTO
THE PERIPHERY OF A
TUBULAR MEMBER
]22[
]51[
]71[
]72[
]74[
27.11.2003
Int. Cl.(2010.01) B05B 13//04
KAL SAL LTD.
SHLOMO KLINE, MARK SELA
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
159104
‫מתקן ושיטה להתזת חומר על ההיקף של חלק‬
‫ לשפור תחזוקתו‬,‫צינורי‬
‫ תל אביב‬,‫קל סל בע"מ‬
‫ מרק סלע‬,‫שלמה קליין‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]57[
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An apparatus for spraying maintenance enhancing material onto the periphery (11) of
a tubular member (10) positioned above a ground surface, comprising:
(a) one or more means for generating spray onto the periphery of the tubular member;
(b) means for positioning said one or more spray generating means in such a way that(i) the periphery of said tubular member is completely impinged by the spray issuing
from said one or more spray generating means; and
(ii) that a line (6) corresponding to the shortest distance of a spray issuing from a first
spray generating means to a first peripheral portion of said tubular member is oblique
with a radius (R) of said tubular member which bisects said first peripheral portion,
wherein the angle between said line and the vertical centerline of said tubular member
is greater than 20 degrees when the first peripheral portion includes a lowest point of a
horizontally disposed tubular member, said angle being equal to a maximum value
when said line is tangential to the periphery of said horizontally disposed tubular
member.
__________________
]11[]21[
159839
‫ תהליך להכנתם‬,‫פירזולילקרבוכסאנילידים‬
‫ושימוש בהם לבקרה על מיקרואורגניזמים בלתי‬
‫רצויים‬
]54[
PYRAZOLYLCARBOXANILIDES,
PROCESS FOR THEIR
PREPARATION AND THEIR USE
FOR CONTROLLING UNDESIRED
MICROORGANISMS
]22[
]31[
]51[
]71[
12.07.2002
10136065.7
]32[ 25.07.2001
]33[
Int. Cl.(2010.01) A01N 43//56, C07D 23/1/16
BAYER CROPSCIENCE AG,
GERMANY
WO/2003/010149
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Novel pyrazolylcarboxanilides of formula (I), where R1, R2, G, R3 and n have the
meanings given in the description, several methods for production of said materials and
uses thereof for treating undesirable microorganisms. The invention also relates to
novel intermediates and production thereof.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
DENTAL APPARATUS FOR
WHITENING TEETH USING
OZONE
]22[
]31[
31.07.2002
60/309570
]32[ 02.08.2001
10/196854
17.07.2002
Int. Cl.(2010.01) A61C 17//02, 19//06
CUROZONE IRELAND LTD.,
IRELAND
WO/2003/011170
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
159850
‫מכשיר דנטלי להלבין שיניים בשיםוש של אוזון‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method and apparatus for whitening teeth includes a source of oxidizing gas (12)
and a handpiece (16) for delivering the gas to the tooth (40). A cup (34) attached to the
handpiece (16) is provided for receiving the gas and exposing a selected area of the
tooth (40) to the gas. The cup (34) includes a resilient edge (44) for sealing the edge
(44) for engaging the tooth (40) around the selected area to prevent escape of a gas.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
MULTI-COMPARTMENT
CONTAINER ASSEMBLY SYSTEM
]22[
]31[
]51[
]71[
]72[
]87[
]74[
06.08.2002
60/310414
]32[ 06.08.2001
Int. Cl.(2010.01) B65D 25//08, 81//32
M.L.I.S. PROJECTS LTD.
IGAL SHARON
WO/2003/013960
DVORA GADOR,
53 DERECH HASHALOM ,
GIVATAYIM 53454
]57[
160007
‫מערכת הרכבת מיכל רב–תאי‬
]33[
US
‫ מושב בית יצחק‬,‫ בע"ם‬.‫ס‬.‫י‬.‫ל‬.‫מ‬
‫יגאל שרון‬
,'‫ גדור ושות‬,‫דבורה גדור עו"ד בלום‬
53 ‫דרך השלום‬
‫גבעתיים‬
A container assembly system for storing multiple components of a formulation in
separate individual container assembly units (10, 30, 30', 130, 130', 230, 230') that can
be assembled easily into a single multi-compartment container. The components of a
formulation may be stored in each assembly units (10, 30, 30', 130, 130', 230, 230')
and then assembled into a multi-compartment container so that the components can be
mixed into a formula just prior to use. The assembly units, each containing a
component of a formulation, can also be assembled into a single multi-compartment
container first and then stored until ready for use.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
‫קירור של מערכות לייזר כוח גבוה‬
]54[
COOLING OF HIGH POWER
LASER SYSTEMS
]22[
]31[
]51[
]71[
09.08.2002
09/932869
]32[ 17.08.2001
Int. Cl.(2010.01) H01S 03//042
TEXTRON SYSTEMS
CORPORATION, U.S.A.
WO/2003/017438
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
160110
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]57[
A method and apparatus for cooling a high power laser oscillator (200) or amplifier is
disclosed in which a plurality of laser gain media (102) that are configured such that
the width of the media is greater than the thickness of the media, are sandwiched
between pairs of optically transparent materials (104) having high thermal
conductivity. In this way, a shortened thermal path is created from the face surface of
the laser gain media (102) axially via the optically transparent heat conductor (104) to
an external heat exchange system (202). This provides an increased level of cooling of
the interior of the laser gain media (102) and avoids the deleterious effects caused by
over heating of the laser gain media (102) particularly with large effective cross
sections desired for high power and/or high pulse repetition and high pulse energy
operation.
__________________
]11[]21[
]54[
DIAMINE DERIVATIVES, SALTS
THEREOF AND SOLVATES AND NOXIDES THEREOF WHICH EXIBIT
POTENT FXA-INHIBITING EFFECT
AND ANTICOAGULANT EFFECT
]22[
]31[
08.08.2002
2001-243046
2001-311808
2001-398708
PCT/JP02/02683
]32[
09.08.2001
09.10.2001
28.12.2001
20.03.2002
160204
–N ‫ מלחים מזה וסולבנטים ו‬,‫תולדות דיאמין‬
‫ אשר מראים יכולת של אפקט‬,‫אוקסידים‬
‫ ואפקט נוגדי קרישה‬FXa ‫מדכאי‬
]33[
JP
JP
JP
WO
November 30, 2010-‫כג' בכסלו התשע"א‬
]51[
]71[
]87[
]74[
]57[
PCT/JP02/06141
20.06.2002
WO
Int. Cl.(2010.01) A61K 31//429, 31//4436, 31//506, A61P 07//02, C07D 40/1/14,
40/9/12, 51/3/04
DAIICHI SANKYO COMPANY,
LIMITED, JAPAN
WO/2003/016302
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
Compounds represented by the following general formula (1), salts thereof, solvates of
the same or N−oxides of the same: Q1−Q2−T0−N(R1)−Q3−N(R2)−T1−Q4 (1)
wherein R1 and R2 represent each hydrogen, etc.; Q1 represents optionally substituted,
saturated or unsaturated 5− or 6−membered hydrocarbyl, etc.; Q 2 represents a single
bond, etc.; Q3 represents the following group; (wherein Q5 represents C1−8 alkylene,
etc.); and T0 and T1 represent each carbonyl, etc. These compounds are useful as
preventives and/or remedies for brain infarction, cerebral embolism, myocardial
infarction, angina, pulmonary infarction, pulmonary embolism, Buerger’s disease,
bottom venous thrombosis, disseminated intravascular coagulation, thrombosis
following artificial valve/joint replacement, thrombosis and reocclusion following
circulation reconstruction, systemic inflammatory responsive syndrome (SIRS),
multiple organ dysfunction (MODS), thrombosis in extracorporeal circulation or blood
coagulation in collecting blood.
__________________
]11[]21[
160231
]54[
ADENOSINE A3 RECEPTOR
AGONISTS
]22[
]31[
]51[
]71[
06.08.2002
60/311069
]32[ 08.08.2001
]33[ US
Int. Cl.(2010.01) A61K 31//70, A61P 35//00, C07H 19//16
GILEAD PALO ALTO, INC., U.S.A.
‫ רספטור‬A3 ‫אגוניסטים של אדנוסין‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
WO/2003/014137
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Disclosed are novel compounds of the Formula I that are A3 adenosine receptor
agonists, useful for treating various disease states, including cancer, cardiac ischemia,
leukopenia, and neutropennia. Formula (I) wherein: R1 is optionally substituted lower
alkyl, optionally substituted cycloalkyl, optionally substituted aryl, or optionally
substituted heteroaryl; X is a covalent bond or optionally substituted alkylene; R1 is R4
Z-Y-C=C- or optionally substituted pyrazolyl: in which Y is optionally substituted
alkylene, Z is oxygen, sulfur or NH-, and R4 is optionally substituted aryl or optionally
substituted heteroaryl; and R3 is hydroxymethyl or C(O)-NR5R6; in which R5 and R6
are independently hydrogen or lower alkyl.
__________________
]11[]21[
160633
‫ספר אלקטרוני סורק‬
]54[
SCANNING ELECTRONIC BOOK
]22[
]31[
]51[
]71[
29.08.2002
09/942602
]32[ 31.08.2001
]33[ US
Int. Cl.(2010.01) G06F 01//16, G06K 09//20, 13//06
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2003/019338
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
]57[
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
An electronic book for presenting text and/or graphics includes a scanner for scanning
data cards bearing a pattern encoding the text and/or graphics. The electronic book
further includes a programmed processor for decoding the text and/or graphics and a
screen for displaying same. In a preferred embodiment the electronic book is provided
in a compact foldable housing with an appearance similar to a conventional book
including a flexible and foldable screen. The housing includes a spine having a recess
to allow the folded screen to loop without damage occurring due to creasing.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
160665
]54[
METHOD AND DEVICE FOR
PROVIDING COMMUNICATION
SERVICES
]22[
]51[
]71[
]74[
01.03.2004
Int. Cl.(2010.01) H04L 12//28, H04Q 11//04
ECI TELECOM LTD.
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
]57[
‫שיטה והתקן לאספקת שירותי תקשורת‬
‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫איי‬.‫סי‬.‫אי‬
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
30 ‫רחוב הסיבים‬
‫פתח תקוה‬
Technology for providing subscribers with communication services in accordance
with their agreements with a service provider, that comprises:
(a) determining a plurality of subscribers to be connected to the service provider
via a distribution unit located in an access network;
(b) selecting a default advanced broadband technology (DABT) for the
distribution unit;
(c) in the distribution unit, providing a plurality of communication devices to
reserve for each of the plurality of subscribers, irrespective of their agreements
reached with the service provider, an individual communication link for supplying
broadband communicatiom services based on the selected DABT;
while
(d) enabling each of the plurality of subscribers to receive services in accordance
with their respective agreements with the service provider.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
160983
]54[
USE OF PYY FOR PREPARATION
OF A MEDICAMENT FOR
MODIFICATION OF FEEDING
BEHAVIOR
]22[
]31[
24.09.2002
60/324406
]32[ 24.09.2001
]33[ US
0200507.2
10.01.2002
GB
60/392109
28.06.2002
US
Int. Cl.(2010.01) A61K 31//137, 31//138, 31//403, 38//22, A61P 03//04, 03//10
IMPERIAL INNOVATIONS
LIMITED, UNITED KINGDOM
OREGON HEALTH & SCIENCE
UNIVERSITY, U.S.A.
WO/2003/026591
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]51[
]71[
]87[
]74[
]57[
‫ להכנת תכשיר תרופתי לויסות‬PYY–‫שימוש ב‬
‫התנהגות בעת אכילה‬
Methods are disclosed for decreasing calorie intake, food intake, and appetite in a
subject. The methods include peripherally administering a therapeutically effective
amount of PYY or an agonist thereof to the subject, thereby decreasing the calorie
intake of the subject.
The applications for division
from this application have
not yet been published
,199364
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
161120
‫נגזרות של הטרואריל כליגנדים ראשונים במעלה‬
ORL–1 ‫לרצפטור נוציספטין מסוג‬
]54[
HETEROARYL DERIVATIVES AS
SUPERIOR LIGANDS FOR
NOCICEPTIN RECEPTOR ORL-1
]22[
]31[
]51[
]71[
06.11.2002
60/333284
]32[ 07.11.2001
]33[ US
Int. Cl.(2010.01) A61K 31//46, A61P 43//00, C07D 40/1/04, 40/1/14, 45/1/06
SCHERING CORPORATION, U.S.A.
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
WO/2003/039469
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
Novel compounds of the formula (I), wherein R is optionally substituted heteroaryl or
(a); R1 is H or C1-C6 alkyl; and R2 and R3 are -CH3, -OCH3 or halo; or a
pharmaceutically acceptable salt or solvate thereof, pharmaceutical compositions
therefor, and the use of said compounds in the treatment of pain, anxiety, cough,
asthma, depression and alcohol abuse are disclosed.
__________________
]11[]21[
161121
‫קופולימרים ליניאריים רנדומאליים לדיכוי‬
‫מחלות של מערכת החיסון ושיטות שימוש‬
]54[
LINEAR RANDOM COPOLYMERS
FOR SUPRESSION OF
AUTOIMMUNE DISEASES AND
METHODS OF USE
]22[
]31[
]51[
03.10.2002
60/326705
]32[ 03.10.2001
]33[ US
Int. Cl.(2010.01) A61K 38//07, 38//08, 38//16, A61P 37//02, C07K 05//10, 07//06,
14//00
PRESIDENT AND FELLOWS OF
HARVARD COLLEGE, U.S.A.
WO/2003/029276
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]71[
]87[
]74[
]57[
Random three- and four-amino acid copolymers having lengths of 14-,35- and 50amino acid residues are provided. Fifty-mers of FEAK were effective inhibitors of
MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell
clones. These copolymers efficiently suppressed EAE induced in susceptible SJL/J (H2s) strain of mice with either whole spinal cord homogenate (WSCH) or with the
encephalitogenic epitope PLP 139-151. YFAK 50-mer having a molar ratio of about y
0.8:F 0.2 inhibited binding of biotinylated MBP 85-99 epitope to HLA-DR-2
molecules more efficiently than either unlabeled MBP 85-99 or Copaxone®. YFAK
November 30, 2010-‫כג' בכסלו התשע"א‬
and FAK copolymers efficiently suppressed EAE induced in SJL/J (H-2s) mice with
the encephalitogenic epitope PLP 139-151. Copolymers YFK, VYAK and tryptophancontaining VWAK were efficacious in alleviating severity and duration of symptoms
of EAE induced by MBP 85-99, in a humanized mouse model expressing genes for
both an HLA-DR-2 linked to multiple sclerosis (MS) in humans and for a T cell
receptor from an MS patient.
,203117
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
VERIFICATION OF A PERSON
IDENTIFIER RECEIVED ONLINE
]22[
]31[
16.10.2002
60/329518
]32[ 17.10.2001
60/374548
23.04.2002
Int. Cl.(2010.01) H04L 09//32
PAYPAL ISRAEL LTD
SAAR WILF, SHVAT SHAKED
WO/2003/034633
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]51[
]71[
]72[
]87[
]74[
]57[
161437
‫אימות מזהה אדם שמתקבל און–ליין‬
]33[
US
US
‫ תל אביב‬,‫פייפאל ישראל בע"מ‬
‫ שבט שקד‬,‫סער וילף‬
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
A_system and method for verification of a person identifier received online is
described. The method includes receiving a request for verifying a person identifier
(P11); and estimating whether (a) P11(100) identifies the same person as another
person identifier (P12), (b) sender of P11 is the same person as sender of P12(106),
November 30, 2010-‫כג' בכסלו התשע"א‬
and (c) P12 identifies the sender of P12.
__________________
]11[]21[
161461
‫תאים אנדותליאלים המפקים מתאי גזע עוברים‬
‫של פרימאטים‬
]54[
ENDOTHELIAL CELLS DERIVED
FROM PRIMATE EMBRYONIC
STEM CELLS
]22[
]31[
]51[
]71[
01.11.2002
60/335332
]32[ 02.11.2001
]33[
Int. Cl.(2010.01) C12N 05//02, 05//0735
WISCONSIN ALUMNI RESEARCH
FOUNDATION, U.S.A.
WO/2003/040319
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method is described to induce primate embryonic stem cells to differentiate into a
relatively homogenous population of endothelial cells. The ES derived endothelial
cells have the general morphological and cell surface marker characteristics of
endothelial cells. The ES derived endothelial cells also are capable of inducing and
participating in blood vessel formation (or vascularization) when transplanted into
tissue in vivo.
__________________
]11[]21[
]54[
SOY MILK COMPOSITIONS
PREPARED BY A PROCESS
PROVIDING IMPROVED
TEXTURE AND THE PROCESS
FOR SUCH A PREPARATION
]22[
26.11.2002
161631
‫תכשירים של חלב סויה המוכנים בתהליך‬
‫המספק מבנה משופר והתהליך להכנתם‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
995247
]32[ 27.11.2001
Int. Cl.(2010.01) A23L 01//20
JENEIL BIOTECH, INC., U.S.A.
WO/2003/045170
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Soy milk and beverage compositions together with methods for preparation, such
compositions utilizing soy particulates of consistent micron dimension, either alone or
in conjunction with high process pressures, to provide texture and taste characteristics.
__________________
]11[]21[
]54[
CONTEXT MANAGEMENT
SUPER TOOLS AND
FILTER/SORT MODEL FOR
AGGREGATED DISPLAY
WEBPAGES
]22[
]31[
]51[
]71[
]87[
]74[
25.10.2002
10/001744
]32[ 31.10.2001
Int. Cl.(2010.01) G06F 17//30
IBM CORPORATION, U.S.A.
WO/2003/038583
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
]57[
161653
‫מיון‬/‫כלי–על לניהול סביבה ודוגמה לסינון‬
‫לעמודי רשת המיועדים לתצוגה מקובצת‬
]33[
US
,‫מעבדות יבמ מחלקת קנין רוחני‬
‫אוניברסיטת חיפה הר הכרמל‬
‫חיפה‬
An information aggregation and management system and method having selective
'drill-down' capabilities and employing an Object-Action Navigation methodology. A
user first selects an object of interest, and then selects one or more actions to perform
on said selected object. An informational object may be selected from a Context Pane,
and then an available action for that object may be selected from execution. A Content
Pane displays the results of the actions on the object or objects. The user may
rearrange, summarize, maximize, filter and sort information for display to effectively
manage display area and minimize operations necessary to obtain information and
analysis of interest.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
METHOD AND APPARATUS FOR
REDUCING
ELECTROMAGNETIC
INTERFERENCE AND JAMMING
IN GPS EQUIPMENT OPERATING
IN ROLLING ENVIRONMENTS
]22[
]31[
]51[
]71[
04.12.2002
60/335266
]32[ 04.12.2001
Int. Cl.(2009.01) G01S 01/00, 07/36
HONEYWELL INTERNATIONAL
INC., U.S.A.
WO/2003/048799
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
162220
‫שיטה ומכשיר להפחתת הפרעה ושיבוש‬
‫ הפועל בסביבות‬GPS ‫אלקטרומגנטיים בציוד‬
‫מסתובבות‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method and apparatus for reducing electromagnetic interference (EMI) and jamming
in Global Positioning System (GPS) receivers operating on rolling or spinning
platforms and/or environments is provided. An antenna system having a pair of
diametrically-mounted elements provides interferometric cancellation for spatial and
polarization nulling of interference signals. The antenna system, operating in
conjunction with multiplexing and anti jamming electronics, provides interference
suppression for a GPS receiver connected thereto. Interference cancellation is provided
in jamming and non-jamming environments by selectively employing spatial or
polarization nulling of the interference signal.
__________________
]11[]21[
]54[
HYPERTHERMIA TREATMENT
APPARATUS AND PROBE
THEREFOR
162483
‫מכשיר לטיפול בהיפרתרמיה ואמצעי לשם כך‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
12.12.2002
10/014846
]32[ 14.12.2001
]33[
Int. Cl.(2010.01) A61B 19//00, A61H 07//00
MONTERIS MEDICAL, INC.,
CANADA
WO/2003/051217
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
US
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
An MRI guided surgical apparatus includes a heat source formed by a laser and an
optical fiber carrying the heat energy into a part to be coagulated by hyperthermia with
an end reflector to direct the energy in a beam to one side of the fiber end. A
reinforcing sleeve for the fiber is mounted in a shielded, Piezo-electric motor which
causes movement of the fiber longitudinally and angularly within a rigid elongate
cannula. A magnetic resonance imaging system is arranged to generate a series of
output signals over a period of time representative of temperature in the part as the
temperature of the part changes during that time. The heat source is controlled in heat
energy applied and location and orientation of the beam to stop heating when the
temperature at the boundary of a tumor reaches the required hyperthermic temperature.
Cooling of the tip portion of the probe is effected by expansion of a supplied cooling
fluid in gaseous form through a restrictive orifice into an expansion zone at the probe
end. The fiber is thus encased in a stiff tubular titanium probe with a relatively small
fluid supply duct along the inside of the probe with the interior of the probe acting as a
return duct for the expanded gas. Thus the fiber end is contained in gas rather than
liquid and the temperature of the probe end can be monitored by a sensor in the probe
end and controlled by controlling the pressure in the supplied cooling fluid. The probe
is driven in the longitudinal and rotational directions to move the fiber tip.
__________________
]11[]21[
]54[
METHOD AND APPARATUS FOR
162812
‫שיטה ומכשיר לבקרת תקשורת נתונים מתחנות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫מוצא מרובות לתחנה ניידת במערת תקשורת‬
CONTROLLING
COMMUNICATIONS OF DATA
FROM MULTIPLE BASE
STATIONS TO A MOBILE
STATION IN A
COMMUNICATION SYSTEM
]22[
]31[
]51[
]71[
]87[
]74[
]57[
03.01.2003
60/346987
]32[ 08.01.2002
]33[ US
60/359005
20.02.2002
US
10/274343
18.10.2002
US
Int. Cl.(2009.01) H04J 11/00, H04L 01/00, 12/28
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/059002
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An apparatus and method provides for controlling communications from multiple base
stations to a mobile station in a communication system. A mobile station transmitter
transmits from the mobile station channel quality indicator data of a first base station.
The data is covered with Walsh code assigned to the first base station. A base station
receiver receives the transmission of the channel quality indicator data of the first base
station. The mobile station transmitter punctures the transmission of the channel
quality indicator data of the first base station with null channel quality indicator data,
and covers the null channel quality data with Walsh code assigned to a second base
station of the multiple base stations to indicate a desire to switch a source of
transmission of traffic data from the first base station to the second base station.
The applications for division
from this application have
not yet been published
,206251
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
162822
‫שימוש באנטגוניסטים של רצפטור סלקטיבי‬
‫לאוקסיטוצין בהכנת תרופות לטיפול בשפיכה‬
‫ שיטת ניסוי לזיהוי אנטגוניסטים‬,‫מוקדמת‬
‫שכאלה ותכשירים רפואיים המכילים אחד או‬
‫יותר מהאנטגוניסטים הנ"ל ואחד או יות‬
PDEIs
]54[
USE OF A SELECTIVE OXYTOCIN
RECEPTOR ANTAGONIST IN THE
MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF PREMATURE
EJACULATION, AN ASSAY
METHOD FOR IDENTIFYING
SUCH AGONISTS AND
PHARMACEUTICAL
COMPOSITIONS CONSISTING OF
ONE OR MORE OF SAID
ANTAGONISTS AND ONE OR
MORE PDEIS
]22[
]31[
]51[
20.01.2003
0202282.0
]32[ 31.01.2002
]33[ GB
Int. Cl.(2010.01) A01K 67//027, A61K 31//495, 38//11, 45//06, A61P 15//00, C07D
29/5/26
PFIZER INC., U.S.A.
WO/2003/064402
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]71[
]87[
]74[
]57[
A composition comprising a selective oxytocin antagonist for use in the treatment
and/or prevention of a male ejaculatory disorder; which selective oxytocin antagonist
is optionally admixed witha a pharmaceutically acceptable carrier, diluent or excipient.
__________________
]11[]21[
]54[
METHOD AND SYSTEM FOR
EFFECTIVELY PERFORMING
EVENT DETECTION IN A LARGE
NUMBER OF CONCURRENT
IMAGE SEQUENCES
162879
‫שיטה ומערכת לביצוע יעיל של אירוע זיהוי‬
‫במספר רב של רצפי דמות המתרחשים בו–זמנית‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
03.07.2003
60/394205
]32[ 05.07.2002
]33[ US
Int. Cl.(2010.01) G06K 09//00, G06T 07//20, G08B 13//196, H04N 07//18
ASPECTUS LTD.
‫ פ"ת‬,‫אספקטוס בע"מ‬
WO/2004/006184
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
Method and system for performing event detection and object tracking in image
streams by installing in field, a set of image acquisition devices, where each device
includes a local programmable processor for converting the acquired image stream that
consist of one or more images, to a digital format, and a local encoder for generating
features from the image stream. These features are parameters that are related to
attributes of objects in the image stream. The encoder also transmits a feature stream,
whenever the motion features exceed a corresponding threshold. Each image
acquisition device is connected to a data network through a corresponding data
communication channel. An image processing server that determines the threshold and
processes the feature stream is also connected to the data network. Whenever the
server receives features from a local encoder through its corresponding data
communication channel and the data network, the server provides indications
regarding events in the image streams by processing the feature stream and
transmitting these indications to an operator.
__________________
]11[]21[
162963
]54[
ANTIVIRAL COMPOSITION
DERIVED FROM ALLIUM CEPA
AND THERAPEUTIC USE
THEREOF
]22[
]31[
]51[
]71[
]72[
16.10.2002
10/076247
]32[ 14.01.2002
]33[
Int. Cl.(2010.01) A61K 35//00, 36//8962
DIEPON S.A., URUGUAY
ADOLFO GOREN, WALTER F.
GOLDMAN, ZILA TRAININ, SIMON
P. GOLDMAN
WO/2003/059071
DR. MARK FRIEDMAN LTD.,
]87[
]74[
CEPA –‫הרכב אנטי–ויראלי המופק מ‬
‫ ושימוש רפואי שלו‬ALLIUM
US
,‫ד"ר מרק פרידמן בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]57[
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
Novel medicinal extracts derived from Allium species, preferably Allium cepa are
provided. These extracts have broad medicinal properties, especially for treatment of
AMS and other viral infections.
__________________
]11[]21[
163092
‫עיבוד חבילות המועברות ברשתות תקשורת‬
]54[
PROCESSING OF PACKETS
FORWARDED IN
COMMUNICATION NETWORKS
]22[
]51[
]71[
]74[
19.07.2004
Int. Cl.(2010.01) H04L 12//56
VERAZ NETWORKS LTD.
‫ פתח תקוה‬,‫וראז נטוורקס בע"מ‬
ALEF GIMEL - INTELLECTUAL
,‫ ייעוץ לקניין רוחני בע"מ‬- .‫ג‬.‫א‬
PROPERTY CONSULTING LTD.,
‫רחובות‬2079 .‫ד‬.‫ ת‬,
P.O.B. 2079,
REHOVOT 76120
A method for processing a packet belonging to a communication signal, that
comprises a header and a payload and is to be conveyed in a packet switched
communication network,
characterized in that said method comprises associating said packet with a processing
indication to provide one or more processing instructions therefor and wherein said
indication is derived based upon parameters associated with the payload of said packet
and with the payload of at least one other packet belonging to said communication
signal.
]57[
__________________
]11[]21[
]54[
ALKOXYLATED AMINES FOR
USE IN ENHANCING THE
163325
‫אמינים אלקוקסים לשימוש בהגברת פעילותן‬
‫ תכשירים המכילים‬,‫של תכשירים כנגד פטריות‬
‫אותם ותהליכים להכנתם של תכשירים אלו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
ACTIVITY OF FUNGICIDAL
FORMULATIONS,
COMPOSITIONS COMPRISING
THEM AND PROCESS FOR THE
PREPARATION OF SAID
COMPOSITIONS
]22[
]31[
]51[
]71[
]87[
]74[
]57[
03.02.2003
02075466.9
]32[ 05.02.2002
]33[ EP
02080349.0
18.12.2002
EP
Int. Cl.(2009.01) A01N 33/08, 43/653, 55/10, C07C 215/12, 215/28, 217/08, 217/10,
217/28, C07D 249/08, 401/04, 405/06, C07F 07/12
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2003/065807
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The present invention relates to the use of alkoxylated amines to enhance the activity
of fungicidal formulations comprising fungicidal triazoles. It also relates to
formulations comprising one or more fungicidal triazoles and alkoxylated amines.
These formulations are useful for the protection of any living or non-living material,
such as crops, plants, fruits, seeds, objects made of wood, thatch or the like,
biodegradable material and textiles against deterioration due to the action of fungi.
__________________
]11[]21[
163414
‫מולקולה של חומצת גרעין המקודד לפוליפפטיד‬
)gp (R – GLM 130 ‫קולטן של מונוציטים דמוי‬
R – GLM ‫ושימושו להכנת פולפפטיד‬
]54[
NUCLEIC ACID MOLECULE
ENCODING A GP 130 - LIKE
MONOCYTE RECEPTOR (GLM-R)
POLYPEPTIDE AND ITS USE FOR
PRODUCING A GLM-R
POLYPEPTIDE
]22[
]31[
]51[
24.02.2003
60/359806
]32[ 25.02.2002
]33[ US
Int. Cl.(2009.01) A01K 67/027, A61P 37/02, C07K 14/715, C12N 01/21, 05/10,
G01N 33/566
GENENTECH, INC., U.S.A.
]71[
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
WO/2003/072740
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention is directed to novel polypeptides and variants thereof of GLM-R
polypeptides and to nucleic acid molecules encoding those polypeptides. Also
provided herein are vectors and host cells comprising those nucleic acid sequences,
chimeric polypeptide molecules comprising the polypeptides of the present invention
fused to heterologous polypeptide sequences, antibodies which bind to the
polypeptides of the present invention and to methods for producing the polypeptides of
the present invention. Also provided are methods for detecting agents that modulate
the activity of GLM-R. Also provided are methods for diagnosing and for treating
disorders characterized by the over or under abundance of monocytes or macrophages.
__________________
]11[]21[
163552
,‫צימודים של תרכובות בעלות פעילות ביולוגית‬
‫שימושיהם ותכשירי רוקחות המכילים אותם‬
]54[
CONJUGATES OF
BIOLOGICALLY ACTIVE
COMPOUNDS, USES THEREOF
AND PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME
]22[
]31[
14.02.2003
60/357434
]32[ 15.02.2002
]33[ US
10/367105
14.02.2003
US
Int. Cl.(2010.01) A01N 43//04, A61K 31//70, C07G 11//00, C07H 05//06, 17//08
MERCKLE GMBH, GERMANY
WO/2003/070174
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]51[
]71[
]87[
]74[
]57[
This invention features a compound of the following formula T-(-L-C)m, wherein T is a
transportophore (a transport mediating molecule), L is a a non-antibiotic therapeutic
agent, and m is l- 8, in which the transportophore has an immune selectivity ratio of at
least 2, the transportophore is covalently bonded to the non-antibiotic therapeutic agent
via the bond or the linker, and the compound has an immune selectivity ratio of at least
2. Figure 1 depicts comparison of selective uptake of diverse structure types into white
November 30, 2010-‫כג' בכסלו התשע"א‬
blood cells from a complex blood mix.
__________________
]11[]21[
]54[
SPRINKLER WITH A BALL
BEARING FOR ROTATIONAL
AND LINEAR MOVEMENTS
]22[
]51[
]71[
18.08.2004
Int. Cl.(2010.01) B05B 03//06
PLASTRO IRRIGATION SYSTEMS
LTD.
ZVIKA EINAV
WEBB & CO.,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
]72[
]74[
]57[
163606
‫ממטרה עם מיסב כדוריות לתנועות סיבוביות‬
‫וקוויות‬
‫ קיבוץ גבת‬,‫פלסטרו מערכות השקיה בע"מ‬
‫צביקה עינב‬
,'‫ד"ר וב ושות‬
2 ‫רח' פקריס‬
‫רחובות‬2189 .‫ד‬.‫ ת‬,
A revolving sprinkler (10) that comprises a static base assembly (28), adapted to receive a liquid into it, and
a revolving liquid spraying assembly (40), adapted to accept said liquid from said base
assembly and to move in an essentially linear motion relative to said base assembly in
a manner that would enable the sprinkling of said liquid outwards from the sprinkler,
and by an angular revolving motion relative to said base assembly it would enable
sprinkling said liquid around said sprinkler, and
a bearing means (210) for bearing said two motions - the linear one and the revolving
one- relative to said base assembly, and
wherein said revolving sprinkler is characterized by that said bearing means comprises a balls array mounted between said base assembly and
said revolving assembly.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
KEYED UNIVERSAL POWER TIP
AND POWER SOURCE
CONNECTORS
]22[
]31[
]51[
]71[
]87[
]74[
24.05.2004
790877
]32[ 02.03.2004
Int. Cl.(2010.01) H01R 27//00
IGO, INC., U.S.A.
WO/2005/096457
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
163615
‫תקע מותאם אוניברסלי ומחברים לספק כח‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A keyed power source connector (32) and keyed device connector (14) that are
backwards compatible, ensuring that the power rated device connectors can only mate
with power source connectors power rated at or above the device connector power
rating. One connector is formed as a plug, and the other connector is formed as a
socket. The connectors have peripheral contoured body portions (16, 34) having a
profile being a function of the respective connector power rating. A keyed portion (41,
62, 72, 82) of the power source connector plug will physically interfere with and not
be receivable within a device connector socket when the device connector power rating
exceeds the power source connector power rating. This connector system ensures that
target portable electronic devices coupled to the device connector can not draw power
exceeding the rating of the power source connector.
__________________
]11[]21[
163730
‫מחולל רדיאואיזוטופים ושיטה לבנייתו‬
]54[
RADIOISOTOPE GENERATOR
AND METHOD OF
CONSTRUCTION THEREOF
]22[
]31[
]51[
]71[
11.12.2002
0208356.6
]32[ 11.04.2002
]33[ GB
Int. Cl.(2010.01) A61M 36//08, G21G 01//00, 04//08
GE HEALTHCARE LIMITED,
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
UNITED KINGDOM
WO/2003/088269
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A device for producing a fluid containing a radioactive constituent, comprising a
shielded chamber (5) with an opening for receiving an isotope container (6) housing a
radioactive isotope (7); a chamber closure (18) adapted for cooperating with and
closing the chamber opening; a first fluid port comprising a first hollow needle
projecting into the shielded chamberfrom the chamber closure for fluid communication
with the isotope container; a second fluid port comprising a second hollow needle
projecting into the shielded chamber from the closed end of the chamber opposite the
chamber closure for fluid communication with the isotope container; first and second
compressible buffers (28, 29) mounted so as to surround at least partially the
respective first and second hollow needles (12, 13), each buffer providing an outer
surface for contact with opposed ends of the isotope container; and a spacer of a
predetermined thickness associated with one or each of the first and second
compressible buffers for determining the positioning of the isotope container within
the shielded chamber.
__________________
]11[]21[
]54[
SYSTEMS AND METHODS FOR
ACTIVE MONITORING AND
MANAGEMENT OF FIBER LINKS
]22[
]31[
26.02.2003
60/359306
60/359305
10/350338
]32[
26.02.2002
26.02.2002
24.01.2003
163760
‫מערכות ושיטות לניטור פעיל וניהול חיבורי‬
‫סיבים‬
]33[
US
US
US
November 30, 2010-‫כג' בכסלו התשע"א‬
]51[
]71[
]87[
]74[
]57[
10/372710
25.02.2003
Int. Cl.(2010.01) H04B 10//08
NESTRONIX, INC., U.S.A.
WO/2003/073137
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
Systems and methods for actively monitoring and managing the integrity of an optical
fiber communications link (157, 158). The optical fiber link integrity is monitored to
guard against intrusions and other security breaches. In one embodiment, a local and a
remote active monitoring system (160, 165) are coupled by four fiber paths (132, 134,
142, 144) that provide primary and back-up transmit and receive paths between
communication equipment (110, 120). In one embodiment, a security light signal (170)
is transmitted using a secondary wavelength that differs from the wavelength used to
transmit a user data light signal and travels in an opposite direction relative to the user
data light signal (173). An active monitoring system (160, 165) monitors both
administrative information contained within the security light signal (900) and the
intensity of the security light signal (1000) to manage the integrity of the fiber optic
link. Methods (1100, 1200) are provided to characterize events (1130) impacting the
fiber optic link integrity.
__________________
]11[]21[
163894
– 3 – ‫ – הידרוקסי‬2 ‫נגזרות של‬
‫ תרכובות הכוללות אותן‬,‫הטרוארילאינדול‬
‫ושימושיהן להכנת תרופות‬
]54[
2-HYDROXY-3HETEROARYLINDOLE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND THEIR USES IN THE
PREPARATION OF
MEDICAMENTS
]22[
]31[
]51[
28.03.2003
0200979-3
]32[ 28.03.2002
]33[ SE
Int. Cl.(2010.01) A61K 31//404, 31//4427, 31//495, A61P 25//00, 43//00, C07D
40/1/04, 40/1/14, 40/3/04, 40/3/14, 40/5/14, 41/3/14, 41/7/14
ASTRAZENECA AB, SWEDEN
]71[
November 30, 2010-‫כג' בכסלו התשע"א‬
]72[
]87[
]74[
]57[
STEFAN BERG, SVEN HELLBERG,
MARTIN NYLOF, YAFENG XUE
WO/2003/082853
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
The present invention provides new compounds of formula Ia and Ib: as well as a
process for their preparation and new intermediates used therein, pharmaceutical
formulations containing said therapeutically active compounds and to the use of said
active compounds in therapy.
__________________
]11[]21[
]54[
CONTRAST AGENTS FOR
MAGNETIC RESONANCE
IMAGING AND METHODS
RELATED THERETO
]22[
]31[
]51[
]71[
07.03.2003
60/363163
]32[ 07.03.2002
Int. Cl.(2010.01) A61K 49//14, 49//18
CARNEGIE MELLON UNIVERSITY,
U.S.A.
WO/2003/075747
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
163937
‫גורמי ניגוד להדמיית תמ"ג ושיטות הקשורות‬
‫לכך‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
In certain aspects of the present invention provides methods and compositions related
to contrast agents for magnetic resonance imaging. In certain variations, contrast
agents provided herein are generated in situ via genetic instructions and become potent
upon sequestering available metal atoms. Exemplary contrast agents include metalNovember 30, 2010-‫כג' בכסלו התשע"א‬
binding proteins.
__________________
]11[]21[
164006
– ‫ – איל‬1 – )‫תולדות של פיפראזין (או פיפרידין‬
]4,2,1[ ‫ או פירידין או‬,‫פירימידין (או פניל‬
‫ – הידרוקסי אמיד חומצה‬5 – )‫טריאזין‬
‫ תכשירי רוקחות המכילים אותן‬,‫קרבוקסילית‬
‫ותהליך להכנתן‬
]54[
DERIVATIVES OF PIPERAZIN
(OR PIPERIDINE) - 1 - YL PYRIMIDINE (PHENYL,
PYRIDINE OR [1,2,4] TRIAZINE) 5 -CARBOXYLIC ACID
HYDROXYAMIDE,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND A PROCESS FOR
THEIR PREPARATION
]22[
]31[
]51[
11.03.2003
60/363799
]32[ 13.03.2002
]33[ US
Int. Cl.(2010.01) A61K 31//40, 31//438, 31//495, 31//505, A61P 35//00, C07D
20/7/09, 29/5/155, 29/5/26, 40/1/04, 40/1/14, 40/3/04, 40/5/06, 40/9/14
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2003/075929
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]71[
]87[
]74[
]57[
This invention comprises the novel compounds of formula (I) wherein n, R 1, R2, R3,
R4, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting
enzymatic activity; their preparation, compositions containing them and their use as a
medicine.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
164043
‫רכיבית ואמצעי ייצורה‬-‫טפטפת דו‬
]54[
DUAL COMPONENT DRIP
EMITTER AND ITS
PRODUCTION MEANS
]22[
]51[
]71[
13.09.2004
Int. Cl.(2010.01) B05B 15//00, F17D 01//14
PLASTRO IRRIGATION SYSTEMS
‫ קיבוץ גבת‬,‫פלסטרו מערכות השקיה בע"מ‬
LTD.
ZVIKA EINAV
‫צביקה עינב‬
WEBB & CO.,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
2 ‫רח' פקריס‬
REHOVOT 76121
‫רחובות‬2189 .‫ד‬.‫ ת‬,
A dual component drip emitter (10) that comprisesan internal component (20) that includes a labyrinth with a flow passage (45) in it, and
an external component (30) that includes an exit pool formed at its outer wall surface,
and
wherein said drip emitter is characterized bysaid internal component is suited by its dimensions for being assembled into said
external component, using a linear movement so that upon assembling said internal
component inside said external component, said flow passage provided in said
labyrinth will be connected and provide for a water flow passage leading into said exit
pool.
]72[
]74[
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
LEAD IRON TUNGSTATE
CAPACITIVE TRANSDUCER,
RELAXOR MATERIAL
THEREFOR AND METHOD OF
MANUFACTURE OF RELAXOR
MATERIAL
]22[
]51[
]71[
28.03.2002
Int. Cl.(2010.01) G01L 09//12
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH, INDIA
INDIAN INSTITUTE OF
TECHNOLOGY, INDIA
WO/2003/083428
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
164145
‫ חומר‬,‫שנאי עם קיבול מעופרת ברזל טונגסטאט‬
‫ שיטת ייצור של חומר הרפיה‬,‫הרפיה עבורו‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention discloses a relaxor material lead iron tungstate which has been
synthesized in doped and undoped conditions by single and two step heat treatment.
The relaxor material is seen to exhibit almost negligible hysteresis and a transducer
made thereby shows pressure measurement capability over a wide range from 0.5MPa
to 415MPa with accuracy of ± 0.05%.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
164169
‫תרכובות מאפננים לא סטרואידליים של קולטן‬
‫ והשימוש בהם בריפוי‬,‫פרוגסטרון‬
]54[
NON-STEROIDAL
PROGESTERONE RECEPTOR
MODULATOR COMPOUNDS AND
THEIR USE IN THERAPY
]22[
]31[
]51[
]71[
01.04.2003
02076350.4
]32[ 04.04.2002
]33[ EP
Int. Cl.(2010.01) A61K 31//55, A61P 05//24, C07D 47/1/04, 49/8/04, 51/3/04
N.V. ORGANON, THE
NETHERLANDS
WO/2003/084963
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]87[
]74[
]57[
The present invention provides compounds according to general Formula (I), a prodrug
thereof, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable
salt of a prodrug thereof. More particularly, the present invention provides high
affinity non-steroidal compounds which are agonists, partial agonists or antagonists of
the progesterone receptor.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
GROWTH MEDIUM FOR
MICROORGANISMS
COMPRISING THE BIOMASS OF
METHANOTROPHIC AND
HETEROTROPHIC BACTERIA
]22[
]31[
]51[
]71[
]87[
]74[
17.04.2003
0209007.4
]32[ 19.04.2002
Int. Cl.(2010.01) C12N 01//00, 01//20
STATOILHYDRO ASA, NORWAY
WO/2003/089625
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
164517
‫מצע לגידול מיקרואורגניזמים המכילים‬
‫ביומאסה של בקטריה מתאנוטרופית‬
‫והטרוטרופית‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a microorganism growth substrate which comprises a sterile
nutrient composition derived from the biomass of a culture of bacteria including
methanotrophic bacteria and further containing at least one sterile nutrient. A preferred
biomass material is that derived from a microbial culture comprising Methylococcus
capsulatus (Bath) (strain NCIMB 11132), Ralstonia sp. DB3 (strain NCIMB 13287)
and Brevibacillus agri DB5 (strain NCIMB 13289), optionally in combination with
Aneurinibacillus sp. DB4 (strain NCIMB 13288).
__________________
]11[]21[
]54[
PROCESS FOR PREPARING 5-[[2(R)-[1(R)-[3,5BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]3(S)-(4-FLUOROPHENYL)-4- MORPHOLINYL]
METHYL]-1,2-DIHYDRO-3H-1,2,4-TRIAZOL-3ONE
164586
R )1]–(2[[–5 ‫תהליך להכנת‬
‫ –ביס‬5,3 [ – )ׂ(R
]‫(טריפלואורומתיל) פניל‬
–) S (3– ]‫אתוקסי‬
– 4–)‫ –פלואורופניל‬4 (
– ,2 ,1– ]‫מורפוליניל] מתיל‬
–‫דיהידרו‬
‫ –און‬3–‫ טריאזול‬H31
November 30, 2010-‫כג' בכסלו התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
17.04.2003
60/373,734
]32[
18.04.2002
Int. Cl.(2010.01) C07D 41/3/06
MERCK SHARP & DOHME CORP., U.S.A.
MERCK SHARP & DOHME LTD, UNITED
KINGDOM
WO/2003/089429
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]33[
US
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
The present invention is concerned with a novel process for the preparation of the
compound 5-[[2(R)-[1(R)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one. This
compound is useful as a substance P (neurokinin-1) receptor antagonist. In particular,
the compound is useful e.g., in the treatment of psychiatric disorders, inflammatory
diseases and emesis.
__________________
]11[]21[
]54[
INK CARTRIDGE FOR COMPACT
PRINTER SYSTEM
]22[
]31[
]51[
]62[
]71[
24.05.2000
PQ0560
]32[ 25.05.1999
Int. Cl.(2008.04) B41J 2/
DIVISION FROM 146719
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/071349
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
164692
‫מחסנית דיו עבור מדפסת קומפקטית‬
]33[
AU
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
An ink cartridge for a printer module of a compact printer system. The ink cartridge is
characterized by being located on the opposite side of a printable media from a
printhead in the printer module. The ink cartridge houses a pair of neutral rollers that
cooperate with powered rollers in the printer module to urge the printable media past
November 30, 2010-‫כג' בכסלו התשע"א‬
the printhead.
__________________
]11[]21[
165194
]54[
T CELL RECEPTOR CDR3
PEPTIDE FOR TREATING AN
AUTOIMMUNE DISEASE
]22[
]31[
]51[
]71[
05.06.2003
60/386,287
]32[ 05.06.2002
]33[ US
Int. Cl.(2009.01) A61K 38/17, C07K 14/705, C12N 15/13
OPEXA PHARMACEUTICALS INC.,
U.S.A.
BAYLOR COLLEGE OF MEDICINE,
U.S.A.
WO/2003/104407
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
‫ לטיפול במחלה‬T ‫ של קולטן תא‬CDR3 ‫פפטיד‬
‫אוטואימונית‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention relates generally to the field of treating autoimmune diseases,
such as multiple sclerosis (MS), rheumatoid arthritis (RA) and others. Methods of
treating and monitoring an autoimmune disease by utilizing T-cell receptors peptides
are disclosed. Nucleic acid and peptide sequences of T-cell receptors found in a
population of MS patients are also disclosed.
The applications for division
from this application have
not yet been published
,206650
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
SYSTEM AND METHOD FOR
AUTOMATICALLY
CALIBRATING AN ALIGNMENT
REFERENCE SOURCE
]22[
]31[
]51[
]71[
]87[
]74[
07.08.2003
10/215578
]32[ 09.08.2002
Int. Cl.(2010.01) G01B 11//27
RAYTHEON COMPANY, U.S.A.
WO/2004/015893
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
165561
‫מערכת ושיטה לכיול אוטומטי של מקור קוונון‬
‫להשוואה‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A system (10, 12, 34) for calibrating an apparatus (10) for aligning components (20)
relative to a desired line of sight. The system includes a first mechanism (70) for
generating a command designed to move a line-of-sight of one of the components (20)
to a first position, the line-of-sight moving to a second position in response thereto. A
second mechanism (36, 38, 74, 78) automatically compensates for a variation between
the first position and the second position via a scale factor (78). In a specific
embodiment, the system (10, 12, 34) further includes a third mechanism (74) that
adjusts the command via the scale factor (78) so that the second position matches the
first position. The line-of-sight is coincident with a first reference beam (50). The
second mechanism (36, 38, 74, 78) includes a photodetector (36) and the steering
mirror (38). The steering mirror (38) is responsive to the command and positioned to
direct the first reference beam (50) onto the photodetector (36) to create a reference
spot corresponding to the first reference beam (50) on the surface of the photodetector
(36). The second mechanism (36, 38, 74, 78) includes a computer (12) that
communicates with the steering mirror (38) and receives output from the photodetector
(36). The computer (12) runs software (34, 70) for generating the command and
measuring the first position and the second position of the first reference beam (50) by
measuring corresponding positions of the reference spot on the surface of the
photodetector (36).
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
AUDIO CODING SYSTEM USING
SPECTRAL HOLE FILLING
]22[
]31[
]51[
]71[
30.05.2003
10/174493
]32[ 17.06.2002
Int. Cl.(2010.01) G10L 19//02
DOLBY LABORATORIES
LICENSING CORPORATION, U.S.A.
WO/2003/107328
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
165650
‫מערכת לקידוד אודיו המשתמשת כמילוי של חור‬
‫ספקטראלי‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Audio coding processes like quantization can cause spectral components of an encoded
audio signal to be set to zero, creating spectral holes in the signal. These spectral holes
can degrade the perceived quality of audio signals that are reproduced by audio coding
systems. An improved decoder avoids or reduces the degradation by filling the spectral
holes with synthesized spectral components. An improved encoder may also be used to
realize further improvements in the decoder.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
165657
‫ תכשירים הכוללים‬,‫ תהליך להכנתן‬,‫תרכובות‬
‫אותן ושימושן בהכנת תרופות לטיפול במחלות‬
‫ובמצבים דלקתיים‬
]54[
COMPOUNDS, PROCESS FOR
THEIR PREPARATION,
COMPOSITIONS COMPRISING
THEM AND USE THEREOF FOR
THE MANUFACTURE OF
MEDICAMENTS FOR TREATING
INFLAMMATORY DISEASES AND
CONDITIONS
]22[
]31[
]51[
08.07.2003
60/394,670
]32[ 08.07.2002
]33[ US
Int. Cl.(2010.01) A61K 31//58, 31//7048, A61P 01//04, 05//44, 09//10, 11//06, 17//00,
17//06, 19//02, 19//06, 27//02, 29//00, 37//00, C07H 17//08, C07J 21//00, 43//00
GLAXOSMITHKLINE
ISTRAZIVACKI CENTAR ZAGREB
D.O.O., CROATIA
WO/2004/005310
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]71[
]87[
]74[
]57[
The present invention relates (a) to new compounds represented by Formula (I):
wherein M represents a macrolide subunit (macrolide moiety) derived from macrolide
possessing the property of accumulation in inflammatory cells, S represents a steroid
subunit (steroid moiety) derived from steroid drug with anti-inflammatory activity and
L represents a linker molecule linking M and S, (b) to their pharmacologically
acceptable salts, prodrugs and solvates, (c) to processes and intermediates for their
preparation, and (d) to their use in the treatment of inflammatory diseases and
conditions in humans and animals. Such compounds inhibit many cytokines and
immune mediators involved in immune responses which cause inflammation, allergy,
or alloimmunity, including without limitation IL-1, 2, 4, 5, 6, 10, 12, GMCSF, ICAM,
and TNF-&agr;. Importantly, anti-inflammatory steroids exert a direct antiinflammatory effect through binding to the glucocorticosteroid receptor.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
165721
]54[
REDUCING CROSSINTERFERENCE IN A
COMBINED GPS RECEIVER AND
COMMUNICATION SYSTEM
]22[
]51[
]71[
20.06.2002
Int. Cl.(2010.01) G01S 01//00, 05//14, H04B 01//38
SNAPTRACK INCORPORATED,
U.S.A.
WO/2004/000019
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
‫ (מערכת‬GPS ‫הקטנת הפרעת מטלבת במקלט‬
‫מיקום גלובלי) מאחד ומערכת תקשורת‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method of operating a mobile device is disclosed. A first activity of the mobile
device is detected. The following two operations are executed upon detection of the
first activity; (i) wireless transmission of data over a wireless data link from a
communication unit of the mobile device is disabled for a period of time, and (ii) a
first control signal is transmitted from a communication unit to a satellite positioning
system receiver of the mobile device, the first control signal enabling processing of
signal positioning system signals received by the receiver during this period of time.
The size of this period of time may be predetermined or adaptable.
__________________
]11[]21[
]54[
METHOD FOR DIAGNOSING
MULTIPLE SCLEROSIS
]22[
]31[
04.08.2003
60/400914
]32[ 02.08.2002
60/447076
13.02.2003
60/462984
15.04.2003
60/473231
23.05.2003
Int. Cl.(2009.01) G01N 33/564
GLYCOMINDS LTD.
]51[
]71[
166539
‫שיטה לאבחון תרשת נפוצה‬
]33[
US
US
US
US
‫ לוד‬,‫ בנין אלון‬,‫גליקומיינדס בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
WO/2004/015420
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Disclosed is a method for diagnosing multiple sclerosis and more particularly to a
method for diagnosing multiple sclerosis by measuring levels of antibodies to glycans
in a biological sample. In one embodiment, the antibodies are anti-maltose IgM. In a
specific embodiment, the levels of antibodies to a set of different glycans are measured
by means of carbohydrate-chips.
__________________
]11[]21[
]54[
MAGAZINE HOLDER FOR A
FIREARM
]22[
]51[
]71[
27.01.2005
Int. Cl.(2009.01) F41A 09/61
FAB MANUFACTURING &
IMPORT OF INDUSTRIAL
EQUIPMENT LTD.
BLUM, GADOR & CO.,
53 HASHALOM RD.,
GIVATAYIM 53454
]74[
]57[
166542
‫מחזיק מחסנית עבור כלי ירי‬
‫ משמר‬,‫פאב ייצור ויבוא ציוד תעשייתי בע"מ‬
‫השבעה‬
,'‫ גדור ושות‬,‫בלום‬
‫ מגדל הורד‬23 ‫ קומה‬,53 ‫דרך השלום‬
‫גבעתיים‬
A magazine carrier (20) for a firearm having a magazine holder (32), the magazine
carrier comprising:
a substantially hollow body adapted and configured to receive and hold a spare
ammunition magazine; said substantially hollow body having an outer surface
ergonomically shaped like a pistol grip (60), the magazine carrier serves also as a
forehand grip; and a mounting rail (50) for removably mounting the magazine carrier
externally on the firearm; said mounting rail being adapted and configured for
mounting the magazine carrier on a complementary mounting rail on the firearm.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
CLOSURE SYSTEM FOR A VIAL,
VIAL, METHOD OF CLOSING
AND FILLING A VIAL AND
STAND FOR A VIAL
]22[
]31[
15.08.2003
0219152.6
]32[ 16.08.2002
0304268.6
25.02.2003
Int. Cl.(2010.01) B65D 51//18
ASEPTIC TECHNOLOGIES S.A.,
BELGIUM
WO/2004/018317
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
166637
‫ שיטה‬,‫ בקבוקון‬,‫מערכת סגירה לבקבוקון‬
‫לסגירה ומילוי הבקבוקון ומעמד לבקבוקון‬
]33[
GB
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A closure system for a pharmaceutical vial, comprising an elastomer closure part (20),
a clamp part (30) which holds the closure part in engagement with the mouth of the
vial, and a cover part (40) which engages with the clamp part. The interior of the
closure part is profiled to minimise retention of residual liquid therein.
The applications for division
from this application have
not yet been published
,194765,194764
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
PROCEDURE FOR JAMMER
DETECTION
]22[
]31[
]51[
]71[
28.08.2003
10/232637
]32[ 29.08.2002
Int. Cl.(2009.01) G01S 01/00
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/021030
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
166788
)‫ניהול לגילוי ג'מר (גורם מתקיע‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method of and system for detecting whether a peak of a correlation function derived
from a received signal is due to a jammer. The peak is within a localized portion of the
correlation function which has a total number of peaks. In one embodiment, the total
number of peaks is compared to a threshold number of peaks, and the peak is identified
as being due to a jammer if the total number of peaks equals or exceeds a threshold
number of peaks. In a second embodiment, the peak energy in relation to a noise
estimate for the localized portion of the correlation function is compared to a jammer
threshold. The peak is identified as being due to a jammer if the peak energy in
relation to the noise estimate is less than or equal to the jammer threshold.
__________________
]11[]21[
]54[
APPARATUS FOR INSERTING A
CATHETER DEVICE
]22[
]51[
]71[
14.02.2005
Int. Cl.(2010.01) A61M 25//01
FLEXICATH LTD.
166863
‫מתקן להחדרת התקן קטטר‬
‫ חיפה‬,‫פלקסיקט בע"מ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]72[
]74[
]57[
SHAI AMISAR, RONEN
‫ רונן רדומסקי‬,‫שי עמישר‬
RADOMSKI
PYERNIK RUTMAN,
,‫פיירניק רוטמן עו"פ‬
BEIT ETSION,
91 ‫ רח' הרצל‬,‫בית עציון‬
91 HERZL ST.,
‫באר שבע‬10012 .‫ד‬.‫ ת‬,
P.O.B. 10012,
BEER SHEVA
The present invention relates to systems for inserting a catheter device into a subject,
wherein the catheter insertion system generally comprises a flexible sleeve containing
a catheter tube and advancing means for advancing the catheter contained within said
system in a distal direction, wherein the flexible sleeve has a sealed proximal end and
a distal end which may comprise a slender passage adapted to allow passage of said
catheter tube therethrough while preventing backflow of fluid into the flexible sleeve.
__________________
]11[]21[
]54[
SYSTEM FOR IN VIVO
SAMPLING AND ANALYSIS
]22[
]31[
]51[
]71[
]72[
]87[
]74[
07.08.2003
60/402703
]32[ 13.08.2002
Int. Cl.(2010.01) A61B 05//00
GIVEN IMAGING LTD.
YORAM PALTI
WO/2004/014227
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]57[
166884
‫מערכת לדיגום וניתוח תוך גופי‬
]33[
US
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
‫יורם פלטי‬
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
A system for in vivo analysis which includes agglutinative particles capable of
interacting with at least one analyte so as to cause an optical change; and at least one in
vivo imaging system (220, 230, 240) configured for detecting the optical change in
vivo. The system may be incorporated within an ingestible capsule (100).
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
LOW PROFILE WIDEBAND
ANTENNA ARRAY
]22[
]31[
]51[
]71[
]87[
]74[
19.09.2003
10/255313
]32[ 26.09.2002
Int. Cl.(2010.01) H01Q 21//06
RAYTHEON COMPANY, U.S.A.
WO/2004/030151
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
166916
‫מערך אנטנה פס–רחב בעל פרופיל נמוך‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A phased array antenna (10) (Figure 6) having a low profile (approximately 1/8
wavelength) wide bandwidth (approximately 50%). The invention teaches making
such an antenna using open channel resonators (22) and monopole wave launchers
(110). The wave launchers may conveniently be made on circuit card assemblies (106)
with strip lines (110) that mimic coaxial cable monopole wave launchers. The channel
resonators (22) may be made in sections that are connected to the circuit card
assemblies. The circuit card assemblies (106) have plated through holes that trace the
edges of the resonator sections to provide electrical continuity.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
NETWORK EDGE DEVICE AND
TELECOMMUNICATIONS
NETWORK
]22[
]51[
]71[
]74[
23.02.2005
Int. Cl.(2010.01) H04L 12//56
TEJAS ISRAEL LTD
BLUM, GADOR & CO.,
53 HASHALOM RD.,
GIVATAYIM 53454
]57[
167059
‫מכשיר קצה ורשת תקשורת‬
,'‫ גדור ושות‬,‫בלום‬
‫ מגדל הורד‬23 ‫ קומה‬,53 ‫דרך השלום‬
‫גבעתיים‬
A configurable edge device (10, 22) for use in a network, the edge device being
adapted and configured to be coupled to at least one other edge device (22') in a
network (20, 30, 52), and having an admission controller (12) and a router, wherein
operation of said admission controller and said router is controlled in accordance with
data defining all physical and logical links in the network, the edge device comprising:
an admission controller (12) for providing rate limiting admission control of ingress
data traffic to the network (20, 30, 52) onto a pre-defined flow (24, 24') over a
physical link; and a router for routing said ingress data traffic through said edge device
onto said pre-defined flow in accordance with a pre-defined routing scheme;
wherein said pre-defined routing scheme is a static routing scheme which is changed
periodically to another static routing scheme.
__________________
]11[]21[
]54[
DECONTAMINATION LIQUID
167066
‫מתקן ריסוס לנוזל טיהור‬
November 30, 2010-‫כג' בכסלו התשע"א‬
SPRAYING APPARATUS
]22[
]31[
]51[
]71[
]87[
]74[
]57[
21.10.2003
20216472.1
]32[ 24.10.2002
Int. Cl.(2010.01) B05B 12//02
OWR AG, GERMANY
WO/2004/037434
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]33[
DE
,‫ד"ר יצחק הס ושותפיו‬
279 ‫רחוב הירקון‬
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
The invention relates to a decontamination liquid spraying apparatus (1) comprising a
reservoir (2) for holding decontamination liquid (4), particularly GD5 solution, and
comprising a spraying device, which is flow-connected to said reservoir (2), for
decontaminating objects contaminated by contaminants. Said spraying apparatus is
characterized in that the reservoir is provided in the form of a pressure reservoir (2)
having a threaded opening (10) made therein, and that the spraying device has an
adapter head (6) that can be screwed into said threaded opening in a pressure-tight
manner. The adapter head supports a regulating valve (26) for regulating the amount of
decontamination liquid (4) to be sprayed and supports a hand-operated air pump (12).
This air pump comprises a pump tube (14), which projects into the pressure reservoir
(2), and a pump plunger (16), which can be displaced inside the pump tube (14) via a
plunger rod (18) that is guided through the adapter head (6), in order to subject the
inner space of the pressure reservoir (2) to an overpressure.
__________________
]11[]21[
]54[
METHOD FOR THE
PREPARATION OF GROWTH
HORMONE AND ANTAGONIST
THEREOF HAVING LOWER
167121
‫שיטה להכנת הורמון גדילה ואנטגוניסט בעלת‬
‫רמות נמוכות יותר של זיהומי איזופורם‬
November 30, 2010-‫כג' בכסלו התשע"א‬
LEVELS OF ISOFORM
IMPURITIES THEREOF
]22[
]31[
]51[
]71[
]72[
]87[
]74[
]57[
26.08.2003
60/406553
]32[ 28.08.2002
]33[ AR
10/646798
25.08.2003
US
Int. Cl.(2010.01) C07K 01//113, 01//18, 14//575, 14//61
PHARMACIA CORPORATION,
U.S.A.
ANURAG S. RATHORE, STEPHEN
B. LYLE, DAVID E. STEINMEYER,
SCOTT I. ALLEN, JOHN MEYER,
DENNIS M. BOYLE, JOHN J.
BUCKLEY, GARY V. JOHNSON
WO/2004/031213
EDWARD LANGER,
MERKAZ GERON H. 312
P.O.B. 410,
RAANANNA 43103
,‫אדוארד לנגר‬
‫רעננה‬410 .‫ד‬.‫ ת‬,
The present invention is directed generally to recombinant methods for making a
desired polypeptide. These method(s) yield a polypeptide product containing reduced
levels of isoform impurities thereof. In particular, the present invention is directed to
(1) a recombinant method for preparing growth hormone with reduced isoform
impurities thereof and (2) a recombinant method for preparing a growth hormone
antagonist, such as pegvisomant, and its protein intermediate, also having reduced
isoform impurities thereof. More specifically, the isoform impurities that are decreased
by methods of the present invention are the trisulfide and des-phe isoform impurities
of growth hormone and growth hormone antagonist (or its intermediate), respectively.
__________________
]11[]21[
]54[
ARRANGEMENT FOR
MONITORING PATCH PANELS
AT DISTRIBUTOR POINTS IN
DATA NETWORKS
]22[
]31[
]51[
]71[
]87[
09.09.2003
10244304.1
]32[ 09.09.2002
Int. Cl.(2010.01) H04Q 01//14
DATA-COMPLEX E.K., GERMANY
WO/2004/030154
167281
‫סידור לניטור לוחות גישור בנקודות מפלג‬
‫ברשתות נתונים‬
]33[
DE
November 30, 2010-‫כג' בכסלו התשע"א‬
]74[
]57[
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
The invention relates to an arrangement for monitoring patch panels (10) at distributor
points in data networks. Said arrangement comprises patch cables (20) which can be
inserted into the connections in the patch panels (10) by means of a plug (21). Each
plug (21) is fitted with a transponder (22). Readers (12) with reader spools (13) are
also provided. Each connection attachment in a patch panel is fitted with a reader spool
or with a reader. A data link exists between the readers and an evaluation unit (30).
__________________
]11[]21[
167286
‫אנאליזה ואימות גנטי‬
]54[
GENETIC ANALYSIS AND
AUTHENTICATION
]22[
]31[
]51[
]71[
04.09.2003
10/238439
]32[ 09.09.2002
]33[ US
Int. Cl.(2010.01) C12Q 01//68, G01N 21//77, 21//78
BIOARRAY SOLUTIONS LTD.,
U.S.A.
WO/2004/023092
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
]87[
]74[
]57[
This invention provides compositions and methods for genetic testing of an organism
and for correlating the results of the genetic testing with a unique marker that
unambiguously identifies the organism. The marders may be internal markers, such as
for example single nucleotide polymorphisms (SNPs), short tandem repeats (STRs), or
other sites within a genomic locus. Alternatively, the markers may be external, such
that they are separately added to the genetic sample before testing.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
‫מסנן הנחיית גל‬
]54[
WAVEGUIDE FILTER
]22[
]31[
]51[
]71[
30.07.2003
10243670.3
]32[ 20.09.2002
Int. Cl.(2010.01) H01P 01//207
EADS DEUTSCHLAND GMBH,
GERMANY
WO/2004/030140
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
]57[
167324
]33[
DE
,‫ד"ר יצחק הס ושותפיו‬
279 ‫רחוב הירקון‬
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
The invention relates to a waveguide filter comprised of a metallic layer (TM), which
is structured on the top side, of a substrate (S), which is coated with one or more
metallic striplines (ML1, ML2), and of a component (FB). Said component (FB) is
placed on the top side of the substrate (S). One sidewall of the waveguide filter is
formed by the structured metallic layer (TM) of the substrate (S), whereby the
remaining sidewalls of the waveguide filter are formed by the component (FB). The
waveguide filter has launching and extraction points for launching the electromagnetic
wave, which is guided inside the stripline (ML1, ML2), into the waveguide filter and
vice versa.
__________________
]11[]21[
]54[
MULTILAYER DOSAGE FORMS
WHICH CONTAIN ACTIVE
167334
‫צורות מינק רב–שכבתיות המכילות חומרים‬
‫פעילים והכוללות לידה נייטרלית וציפוי פנימי‬
‫וחיצוני המכיל מתאקרילאט קופולימרים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫ומתאקרילט מונומר‬
SUBSTANCES AND WHICH
COMPRISE A NEUTRAL CORE
AND AN INNER AND OUTER
COATING CONSISTING OF
METHACRYLATE COPOLYMERS
AND METHACRYLATE
MONOMERS
]22[
]31[
]51[
]71[
]87[
]74[
]57[
04.09.2003
10250543.8
]32[ 29.10.2002
]33[ DE
Int. Cl.(2010.01) A61K 09//00, 09//16, 09//20, 09//28, 31//19
EVONIK ROHM GMBH, GERMANY
WO/2004/039357
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a multilayer dosage form comprised of: a) a neutral core; b) an
inner coating consisting of a methacrylate copolymer; c) an outer coating consisting of
a copolymer of which 40 to 95 % by weight is composed of radically polymerized C1
to C4 alkyl esters of acrylic acid or of methacrylic acid and of which 5 to 60 % by
weight is composed of (meth)acrylate monomers having an anionic group in the alkyl
radical. The invention is characterized in that the inner coating is essentially comprised
of a methacrylate copolymer, of which at least up to 90 % by weight consists of
(meth)acrylate monomers with neutral radicals, which, in accordance with DIN 53
787, has a minimum film formation temperature of no higher than 30 °C, and which
contains the pharmaceutical active substance in bound form.
__________________
]11[]21[
]54[
DARK FIELD INSPECTION
SYSTEM
]22[
]51[
]71[
08.09.2003
Int. Cl.(2009.01) G01N 21/88
APPLIED MATERIALS ISRAEL,
LTD
APPLIED MATERIALS,INC., U.S.A.
WO/2004/031754
SANFORD T.COLB & CO.,
P.O.B. 2273,
]87[
]74[
167352
‫מערכת בדיקה בשדה חשוך‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
REHOVOT 76122
]57[
Apparatus for inspection of a sample includes a radiation source, which is adapted to
direct optical radiation onto an area of a surface of the sample, and a plurality of image
sensors. Each of the image sensors is configured to receive the radiation scattered
from the area into a different, respective angular range, so as to form respective
images of the area. An image processor is adapted to process at least one of the
respective images so as to detect a defect on the surface.
__________________
]11[]21[
]54[
VALVE FOR PREVENTION OF
LOW FLOW RATES THROUGH
FLOW METER
]22[
]31[
]51[
]71[
04.09.2003
151748
]32[ 12.09.2002
Int. Cl.(2010.01) G01F 01//26, 15//00
A.R.I. FLOW CONTROL
ACCESSORIES AGRICULTURAL
COOPERATIVE ASSOCIATION
LTD.
WO/2004/025229
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
167383
‫שסתום למניעת קצבי זרימה נמוכה דרך מדיד‬
‫זרימה‬
]33[
IL
‫ אבזרים להולכת נוזלים אגודה‬.‫י‬.‫ר‬.‫א‬
‫שתופית חקלאית בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A flow responsive valve for a flow metering system comprising a fluid meter having a
minimum measuring flow threshold. The valve is shiftable between an open position at
flow rates above the minimum measuring flow threshold, and a pressure pulsating
position depending on pressure differential over an inlet port and an outlet port of the
valve The pressure pulsating position alters between a closed position essentially
November 30, 2010-‫כג' בכסלו התשע"א‬
prohibiting fluid flow therethrough at flow rates below the minimum measuring flow
threshold, and an open position admitting fluid flow into the supply line at a
measurable flow rate above the minimum measuring flow threshold.
__________________
]11[]21[
167525
‫טיפול קוטל מזיקים עבור מזון מאוחסן או מגדל‬
‫תחמיץ עם תרכובות די סולפיד‬
]54[
PESTICIDAL TREATMENT OF
STORED FOODSTUFFS AND
SILOS WITH DISULFIDE
COMPOUNDS
]22[
]31[
]51[
16.09.2003
02/11605
]32[ 19.09.2002
]33[ FR
Int. Cl.(2010.01) A01N 25//00, C07C 31/3/04, 31/7/04, 31/7/08, 32/1/12, 38/1/02,
38/1/04
ARKEMA FRANCE, FRANCE
WO/2004/026032
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]71[
]87[
]74[
]57[
The invention relates to the pesticidal treatment of stored goods, enclosures, structures
and works of art. According to the invention, a volatile sulphur compound of general
formula (I) is used, wherein R represents an alkyl radical or an alkenyl radical
comprising 1-4 carbon atoms, n is equal to 0, 1 or 2, x is a number ranging from 0 to 4,
and R' represents an alkyl radical or an alkenyl radical containing 1 - 4 carbon atoms
or, only if n = x = 0, a hydrogen atom. The sulphur compounds (especially
dimethyldisulphide) are applied by spraying them directly onto the material to be
treated.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
167715
‫הכנסה באתר בררני של קטו חומצות אמינו לתוך‬
‫חלבונים‬
]54[
SITE SPECIFIC INCORPORATION
OF KETO AMINO ACIDS INTO
PROTEINS
]22[
]31[
15.10.2003
60/419265
]32[ 16.10.2002
]33[ US
60/420990
23.10.2002
US
Int. Cl.(2010.01) C07K 14//195, C12N 01//21, 05//10, 15//60
THE SCRIPPS RESEARCH
INSTITUTE, U.S.A.
WO/2004/035743
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Compositions and methods of producing components of protein biosynthetic
machinery that include orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases,
and orthogonal pairs of tRNAs/synthetases, which incorporate keto amino acids into
proteins are provided. Methods for identifying these orthogonal pairs are also provided
along with methods of producing proteins with keto amino acids using these
orthogonal pairs.
,201208
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
FIBER LASER DEVICE FOR
167740
‫מתקן לייזר סיב לנטרול מטען שלא התפוצץ‬
November 30, 2010-‫כג' בכסלו התשע"א‬
NEUTRALIZING UNEXPLODED
ORDNANCE
]22[
]51[
]71[
30.03.2005
Int. Cl.(2010.01) F42D 05//04
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]72[
]74[
YEHUDA NACHSHON
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
A device (30) for directing a beam of radiation at a target, comprising:
(a) a fiber laser (32) for producing the beam of radiation;
(b) an aiming mechanism (18), for aiming the beam of radiation at the target, that
moves independently of said fiber laser; and
(c) an optical fiber (38) for conveying the beam of radiation to said aiming
mechanism.
]57[
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫יהודה נחשון‬
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
__________________
]11[]21[
167748
]54[
COMPOSITIONS COMPRISING
FGF18 AND HYALURONIC ACID
FOR INTRAARTICULAR
DELIVERY
]22[
]31[
]51[
]71[
07.10.2003
60/416670
]32[ 07.10.2002
]33[
Int. Cl.(2010.01) A61K 38//18, 45//06, 47//36
ZYMOGENETICS INC., U.S.A.
‫ וחומצה היאלורונית‬FGF18 ‫תכשירים הכוללים‬
‫למתן תוך –ארטיקולרי‬
US
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
WO/2004/032849
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
FGF18 is known to stimulate the proliferation of chondrocytes, resulting in increased
cartilage formation. When hyaluronic acid is administered in addition to FGF18, the
effects on chondrocyte proliferation and production of matrix were found to be greater
than administration of FGF18 or hyaluronic acid alone.
__________________
]11[]21[
167928
‫נרתיק בעל שני מרקיבים לנשק ידני‬
]54[
TWO COMPONENT HOLSTER
FOR A HAND GUN
]22[
]51[
]71[
]72[
]74[
07.04.2005
Int. Cl.(2010.01) F41C 33//02
FOBUS INTERNATIONAL LTD.
‫ כפר הס‬,‫פובוס אינטרנשניונל בע"מ‬
CHANAN HAR-SHEN
‫שן‬-‫חנן הר‬
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A modular rigid plastic handgun clip-on holster assembly (10) comprising an
interchangeable rigid plastic inner holster component (2) having inner dimensions
complementary to the configuration of the outer sections of a specific handgun (22) to
be placed therein and an outer housing (16) sized to receive and interchangeably
interlock with said inner holster component as well as with alternative inner holster
components wherein each of said alternative inner holster components is provided
with different inner dimensions respectively complementary to the configuration of
the outer sections of a pre-determined hand gun type to be placed therein.
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
167983
‫תהלוך וחומרי ביניים להכנת‬
‫איזו(תיאו)ציאנטים ושימוש בהם להכנת תולדות‬
‫טריאזולדיאון‬
]54[
PROCESS AND INTERMEDIATES
FOR PREPARING ISO(THIO)
CYANATES AND USE THEREOF
FOR PREPARING
TRIAZOLDIONE
INTERMEDIATES
]22[
]31[
]51[
29.10.2003
10250614.0
]32[ 30.10.2002
]33[ DE
Int. Cl.(2010.01) C07C 30/3/34, 30/7/06, C07D 21/1/16, 21/3/76, 29/5/26, 30/7/52,
31/9/06, 33/3/36
BASF AKTIENGESELLSCHAFT,
GERMANY
WO/2004/039768
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]71[
]87[
]74[
]57[
The invention relates to a method for producing phenyliso(thio)cyanates of general
formula (I) according to which a compound of general formula (II) or the HCl adduct
thereof is reacted with a phosgenating agent, wherein W represents oxygen or sulfur
and Ar and A have the meanings as cited in Claim 1. The invention also relates to the
use of phenyliso(thio)cyanates for producing plant protection products.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
DIRECTIONAL ANTENNA
]22[
]31[
]51[
]71[
]87[
]74[
28.10.2003
10/282955
]32[ 28.10.2002
Int. Cl.(2010.01) H01Q 03//24
IPR LICENSING, INC., U.S.A.
WO/2004/040689
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
167993
‫אנטנה כיוונית‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A directional antenna having a number, N, of outlying monopole antenna elements.
These monopole elements are formed as a first upper conductive segment on a portion
of a dielectric substrate. The array also includes the same number, N, of image
elements. The image elements are formed as a second set of lower conductive
segments on the same substrate as the upper conductive segments. The image
elements, generally having the same length and shape as the monopole elements, are
connected to a ground reference potential. To complete the array, an active antenna
element is also disposed of the same substrate, adjacent to at least one of the monopole
elements. In a preferred arrangement, the passive monopole elements and
corresponding image elements are selectively connected to operate to in either a
reflective or directive mode, such as via a switchable coupling circuit that selectively
changes the impedances connected between them.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
168026
‫תהליך רציף למימון‬
]54[
CONTINUOUS HYDROGENATION
PROCESS
]22[
]31[
]51[
]71[
23.09.2003
10248159.8
]32[ 16.10.2002
]33[
Int. Cl.(2010.01) B01J 08//22, C01B 15//023
EVONIK DEGUSSA GMBH,
GERMANY
WO/2004/052779
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
In the continuous hydrogenation of a working solution containing a hydrogenable
compound with hydrogen in the presence of a heterogeneous catalyst, at least part of
the hydrogen-containing waste hydrogenation gas is recycled into the hydrogenation
reactor after compression. According to the invention, a jet pump is used for the
compression of the waste hydrogenation gas and a liquid or gaseous feedstock of the
hydrogenation process is used as the motive agent. Preferred motive agents are the
hydrogenation gas or a working solution recycled into the process. The process is
particularly suitable for performing the hydrogenation step in the anthraquinone
process for the production of hydrogen peroxide.
__________________
]11[]21[
168147
‫טטרלינים ואינדאנים מותמרים ושימושם‬
]54[
SUBSTITUTED TETRALINS AND
INDANES AND THEIR USE
]22[
]31[
17.10.2003
60/420026
]32[ 21.10.2002
]33[ US
60/495788
15.08.2003
US
Int. Cl.(2010.01) A61K 31//17, A61P 03//04, 03//06, 03//10, 09//10, C07C 27/1/56,
27/5/28, 27/5/32, 32/3/63
JANSSEN PHARMACEUTICA N.V.,
BELGIUM
WO/2004/037779
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
]51[
]71[
]87[
]74[
November 30, 2010-‫כג' בכסלו התשע"א‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
This invention features tetralin and indane compounds, compositions containing them,
and methods of using them as PPAR alpha modulators to treat or inhibit the
progression of, for example, diabetes.
__________________
]11[]21[
168374
‫חיסון וירוס הנילוס המערבי‬
]54[
VACCINES AGAINST WEST NILE
VIRUS
]22[
]31[
07.11.2003
PCT/NL02/00718 ]32[ 08.11.2002
]33[ WO
PCT/EP03/50129
28.04.2003
WO
Int. Cl.(2010.01) A61K 39//12, C12N 07//00, 07//02, 07//04
CRUCELL HOLLAND B.V., THE
NETHERLANDS
ALPHONSUS GERARDUS CORNELIS
MARIA UYTDEHAAG, GOVERT
JOHAN SCHOUTEN, JAAP GOUDSMIT
WO/2004/042042
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
]51[
]71[
]72[
]87[
]74[
]57[
The present invention relates to novel vaccines containing (whole-inactivated) West
Nile Viruses and/or West Nile viral proteins derived there from, produced on human
cells, wherein the human cells comprise a sequence encoding at least one early region1 (El) gene product of an adenovirus. The cells are preferably cultured in suspension to
very high densities and under serum-free conditions. Herein, it is disclosed that use of
such cells results in high titers of West Nile Virus produced
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
FERROMAGNETIC OBJECT
DETECTOR
]22[
]31[
]51[
]71[
05.11.2003
0226334.1
]32[ 12.11.2002
Int. Cl.(2010.01) G08B 13//24
QINETIQ LIMITED, UNITED
KINGDOM
WO/2004/044620
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]87[
]74[
]57[
168467
‫גלאי עצם פרומגנטי‬
]33[
GB
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
An apparatus (2) for detecting ferromagnetic objects in the vicinity of a magnetic
resonance imaging scanner. The apparatus comprises primary sensor means (4; 44)
adapted to measure a magnetic field, arranged in communication with signal
processing means configured to identify temporal variations in the measured magnetic
field due to the movement of a ferromagnetic object within an ambient magnetic field
and to provide an output indicative of the presence of a ferromagnetic object in the
vicinity of the primary sensor means (4; 44). The apparatus further comprises
secondary, non-magnetic, sensor means (60) adapted to detect the movement of
objects in the vicinity of the primary sensor means in order to reduce false alarms. The
output from the signal processing means may be used to operate an audible alarm (20),
a visual alarm (22), an automatic door lock (26) or a physical barrier (28).
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
‫גלאי מיקום‬
]54[
POSITION DETECTOR
]22[
]31[
19.11.2003
102-54.231.7 ]32[ 20.11.2002
102-59.223.3
17.12.2002
Int. Cl.(2010.01) G01D 05//14
WALTER MEHNERT, GERMANY
THOMAS THEIL, GERMANY
]51[
]71[
]87[
]74[
]57[
168712
]33[
DE
DE
WO/2004/046735
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
,'‫זליגסון גבריאלי ושות‬
31 ‫רח' יבנה‬
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
The invention relates to a position detector which, in its simplest form of embodiment,
has two induction coils but only one individual pulse wire. All information required,
for example for a count, is simultaneously available from the triggering direction of the
magnetic reversal and the magnetic reversal direction of the pulse wire, together with
the last established and stored position and polarity. One such position detector
operates using memory elements having low energy requirements, such as FRAMs,
and also without external energy. In order to be able to use one such position detector
even at high temperatures, it can also be fitted with an EEPROM.
__________________
]11[]21[
]54[
INHIBITION OF INFLAMATION
USING ALPHA 7 RECEPTORBINDING CHOLINERGIC
AGONISTS
168787
‫עיכוב דלקת באמצעות שימוש באגוניסטים‬
α 7 ‫כולינרגיים הנקשרים לקולטן‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
05.12.2003
60/431650
]32[ 06.12.2002
]33[ US
Int. Cl.(2010.01) A61K 31//444, 31//454, A61P 01//00, 09//00, 15//00, 29//00, 31//00,
33//00, 37//00, 43//00, C07D 49/8/00
THE FEINSTEIN INSTITUTE FOR
MEDICAL RESEARCH, U.S.A.
WO/2004/052365
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
Methods of inhibiting release of a proinflammatory cytokine from a macrophage are
provided. The methods comprise treating the macrophage with a cholinergic agonist in
an amount sufficient to decrease the amount of the proinflammatory cytokine that is
released from the macrophage, wherein the cholinergic agonist is selective for an
alpha7 nicotinic receptor. Methods for inhibiting an inflammatory cytokine cascade in
a patient are also provided. The methods comprise treating the patient with a
cholinergic agonist in an amount sufficient to inhibit the inflammatory cytokine
cascade, wherein the cholinergic agonist is selective for an alpha7 nicotinic receptor.
Methods for determining whether a compound is a cholinergic agonist reactive with an
alpha7 nicotinic receptor are also provided. The methods comprise determining
whether the compound inhibits release of a proinflammatory cytokine from a
mammalian cell. Additionally, methods for determining whether a compound is a
cholinergic antagonist reactive with an alpha7 nicotinic receptor are provided. These
methods comprise determining whether the compound reduces the ability of a
cholinergic agonist to inhibit the release of a proinflammatory cytokine from a
mammalian cell. Oligonucleotides or mimetics capable of inhibiting attenuation of
lipopolysaccharide-induced TNF release from a mammalian macrophage upon
exposure of the macrophage to a cholinergic agonist are also provided. The
oligonucleotides or mimetics consist essentially of a sequence greater than 5
nucleotides long that is complementary to an mRNA of an alpha7 receptor.
Additionally, methods of inhibiting attenuation of TNF release from a mammalian
macrophage upon exposure of the macrophage to a cholinergic agonist are provided.
These methods comprise treating the macrophage with the above-described
oligonucleotide or mimetic.
The applications for division
from this application have
not yet been published
,206855
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
METHOD AND APPARATUS FOR
OPTIMIZING REFRIGERATION
SYSTEMS
]22[
]31[
09.12.2003
60/431901
]32[ 09.12.2002
60/434847
19.12.2002
10/730791
09.12.2003
Int. Cl.(2010.01) F25B 01//00
HUDSON TECHNOLOGIES, INC.,
U.S.A.
WO/2004/053404
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
]57[
169052
‫שיטה והתקן לייטוב מערכות קירור‬
]33[
US
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
A refrigeration system comprising a compressor (100) for compressing a refrigerant, a
condenser (107) for condensing refrigerant to a liquid, an evaporator (103) for
evaporating liquid refrigerant from the condenser (107) to a gas, an inner control loop
for optimizing a supply of liquid refrigerant to the evaporator (103), and an outer
control loop for optimizing a level of refrigerant in the evaporator (103), said outer
control loop defining a supply rate for said inner control loop based on an optimization
including measurement of evaporator (103) performance, and said inner control loop
optimizing liquid refrigerant supply based on said defined supply rate. Independent
variables, such as proportion of oil in refrigerant, amount of refrigerant, contaminants,
non-condensibles, scale and other deposits on heat transfer surfaces, may be estimated
or measured. A model of the system and/or a thermodynamic model approximating the
system, for example derived from temperature and pressure gages (155, 156), as well
as power computations or measurements, is employed to determine or estimate the
effect on efficiency of deviance from an optimal state. Various methods are provided
for returning the system to an optimal state, and for calculating a cost-effectiveness of
employing such processes.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
MEDICATION
ADMINISTRATION SYSTEM
]22[
]51[
]71[
]87[
]74[
12.12.2002
Int. Cl.(2010.01) G06F 17//00
MDG MEDICAL INC., U.S.A.
WO/2004/053620
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
169083
‫מערכת למתן תרופות‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention comprises a system and method for administering medications
to a plurality of patients in a medication institution. A preferred system comprises a
workflow program (70) for generating a scheduler, wherein the scheduler coordinates
the administration of medications to the patients, a medicine cabinet (30), responsive
to said scheduler, for storing medications and dispensing the medications to an
authorized user for administration to the patients, the workflow program (70)
providing the cabinet (30) with patient specific information relating to said
dispensation of the medications including a physician order for each patient, and a
medicine cart (50), coupled to the medicine cabinet (30), for instructing said
authorized user in the administration of said medication to each of said patients. The
cart (50) comprises a plurality of patient specific cart drawers (51) for storing the
medication to be administered to each patient, wherein each cart drawer (51) remains
unidentified as patient specific until the medication cart (50) receives said patient
specific information, and a cart processor, wherein the cart drawers are filled with
medicine from the medicine cabinet for each patient associated with each patient
specific cart drawer (51) in accordance with the respective physician order for each
patient.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
METHOD AND SYSTEM FOR
ONLINE PAYMENTS USING
SENSING DEVICE
]22[
]31[
24.05.2000
PQ0559
]32[ 25.05.1999
PQ1313
30.06.1999
PQ1312
30.06.1999
PQ2912
17.09.1999
PQ3632
25.10.1999
Int. Cl.(2010.01) G06K 01//18
DIVISION FROM 146606
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/072241
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]62[
]71[
]87[
]74[
]57[
169597
‫שיטה ומערכת לביצוע מקוון של תשלומים‬
‫באמצעות מכשיר חישה‬
]33[
AU
AU
AU
AU
AU
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Methods and systems are disclosed which relate to online payments via interface
surfaces printed with information and coded data. The coded data, encoded visibly or
invisibly, may be queried by an appropriate sensing device. The sensing device
communicates with a computer system. Together, the interface surfaces, sensing
device and computer system are capable of effecting payment transactions over a
network.
__________________
]11[]21[
]54[
FLUID PRESSURE REGULATOR
169872
‫ווסת לחץ לנוזלים עם שסתום אל–נגר ושיטה‬
‫המיושמת בו‬
November 30, 2010-‫כג' בכסלו התשע"א‬
WITH NO-DRAIN VALVE AND A
METHOD USED THEREIN
]22[
]51[
]71[
]72[
]74[
]57[
25.07.2005
Int. Cl.(2010.01) F15C 03//00, G05D 16//00, 16//10
PLASTRO IRRIGATION SYSTEMS
‫ קיבוץ גבת‬,‫פלסטרו מערכות השקיה בע"מ‬
LTD.
ZVI EINAV, MOSHE LUTZKI,
‫ אסף קצין‬,‫ משה לוצקי‬,‫צבי עינב‬
ASAF KATZIN
WEBB & CO.,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
2 ‫רח' פקריס‬
REHOVOT 76121
‫רחובות‬2189 .‫ד‬.‫ ת‬,
A fluid pressure regulator (10) with a no-drain valve, comprisinga housing assembly (205) formed at its one end with a flow inlet and on its other end
with a flow outlet and a flow passage connecting between then and including a flow
control opening formed at said flow inlet and a passage space; and
a cylinder assembly (266) mounted within said passage space wherein its one end
(274) that is formed with a passing thru-hole opening (278), located opposite said flow
control opening and adjacent to it, and its opposite end is open and is located to face
said flow outlet opening; and
a sealing assembly (315) installed at one end of said cylinder that is formed, as said,
with a passing thru-hole opening; and
said cylinder assembly is formed with at least one radial rib (338) around its
circumference, that mounts said cylinder assembly within said housing space, so that
fluid flow passage is enabled from said flow control opening unto said flow outlet
through a gap existing on the sides of said rib; and
the inner space of said cylinder assembly is ventilated to the environmental
atmosphere; and
a movable piston assembly located within said cylinder assembly and is moveable
within said cylinder assembly and through said passing thru-hole opening that formed
at one end of said cylinder assembly; and
said piston assembly is formed with a rod component (327) wherein on its one end it
carries a valve component (366), and whereby said rod component has a small cross
section relative to the cross section of said valve component, and said rod component
is movable through said passing thru-hole opening formed at one end of said cylinder
assembly and through said sealing assembly; and
said rod component that carries said valve component at its one end, is movable by the
motion of said piston assembly towards said flow control opening formed at said
housing assembly and away from it, in order to control the flow through it and towards
said flow outlet from said housing assembly; and
wherein at a fully open state of said valve component, said valve component connects
to form a contact with said sealing assembly; and
a springy means (340) located within the inner space of said cylinder assembly and
stresses said piston component unto said fully open state of said valve component;
wherein said regulator is characterized in thatsaid rod component carries at its other end a bushing component (345) formed with a
bracket and with a protruding shoulder around its circumference wherein on its side,
November 30, 2010-‫כג' בכסלו התשע"א‬
said shoulder connects with said springy means that stresses said piston assembly unto
said fully open state of said valve component; and
said flow outlet includes an exit flow control opening; and
said regulator includes a no-drain valve that comprisesa no-drain spring means (355) whose one end is located on said bracket formed at said
bushing component; and
a no-drain piston assembly (360), movable upon said bushing component, within said
cylinder assembly and through said opposite open end of said cylinder assembly, unto
said exit flow control opening and from it; when said no-drain piston assembly is
formed on its one side, with a bracket and on its second side, with a no-drain valve
component (366) and a protruding shoulder around its circumference that has a
relatively large surface area in comparison to said rod's cross section; and
wherein said second end of said no-drain spring means is located upon said bracket
that is formed in said no drain piston assembly and stresses said no-drain valve
component towards said exit flow control opening, to a fully closed state of said nodrain valve component;
an upper sealing assembly installed between said inner space of said cylinder
assembly to said no-drain piston, in order to seal said inner space of said cylinder
assembly;
so thatwhen said fluid pressure decreases at said flow inlet to a settable in advance level, said
no-drain spring means overcomes the force exerted by the fluid pressure upon said nodrain valve component and said protruding shoulder formed around its circumference,
pushing said no-drain piston assembly and stresses said no-drain valve component
towards said exit flow control opening to said fully closed state of said no-drain valve
component; and
upon an ongoing increase of said fluid pressure at said flow inlet to a settable in
adavance level that is lower than the designed regulated pressure of said regulator or at
most equal to said designed regulated pressure of said regulator, the force that exerts
said fluid pressure on said protruding shoulder surface area formed around said
circumference of said no-drain valve component overcomes said no-drain spring
means and propels said no-drain piston assembly and with it said no-drain valve
component, upon said bushing component within said cylinder assembly and through
its second, open opposite end of said cylinder assembly while opening said exit flow
control opening to fluid passage from said flow inlet to said flow outlet; and
with a further increase of said fluid pressure at said flow inlet to a level higher than
said designed regulated pressure of said regulator, said no-drain piston assembly
drives said bushing component carried upon said rod component to move together said no-drain piston assembly and said piston assembly; whereinthe force exerted by said fluid pressure on said surface area of said no-drain valve
component and said protruding shoulder around its circumference overcomes said
spring means, said no-drain spring means and the force exerted by said fluid pressure
on said surface area of said valve component that is carried by said rod component;
and
said force drives said valve component carried upon one end of said rod component,
towards said flow control opening formed in said housing assembly, in order to
control said flow through it towards said flow outlet from said housing assembly.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
SYSTEM AND METHOD FOR
ENHANCING BIT ERROR
TOLERANCE OVER A
BANDWIDTH LIMITED
CHANNEL
]22[
]31[
]51[
]71[
]87[
]74[
29.01.2004
10/355209
]32[ 31.01.2003
Int. Cl.(2010.01) G10L 19//02
HARRIS CORPORATION, U.S.A.
WO/2004/070540
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
169946
‫מערכת ושיטה להגברת טולרנטיות של שגיאת‬
‫ביט מעבר לערוץ מוגבל ברוחב פס‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
System and method reduces the effects of the bit-error induced distortion of decoded
voice transmission by assigning vectors that are close or similar in Euclidean distance
to respective indices that are close in Hamming distance. The system calculates a first
distortion sum of the distance error induced by single, double or N bit error
possibilities, switches vector assignments and calculates a second distortion sum. If the
second sum is less than the first sum the vector swap is maintained.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
170161
]54[
COTTON EVENT MON 88913 AND
COMPOSITIONS AND METHOD
FOR DETECTION THEREOF
]22[
]31[
]51[
02.02.2004
60/447184
]32[ 12.02.2003
]33[ US
Int. Cl.(2009.01) A01H 05/00, 05/02, 05/04, 05/06, 05/08, 05/10, 05/12, C12N 15/29,
C12Q 01/68
MONSANTO TECHNOLOGY LLC,
U.S.A.
WO/2004/072235
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
]71[
]87[
]74[
]57[
‫ תכשירים‬,‫ בכותנה‬MON 88913 ‫ארוע גנטי‬
‫הכוללים אותו ושיטות לזיהויו‬
The present invention provides a cotton plant event MON 88913 compositions and
seed. Also provided are assays for detecting the presence of the cotton plant event
MON 88913 based on a DNA sequence and the use of this DNA sequence as a
molecular marker in a DNA detection method.
November 30, 2010-‫כג' בכסלו התשע"א‬
The applications for division
from this application have
not yet been published
,202457
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
‫שיטת יציקה רצופה‬
]54[
CONTINUOUS CASTING
METHOD
]22[
]31[
]51[
]71[
24.02.2004
03450060.3
]32[ 28.02.2003
Int. Cl.(2010.01) B22D 11//01
SO & SO SOMMERHOFER OEG,
AUSTRIA
WO/2004/076096
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
]57[
170168
]33[
EP
,‫ד"ר יצחק הס ושותפיו‬
279 ‫רחוב הירקון‬
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
The invention concerns the continuous casting of metals of all kinds by direct cooling
with liquid metal or ionic liquid as coolant, for direct cooling of the strand (4).
According to the invention, the coolant is directed to the strand (4) in at least one jet
(10) and flows in a turbulent flow in this jet.
__________________
]11[]21[
170181
]54[
(4R) AND (4S)-DIASTEREOISOMERS OF
(2S)-2-[OXY-4PROPYLPYRROLIDINYL]BUTANAMIDE,
PHARMACEUTICAL COMPOSITIONS
COMPRISING THEM AND THEIR USE FOR
PREPARING MEDICAMENTS
]22[
]31[
]51[
]62[
21.02.2001
0004297.8
]32[
23.02.2000
]33[ GB
Int. Cl.(2010.01) A61K 31//4015, A61P 25//08, C07D 20/7/27
DIVISION FROM 150842
‫)– דיאסטריואיזומרים‬S4( –‫ ) ו‬R4(
– 4 – ‫ –[אוקסי‬S) – 22( ‫של‬
,‫פרופילפירולידיניל] בוטאנאמיד‬
‫תכשירי רוקחות המכילים אותם‬
‫והשימוש בהם להכנת תרופות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]71[
]87[
]74[
]57[
UCB PHARMA S.A., BELGIUM
WO/2001/062726
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention concerns 2-oxo-1-pyrrolidine derivatives of formula (I) wherein the
substituents are as defined in the specification, as well as their use as pharmaceuticals.
The compounds of the invention are particularly suited for treating neurological
disorders such as epilepsy.
__________________
]11[]21[
170315
‫נגזרות חומצות אלקנואיות מותמרות‬
‫ תכשירים רפואיים ושימוש בהן‬,‫ציקלואלקיל‬
]54[
CYCLOALKYL-SUBSTITUTED
ALKANOIC ACID DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS AND USE
THEREOF
]22[
]31[
]51[
]71[
19.02.2004
10308356.1
]32[ 27.02.2003
]33[
Int. Cl.(2010.01) C07C 27/5/18, 27/5/26
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/076401
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]87[
]74[
]57[
DE
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The invention relates to arylcycloalkyl-substituted alkanoic acid derivatives and the
physiologically acceptable salts and physiologically functional derivatives thereof.
Disclosed are compounds of formula (I), wherein the radicals have the indicated
November 30, 2010-‫כג' בכסלו התשע"א‬
meanings, the physiologically acceptable salts thereof, and methods for the production
thereof. Said compounds are suitable for treating and/or preventing disturbances of
fatty acid metabolism, impaired glucose utilization, and disturbances in which insulin
resistance plays a role.
__________________
]11[]21[
]54[
CHANNEL ESTIMATION OF A
RECEIVER MULTIPATH CDMA
SIGNAL
]22[
]31[
]51[
]71[
18.02.2004
10/368765
]32[ 18.02.2003
Int. Cl.(2010.01) H04L 25//02
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/075019
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
170333
‫ רב–מסלולי‬CDMA ‫הערכה ערוצית של אות‬
‫למקלט‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method for improving channel estimation in a wireless communication system is
disclosed. A wireless signal that includes a plurality of multipath components is
received. N channel estimates are then obtained, where N is any positive integer
greater than one. Each channel estimate of the N channel estimates corresponds to a
different multipath component of the plurality of multipath components. The effects of
interference between the plurality of multipath components on the N channel estimates
is then reduced.
__________________
]11[]21[
]54[
METHOD FOR PREPARING
POLYMORPHISM OF
IRINOTECAN HYDROCHLORIDE
]22[
24.02.2004
170350
‫שיטה עבור הכנת של הידרוכלוריד אירינוטקאן‬
‫רב צורתי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
2003-046908 ]32[ 25.02.2003
]33[ JP
Int. Cl.(2010.01) A61K 31//4745, C07D 49/1/22
KABUSHIKI KAISHA YAKULT
HONSHA, JAPAN
WO/2004/076460
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
,‫ד"ר יצחק הס ושותפיו‬
279 ‫רחוב הירקון‬
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
A method for preparing an irinotecan hydrochloride c-type crystal exhibiting
diffraction peaks (2theta) at 9.15 degrees, 10.00 degrees, 11.80 degrees, 12.20 degrees,
13.00 degrees and 13.40 degrees in the powder X-ray diffractometry, characterized in
that it comprises mixing irinotecan with one or more solvents selected from the group
consisting of acetone, acetonitrile and tetrahydrofuran, adding hydrochloric acid to the
resultant solution, and taking out formed crystals. The invention provides a method for
preparing a polymorphism of irinotecan hydrochloride which is excellent in its
solubility in water and is reduced in the content of impurities.
__________________
]11[]21[
170397
]54[
METHOD AND APPARATUS FOR
RIDE-ON TOY
]22[
]31[
]51[
]71[
]87[
]74[
18.02.2004
10/371576
]32[ 24.02.2003
]33[
Int. Cl.(2010.01) A63G 25//00, G08C 17//02
DAN AND HANNA GAVISH
WO/2004/075456
DAN AND HANNA GAVISH,
HARAKAFOT 4
HEIFA 34745
]57[
‫שיטה והתקן לצעצוע רכוב‬
US
‫ חיפה‬,‫דן וחנה גביש‬
,‫דן וחנה גביש‬
4 ‫הרקפות‬
‫חיפה‬
A method and apparatus by which an adult accompanying a child riding a mobile rideon toy (120), can continuously determine if the child is free to fully operate the toy
(120), The adult can force the toy (120) to slow down, or to stop or to otherwise
control the ride-on toy (120) in order to protect the child's safety. The adult can gain
control by operating a wireless remote-control unit (110). Furthermore, the adult can
limit the distance between the ride-on toy and the adult, so that the child cannot drive
too far away from the adult, i.e., the toy (120) stops as soon as the predetermined range
limit is reached. The ride-on toy (120) can be used as long as it is under the control of
the adult, but it automatically stops when the adult loses control over the ride-on toy
November 30, 2010-‫כג' בכסלו התשע"א‬
(120).
__________________
]11[]21[
]54[
REACTOR FOR INDUSTRIAL
CULTURE OF PHOTOSYNTHETIC
MICRO-ORGANISMS
]22[
]31[
]51[
]71[
24.02.2004
FI2003A000047 ]32[ 24.02.2003
Int. Cl.(2010.01) C12M 01//00
UNIVERSITA DEGLI STUDI DI
FIRENZE, ITALY
MARIO TREDICI, LILIANA RODOLFI
WO/2004/074423
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]72[
]87[
]74[
]57[
170429
– ‫סביבת פעולה לתירבות תעשייתי של מיקרו‬
‫אורגניזים פוטוסינטטים‬
]33[
IT
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The present invention refers to a reactor for the culture of photosynthetic microorganisms or plant cells suspended in a suitable culture medium, comprising a culture
chamber made of a material which is transparent to photosynthetically active radiation,
a large-meshed grid structure (2) suitable to contain the culture chamber, and an
external support framework (1,3).
__________________
]11[]21[
]54[
PILOT ESTIMATION USING
PREDICTION ERROR METHOD
SWITCHED FILTERS
]22[
]31[
11.03.2004
60/454378
]32[ 12.03.2003
10/643639
18.08.2003
Int. Cl.(2010.01) H04B 01//707
]51[
170784
‫הערכה ניסיונית באמצעות מעבר בין פילטרים‬
‫המבוסס על ניבוי שגיאות‬
]33[
US
US
November 30, 2010-‫כג' בכסלו התשע"א‬
]71[
]87[
]74[
]57[
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/082166
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A system is disclosed for use in a wireless communication system to provide an
estimated pilot signal. The system includes a receiver and a front-end processing and
despreading component in electronic communication with the receiver for despreading
a CDMA signal. A pilot estimation component is in electronic communication with the
frontend processing and despreading component for estimating an original pilot signal
using a pilot estimator that includes more than one filter and that includes a switching
method for using the more than one filter. The switching method uses a prediction
error. A demodulation component is in electronic communication with the pilot
estimation component and the front-end processing and despreading component for
providing demodulated data symbols.
__________________
]11[]21[
170788
,‫הפקת נגזרות של נוירונים מופעלי דופאמין‬
‫ ושמקורם בתאי‬,‫אשר עברו התמיינות סופית‬
‫גזע עובריים אנושיים‬
]54[
DERIVATION OF TERMINALLY
DIFFERENTIATED
DOPAMINERGIC NEURONS FROM
HUMAN EMBRYONIC STEM
CELLS
]22[
]31[
11.03.2004
269/mum/2003 ]32[ 12.03.2003
]33[ IN
60/520048
14.11.2003
US
Int. Cl.(2010.01) A61K 48//00, A61P 25//16, C12N 05//0735
RELIANCE LIFE SCIENCES PVT.
LTD., INDIA
WO/2004/081172
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The present disclosure is directed to improved methods for efficiently producing
neuroprogenitor cells and differentiated neural cells such as dopaminergic neurons and
serotonergic neurons from pluripotent stem cells, for example human embryonic stem
cells. Using the disclosed methods, cell populations containing a high proportion of
]51[
]71[
]87[
]74[
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
cells positive for tyrosine hydroxylase, a specific marker for dopaminergic neurons,
have been isolated. The neuroprogenitor cells and terminally differentiated cells of the
present disclosure can be generated in large quantities, and therefore may serve as an
excellent source for cell replacement therapy in neurological disorders such as
Parkinsons disease.
__________________
]11[]21[
]54[
METHOD FOR RECORDING A
LEAD-OUT ON AN OPTICAL DISC
]22[
]31[
]51[
]71[
11.03.2004
03100756.0
]32[ 24.03.2003
Int. Cl.(2010.01) G11B 20//12
KONINKLIJKE PHILIPS
ELECTRONICS N.V., THE
NETHERLANDS
WO/2004/086398
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
171011
‫שיטה להקלטת התחלה על דיסק אופטי‬
]33[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A method of recording information stores lead-out information on a multilayer record
carrier of an opposite track path type. A two part recording area (54,61) across two
layers is logically interrupted by an intermediate zone (55,56). According to a
standardized recording format like DVD the recording area is preceded by a lead-in
zone (53) located at the start of the first recording layer and followed by a lead-out
zone (64) located at the end of the second recording layer. An outer lead-out part (62)
and an inner lead-out part (63) are recorded separated by an unrecorded area (65) and
together constituting the lead-out information on the second recording layer. The inner
lead-out part covers a predefined radial position range corresponding to a range of
radial positions used by reading devices for accessing the second recording layer
during a disc loading procedure. The outer lead-out part is recorded at the end of an
area of the second recording layer containing user information.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
171201
]54[
METHOD FOR AVOIDING GCHOUTAGE BY APPLIANCE OF THE
GREEDY ALGORITHM IN A
GRANT CHANNEL SCHEDULING
METHOD AND
CORRESPONDINGLY ADAPTED
BASE STATION, TRANSCEIVER
CONTROLLER AND CDMA
COMMUNICATIONS NETWORK
]22[
]31[
13.04.2004
60/463414
]32[ 15.04.2003
]33[ US
10/633013
01.08.2003
US
Int. Cl.(2010.01) H04L 12//56, H04W 72//14, 84//04
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/093483
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
‫ על ידי‬GCH – ‫שיטה להימנעות מהפסקת‬
‫יישום אלגוריתם החמדנות בשיטה לתזמון ערוץ‬
‫ בקר‬, ‫ ותחנת בסיס מתואמת בהתאמה‬,‫הענקה‬
CDMA ‫מקלט משרד ורשת תקשורת‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Methods and apparatus for scheduling grant channels to carry grant messages to a
plurality of scheduled mobile stations. The scheduling of grant channels involves
statically assigning atleast on grant channel to each mobile station to monitor, and
dinamically assigning to a current mobile station of the plurality of scheduled mobile
stations, a previously unassigned grant channel from a list of grant channels monitored
by the current mobile station (300). If there are more mobile stations to be processed in
the plurality of scheduled mobile stations (302), then the scheduling moves to a next
mobile station in the plurality of scheduled mobile stations (304), and the assignment
process is repeated. Furthermore, if not every grant channel has been assigned a
mobile station (306), then the order of the plurality of scheduled mobile stations is
rearranged (308), and the assignment and the movement processes are repeated.
__________________
]11[]21[
]54[
INTEGRATED CIRCUIT
SUPPORT STRUCTURES AND
171378
‫מצעים לשבבים ושיטה ליצורים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
THE FABRICATION THEREOF
]22[
]51[
]71[
]72[
]74[
]57[
11.10.2005
Int. Cl.(2010.01) H01L 21//306
AMITECH LTD.
‫ מגדל העמק‬,‫עמיטק בע"מ‬
DROR HURWITZ, BORIS
,‫ בני מיכאלי‬,‫ בוריס סטטניקוב‬,‫דרור הורביץ‬
STATNIKOV, BENNY MICHAELI,
‫ מרדכי פרקש‬,‫ אווה איגנר‬,‫עמית זיידלר‬
AMIT ZEIDLER, EVA IGNER,
MORDECHAY FARKASH
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A method of fabricating an electronic substrate comprising the steps of fabricating a
full stack by:
(A) selecting a first base layer;
(B) depositing a first etchant resistant barrier layer comprising tantalum or nickel onto
said first base layer;
(C) building up a first half stack of alternating conductive layers and insulating layers,
the conductive layer being interconnected by vias through the insulating layers;
(D) applying a second base layer onto said first half stack;
(E) applying a protective coating of photoresist to said second base layer;
(F) etching away said first base layer by exposing said first base layer to a solution of
ammonium hydroxide at an elevated temperature;
(G) removing the protective coating of photoresist;
(H) removing said first etchant resistant barrier layer;
(I) building up a second first half stack of alternating conductive layers and insulating
layers, the conductive layer being interconnected by vias through the insulating layers,
wherein second half stack has a substantially symmetrical lay up to first half stack;
(J) applying an insulating layer onto said second half stack of alternating conductive
layers and insulating layers, and
(K) removing said second base layer.
__________________
]11[]21[
]54[
METHOD FOR PREPARING AND
IDENTIFYING, ANALYSIS AND
USE OF PAR1 POLYMORPHISM
FOR EVALUATING THE RISK OF
CARDIOVASCULAR DISORDERS
]22[
16.04.2004
171477
‫ בדיקה ושימוש של‬,‫שיטה להכנה וזיהוי‬
‫ להערכת הסיכון להפרעות‬PAR 1 ‫פולימורפיזם‬
‫קרדיו וסקולריות‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
10318496.1
]32[ 24.04.2003
]33[ DE
Int. Cl.(2009.01) C07K 14/435, 14/72, C12Q 01/68
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/094470
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The invention relates to polynucleotide sequences comprising genetic variations of
PAR 1 gene on positions 3090 and/or 3329. Surprisingly, the presence of said variants
in humans correlates with specific cardiovascular diseases. The invention also relates
to methods for the detection of said genetic variations.
__________________
]11[]21[
]54[
ENHANCING MOBILE
MULTIPLE-ACCESS
COMMUNICATION NETWORKS
]22[
]31[
28.04.2004
60/465770
]32[ 28.04.2003
60/465764
28.04.2003
60/465768
28.04.2003
60/474251
30.05.2003
60/474252
30.05.2003
Int. Cl.(2010.01) H04B 07//00
ELBIT SYSTEMS LTD.
AVIV TZIDON
WO/2004/098111
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]51[
]71[
]72[
]87[
]74[
]57[
171578
‫הרחבת רשתות תקשורת ניידות בעלות‬
‫קישוריות מרובה‬
]33[
US
US
US
US
US
‫ חיפה‬,‫אלביט מערכות בע"מ‬
‫אביב צידון‬
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The present invention relates to mobile multiple access communication. More
particularly it relates to novel features in mobile multiple access communication
system (50).
November 30, 2010-‫כג' בכסלו התשע"א‬
The applications for division
from this application have
not yet been published
,206551,206550
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
METHOD AND APPARATUS FOR
FACILITATING EFFICIENT
DEINTERLEAVING AND
DIVERSITY-COMBINING OF A
DATA SIGNAL
]22[
]31[
]51[
]71[
]87[
]74[
29.04.2004
10/426488
]32[ 30.04.2003
Int. Cl.(2010.01) H04B 07//10
MOTOROLA, INC., U.S.A.
WO/2004/100436
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
171584
‫שיטה והתקן לסיוע יעיל בפרימת שזירה ושילוב‬
‫מגוון של אות נתונים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A processor (604) determines (502) a channel metric from a data signal received on a
diversity branch. The processor calculates (504) an index into a final metrics buffer
(702), the index determined from a position of the channel metric within an interleaved
frame of data. The processor places (506) a value derived from the channel metric into
the final metrics buffer at a location defined by the index. A corresponding method and
apparatus as well as communications receiver utilizing the processor (604) are
described.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
171782
‫פפטידים דימרים שמכילים פוליאתלין גליקול‬
‫ תכשירים‬,‫הנקשרים לקולטן אריתרופואטים‬
‫שמכילים אותם ושימוש בהם‬
]54[
PEPTIDE DIMERS WHICH
COMPRISE POLYETHYLENE
GLYCOL THAT BIND TO THE
ERYTHROPOIETIN RECEPTOR,
PHARMACEUTICAL
COMPOSITIONS THEREOF AND
USE THEREOF
]22[
]31[
12.05.2004
60/469993
]32[ 12.05.2003
]33[ US
60/470244
12.05.2003
US
Int. Cl.(2010.01) A61K 38//10, A61P 07//06, C07K 07//08, 14//505
AFFYMAX, INC., U.S.A.
WO/2004/101606
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention relates to peptide compounds that are agonists of the
erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods
using such peptide compounds to treat disorders associated with insufficient or
defective red blood cell production. Pharmaceutical compositions, which comprise the
peptide compounds of the invention, are also provided .
]51[
]71[
]87[
]74[
]57[
The applications for division
from this application have
not yet been published
,206418
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
171827
‫התקן ידני לניפוק ונתינה‬
]54[
HAND HELD DISPENSING AND
APPLICATION APPARATUS
]22[
]31[
]51[
]71[
07.05.2004
10/431769
]32[ 08.05.2003
]33[
Int. Cl.(2010.01) A45D 34//04, B65D 75//58
R.P. SCHERER TECHNOLOGIES,
INC., U.S.A.
WO/2004/101423
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A dispensing and application apparatus designed to contain pre-measured amounts of a
flowable substance. The apparatus comprises a compartment (130) for storing the
substance that is partially enclosed by a frangible seal (210), an applicator (100), and
an expandable chamber (170) designed to accept and dissipate the hydraulic force
created when pressure is applied to the compartment (130), rupturing the frangible seal
(210), and expelling the substance into the chamber (170). The applicator (100) is
attached to the chamber (170) with an applicator bond area (180). The expandability of
the chamber (170) is conferred by expandability of the applicator (100), and is varied
in different embodiments by altering the ratio between the area of the applicator bond
area (180) and the area of the applicator (100). The frangible seal (210), in one of
many embodiments, may be a chevron shape stress riser (250) with a point of
inflection (240) oriented towards the compartment (130). A removable cap may cover
the applicator.
__________________
]11[]21[
171847
November 30, 2010-‫כג' בכסלו התשע"א‬
]54[
CARD WITH EMBEDDED IC AND
ELECTROCHEMICAL CELL
]22[
]31[
]51[
]71[
]87[
]74[
12.05.2004
10/437546
]32[ 13.05.2003
Int. Cl.(2010.01) H01L 23//02
SOLICORE INC., U.S.A.
WO/2004/102618
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
‫ (מעגל משולב) מקובע ותא‬IC ‫כרטיס עם‬
‫אלקטרוכימי‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An IC card includes at least one plastic layer (915), a battery (865) and at least one
electronic device (980) embedded in the plastic layer (915). The battery (865) is
electrically connected to the electronic device (980) for providing power to the device
(980). The battery (865) includes an anode, a cathode, and at least one polymer matrix
electrolyte (PME) separator disposed between the anode and the cathode. The PME
separator includes a polyimide, at least one lithium salt and at least one solvent all
intermixed. The PME is substantially optically clear and stable against high
temperature and pressure, such as processing conditions typically used in hot
lamination processing or injection molding.
__________________
]11[]21[
171946
‫משטח רוטנן מצופה באמצעות קו–אקסטרוזיה‬
‫ללא אפקט משולש‬
]54[
GROUSER PLATE COATED BY
COEXTRUSION WITHOUT ANY
TRIANGLE EFFECT
]22[
]31[
]51[
]71[
04.05.2004
10322003.8
]32[ 16.05.2003
]33[ DE
Int. Cl.(2010.01) B29C 47//20, 47//70, B29D 24//00
BAYER SHEET EUROPE GMBH,
GERMANY
WO/2004/101257
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for producing wedge-less, co-extruded grouser
plates, special extrusion nozzles for producing such plates, the use of said nozzles for
producing such plates, co-extruded grouser plates having at least one base structure
November 30, 2010-‫כג' בכסלו התשע"א‬
containing a thermoplastic material and at least one co-extruded coating (9, 10)
without any triangle effect, and other products containing said co-extruded grouser
plate.
__________________
]11[]21[
]54[
METHOD FOR PREPARATION
OF ALPHA, BETA-UNSATURATED
CYCLIC KETONES BY
DEHYDROGENATION OF
SECONDARY ALLYLIC CYCLIC
ALCOHOLS
]22[
]31[
]51[
]71[
07.05.2004
10/449859
]32[ 30.05.2003
Int. Cl.(2009.01) C07C 45/00, 45/67
MILLENNIUM SPECIALTY
CHEMICALS, U.S.A.
WO/2004/108646
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
172088
‫ – קטונים טבעתיים בלתי‬ß,α ‫שיטה להכנת‬
‫רוויים באמצעות דהידרוגנציה של אלכהולים‬
‫אליליים טבעתיים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A process for the manufacture of an alpha, beta-unsaturated cyclic ketone, such as
carvone, comprises the dehydrogenation of a secondary allylic cyclic alcohol, such as
carveol, in the presence of at least one metal carboxylate. The process can be
performed in a batchwise or continuous mode. Examples of suitable metal
carboxylates include magnesium stearate, calcium 2-ethylhexanoate, and zinc 2ethylhexanoate.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
METHOD, APPARATUS AND
COMPUTER PROGRAM FOR
CALCULATING AND ADJUSTING
THE PERCEIVED LOUDNESS OF
AN AUDIO SIGNAL
]22[
]31[
]51[
]71[
27.05.2004
60/474077
]32[ 28.05.2003
Int. Cl.(2010.01) G10L 11//00
DOLBY LABORATORIES
LICENSING CORPORATION, U.S.A.
WO/2004/111994
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
172108
‫ התקן ותוכנת מחשב לחישוב ולהתאמת‬,‫שיטה‬
‫עוצמת הקול הנקלטת מאות אודיו‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
One or a combination of two or more specific loudness model functions selected from
a group of two or more of such functions are employed in calculating the perceptual
loudness of an audio signal. The function or functions may be selected, for example,
by a measure of the degree to which the audio signal is narrowband or wideband.
Alternatively or with such a selection from a group of functions, a gain value G[t] is
calculated, which gain, when applied to the audio signal, results in a perceived
loudness substantially the same as a reference loudness. The gain calculating employs
an iterative processing loop that includes the perceptual loudness calculation.
__________________
]11[]21[
]54[
PESTICIDAL OIL-IN-WATER
172441
‫אמולסית שמן במים מזיקים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
EMULSION
]22[
]31[
]51[
]71[
]74[
]57[
07.12.2005
2004-360988 ]32[ 14.12.2004
]33[ JP
Int. Cl.(2010.01) A01N 43//76, C07D 21/3/62
SUMITOMO CHEMICAL
COMPANY, LIMITED., JAPAN
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A pesticidal oil-in-water emulsion comprising:
(a) 4-phenoxyphenyl 2- (2-pyridyloxy) propyl ether,
(b) a hydrophobic organic solvent capable of dissolving 0.1- fold by weight of 4phenoxyphenyl 2- (2-pyridyloxy) propyl ether at 0ºC,
(c) polyvinyl alcohol,
(d) a nonionic surfactant selected from the group consisting of alkoxylated castor oil,
alkoxylated hydrogenated castor oil and alkoxylated hydrogenated castor oil fatty acid
ester, and
(e) water,
wherein a weight ratio of (a) 4-phenoxyphenyl 2- (2-pyridyloxy) propyl ether and (e)
water is in the range from 1:20 to 1:3.
__________________
]11[]21[
172454
]54[
GATEWAY CONNECTING A
HOME NETWORK AND AN
EXTERNAL NETWORK
]22[
]51[
]71[
]74[
08.12.2005
Int. Cl.(2010.01) H04L 12//56, 12//66, 29//06
ECI TELECOM LTD.
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
]57[
‫ המקשר בין רשת ביתית לרשת‬GATEWAY
‫חיצונית‬
‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
30 ‫רחוב הסיבים‬
‫פתח תקוה‬
A Home Gateway HGW interconnecting a Home Network (HN) and an Exteral
Network (EN), the HGW being adapted to communicate with the HN and EN at a
Network layer and being provided with a Service Application Programming Interface
Layer (SAPI Layer) capable of performing, at an Application layer, mediator functions
for supporting communication and services between said HN and EN.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
172584
‫ממבראנות ויראליות משוחזרות‬
‫פונקציונאלית הכוללות סייע ושיטות‬
‫לייצורם‬
]54[
FUNCTIONALLY RECONSTITUTED
VIRAL MEMBRANES CONTAINING
ADJUVANT AND METHODS FOR
THEIR PRODUCTION
]22[
]31[
]51[
]71[
18.06.2004
PCT/NL03/00450 ]32[ 19.06.2003
]33[ WO
Int. Cl.(2010.01) A61K 39//12, 39//145, 39//39, C07K 14//11, 16//10
BESTEWIL HOLDING B.V.,
KONINGSPLEIN 1,, THE
NETHERLANDS
ANTONIUS JOHANNES HENDRIKUS
STEGMANN, JAN CHRISTIAAN
WILSCHUT, JOHANNES HENRICUS
GERARDUS VAN BERKUM
WO/2004/110486
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
11
RAMAT GAN 52521
‫רמת גן‬
]72[
]87[
]74[
]57[
The present invention relates to vaccines directed against antigens such as membrane
proteins from pathogens or tumor cells. The invention further relates to methods of
forming reconstituted viral membranes, with membrane fusion activity, which are lipid
bilayer membranes preferably containing natural lipids of a virus, a viral fusion
protein, one or more optional further antigens as well as amphiphilic adjuvants.
Pharmaceutical compositions comprising such reconstituted viral membranes are also
part of the invention.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
172589
‫שיטה להסבת פגז רב פצצונות לפגז אחיד‬
]54[
METHOD OF CONVERTING A
CLUSTER BOMB INTO A
UNITARY BOMB
]22[
]51[
]71[
14.12.2005
Int. Cl.(2010.01) F42B 12//58
ISRAEL MILITARY INDUSTRIES
LTD.
]74[
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
A method of converting a cluster bomb having an expelling charge (54) and
submunitions (62) into a unitary bomb, characterized in that said cluster bomb is
prepared for the insertion of a shock wave destructive charge (12) including removing
said expelling charge and inserting said shock wave destructive charge into said
cluster bomb such that said destructive charge operatively contacts at least one
submunition.
]57[
‫ רמת‬,‫התעשייה הצבאית לישראל בע"מ‬
‫השרון‬
,'‫זליגסון גבריאלי ושות‬
31 ‫רח' יבנה‬
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
__________________
]11[]21[
]54[
AD HOC COMMUNICATION
SYSTEM AND METHOD OF
ROUTING SPEECH PACKETS
THEREIN
]22[
]31[
]51[
22.12.2005
60/638239
]32[ 23.12.2004
Int. Cl.(2010.01) H04W 84//18
172748
‫ ושיטה לניתוב שיחות‬Ad hoc ‫מערכת תקשורת‬
‫בה‬
]33[
US
November 30, 2010-‫כג' בכסלו התשע"א‬
]71[
CARMEL-HAIFA UNIVERSITY
ECONOMIC CORP. LTD.
]72[
SHARONI FELDMAN, YOSI BEN
ASHER
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
‫החברה הכלכלית של אוניברסיטת‬-‫כרמל‬
‫ חיפה‬,‫חיפה בע"מ‬
‫ יוסי בן אשר‬,‫שרוני פלדמן‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
An ad hoc communication system comprising a plurality of communication devices,
each device having a transmission range, wherein the devices are organized into one or
more communication graphs, each communication graph comprising one or more
nodes, each node representing a device of the system and an edge joining two nodes
indicating that the two nodes are in each other's transmission range, wherein at least
one of the graphs is a rooted tree.
__________________
]11[]21[
]54[
PREPARATION OF 1,3DIPHENYLPROP-2-EN-1-ONE
DERIVATIVES
]22[
]31[
]51[
]71[
]87[
]74[
08.07.2004
03/08354
]32[ 08.07.2003
Int. Cl.(2010.01) C07C 51//09, 67//31
GENFIT, FRANCE
WO/2005/005369
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]57[
172825
‫–און‬1–‫–אנ‬2–‫ – דיפנילפרופ‬1 ,3 ‫הכנת נגזרות של‬
]33[
FR
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
The invention relates to a method for the preparation of 1,3-diphenylprop-2-en-1-one
substituted on one of the two phenyl groups by a carboxyalkyloxy group or a
carboxyalkylthio group.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
METHOD FOR MEASURING THE
PROXIMITY OF TWO CONTOURS
AND SYSTEM FOR AUTOMATIC
IDENTIFICATION OF TARGETS
]22[
]31[
]51[
]71[
]87[
]74[
13.07.2004
0308707
]32[ 17.07.2003
Int. Cl.(2010.01) G06K 09//64
THALES, FRANCE
WO/2005/017818
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
173125
‫שיטה למדידת הקרבה בין שני קווי מתאר‬
‫ומערכת לזיהוי אוטומטי של מטרות‬
]33[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention relates to a method for measuring the proximity of a second contour
(CM) to a first contour (CI), comprising a step of association of each point of the first
contour with a point of the second contour determined to be the closest and a step for
pairing each point (M15) of the second contour with one or no points of the first
contour, by determination of the point of the first contour which is the closest (I 24)
among the set of points (I24, I28, I29) of the first contour associated with said point of
the second contour. A method for automatic identification of targets applies said
method of proximity measurement to determine the level of proximity of a model
contour, applied as the second contour to an image contour, applied as first contour.
__________________
]11[]21[
]54[
HEPARIN-DERIVED
OLIGOSACCHARIDE MIXTURES,
PREPARATION THEREOF AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
173206
‫ הכנתן‬,‫תערובות אוליגו–סוכר המופקות מהפרין‬
‫ותכשירים רפואיים הכוללים אותן‬
November 30, 2010-‫כג' בכסלו התשע"א‬
SAID MIXTURES
]22[
]31[
]51[
]71[
]87[
]74[
]57[
22.07.2004
0309041
]32[ 24.07.2003
Int. Cl.(2010.01) C08B 37//10
AVENTIS PHARMA S.A., FRANCE
WO/2005/010051
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]33[
FR
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The present invention relates to heparin-derived oligosaccharide mixtures, having an
average molecular weight from 1,800 to 2,400 daltons and characterized by a high aXa
activity and by the absence of aIIa activity. Said invention also relates to the
preparation method thereof and to the pharmaceutical compositions containing said
mixtures.
__________________
]11[]21[
]54[
AUDIO FILE FORMAT
CONVERSION
]22[
]31[
13.07.2004
10333071.2
]32[ 21.07.2003
10339498.2
27.08.2003
Int. Cl.(2010.01) G10L 19//14
FRAUNHOFER-GESELLSCHAFT
ZUR FORDERUNG DER
ANGEWANDTEN FORSCHUNG
E.V., GERMANY
WO/2005/013491
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]51[
]71[
]87[
]74[
]57[
173223
‫המרת פורמט של קבצי אודיו‬
]33[
DE
DE
,'‫זליגסון גבריאלי ושות‬
31 ‫רח' יבנה‬
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
According to the invention, the manipulation of audio data can be simplified, such as,
for example, with relation to the combination of individual audio channels to give
multi-channel audio data streams, or for the general manipulation of an audio data
stream, whereby a data block is modified (56) in an audio data stream (10), divided
into data blocks (10a, 10b) with determining blocks (14, 16) and data block audio data
November 30, 2010-‫כג' בכסלו התשע"א‬
(18) such as, for example, by inclusion in, addition to, or replacement of a part thereof,
itself containing a length indicator which expresses a data amount or length of the
block audio data, or a data amount or length of the data block, such as to give a second
audio data stream with modified data blocks. Alternatively, an audio data stream (10)
with pointers in determining blocks (14, 10), which point to the determining block
audio data (44, 46), allocated to the determining blocks, but distributed in various data
blocks, is converted into an audio stream, whereby the determining block audio data
(44, 46) are combined to give coherent determining block audio data (48). The
coherent determining block audio data (48) can be contained with the corresponding
determining block (14, 16) in a self-contained channel element (52a).
__________________
]11[]21[
]54[
NIGHT VISION AIMING SIGHT
WITH TWO EYEPIECES
]22[
]31[
]51[
]71[
]87[
]74[
09.07.2004
0309165
]32[ 25.07.2003
Int. Cl.(2010.01) F41G 01//32
THALES, FRANCE
WO/2005/017441
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
173234
‫כוונת לראיית לילה דו–עינית‬
]33[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention relates to aiming sights for firearms with a light intensifier. A firearm
(31) may be provided with a camera (1) which permits the infantryman to take aim
whilst remaining protected, in order to render safer certain types of firing. The aim of
the invention is to provide said function at night. Said aim is achieved, whereby a night
vision aiming sight (2) with light intensifier, having two optical paths is provided on
the firearm (31). The first optical path provides an intensified image to the camera (1),
arranged on the firearm (1). The second path provides the person firing with a directly
observable intensified image. In one embodiment, the sight (2) also comprises a
November 30, 2010-‫כג' בכסלו התשע"א‬
display (282) which provides the infantryman with supplementary information
superimposed on the intensified images.
__________________
]11[]21[
]54[
SYSTEM AND METHOD FOR
ESTABLISHING THAT A SERVER
AND A CORRESPONDENT HAVE
COMPATIBLE SECURE EMAIL
]22[
]31[
07.02.2006
60/659279
]32[ 07.03.2005
11/107011
15.04.2005
Int. Cl.(2010.01) H04L 09//00
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]74[
]57[
173581
‫מערכת ושיטה לביסוס העובדה שלמשתמש‬
‫ולבעל שיחו ישנו דואר אלקטרוני מאובטח‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A method for determining that a potential correspondent domain has compatible secure
email technology in order to establish a link between a server of a source domain and a
computer of a correspondent domain comprising:
transmitting a discovery secret from the source domain to the correspondent domain
wherein the discovery secret includes a data element specific to the correspondent
domain and wherein the discovery secret includes a source domain address to which
the correspondent domain sends a message in order to establish compatibility between
the source domain and the correspondent domain; and
receiving by the source domain via the source domain address an invitation from the
correspondent domain wherein the invitation includes the data element or an element
corresponding to the data element which may be used by the correspondent domain to
initiate a process to establish compatibility with the correspondent domain;
wherein the source domain verifies the data element received from the correspondent
domain by re-computing and then comparing the data element received for the
November 30, 2010-‫כג' בכסלו התשע"א‬
correspondent domain with the data element included in the discovery secret
transmitted to the correspondent domain; and
wherein the source domain only corresponds with the correspondent domain when the
data element provided by the correspondent domain is the same as the data element
included in the discovery secret so that a denial of service attack from a correspondent
domain in mitigated.
__________________
]11[]21[
173752
‫אוקסאזאבורולידינים כמשפיעים על בקטריה‬
]54[
OXAZABOROLIDINES AS
BACTERIA EFFECTORS
]22[
]31[
]51[
]71[
02.09.2004
60/499005
]32[ 02.09.2003
]33[ US
Int. Cl.(2009.01) A61K 31/69, A61P 31/00, C07F 05/02
YISSUM RESEARCH
‫יישום חברה לפיתוח המחקר של‬
DEVELOPMENT COMPANY OF
‫ ירושלים‬,‫האוניברסיטה העברית בירושלים‬
THE HEBREW UNIVERSITY OF
JERUSALEM
WO/2005/021559
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]87[
]74[
]57[
The invention relates to a composition for modulation of at least one bacteria-related
parameter comprising oxazaborolidine derivative compounds. The invention
additionally relates to new oxazaborolidine derivative compounds. The invention
further relates to a composition for decreasing bacterial growth, a composition for
increasing the susceptibility of bacteria to the cytotoxic effects of other antibacterial
agents, and a pharmaceutical composition comprising as an active ingredient an
oxazaborolidine derivative compound. Methods for modulating at least one bacteriarelated parameter, for preventing, decreasing or eliminating bacterial growth, and for
making bacteria more susceptible to other antibacterial compounds are also described.
__________________
]11[]21[
173910
November 30, 2010-‫כג' בכסלו התשע"א‬
]54[
PHARMACEUTICAL
FORMULATION COMPRISING A
PYRIMIDINE-A-ONE
DERIVATIVE COATED WITH AN
ENTERIC POLYMER
]22[
]31[
]51[
]71[
31.08.2004
0320522.6
]32[ 02.09.2003
]33[ GB
Int. Cl.(2010.01) A61K 09//00, 09//20, 09//30, 31//513
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2005/021002
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
]57[
A––‫תכשיר רוקחות המכיל נגזרת של פירימידין‬
‫ המצופה עם פולימר אנטרי‬1
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
The present invention provides enteric polymer coated tablet formulations for oral
administration which comprise a phospholipase A2 enzyme Lipoprotein Associated
Phospholipase A2 (Lp-PLA2) inhibitor, processes for preparing such formulations and
their use in therapy, in particular the treatment of atherosclerosis.
__________________
]11[]21[
]54[
ACTUATION ASSEMBLY FOR
OPERATING A BLIND INSIDE A
CHAMBER FORMED BY PANES OF
GLASS SUPPORTED WITHIN A
FRAME
]22[
]31[
]51[
]71[
]87[
]74[
05.11.2003
MI2003A001902 ]32[ 03.10.2003
Int. Cl.(2010.01) E06B 09//264, 09//42
PELLINI S.P.A., ITALY
WO/2005/033462
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]57[
174019
‫מכלול הפעלה לתיפעול תריס בתוך תא‬
‫המיוצר משמשות זכוכית הנתמכות בתוך‬
‫מסגרת‬
]33[
IT
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
System for operating a plain blind within a glass-enclosed chamber having a first end
fixed to a blind-roller by means of devices that pull on said blind-roller and on the
second end of the blind.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
174072
‫פאנלים מופרדים‬
]54[
INSULATED PANELS
]22[
]31[
03.09.2004
2003904771
]32[ 03.09.2003
]33[ AU
2003907213
31.12.2003
AU
Int. Cl.(2009.01) E04C 02/26, 02/34, E06B 03/22, 03/263, 03/66, 03/677, F25D
21/04, 23/02
JULIAN MCKINLAY KING,
AUSTRALIA
ROSS CAMPBELL MCKINLAY,
AUSTRALIA
MURRAY CHRISTIAN PICKFORD,
AUSTRALIA
WO/2005/021886
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
]51[
]71[
]87[
]74[
]57[
A panel comprising: a frame member (70) defining a periphery of said panel; a first
wall (77) retained by the frame (70) and a seoond wall (79) opposing said first wall
(77) and together with the first wall (77) defining an internal space (73, 74) of the
panel; the panel further comprising at least one intermediate wall (78) disposed in said
internal space intermediate the first (77) and second walls (79) and which creates a
first space (73) in said internal space between said intermediate wall (78) and said first
wall (77) and a second space (74) in said internal space between said intermediate wall
(78) and said second wall (79); charactedized in that the frame includes respective
abutment surfaces (80, 81, 82) which receive and retain respective first, second and
intermediate walls wherein; the intermtediate wall (78) insulates said first wall (77)
from said second wall (79).
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
DATA BOUNDARY AWARE BASE
STATION ASSISTED POSITION
LOCATION METHOD
]22[
]31[
]51[
03.09.1999
09/150410
]32[ 09.09.1998
Int. Cl.(2010.01) G01S 01//00, 05//00
174120
‫שיטת איתור מיקום הנעזרת בתחנת בסיס‬
‫המודעת לגבולות מידע‬
]33[
US
November 30, 2010-‫כג' בכסלו התשע"א‬
]62[
]71[
]87[
]74[
]57[
DIVISION FROM 141707
QUALCOMM INCORPORATED,
U.S.A.
WO/2000/014571
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The present invention is a novel and improved method and apparatus for performing
position location in wireless communications system. A method for performing
position location on a subscriber unit in a terrestrial wireless telephone system using a
set of satellites each transmitting a signal, the terrestrial wireless telephone system
having base stations (12), including the steps of transmitting an aiding message from
the base station (12) to the subscriber unit, said aiding message containing information
regarding a data boundary for each signal from the set of satellites, applying
correlation codes to each signal yielding corresponding correlation data and
accumulating said correlation data over a first interval preceding a corresponding data
boundary yielding a first accumulation result, and a second interval following said
corresponding data boundary yielding a second accumulation result.
__________________
]11[]21[
174163
–‫פלטפורמה לניתוח תוכן של רשתות ביצועים‬
‫גבוהים‬
]54[
HIGH-PERFORMANCE
NETWORK CONTENT ANALYSIS
PLATFORM
]22[
]31[
]51[
]71[
09.09.2004
10/658777
]32[ 10.09.2003
]33[ US
Int. Cl.(2010.01) G06F 15//16, 15//173, 17//30, H04L 29//06
FIDELIS SECURITY SYSTEMS,
U.S.A.
WO/2005/027539
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]87[
]74[
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
November 30, 2010-‫כג' בכסלו התשע"א‬
]57[
One implementation of a method reassembles complete client-server conversation
streams, applies decoders and/or decompressors, and analyzes the resulting data stream
using multi-dimensional content profiling and/or weighted keyword-in-context. The
method may detect the extrusion of the data, for example, even if the data has been
modified from its original form and/or document type. The decoders may also uncover
hidden transport mechanisms such as, for example, e-mail attachments. The method
may further detect unauthorized (e.g., rogue) encrypted sessions and stop data transfers
deemed malicious. The method allows, for example, for building 2 Gbps (FullDuplex)-capable extrusion prevention machines.
,198794
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
174200
]54[
DEVICE FOR DIVISION OF A
NON-NEWTONIAN LIQUID
FLOWING THROUGH A
PASSAGE
]22[
]51[
]71[
]74[
09.03.2006
Int. Cl.(2009.01) B32B 01/00, F15D 01/02
INCOE CORPORATION, U.S.A.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
‫התקן לחילוק נוזל לא–ניוטוני הזורם דרך מעבר‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A device for dividing a non-Newtonian liquid material flowing through a passage, the
material having a flow-conditioned viscosity decreasing outward in cross-section in
flow through a substantially T-shaped passage branching deflecting and dividing the
liquid flow, comprising a partition member positioned in a partition plug member
adjacent the end of the supply passage in the passage branching which divides the
liquid flowing counter from the supply passage segment into two halves, said partition
member positioned in a dome-shaped recess in said partition plug member, the angular
November 30, 2010-‫כג' בכסלו התשע"א‬
position of the partition member having a setting adapted to the distribution of the
differentially viscous components of the liquid in the supply passage segment, wherein
the liquid flowing into the said discharge passage does not have substantial
distribution of the differentially viscous components of the liquid.
__________________
]11[]21[
174227
‫ציוד למשתמש לקבלת והעברת אותות תקשורת‬
]54[
USER EQUIPMENT FOR
RECEIVING AND
TRANSMITTING
COMMUNICATION SIGNALS
]22[
]31[
]51[
]62[
]71[
24.05.2000
60/136664
]32[ 28.05.1999
]33[ US
Int. Cl.(2010.01) H04B 07//204, 07//26, H04L 05//14
DIVISION FROM 146742
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2000/074276
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A user equipment (UE) capable of receiving and transmitting communication signals
in a time division duplex using code division multiple access format, the user
equipment comprising:
an antenna for receiving a primary code synchronization signal, the primary code
synchronization signal received in a selected time slot out of a plurality of time slots in
a primary code synchronization channel;
a plurality of matched filters for identifying synchronization signals, the secondary
synchronization signals received along with the primary code synchronization signals;
and
a processor for time synchronizing with a received timing of the primary code
synchronization signals, and for determining an assigned code group and the selected
time slot, based on the identified secondary synchronization signals; and
wherein the assigned code group is out of a predetermined number N of possible code
groups, each selected time slot out of the plurality of time slots associated with a
unique combination of secondary signals from a set of secondary signals which does
not exceed (log2 N) + 1 in number.
November 30, 2010-‫כג' בכסלו התשע"א‬
,206600
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
OZONE PLASMA MEDICAL
STERILIZATION
]22[
]31[
]51[
]71[
]72[
05.09.2004
10/659354
]32[ 11.09.2003
Int. Cl.(2010.01) A61L 02//00
TUTTNAUER ISRAEL LTD.
GENA PERLOV, SHMUEL YANNAI,
BORIS MALKIN
WO/2005/023319
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]87[
]74[
]57[
174234
‫עיקור אוזון פלזמה רפואי‬
]33[
US
‫ ירושלים‬,‫טוטנאואר ישראל בע"מ‬
‫ בוריס מלקין‬,‫ שמואל ינאי‬,‫ג'ינה פרלוב‬
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
A method for sterilizing at least one item in a chamber (12), including the steps of:
disposing the at least one item in the chamber (12); pumping the atmosphere from the
chamber (12) until the atmosphere of the chamber (12) has a pressure of less than ten
torr; adding water vapor and ozone to the chamber; and generating electrical discharge
in the chamber (12), such that the electrical discharge produces OH radicals from the
water vapor and the ozone so as to contribute to sterilization of at least part of the at
least one item.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
174259
‫התקן שיוף‬
]54[
SANDING APPARATUS
]22[
]31[
]51[
]71[
]74[
12.03.2006
11/079770
]32[ 14.03.2005
]33[ US
Int. Cl.(2010.01) B24B 23//00
ALLWAY TOOLS, INC, U.S.A.
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A sander for applying sandpaper or abrasive screening to a surface, the sander
comprising:
a body member having upstanding walls and a bottom wall;
a pad member made of thermoplastic material having upstanding walls and an upper
wall;
attachment means on the body member for detachably joining sandpaper or abrasive
screening along the bottom wall of the pad member;
the upstanding walls and the upper wall of the pad member being co-molded about and
overlying the upstanding walls and bottom wall of the body member respectively;
the upstanding walls of the pad member having a top portion that defines a
substantially immovable upper lip which is substantially continuous and which
overlies all of the upstanding walls of said body member; and
the body member being made of a substrate which is chemically compatible with and
molecularly bonded to said pad member without the use of an adhesive.
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
174312
‫שיטה ומערכת לעיבוד לולאת פקודות‬
]54[
METHOD AND SYSTEM FOR
PROCESSING A LOOP OF
INSTRUCTIONS
]22[
]31[
]51[
]71[
]87[
]74[
28.09.2004
10/675092
]32[ 30.09.2003
]33[ US
Int. Cl.(2010.01) G06F 09//00, 09//30, 09//32, 09//38
STARCORE, LLC, U.S.A.
WO/2005/033862
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]57[
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
An information handling system (10) processes a loop of instructions. In response to
detecting processing of a particular instruction (52, 58) during a pass through the loop,
the system initiates a fetch (50) of an initial instruction that is programmed at a start of
the loop, and stores an identification of a different instruction that is programmed
between the initial instruction and the particular instruction. According to the stored
identification, in response to detecting processing of the different instruction during an
additional pass through the loop, the system initiates an additional fetch (50) of the
initial Instruction.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
MILLIMETRE AND SUBMILLIMETRE IMAGING DEVICE
]22[
]31[
15.09.2004
0321628.0
]32[ 15.09.2003
0322847.5
30.09.2003
Int. Cl.(2010.01) G01V 08//00
THE SCIENCE AND TECHNOLOGY
FACILITIES COUNCIL, UNITED
KINGDOM
WO/2005/026833
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
]57[
174313
‫התקן הדמייה מילימטרי ותת–מילימטרי‬
]33[
GB
GB
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
The terahertz camera has a fixed objective lens (2) and a plurality of detectors (3)
positioned at the focal plane of the objective lens (2). Each of the detectors (3) is
mounted on a movable support (10) so that the antenna is capable of movement across
the focal plane of the objective lens (2) and is provided with a flexible waveguide (4)
for connecting the output of the detector (3) with signal processing means. Each
detector (3) is also provided with a retroreflector (6) which is reflective at frequencies
other than terahertz frequencies. During use of the camera, the retroreflector (6) of
each detector (3) is illuminated at non-terahertz frequencies so that the spatial position
of each detector (3) and hence the spatial source of signals generated by the detector
can be accurately identified. The terahertz camera is particularly suited for use in
security installations and in chemical and food processing industries.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
SYSTEM AND METHOD FOR
INTEGRATION OF WIRELESS
COMPUTER NETWORK IN
POSITION DETERMINING
TECHNOLOGY
]22[
]31[
]51[
]71[
17.09.2004
10/665747
]32[ 19.09.2003
Int. Cl.(2010.01) G01S 05//14
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/029120
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
174366
‫מערכת ושיטה למיזוג של רשת מחשב אלחוטית‬
‫בטכנולוגית קביעת מיקום‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A wireless communication device, known as a mobile station (MS), contains a
conventional wireless communication system and further comprises a wireless
computer network communication subsystem and may also include GPS capability.
The operator of the MS may utilize any or all of these subsystems to determine the
current position of the MS. Based on the current position of the MS, location-based
services are provided to the MS as sales information, schedules, prices, maps, and the
like. In a typical implementation a plurality of computer network access points, or
beacons, are distributed throughout a geographic region and used to determine the
position of the MS with a reasonably high degree of accuracy. Based on the current
position of the MS, the beacons can provide location-based services.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
OMNIDIRECTIONAL
LENTICULAR AND BARRIERGRID IMAGE DISPLAYS AND
METHODS FOR MAKING THEM
]22[
]31[
]51[
]71[
]87[
]74[
22.09.2004
60/504809
]32[ 29.09.2003
Int. Cl.(2010.01) G02B 27//10
GENE DOLGOFF, U.S.A.
WO/2005/031687
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]57[
174490
‫תצוגות מסוג עדשה ומחסום–רשת רב–כיווניות‬
‫ושיטות לייצורן‬
]33[
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
Image-directing devices, e.g. barriers or lenticular lens (655), tilted so as to be other
than vertical (zero degrees) or horizontal (ninety degrees), displays two or more
individual images each viewable from different view points. Composite images so
displayed provide substantially the desired viewing experience regardless of whether
their viewing surfaces are tipped about a vertical (610) or horizontal axis (600).
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
174509
‫מתקן כמילומיניסצנטי רב–צורתי ורב–צבעוני‬
]54[
MULTI-SHAPE AND MULTICOLOR CHEMILUMINESCENCE
DEVICE
]22[
]31[
]51[
]71[
]72[
]87[
]74[
23.09.2004
10/672168
]32[ 26.09.2003
]33[
Int. Cl.(2010.01) B65D 81//32, F21K 02//06
FORMAGLOW LTD.
YUVAL GOYCHRACH
WO/2005/031298
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]57[
US
‫ ערבה‬,‫פורמגלו בע"מ‬
‫יובל גיוכרך‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
Provided is a chemiluminescent device and a method for producing it. The device (10)
, providing multiple shapes and optionally multicolor, glowing images, has separation
means that prevents the chemiluminescent reactants from mixing before wishing to st
the reaction, and partition means that enables to prevent at least one of the reactants
from mixing with the others even after starti the reaction. The device is useful in
creating two and three dimensional aesthetic glowing artifacts, and it may be used in
the do of entertainment and advertising , and further in the situations of emergency and
in areas without energy supply.
__________________
]11[]21[
]54[
POSITIVE TYPE RADIATIONSENSITIVE RESIN
COMPOSITION
]22[
]31[
]51[
]71[
27.03.2006
2005-093385 ]32[ 29.03.2005
Int. Cl.(2010.01) G03F 07//004
JSR CORPORATION, JAPAN
174569
‫הרכב שרפי מטיפוס חיובי הרגיש לקרינה‬
]33[
JP
November 30, 2010-‫כג' בכסלו התשע"א‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
]74[
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A positive type radiation-sensitive resin composition for KrF excimer laser
comprising:
(A) a photoacid generator and
(B) an acid-labile group-containing resin which is insoluble or scarcely soluble in
alkali, but becomes alkali-soluble by the action of an acid,
wherein (A) a photoacid generator of the formula (1) as depicted in the specification
and (A2) a photoacid generator which is at least one compound selected from the
group consisting of sulfonyloxyimides and disulfonyldiazomethanes,
wherein R1 represents a same or different monovalent organic group containing
fluorine atoms, or a fluorine atom, R2 represents a same or different monovalent
organic group containing no fluorine atoms, or a hydrogen atom, n and m are integers
of 1-5, and X' represents an anion of camphorsulfonic acid or
nonafluorobutanesulfonic acid.
__________________
]11[]21[
174647
‫ תכשירי‬,‫פיראזולופירידינים ואנלוגים שלהם‬
‫רוקחות המכילים אותם ושימוש בהם להכנת‬
‫תרופות‬
]54[
PYRAZOLOPYRIDINES AND
ANALOGS THEREOF,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND THEIR USE IN THE
MANUFACTURE OF
MEDICAMENTS
]22[
]31[
01.10.2004
60/508352
]32[ 03.10.2003
]33[ US
60/554680
19.03.2004
US
60/603303
20.08.2004
US
Int. Cl.(2010.01) A61K 31//4353, C07D 21/3/00, 47/1/04, 47/1/14, 48/7/02, 48/7/12
3M INNOVATIVE PROPERTIES
COMPANY, U.S.A.
WO/2005/079195
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]51[
]71[
]87[
]74[
]57[
Pyrazolopyridin-4-amines, pyrazoloquinolin-4-amines, pyrazolonaphthyridin-4November 30, 2010-‫כג' בכסלו התשע"א‬
‫‪amines, and 6,7,8,9-tetrahydropyrazoloquinolin-4-amines, pharmaceutical‬‬
‫‪compositions containing the compounds, intermediates, and methods of use of these‬‬
‫‪compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in‬‬
‫‪animals and in the treatment of diseases including viral and neoplastic diseases, are‬‬
‫‪disclosed.‬‬
‫__________________‬
‫‪174712‬‬
‫מכשיר לסחיטת נוזלים ושיטה לשימוש בו לייצור‬
‫מוצרים‬
‫[‪]11[]21‬‬
‫‪APPARATUS FOR SQUEEZING‬‬
‫‪FLUIDS AND METHOD FOR ITS‬‬
‫‪USE IN MANUFACTURING‬‬
‫‪PRODUCTS‬‬
‫[‪]54‬‬
‫‪02.04.2006‬‬
‫‪Int. Cl.(2010.01) B01D 33//00, B30B 07//00, C11B 01//06‬‬
‫‪LEV SHURIN‬‬
‫‪LEV SHURIN,‬‬
‫‪1/8 DAVIDZON ST.,‬‬
‫‪RISHON LEZION 75357‬‬
‫[‪]22‬‬
‫[‪]51‬‬
‫[‪]71‬‬
‫[‪]74‬‬
‫מכשיר לסחיטת נוזלים מתוך מסה המכילה את הנוזל‪ ,‬המכשיר כולל תא דחיסה סגור‪,‬‬
‫הכולל את צילינדר ומסנן המשתרע בין קצה ראשון לקצה שני שלו לאורך ציר אורכי‪,‬‬
‫ובעל שטח חתך נתון ‪ ,Ac‬תא הדחיסה כולל לפחות פתח ניקוז אחד לצורך פינוי הנוזל‬
‫הנסחט‪ ,‬כאשר אל קצהו הראשון של תא הדחיסה מחוברת בוכנה ראשונה המיודעת‬
‫לבצע תנועה מתוך תא הדחיסה לאורך הציר האורכי ובעלת ראש בוכנה ראשן בעל שטח‬
‫חתך ‪ 1A‬קטן משטח החתך ‪ Ac‬הנתון )‪ ,(Ac > A1‬ואל קצהו השני של תא הדחיסה‬
‫מחוברת בוכנה שניה המיועדת לבצע תנועה בתוך תא הדחיסה לאורך הציר האורכי‬
‫ובעלת ראש בוכנה שני בעל שטח חתך ‪ 2A‬כך ש‪.Ac = A2 > A1 :‬‬
‫[‪]57‬‬
‫לב שורין‪ ,‬ראשון‪-‬לציון‬
‫לב שורין‪,‬‬
‫דוידזון ‪1/8‬‬
‫ראשון‪-‬לציון‬
‫__________________‬
‫‪174762‬‬
‫תכשירי רוקחות המכילים אגוניסט בררני‬
‫לקולטן אימידזול ‪ I1‬וחוסם קולטן אנגיוטנסין ‪II‬‬
‫והשימושים בהם‬
‫כג' בכסלו התשע"א‪November 30, 2010-‬‬
‫[‪]11[]21‬‬
‫‪PHARMACEUTICAL‬‬
‫‪COMPOSITION COMPRISING A‬‬
‫‪SELECTIVE I1 IMIDAZOLINE‬‬
‫‪RECEPTOR AGONIST AND AN‬‬
‫‪ANGIOTENSIN II RECEPTOR‬‬
‫[‪]54‬‬
BLOCKER AND USES THEREOF
]22[
]31[
]51[
]71[
]87[
]74[
]57[
07.10.2004
03103763.3
]32[ 10.10.2003
Int. Cl.(2010.01) A61K 45//06
SOLVAY PHARMACEUTICALS
GMBH, GERMANY
WO/2005/039639
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to pharmaceutical compositions comprising selective
imidazoline receptor agonists combined with angiotensin II receptor blockers. In
particular, the present invention relates to pharmaceutical compositions comprising
Moxonidine and Eprosartan mesylate. The invention also relates to the use of said
compositions in the manufacture of a medicament for the treatment of hypertension,
especially in hypertensive patients already suffering from type II diabetes or being
susceptible to developing type II diabetes.
__________________
]11[]21[
]54[
SYSTEMS AND METHODS FOR
IMMOBILIZATION USING
CHARGE DELIVERY
]22[
]31[
07.10.2004
60/509577
]32[ 07.10.2003
60/509480
08.10.2003
10/714572
13.11.2003
10/750374
31.12.2003
Int. Cl.(2010.01) H05C 01//00
TASER INTERNATIONAL, INC.,
U.S.A.
WO/2005/086618
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]51[
]71[
]87[
]74[
]57[
174776
‫מערכות ושיטות למניעת תנועה בעזרת מתן‬
‫מטענים חשמליים‬
]33[
US
US
US
US
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
Systems and methods for immobilizing a target such as a human or animal with a
stimulus signal coupled to the target via electrodes provide the stimulus signal in
November 30, 2010-‫כג' בכסלו התשע"א‬
accordance with a strike stage, a hold stage, and a rest stage. Systems include a launch
device (102) and separate projectile (132), where the projectile includes a battery
(134), a waveform generator (136), and electrodes. The strike stage and hold stage may
include pulses at a pulse repetition rate, for example, from 10 to 20 pulses per second,
each pulse delivering a predetermined amount of charge, for example, about 100
microcoulombs at less than about 500 volts peak. The hold stage may continue
immobilization at a lesser expenditure of energy compared to the strike stage. Because
the strike stage and hold stage may immobilize by interfering with skeletal muscle
control by the target's nervous system, a rest stage may allow the target to take a
breath.
__________________
]11[]21[
174793
‫שיטה ליצור פחמימנים ותרכובות המכילות‬
‫חמצן ממאסה ביולוגית‬
]54[
METHOD FOR PRODUCING
HYDROCARBONS AND OXYGENCONTAINING COMPOUNDS
FROM BIOMASS
]22[
]31[
22.10.2004
0302800-8
]32[ 24.10.2003
]33[ SE
60/513583
24.10.2003
US
Int. Cl.(2010.01) C12P 07//02, 07//06, 07//18, 07//24, 07//40, 07//54
SWEDISH BIOFUELS AB, SWEDEN
WO/2005/040392
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]51[
]71[
]87[
]74[
]57[
A method which can be used in fermenting carbohydrate substrates of plant origin for
producing C1-C5 alcohols, and for synthesis of higher alcohols, and other oxygencontaining compounds. Since C6 and higher alcohols are not obtainable by a direct
biochemical route, it is proposed to synthesize these using known chemical reactions,
November 30, 2010-‫כג' בכסלו התשע"א‬
wherein the raw material for synthesis is biogas and lower C 2-C5 alcohols obtained by
the inventive method wherein the amino acids leucine, isoleucine, and valine, or a
mixture thereof, optionally obtained from yeast autolysate, is used as a biocatalyst at
the stage of fermentation. It is also proposed to use wasters of C2-C5 alcohols
production for obtaining biogas. The method offers a solution to the following
problems: to considerably increase the yield of C2-C5 alcohols in fermentation of
carbohydrate substrates; to increase by 1.5-2.0 times the productivity of the
fermentation in terms of C2-C5 alcohols production; to utilize the protein-containing
waste for C2-C5 alcohols production, to reach highest efficiency of biomass utilization
in producing higher oxygen-containing compounds and hydrocarbons.
__________________
]11[]21[
174823
‫התקן הזרקה רפואי הניתן להעמסה על העור‬
]54[
MEDICAL INJECTION DEVICE
MOUNTABLE TO THE SKIN
]22[
]31[
21.10.2004
03024626.8
]32[ 27.10.2003
]33[ EP
60/518836
10.11.2003
US
Int. Cl.(2010.01) A61M 05//142, 05//145, 05//148
NOVO NORDISK A/S, DENMARK
WO/2005/039673
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A medical device is provided comprising a transcutaneous device unit and a reservoir
unit. The transcutaneous device unit comprises a transcutaneous device for
transporting a fluid through a skin portion of a subject, and a mounting surface adapted
for application to the skin of the subject. The reservoir unit comprises a reservoir
adapted to contain a fluid drug, the reservoir comprising an outlet means allowing the
transcutaneous device to be arranged in fluid communication with an interior of the
reservoir, and an expelling assembly for expelling a fluid drug out of the reservoir and
through the skin of the subject via the transcutaneous device. The transcutaneous
device unit and the reservoir unit further comprise coupling means allowing the
reservoir unit to be secured to the transcutaneous device unit in the situation of use. By
this arrangement a two-unit system is provided which can be used in a convenient and
cost-effective manner.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
174986
‫הרכב אימונוגני והשתמשות בו בשיטה להכנת‬
HIV ‫תרכיב חיסון נגד‬
]54[
IMMUNOGENIC COMPOSITION
AND METHOD USING SAME TO
PREPARE AN HIV VACCINE
]22[
]31[
]51[
]71[
]72[
]87[
]74[
25.10.2004
60/513827
]32[ 23.10.2003
]33[
Int. Cl.(2010.01) A61K 09//00, 39//21, 47//12
NELSON M. KARP, U.S.A.
NELSON M. KARP
WO/2005/039501
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]57[
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
The present invention relates to an immunogenic composition. More particularly, the
present invention is a composition directed to eliciting an immune response to HIV
fusion protein. The present invention contemplates three categories of embodiments:
protein or protein fragments, messenger RNA, or DNA/RNA. DNA/RNA composition
may be either naked or recombinant. The present invention further contemplates use
with a variety of immune stimulants.
__________________
]11[]21[
]54[
MAT FOR REDUCING THE
DISTURBANCE OF
175451
‫שטיחון להפחתת ההפרעה של רוח לחומר‬
‫חלקיקי ולנוזלים‬
November 30, 2010-‫כג' בכסלו התשע"א‬
PARTICULATE MATTER AND
LIQUIDS BY WIND
]22[
]31[
]51[
]71[
]87[
]74[
]57[
05.11.2004
2003906097
]32[ 05.11.2003
]33[ AU
Int. Cl.(2010.01) B32B 03//24, B64F 01//36, E01F 03//00, E02D 17//20
C GEAR AUSTRALIA PTY LTD.,
AUSTRALIA
WO/2005/045138
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
A mat for reducing the disturbance of particulate matter by wind, has a first layer of
coarse mesh material, and a second layer of coarse mesh material. The first layer is
held in a substantially fixed position relative to the second layer. The mat is
particularly suitable for use as a helicopter landing mat, in conditions where dust, sand,
snow, water or other particles or liquids might otherwise cause a disturbance resulting
in loss of visibility, damage or wear to parts of the helicopter, and injury or damage to
nearby people or equipment.
__________________
]11[]21[
]54[
EYEGLASS MANUFACTURING
METHOD
]22[
]31[
29.10.2004
60/520065
]32[ 14.11.2003
60/546378
20.02.2004
10/936131
07.09.2004
10/936132
07.09.2004
Int. Cl.(2010.01) G02C 07//02
]51[
175497
‫שיטה לייצור משקפיים‬
]33[
US
US
US
US
November 30, 2010-‫כג' בכסלו התשע"א‬
]71[
]87[
]74[
]57[
OPHTHONIX, INC., U.S.A.
WO/2005/050289
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
A method of making corrective eyeglasses is disclosed. One embodiment is a method
of making corrective eyeglasses. The method includes obtaining vision parameters of a
patient's eyes, obtaining an eyeglass frame comprising at least one mounted optical
element, and programming the optical element to define a pattern of refraction that is
associated with the vision parameters.
__________________
]11[]21[
175648
‫זיהוי מיקום באמצעות שדות מגנטיים המדמים‬
‫זרם ישר‬
]54[
POSITION TRACKING USING
QUASI-DC MAGNETIC FIELDS
]22[
]31[
]51[
]71[
]74[
15.05.2006
11/130423
]32[ 16.05.2005
]33[ US
Int. Cl.(2010.01) A61N 02//00
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.BOX 33111
‫תל אביב‬33111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
A method for tracking a position of a sensor, comprising:
generating a periodic magnetic field in a vicinity of the sensor, the field having a
positive polarity phase and a negative polarity phase with respective constant positive
and negative amplitudes;
producing first and second field measurement signals responsively to the magnetic
field at the sensor during the positive and negative polarity phases, respectively; and
determining the position of the sensor responsively to the first and second field
measurement signals.
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
175668
‫ שיטה ליצורו‬,‫חומר קשיח מרובה פאזות‬
‫ושימוש בו‬
]54[
DUAL-PHASE HARD MATERIAL,
METHOD FOR THE
PRODUCTION THEREOF AND ITS
USE
]22[
]31[
]51[
]71[
16.11.2004
10354543.3
]32[ 21.11.2003
]33[ DE
Int. Cl.(2010.01) C01B 31//34, C04B 41//87, C23C 08//00, E21B 10//00
BAYER
BETEILIGUNGSVERWALTUNG
GOSLAR GMBH, GERMANY
WO/2005/049490
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]87[
]74[
]57[
The invention relates to tungsten carbide powder consisting of powder particles, which
have a core comprised of tungsten cast carbide and a covering comprised of tungsten
monocarbide, to the production thereof by heating a tungsten cast carbide powder in
the presence of a carbon source to a temperature ranging from 1300 to 2000 °C, and to
the use thereof for coating surfaces of parts subjected to wear and for producing drill
bits.
__________________
]11[]21[
176149
November 30, 2010-‫כג' בכסלו התשע"א‬
]54[
METHOD FOR PREPARING
PHTHALOCYANINES
]22[
]31[
]51[
]71[
]87[
]74[
30.12.2004
102004001457.4 ]32[ 08.01.2004
Int. Cl.(2010.01) C07D 48/7/22
BASF SE, GERMANY
WO/2005/066179
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
‫שיטה להכנת פתלוציאנינים‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A method is disclosed for preparing metal-free phthalocyanines having the formula (I)
by reaction of an ortho-phthalodinitrile of formula (Ia) in an inert solvent having a
boiling temperature of at least 120 °C (under normal pressure) in the presence of
ammonia. In formulae I and Ia, the variable n can take the value of 1, 2, 3 or 4 and the
radicals R denote a five- or six-membered saturated, nitrogen-containing heterocyclic
ring that is optionally substituted by one or two C1-C8 alkyl groups, the heterocyclic
ring being bonded to the benzene ring by a nitrogen atom in the ring; the heterocyclic
ring may further contain one or two additional nitrogen atoms or an additional oxygen
or sulphur atom. The method is characterised in that the reaction is performed in the
presence of an alkaline metal hydroxide or alkaline metal carbonate.
__________________
]11[]21[
176373
]54[
METHOD FOR ETCHING
PHOSPHATE ORES
]22[
]31[
]51[
]71[
23.12.2004
2003/0683
]32[ 24.12.2003
]33[
Int. Cl.(2010.01) C01B 25//00, 25//22, 25//32
ECOPHOS, BELGIUM
‫שיטות לאיכול עפרות פוספטים‬
BE
November 30, 2010-‫כג' בכסלו התשע"א‬
]72[
]87[
]74[
]57[
MOHAMED TAKHIM
WO/2005/066070
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The inventive method for etching phosphate ores involves a single-pass digesting of
ores whose P2O5 content is greater than 20 % in weight by at least 10 % in weight of a
hydrochloric aqueous acid solution associated with an etching solution formation and
the separation of the insoluble solid phase and the aqueous phase of said etching
solution. Said method consists in pre-neutralising the etching solution by a neutralising
agent prior to said separation in such a way that the etching solution pH which is less
than pH to which an important part of phosphate ions in solution precipitates in the
form of calcium monohydrogen phosphate (DCP) is adjusted and in subsequently
neutralising said separated aqueous phase in such a way that a pure DCP is
precipitated.
__________________
]11[]21[
]54[
ELECTROCHEMICAL NITRATE
DESTRUCTION
]22[
]31[
]51[
]71[
20.12.2004
60/535209
]32[ 09.01.2004
Int. Cl.(2010.01) C02F 01//42, 01//461
APPLIED INTELLECTUAL CAPITAL
LIMITED, UNITED KINGDOM
WO/2005/070836
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
176408
‫השמדה אלקטרוכימית של ניטראט‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Devices and methods are presented for removal and destruction of nitrate from water
using an ion exchange medium from which the nitrate is eluted using brine, and in
which the so generated eluent is sequentially reduced and oxidized in distinct
compartments to form nitrogen from nitrate and ammonía, respectively. In especially
preferred devices and methods, the reduced and oxidized eluent is re-reduced to
electrochemically destroy hypohalites formed during oxidation. Among other
advantages, contemplated devices and methods allow nitrate destruction with minimal
concomitant production of nitrite and hypohalites.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
176441
‫חלק מכני ושיטה לייצורו‬
]54[
MECHANICAL PART AND
METHOD OF MANUFACTURING
SUCH A PART
]22[
]31[
]51[
]71[
]74[
20.06.2006
05 06441
]32[ 24.06.2005
]33[ FR
Int. Cl.(2010.01) B29C 70//02, 70//24, B32B 33//00, F16C 07//00
SNECMA, FRANCE
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A mechanical part (10) comprising at least two ends (10a, 10b) and desigmed to be
hinged to other parts at its ends, at least a portion of said mechanical part being made
of composite material from a central fiber preform (13) of three-dimensional woven
fabric, suitable more particularly for withstanding the compression forces to which the
part is subjected in operation, and at least one peripheral fiber preform (11) of threedimensional woven fabric suitable, more particularly, for withstanding the traction
forces to which the part is subjected in operation, said peripheral preform surrounding
said central preform in such a manner as to leave two empty spaces (14) at the ends
(10a) of the part and between the two preforms, which empty spaces are dedicated to
hinging to said other parts, said mechanical part being characterized in that said central
and peripheral preforms are made by three-dimensionally weaving carbon fiber
strands, and in that said central and peripheral preforms are bonded together by
implanted link yarns, each link yarn passing through each of the preforms, at least in
part.
]57[
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
176460
‫מערכת לחימום ולאיחסון מים‬
]54[
WATER HEATING AND
STORAGE SYSTEM
]22[
]51[
]71[
]74[
21.06.2006
Int. Cl.(2010.01) F24J 02//44
SHMUEL BEN-ISHAI
‫ קרית ארבע‬,‫ישי‬-‫שמואל בן‬
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
There is pnovided a water heating and storage system, including a heat-insulated main
heated water storage tank for storing hot water. The storage tank consists of top, side
and bottom walls, has an inlet for heated water entering the tank at a level below the
normal level, and a cold water inlet. The system also includes a consumer hot water
outlet, and an external water heater having a controlled electrical heating unit, an
outlet port for heated water, connectable to the inlet of the tank, and a water inlet port.
]57[
__________________
]11[]21[
176695
‫התפלת מים‬
]54[
WATER DESALINATION
]22[
]31[
]51[
]71[
]72[
]87[
]74[
17.01.2005
2004900164
]32[ 15.01.2004
]33[ AU
Int. Cl.(2010.01) B01D 61//08, C02F 01//44
DESALN8 PTY LTD., AUSTRALIA
CHRISTOPHER BARBER
WO/2005/068371
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
]57[
An in situ desalination apparatus comprising a reverse osmosis unit (15) having a
reverse osmosis medium, the reverse osmosis unit in use to be located within a body of
water under ambient bio-physico-chemical conditions often different from those at the
surface, the unit having an inlet (17) opening to one side of the reverse osmosis
medium, in use the inlet to be located below the upper surface of a body of water, the
unit having a concentrate outlet (25) opening to the one side of the reverse osmosis
November 30, 2010-‫כג' בכסלו התשע"א‬
medium and opening into the exterior of the unit at a position spaced below the inlet to
return concentrate into the water body, the unit having a permeate outlet (27) opening
to the other side of the reverse osmosis medium, the permeate outlet communicating
with a delivery line extending from the body of water, a pump (23) between body of
water and the reverse osmosis unit and adapted to pressurise the water located at the
one side of the reverse osmosis medium.
__________________
]11[]21[
176722
‫שיטות לייצור מלחים של חומצה דיניטראמידית‬
]54[
METHOD OF PRODUCING SALTS
OF DINITRAMIDIC ACID
]22[
]31[
]51[
]71[
21.01.2005
0400117-8
]32[ 21.01.2004
]33[
Int. Cl.(2010.01) C01B 21//082, C06B 25//00
FORSVARETS MATERIELVERK,
SWEDEN
CARIN VORDE, HENRIK SKIFS
WO/2005/070823
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]72[
]87[
]74[
]57[
SE
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
A method of preparing salt of dinitramidic acid, comprising nitration of an initial
compound with a nitrating acid mixture to form dinitramidic acid in a reaction mixture.
A positive ion is added to the reaction mixture and forms with the dinitramide ion an
ion pair complex which precipitates in the acidic reaction mixture, and the precipitate
is separated from the mixture. The remaining spent acid can be reprocessed for
recovery of acid for preparation of a new nitrating acid mixture. The preferred positive
ion is the guanylurea ion which gives a precipitate of guanylurea dinitramide. The
precipitate can be used as starting material for preparation of other dinitramide salts,
such as KDN and ADN. The guanylurea ion can be formed in situ in the process by
November 30, 2010-‫כג' בכסלו התשע"א‬
cyanoguanidine being reacted with the reaction mixture.
__________________
]11[]21[
]54[
METHOD FOR DETERMINING
THE TRUE MERIDIAN OF AN
UNMOVABLE OBJECT ON THE
EARTH AND DEVICE FOR ITS
IMPLEMENTATION
]22[
]51[
]71[
13.07.2006
Int. Cl.(2010.01) G01C 17//38
GEORGE NAUMOV
MICHAEL NAUMOV
]74[
]57[
176828
‫שיטה לקביעת קו האורך האמיתי של אובייקט‬
‫נייח על פני הקרקע ומכשיר ליישום השיטה‬
‫ תל אביב‬,‫גאורג' נאומוב‬
‫ אביב‬-‫ תל‬,‫מיכאל נאומוב‬
MICHAEL NAUMOV,
,‫מיכאל נאומוב‬
HAZOR 3
3 ‫חצור‬
TEL AVIV 69016
‫ אביב‬-‫תל‬
A method for determining true meridian of any object at rest comprising the following
stages:
symmetrical, relative to vertical, positioning pressure determination points of a sensor
for measuring horizontal acceleration,
rotating the said points around the vertical,
stopping the rotation when attaining a linear acceleration zero signal, determining the
true meridian by the stationary position of vessels of the sensor for measuring
horizontal acceleration, for example, by position of a perpendicular in a horizontal
plane to the sensitivity axis of the said sensor.
__________________
]11[]21[
176868
‫שיטה לייצוב תרכובת מקרולידית‬
]54[
METHOD FOR STABILIZING
MACROLIDE COMPOUNDS
]22[
]31[
]51[
]71[
28.01.2005
2004-020804 ]32[ 29.01.2004
]33[ JP
Int. Cl.(2010.01) C07D 31/3/00, 40/7/06, C12N 01//20
MERCIAN CORPORATION, JAPAN
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
EISAI R & D MANAGEMENT CO.
LTD., JAPAN
WO/2005/073223
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
A method of stabilizing a macrolide compound and a process for efficiently producing
the compound. The method, which is for stabilizing a 12-membered cyclic macrolide
compound, e.g., that represented by the formula (I), comprises causing the compound
to coexist with a cyclodextrin. The process, which is for producing the macrolide
compound, comprises causing a cyclodextrin to be present in a culture medium
containing an actinomyces having the ability to produce the macrolide compound. (I)
__________________
]11[]21[
177049
]54[
HETERODIMERIC FOLLICLE
STIMULATING HORMONE - FC
(FSH-FC) FUSION PROTEINS FOR
THE TREATMENT OF
INFERTILITY
]22[
]31[
]51[
]71[
27.01.2005
60/540236
]32[ 28.01.2004
]33[ US
Int. Cl.(2010.01) A61K 38//00, C07K 14//59, 16//46, C12N 15//62
SYNTONIX PHARMACEUTICALS,
INC, U.S.A.
WO/2005/073383
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]87[
]74[
]57[
Fc – ‫חלבונים מאוחים הורמון – מעורר– זקיק‬
‫() הטרודימרים לטיפול בעקרות‬Fc–FSH
The invention provides novel heterodimeric fusion proteins comprising a first
polypeptide including an alpha subunit of FSH (aFSH) linked directly or indirectly to a
binding partner of neonatal Fc receptor (FcRn) and a second polypeptide including a
November 30, 2010-‫כג' בכסלו התשע"א‬
beta subunit of FSH (ßFSH) linked directly or indirectly to an FcRn binding partner. In
one embodiment the FcRn binding partner includes an Fc fragment of an
immunoglobulin, e.g., an Fc fragment of IgG. Also provided are methods making and
using the fusion proteins of the invention. The invention provides a method for
increasing fertility in a subject and a method for treating a subject having a disease
state responsive to treatment by FSH.
The applications for division
from this application have
not yet been published
,206518
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
MULTICHANNEL AUDIO
CODING
]22[
]31[
28.02.2005
60/549368
]32[ 01.03.2004
60/579974
14.06.2004
60/588256
14.07.2004
Int. Cl.(2010.01) G10L 19//00
DOLBY LABORATORIES
LICENSING CORPORATION, U.S.A.
WO/2005/086139
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
177094
‫הצפנת קול רב–ערוצית‬
]33[
US
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Multiple channels of audio are combined either to a monophonic composite signal or
to multiple channels of audio along with related auxiliary information from which
multiple channels of audio are reconstructed, including improved downmixing of
multiple audio channels to a monophonic audio signal or to multiple audio channels
and improved decorrelation of multiple audio channels derived from a monophonic
audio channel or from multiple audio channels. Aspects of the disclosed invention are
usable in audio encoders, decoders, encode/decode systems, downmixers, upmixers,
November 30, 2010-‫כג' בכסלו התשע"א‬
and decorrelators.
__________________
]11[]21[
177338
‫כדורי טחינה ושיטה להכנתם‬
]54[
GRINDING BALLS AND
PRODUCTION METHOD
THEREOF
]22[
]31[
]51[
]71[
07.02.2005
04447035.9
]32[ 10.02.2004
]33[ EP
Int. Cl.(2010.01) B02C 15//00, 17//20, C04B 35//106, 35//119
MAGOTTEAUX INTERNATIONAL
S.A., BELGIUM
LOUIS BOULANGER, STEPHANE
DESILES
WO/2005/075375
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]72[
]87[
]74[
]57[
The invention relates to sintered ceramic grinding balls comprising the following
compounds (by wt.-%): 18 to 50 wt.- % mullite (3Al2O3.2SiO2); 9 to 25 wt.- %
zirconium (ZrO2 + HfO2) stabilised by 0.5 to 3 wt.- % rare earth oxide; and 25 to 72
wt.- % alumina (Al2O3).
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
177376
]54[
CRYSTALLINE (R-R*R*)-2-(4FLUOROPHENYL)-BETA-DELTADIHYDROXY-5-(1METHYLETHYL)-3-PHENYL-4[(PHENYLAMINO)CARBONYL]IH-PYRROLE-1-HEPTANOIC ACID
HEMI CALCIUM SALT
(ATORVASTATIN)
]22[
]31[
]51[
]62[
]71[
08.07.1996
60/001452
]32[ 17.07.1995
]33[ US
Int. Cl.(2009.01) A61K 31/40, A61P 03/06, C07D 207/34
DIVISION FROM 128864
WARNER-LAMBERT COMPANY
LLC, U.S.A.
WO/1997/003959
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
–)‫פלואורופניל‬R–(R*R*)–2–(–4( ‫קריסטלין‬
)‫–מתיל–אתיל‬1(–5– ‫בטא–דלתא–דיהידרוקסי‬
–1– ‫ פירול‬IH–)‫–(פניאמינו)קרבוניל‬4–‫–פניל‬3
‫חומצה הפטנואית המי מלחת סידן‬
)‫(אטורואסטטין‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Novel crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi
calcium salt designated Form I, Form II, and Form IV are characterized by their X-ray
powder diffraction and/or solid state NMR are described, as well as methods for the
preparation and pharmaceutical composition of the same, which are useful as agents
for treating hyperlipidemia and hypercholesterolemia.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
WRINGER FOR SCRUBBING
BUCKETS
]22[
]31[
]51[
]71[
13.08.2004
P200400466
]32[ 27.02.2004
Int. Cl.(2010.01) A47L 13//58, 13//59
SP BERNER PLASTIC GROUP, S.L.,
SPAIN
WO/2005/082224
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
177699
‫מתקן סחיטה לדליי ניקוי‬
]33[
ES
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The inventive wringer for scrubbing buckets basically comprises two independent
tilting parts of a wringer (4) which are pivotally coupled inside the space of a support
(1) fixed to the bucket mouthpiece. Said independent parts (4) are pivotally coupled
with parallel axes communicating with the end spaces (3) of the support (1) and are
tiltable oppositely to the resistance of spring elements (5).
__________________
]11[]21[
]54[
INFANT SEAT FOR MOTORCARS
]22[
]31[
29.08.2006
U 200502001 ]32[ 12.09.2005
U
Int. Cl.(2010.01) B60N 02//28
JANE, S.A., SPAIN
]51[
]71[
177749
‫מושב של תינוק עבור מכוניות‬
]33[
ES
November 30, 2010-‫כג' בכסלו התשע"א‬
]74[
]57[
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
An infant seat for motorcars that comprises a body (1) forming the actual seat (2) and
the backrest (3) and being provided with safety straps (4, 5) for the child, said straps
being fitted to a crotch strip (7); characterized in that the straps are fitted to a headrest
(8) being fitted to the backrest in a vertically shiftable arrangement and being
integrally provided with a mechanism from which a transmission element extends
which is linked to the lower end of the crotch strip, this latter being also fitted in a
slidable arrangement, in such a way that the lifting and lowering motions of the
headrest bring about a joint increase or reduction of the space being afforded both by
the straps and the crotch strip.
__________________
]11[]21[
177956
]54[
ANTI-MYOSTATIN ANTIBODIES
]22[
]31[
17.03.2005
60/555456
]32[ 23.03.2004
]33[ US
60/559621
05.04.2004
US
Int. Cl.(2010.01) A61K 39//395, C07K 16//22, C12P 21//08
ELI LILLY AND COMPANY, U.S.A.
WO/2005/094446
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
]57[
‫נוגדני מיוסטטין‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
A neutralizing epitope is identified within amino acids 40-64 of the mature form of
human myostatin. Antibodies that bind this epitope fall within the scope of the
invention and may be murine, chimeric, or humanized antibodies, immunoconjugates
of the antibodies or antigen-binding fragments thereof. The antibodies of the invention
November 30, 2010-‫כג' בכסלו התשע"א‬
are useful for increasing muscle mass, increasing bone density, or for the treatment of
various disorders in mammals.
__________________
]11[]21[
]54[
METHODS AND APPARATUSES
FOR CREATING
AUTHENTICATABLE PRINTED
ARTICLES AND SUBSEQUENTLY
VERIFYING THEM
]22[
]31[
09.03.2005
0405641.2
]32[ 12.03.2004
60/601463
13.08.2004
0418138.4
13.08.2004
60/601464
13.08.2004
0420524.1
15.09.2004
60/610075
15.09.2004
Int. Cl.(2010.01) G06K 07//14
INGENIA HOLDINGS LTD.,
BRITISH VIRGIN ISLANDS
WO/2005/088517
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
177966
‫שיטות ומערכות ליצירת מאמרים מודפסים‬
‫הניתנים לאישור ולאחר מכן אימות שלהם‬
]33[
GB
US
GB
US
GB
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A printer with integral scanner for obtaining a digital signature from a sheet of paper
or other article as it is printed. The integral scanner has a coherent source which directs
a light beam to illuminate the article and a detector arrangement to collect data points
from light scattered from many different parts of the article to collect a large number
of independent data points, typically 500 or more. The digital signature derived from
the data points is stored in a database with an image of what was printed on the article.
At a later time, the authenticity of an article purported to be the originally printed
article can be verified by scanning the purported genuine article to obtain its digital
signature. The database is then searched, to estate ish whether there is a match. If a
match is found, the image stored in the database with the matched digital signature is
displayed to the user to allow a further visual check that the article is genuine. The
image is displayed together with other relevant bibliographic data relevant to the
article.
November 30, 2010-‫כג' בכסלו התשע"א‬
,202539
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
NON-CONTACT THERMAL
PLATFORMS
]22[
]31[
]51[
]71[
16.03.2005
60/553546
]32[ 17.03.2004
Int. Cl.(2010.01) H01L 21//683
COREFLOW SCIENTIFIC
SOLUTIONS LTD.
YUVAL YASSOUR, ARIE HARNIK,
HILEL RICHMAN
WO/2005/086588
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]72[
]87[
]74[
]57[
177999
‫משטחים טרמיים ללא מגע‬
]33[
US
‫ יקנעם‬,‫קורפלוו פתרונות מדעיים בע"מ‬
‫ הלל ריצ'מן‬,‫ אריה הרניק‬,‫יובל יסעור‬
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
A thermal treatment system (100) with at least one apparatus (102) comprising: one
platform (110)or two substantially opposite platforms, where at least one of the
platforms has at least one thermal means (140) for heating or cooling of the object and
fluid-mechanical means for supporting the object without contact. The platform
comprises at least one of a plurality of basic cells, each basic cell having at least one of
a plurality of pressure outlets (114) and one of a plurality of fluid-evacuation channels
(117). The pressure outlets of each basic cell is fluidically connected through a flow
restrictor (119) to a high-pressure fluid supply, the pressure outlets providing
pressurized fluid for maintaining a fluid-cushion between the object and the platform.
The flow restrictor characteristically exhibits fluidic return spring behavior. Each of
the evacuation channels has an inlet and outlet, for locally balancing mass flow for the
November 30, 2010-‫כג' בכסלו התשע"א‬
basic cells.
__________________
]11[]21[
]54[
USE OF 1-BENZOYL-4-[2-[4METHOXY-7-(3-METHYL-1H1,2,4-TRIAZOL-1-YL)-1HPYRROLO[2,3-C]PYRIDINE-3-YL]1,2-DIOXOETHYL]-PIPERAZINE
IN THE MANUFACTURE OF A
MEDICAMENT FOR USE IN
CONJUNCTION WITH AT LEAST
ONE OTHER AGENT USED FOR
TREATMENT OF AIDS OR HIV
INFECTION
]22[
]31[
]51[
]71[
01.03.2005
60/555767
]32[ 24.03.2004
Int. Cl.(2010.01) A61K 45//06
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2005/102392
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]87[
]74[
]57[
178141
–3(–7–‫–מתוקסי‬4[–2[–4–‫–בנזויל‬1–‫שימוש ב‬
– H1–‫מתיל‬
]C–3,2[‫–פירולו‬1–)‫–יל‬1–‫– טריאזול‬4,2,1
‫–דיוקסואתיל]– פיפראזין‬2,1–]‫–יל‬3–‫פירידין‬
‫בצירוף עם‬HIV ‫ או‬AIDS ‫ביצור תרופה לטיפול‬
‫לפחות חומר פעיל אחר נוסף‬
]33[
US
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
The invention encompasses pharmaceutical compositions and methods for using
Compound (1) in combination with other agents for treating patients with AIDS of
HIV infection.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
178350
]54[
VITAMIN D DERIVATIVES
]22[
]31[
14.06.2001
2000-179251 ]32[ 15.06.2000
]33[ JP
2000-351412
17.11.2000
JP
2000-375024
08.12.2000
JP
Int. Cl.(2010.01) A61K 31//59, C07C 40/1/00, C07J 07//00, 09//00
DIVISION FROM 153395
CHUGAI SEIYAKU KABUSHIKI
KAISHA, JAPAN
KAZUMI MORIKAWA, MASAYUKI
OHMORI, KAZUKI SHIMIZU,
AKIRA KAWASE, TAKASHI
EMURA
WO/2001/096293
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A method of carbonylating a compound of Formula (2):
wherein:
R12 and R13 each respresent a protecting group, and R14 represents a leaving group,
in a solvent in the presence of an organoaluminum reagent and a palladium catalyst
under a carbon monoxide atmosphere to prepare a compound of Formula (3):
wherein:
R12 and R13 are as defined above, and R15 represents an alkyl group, an aryl group, an
alkenyl group or an alkynyl group.
]51[
]62[
]71[
]72[
]87[
]74[
]57[
D ‫תולדות של ויטמין‬
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
178490
‫תכשיר מנסיוב של עז לטיפול במחלות‬
‫אוטואימוניות‬
]54[
GOAT SERUM COMPOSITION
FOR THE TREATMENT OF
AUTOIMMUNE DISORDERS
]22[
]31[
01.04.2005
0407710.3
]32[ 05.04.2004
]33[ GB
0410966.6
17.05.2004
GB
Int. Cl.(2010.01) A61K 39//395, A61P 25//00, C07K 16//10, 16//28
AIMSCO LIMITED, UNITED
KINGDOM
WO/2005/097183
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]51[
]71[
]87[
]74[
]57[
Methods of treatment of various non-demyelinating and demyelinating neural
disorders are provided, comprising administering a serum composition obtained from a
goat after challenge with an immunogen. Also provided are methods of treatment of
certain autoimmune disorders using such a composition.
The applications for division
from this application have
not yet been published
,206516
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
178898
‫שיטה ומערכת לסילוק רעל מטבולי‬
]54[
METABOLIC DETOXIFICATION
SYSTEM AND METHOD
]22[
]31[
]51[
]71[
]87[
]74[
23.02.2005
60/565888
]32[ 27.04.2004
]33[ US
Int. Cl.(2010.01) A61M 01//34, 37//00, B01D 61//20
VITAL THERAPIES, INC., U.S.A.
WO/2005/107928
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
An extracorporeal filtration and detoxification system and method generally comprise
separating ultrafiltrate from cellular components of blood, treating the ultrafiltrate
independently of the cellular components in a recirculation circuit, recombining treated
ultrafiltrate and the cellular components, and returning whole blood to the patient. A
recirculation circuit generally comprises an active cartridge including active cells
operative to effectuate a selected treatment; in some embodiments, the active cells are
the C3A cell line.
__________________
]11[]21[
178917
‫שיטה להכנת חלקיקים אלפאויראליים‬
TC – 83 ‫המופקים מ‬
]54[
METHOD FOR PREPARING TC83-DERIVED ALPHAVIRAL
PARTICLES
]22[
]31[
]51[
]71[
]87[
]74[
18.05.2005
60/572212
]32[ 18.05.2004
]33[ US
Int. Cl.(2010.01) A61K 39//12, 48//00, C12N 05//10, 15//86
ALPHAVAX, INC., U.S.A.
WO/2005/113782
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]57[
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
The present disclosure provides TC-83 VEE-derived replicons, alphaviral replicon
particles and immunogenic compositions containing TC-83 alphaviral replicon
November 30, 2010-‫כג' בכסלו התשע"א‬
particles which direct the expression of at least one antigen when introduced into a
suitable host cell. The TC-83 VEE-derived ARPs described herein are improved in that
they are subject to a lower vector-specific immune response than prior art ARPs.
__________________
]11[]21[
179135
‫מנגנון תצוגה עילית‬
]54[
HEAD UP DISPLAY MECHANISM
]22[
]31[
]51[
]71[
08.11.2006
171880
]32[ 10.11.2005
]33[ IL
Int. Cl.(2010.01) B64D 43//00, G02B 27//01, 27//14
ELBIT SYSTEMS ELECTRO-OPTICS
‫אופטיקה אלאופ‬-‫אלביט מערכות אלקטרו‬
ELOP LTD.
‫ רחובות‬,.‫בע"מ‬
]74[
BOROCHOV, KORAKH & CO.,
,'‫בורוכוב קורח ושות‬
15TH FLOOR, ATIDIM TOWER,
‫מגדל כלל עתידים‬
KIRYAT ATIDIM,
‫אביב‬-‫תל‬58100 .‫ד‬.‫ ת‬,
P.O.B. 58100,
TEL AVIV 61580
An emergency mechanism for moving an element in a vehicle from a deployed
position to an emergency position in a state of emergency, said element being firmly
coupled with said emergency mechanism, said emergency mechanism being pivotally
coupled with a deployment mechanism of said element by a cam pivot, said
emergency mechanism comprising:
a lever having a first end and a second end;
a spring having a first end and a second end, said first end of said spring firmly
coupled with said emergency mechanism, said second end of said spring coupled with
said first end of said lever;
a cam follower, coupled with said second end of said lever;
a cam firmly coupled with said deployment mechanism, said cam pivot passing
through said cam, said cam further including:
a tapering section having a first side and a second side, said cam follower being
pressed against said first side of said tapering section when said element is in said
deployed position, said cam follower being pressed against said second side of said
tapering section when said element is in said emergency position;
stopping arm, said stopping arm extending outward of said cam, distant from said
tapering section;
a deployed stopper, located on the one side of said stopping arm, for stopping said
emergency mechanism where said element is in said deployed position, and
an emergency stopper, located on the other side of said stopping arm, for stopping said
emergency mechanism when said element is in said emergency position, when in said
state of emergency, said vehicle decelerates with a deceleration greater than a
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
predetermined value, causing said cam follower to roll along an edge of said tapering
section, said spring pressing said cam follower against said second side of said
tapering section, thereby rotating emergency mechanism and said element around said
cam pivot, until said stopping arm contacts with said emergency stopper, and said
element is located away from an operator of said vehicle.
__________________
]11[]21[
179539
‫מתקן דנטלי לשטיפה‬
]54[
DENTAL IRRIGATOR
]22[
]51[
]71[
]72[
]74[
23.11.2006
Int. Cl.(2010.01) A61C 01//00
REDENT-NOVA LTD.
‫ רעננה‬,‫נובה בע"מ‬-‫רידנט‬
REPHAEL HOF
‫רפאל חוף‬
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A dental irrigator for delivering irrigation solution from an irrigation solution reservoir
to the site of a dental procedure, said irrigator comprising:
(a) a hollow dental tool (100) comprising a neck (120) used to attach said dental tool
to a dental hand-piece, wherein said neck comprises one or more curved impeller
blades (122);
(b) one or more inlets created through the wall of said neck;
(c) a housing (112) adapted to provide a watertight volume surrounding said inlets
while allowing said tool to be freely moved with respect to said housing; and
(d) a supply hose (110) which connects said reservoir to said housing;
wherein, when said dental tool is attached to said dental hand-piece and said handpiece is activated causing said tool and said curved impeller blades to move with
November 30, 2010-‫כג' בכסלו התשע"א‬
]57[
respect to said housing, said irrigation solution flows from said reservoir through said
supply hose at low pressure into said housing and from said housing through said
inlets into the hollow interior of said neck of said tool whereupon said moving curved
impeller blades exert forces on said irrigation fluid in said hollow interior of said neck
of said tool that increase the pressure of said irrigation fluid and cause it to flow at
high pressure through said dental tool;
said dental irrigator characterized in that said curved impeller blades extend curvedly
inwards into the hollow internal space of said neck.
__________________
]11[]21[
]54[
APPARATUS FOR FILTERING
LIQUIDS
]22[
]31[
]51[
]71[
]87[
]74[
27.04.2005
102004026167.9 ]32[ 28.05.2004
Int. Cl.(2010.01) B01D 35//157
BRITA GMBH, GERMANY
WO/2005/118104
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]57[
179624
‫התקן לסינון נוזלים‬
]33[
DE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
Disclosed are an apparatus for filtering liquids and an associated filter cartridge (100)
by means of which the throughput through the filter cartridge (100) can be reduced and
adjusted in a simple manner. The inventive apparatus is characterized in that at least
one throttling mechanism (200, 200') is disposed between the outlet (113) of the filter
cartridge (100) and the outlet (17) of the reservoir (14).
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
METHOD FOR PRODUCING
EXPANDED METAL PROFILES AND
PROFILE PRODUCED BY THE
METHOD
]22[
]31[
]51[
]71[
]87[
]74[
14.06.2005
VE2004A000027 ]32[ 17.06.2004
Int. Cl.(2010.01) B21D 05//08, 47//02
DALLAN S.P.A., ITALY
WO/2005/123298
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]57[
179990
‫שיטה לייצור פרופילים מורחבים ממתכת‬
‫ופרופיל המיוצר על ידי השיטה‬
]33[
IT
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A method for producing expanded metal profiles, consisting of subjecting a metal strip
of width less than the development of the profile to be produced to the following
operations: - forming longitudinal slits in at least that longitudinal band which is to
form the central web of the profile, - bending the edges of the slits, - profiling said
strip, - transversely stretching that band containing the slits, - pressing areas of said
central web in correspondence with said stretched band to displace them external to the
plane of said web, characterised by subjecting the bent edges to drawing to obtain
radiused edging having the tangent to the free edge forming an angle not less than 90 0
to the surface of the strip.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
180622
‫מערכת זרז דו–מרכבית לאיזומריזציה של קסילן‬
]54[
XYLENE ISOMERIZATION TWOCOMPONENT CATALYST
SYSTEM
]22[
]31[
]51[
]71[
08.06.2005
10/902322
]32[ 29.07.2004
]33[
Int. Cl.(2010.01) C07C 05//27, C10G 45//64
EXXONMOBIL CHEMICAL
PATENTS INC., U.S.A.
WO/2006/022991
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
]57[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
A catalyst system that exhibits a ratio of ethylene saturation to aromatics ring
saturation of greater than 3,500. The catalyst system comprises two components and
each component comprises a crystalline molecular sieve having a Constraint Index of
from about 1 to about 12 and an effective amount of Group VIII metal. The catalyst
system finds particular application in ethylbenzene conversion/xylenes isomerization
reactions. The catalyst system can be prepared by incorporating the Group VIII metal
into the molecular sieves by competitive ion exchange.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
180920
‫מתקן להצמדה של מכשיר מוחדר במכונת‬
‫השחזה‬
]54[
DEVICE FOR CLAMPING A TOOL
INSERT IN A GRINDING
MACHINE
]22[
]31[
]51[
]71[
]87[
]74[
12.07.2005
04405487.2
]32[ 30.07.2004
]33[ EP
Int. Cl.(2010.01) B23Q 03//00, 03//155, B24B 03//00
ROLLOMATIC SA,, SWITZERLAND
WO/2006/010281
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The insert (2) is set on the receiving surface (10) of the interchangeable support (9). A
simple movement of the piston (35) to the right in the barrel (7) of the headstock (1)
drives the cam (32) such that the lever (13) pivots and moves to insert its nose (15) in
the bore (27) of the insert, the nose drawing the insert rearwards which is then pressed
against the vertical surface (11) of the support, the insert being also pressed against the
horizontal surface (10) of the support under the action of the locking shoe (14),
enabling the insert to be fixed in a precisely determined position. The measuring
device (12) determines said position using a position probe (20) and controls the
grinding operations.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
181065
‫מתיז מים ופילטר נייד ושימוש בתוך מתיז המים‬
]54[
WATER DISPENSER AND FILTER
CARTRIDGE FOR USE THEREIN
]22[
]31[
]51[
]62[
]71[
31.03.2005
60/559351
]32[ 02.04.2004
Int. Cl.(2008.04) B67D 1/16
DIVISION FROM 167788
TANA INDUSTRIES (1991) LTD.
]74[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
A user-replaceable filter cartridge for use in a water dispenser, said filter cartridge
comprising:
a housing defining a housing top portion and a bicameral main housing portion
supported by and depending from said housing top portion,
said housing top portion including a manifold defining planar element defining a water
inlet manifold and a water outlet manifold communicating respectively with a water
inlet connector and a water outlet connector, said water inlet connector and said water
outlet connector depending from said water inlet manifold and said water outlet
manifold respectively,
said bicameral main housing portion also defining at least first and second filter
element housing portion housing at least first and second filter elements, each of said
at least first and second filter element housing portions communicating with said water
inlet manifold and with said water outlet manifold.
]33[
US
‫ אור‬,‫) בע"מ‬1991( ‫חברת תנה תעשיות‬
‫יהודה‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
SUSTAINED DRUG RELEASE
COMPOSITION
DEMONSTRATING AN
ASCENDING ZERO ORDER
RELEASE PATTERN AND
METHODS OF MANUFACTURING
SUCH A COMPOSITION
]22[
]31[
]51[
]71[
]87[
]74[
02.08.2005
60/599126
]32[ 04.08.2004
Int. Cl.(2010.01) A61K 09//20, 09//50
ALZA CORPORATION, U.S.A.
WO/2006/017537
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]57[
181117
‫תרכיב תרופתי בעל שיחרור ממושך המציג דפוס‬
‫שיחרור בעל סדר אפס עולה ושיטות ליצור‬
‫התרכיב‬
]33[
US
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
Disclosed are dosage forms and methods for sustained release of a drug including : a
delay layer comprising a polymeric matrix, and microencapsulated drug, wherein the
delay layer is substantially free of non-microencapsulated drug; and a second layer
including a polymeric matrix, and non-microencapsulated drug matrix; wherein the
second layer is located adjacent to the delay layer.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
]54[
CATALYZED DECOMPOSING
STRUCTURAL PAYLOAD FOAM
]22[
]31[
]51[
]71[
]87[
]74[
16.08.2005
10/920976
]32[ 18.08.2004
Int. Cl.(2010.01) B64G 01//00, 01//64
RAYTHEON COMPANY, U.S.A.
WO/2006/127021
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
181205
‫קצף מטען מבני המתפרק במהירות מוגברת‬
‫בשל קטליזטור‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A high energy, e.g., ultraviolet (UV), catalyzed decomposing foam (40) encapsulating
a payload (30, 116) to be boosted in space provides an ultra-light weight, adaptable
means to facilitate survival of much lighter, smaller satellites (18) and space hardware
under boost environment. The decomposable foam is to contain multiple satellites
within a booster payload (30) in lieu of the traditionally heavy and complex structural
framework (10). The catalyzed decomposing foam significantly lowers the weight and
structure of all space hardware. This packaging system is especially beneficial where
several or even hundreds of satellites are required for a constellation system, thereby
significantly benefiting all technologies applied in space, ranging from the
telecommunication industry to DOD applications. In addition to weight and cost
savings, advantages of this foam are many in that it is adaptable to any payload shape
as it may be injected, sprayed, formed, molded, easily cut or manufactured to support
any geometry required.
__________________
]11[]21[
]54[
MEDICAL TUBE SET
]22[
15.02.2007
181380
‫מערך לצינור רפואי‬
November 30, 2010-‫כג' בכסלו התשע"א‬
]31[
]51[
]71[
]74[
]57[
2006-63827
]32[ 09.03.2006
Int. Cl.(2010.01) A61B 19//02
SHERWOOD SERVICES AG,
SWITZERLAND
NIPPON SHERWOOD MEDICAL
INDUSTRIES LTD, JAPAN
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
JP
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A medical tube set comprising a tube for insertion into a patient and a stylet disposed
within said tube, characterized in that said stylet comprises a core unit and an apical tip
unit attached to a distal end of said core unit and wherein said apical tip unit is
arranged to engage with a distal end of said tube for insertion of said tube and stylet
into a patient and wherein the stylet further comprises an expansion member movable
with respect to the core unit such that said expansion member is deployable to expand
said distal end of said tube so as to allow retraction of said stylet from said tube.
__________________
]11[]21[
181814
‫מתקן גלילי מצופה בחומרים מחוברים‬
]54[
TUBULAR ELEMENTS COATED
BY FASTENING MATERIALS
]22[
]51[
]71[
]74[
08.03.2007
Int. Cl.(2010.01) B65B 13//00, B65H 39//00, 81//00
SHILTEX LTD.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
A coated tubular element comprising:
a cylindrical core;
a fastening material layer wrapped around said cylindrical core; and
a plurality of threads arranged around said fastening material layer by at least one of
braiding, weaving, knitting and wrapping, and operative to maintain said fastening
material layer wrapped around said cylindrical core.
‫שילטקס בע"מ‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
181908
]54[
METHOD FOR MATURATION OF
OOCYTES USING IL-17
]22[
]31[
]51[
]71[
30.09.2005
60/614667
]32[ 30.09.2004
]33[ US
Int. Cl.(2010.01) A61K 38//20, C07K 14//54, C12N 05//075
MERCK SERONO S.A.,
SWITZERLAND
STEPHEN S. PALMER, CAM ANH
TRAN, DANIEL G. DE MATOS, ANN
M. CLARK
WO/2006/039592
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
18 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
]72[
]87[
]74[
]57[
IL– 17 ‫שיטה להבשלת ביציות בשימוש של‬
The use of IL-17 for the in vitro maturation of mammalian oocytes is described. The in
vitro matured oocytes may be used for in vitro fertilization protocols.
The applications for division
from this application have
not yet been published
,206440
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
181930
‫שימת חיתוך הניתן לסימון ושיטה לייצורה‬
]54[
INDEXABLE CUTTING INSERT
AND METHOD FOR PRODUCING
THE SAME
]22[
]31[
]51[
]71[
24.07.2006
2005-221130 ]32[ 29.07.2005
]33[ JP
Int. Cl.(2010.01) B23B 27//14, 51//00, B23C 05//20, B23P 15//28
SUMITOMO ELECTRIC
HARDMETAL CORP., JAPAN
YOSHIO OKADA, SHINYA
IMAMURA, NAOYA OMORI,
MINORU ITOH, NORIHIRO
TAKANASHI
WO/2007/013392
]72[
]87[
November 30, 2010-‫כג' בכסלו התשע"א‬
]74[
]57[
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
An edge replacing cutting tip (1) having at least one face (2), at least two flanks (3), at
least one edge ridgeline (4), and at least one corner (9), wherein a base layer develops
a color different from that of a use-state display layer, and the use-state display layer is
formed on at least one of the flanks (3). The flank (3) formed with the use-state display
layer is characterized by having the use-state display layer formed on the base layer in
the whole or part of region A2 excluding one or more regions A1 of at least 2 mm 2
including at least one corner (9).
__________________
]11[]21[
181977
‫שיטה ומערכת לביצוע מסירה במערכת תקשורת‬
‫ כגון מסירה קשיחה‬,‫אלחוטית‬
]54[
METHOD AND SYSTEM FOR
PERFORMING A HANDOFF IN A
WIRELESS COMMUNICATION
SYSTEM, SUCH AS A HARD
HANDOFF
]22[
]31[
]51[
]62[
]71[
11.08.2000
09/372261
]32[ 11.08.1999
]33[ US
Int. Cl.(2010.01) H04B 01//707, H04W 52//28, 52//40, 72//06
DIVISION FROM 147721
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/011914
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method for performing a search excursion from an original frequency on a wideband
code division multiple access (WCDMA) system to a target frequency, comprising:
decoding at least one radio frame in a Transmission Time Interval (TTI) on the original
frequency;
extracting a parameter value from the at least one radio frame and storing the
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
parameter value in a memory element;
tuning to a target frequency after storing the parameter value;
tuning to the original frequency; and
decoding a subsequently received radio frame in the TTI by using the stored parameter
value.
,204550
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
182376
‫תהליך שיחול רציף ליצירת פולימרים מותכים‬
]54[
CONTINUOUS EXTRUSION
PROCESS FOR PRODUCING
GRAFTED POLYMERS
]22[
]31[
]51[
]71[
31.01.2005
60/617548
]32[ 11.10.2004
]33[
Int. Cl.(2010.01) B29C 47//00, 47//50, 47//78
LANXESS CORPORATION, U.S.A.
LANXESS INC., CANADA
ORREX PLASTICS COMPANY,
LLC., U.S.A.
WO/2006/039774
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Continuous extrusion process for the functionalization of polymers through reactive
extrusion. The process uses a continuous extrusion reactor comprising at least two
sequential, very closely-coupled, independently driven screw extruders having a total
effective length to diameter ratio greater than 60 to 1 and as high as 112 to 1 and
providing greatly extended reaction times for efficiently producing a grafted polymer
having a high level of functionalization. Drying of the polymer feed is performed in
November 30, 2010-‫כג' בכסלו התשע"א‬
the continuous extrusion reactor. Multiple injections of reactants may be provided.
Shear modification of the molecular weight 'of the grafted polymer is performed in the
continuous extrusion reactor after the functionalization reactions. A continuous
extrusion reactor and a grafted polymer having a high level of functionalization are
also disclosed.
__________________
]11[]21[
182389
‫שיטה לטיגור אוויר מאבק ופילטר אלקטרומטטי‬
]54[
METHOD OF AIR
PURIFICATION FROM DUST
AND ELECTROSTATIC FILTER
]22[
]51[
]71[
]74[
10.04.2007
Int. Cl.(2010.01) B03C 03//14
YEFIM RISKIN
‫ קצרין‬,‫יפים ריסקין‬
YEFIM RISKIN,
,‫יפים ריסקין‬
30 DOVRAT ST.,
30 ‫רח' דברת‬
P.O.B. 4787,
‫קצרין‬4787 .‫ד‬.‫ ת‬,
KATZRIN 12900
A method for air purification from dust includes electrically charging dust by air
ionization; and collecting the charged dust by an electric field force, performed in a
common airflow while changing the direction of the airflow at least once by an angle
of more than 135º.
]57[
__________________
]11[]21[
182808
‫–קרפוקסילאטים‬5–‫תהליך לייצור פירימידין‬
]54[
PROCESS FOR THE
PRODUCTION OF PYRIMIDINE-5CARBOXYLATES
]22[
]31[
]51[
04.11.2005
04026254.5
]32[ 05.11.2004
]33[
Int. Cl.(2010.01) C07D 23/9/30, 23/9/36
EP
November 30, 2010-‫כג' בכסלו התשע"א‬
]71[
]87[
]74[
]57[
LONZA AG, SWITZERLAND
WO/2006/048297
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Pyrimidine-5-carboxylates of formula wherein R is C1-4 alkyl, R1 is C1_4 alkyl
or trifluoromethyl, R2 is hydrogen or C1 alkyl and X is hydroxy, chlorine or bromine,
are prepared from 3-oxoalkanoates of formula with urea and orthoesters of formula
R2C(OR)3 (III). The intermediate 2-acyl-3-ureidoacrylate, without being isolated, is
reacted to give a 2-hydroxypyrimidine-5-carboxylate [(I), X = OH] or a hydrate
thereof, which is optionally converted into the corresponding chloro or bromo
compound (I, X = Cl, Br).
__________________
]11[]21[
183322
‫מערכת ניתוחית הכוללת אגרנים פנאומטיים‬
‫מובנים‬
]54[
SURGICAL SYSTEM HAVING
MANIFOLDS WITH INTEGRAL
PNEUMATIC ACCUMULATORS
]22[
]31[
20.05.2007
11/437301
]32[ 19.05.2006
]33[ US
11/455490
19.06.2006
US
Int. Cl.(2010.01) A61M 01//00
ALCON, INC., SWITZERLAND
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An ophthalmic surgical system comprising a surgical console having a cassette
receiving portion adapted to receive a cassette for managing irrigation and aspiration
fluid flows, comprising:
]51[
]71[
]74[
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
(a) a common primary fluidics and pneumatics manifold in the cassette receiving
portion of the ophthalmic surgical system;
(b) an infusion manifold mounted on the primary manifold; and
(c) a pneumatic accumulator comprising a space for storing pressurized air formed
within an otherwise unused portion of at least one of the primary or infusion
manifolds.
__________________
]11[]21[
183394
‫מנעול לדלת רכב‬
]54[
CAR DOOR LOCK
]22[
]31[
]51[
]71[
24.05.2007
11/421853
]32[ 02.06.2006
]33[ US
Int. Cl.(2010.01) B66B 13//00, 13//12
THE PEELLE COMPANY LTD.,
CANADA
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A door locking system for a freight or passenger elevator or goods lift installation
having vertically spaced landings served by a vertically movable car (10), the landings
and car each being protected by associated horizontal slide doors (11, 12), a
mechanical interlock device (16) at each landing that prevents a landing door from
opening without the presence of the car in registration with the landing, a door lock
(31) on the car for normally preventing the car door from opening when the car is out
of registration with any landing, the interlock device being positioned to mechanically
enable the door lock to release the car door to open when the car is in registration with
a landing, said interlock device being responsive to vertical movement of said car, said
interlock device being pivoted by elements on said car to release its associated landing
door.
]74[
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
PALLET FOR STORING AND
TRANSPORTING GOODS
]22[
]31[
]51[
]71[
]87[
]74[
06.12.2005
TV2004U000064 ]32[ 06.12.2004
Int. Cl.(2009.01) B65D 19/00, 19/28
COMPARF S.R.L., ITALY
WO/2006/061183
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]57[
183463
‫משטח להובלה ואחסון חפצים‬
]33[
IT
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A pallet for storing and transporting goods by a load platform (2) supported by parallel
supports (4), characterised in that: - the load platform (2) comprises a plurality of
continuous parallel grooves (6), - the supports (4) are tubular and comprise parallel
continuous grooves (16, 18) in their side walls (6) and base (14), in the upper edge of
the side walls (16) they comprising recesses (20) complementary to the grooves (6) of
the platform (2), the axis of said supports (4) being perpendicular to the grooves (6) of
the load platform (2), - the supports (4) are provided with a plurality of internal baffles
(26, 32), - cut-out holes (22) are provided in the side walls (12) of the tubular supports
(4) for the passage of a fork of a lifting means, each cut-out hole being bounded
lowerly and upperly by strips of the support side wall (12), - the lower surface of the
platform (2) is provided with reinforcement elements positioned between said supports
(4) and said platform (2) at said cut-out holes (22).
__________________
]11[]21[
]54[
SYSTEM FOR READING AND
183477
‫שיטה לקריאה ואימות של תמונה מורכבת‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫הנמצאת בעטיפה‬
AUTHENTICATING A
COMPOSITE IMAGE IN A
SHEETING
]22[
]31[
]51[
]71[
]87[
]74[
]57[
27.10.2005
11/002943
]32[ 02.12.2004
Int. Cl.(2010.01) G07D 07//12
3M INNOVATIVE PROPERTIES
COMPANY, U.S.A.
WO/2006/060090
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]33[
US
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
A system for reading and authenticating a composite image in a sheeting. An
exemplary embodiment of the invention provides a system for reading and
authenticating a sheeting including a composite image that appears to the unaided eye
to be floating above or below the sheeting or both. The present invention also relates to
methods of reading and authenticating a composite image that appears to the unaided
eye to be floating above or below the sheeting or both.
__________________
]11[]21[
183812
‫כלי חיתוך מצופה‬
]54[
COATED CUTTING TOOL
]22[
]31[
]51[
]71[
09.12.2005
2004-361652 ]32[ 14.12.2004
]33[ JP
Int. Cl.(2010.01) B23B 27//14, 51//00, B23C 05//16
SUMITOMO ELECTRIC
HARDMETAL CORP., JAPAN
SHINYA IMAMURA, NAOYA
OMORI, MINORU ITOH, NORIHIRO
TAKANASHI, YOSHIO OKADA,
SUSUMU OKUNO
WO/2006/064724
]72[
]87[
November 30, 2010-‫כג' בכסלו התשע"א‬
]74[
]57[
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
This invention relates to a surface-covered cutting tool (1) that comprises a base
material (8) and a film (9) provided on the base material (8). The film (9) comprises a
first film (10) formed of TiCN and a second film (11) formed of alpha -type Al2O 3and
is characterized in that the first film (10) is located between the base material (8) and
the second film (11) and has a tensile stress S1, the second film )11( has a
compression stress S2, and the tensile stress S1 and the compression stress S2 are
specified by formula (I). 400 MPa ≤ S2 - S1 3500 ≤ MPa( ··· I)
__________________
]11[]21[
183925
]54[
CC CHEMOKINE ANTAGONISTS,
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]22[
]31[
19.12.2005
60/638312
]32[ 21.12.2004
]33[ US
04106778.6
21.12.2004
EP
Int. Cl.(2010.01) A61K 38//00, A61P 09//00, 25//00, 29//00, 31//00, 37//00, C07K
14//435, 16//18, C12N 15//12
MERCK SERONO S.A.,
SWITZERLAND
AMANDA PROUDFOOT, ACHIM
FRAUENSCHUH, CHRISTINE
POWER
WO/2006/067124
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
18 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
]51[
]71[
]72[
]87[
]74[
‫ הכנתם‬,‫ קמוקינים‬CC ‫אנטגוניסטים ל‬
‫ותכשירי רוקחות המכילים אותם‬
November 30, 2010-‫כג' בכסלו התשע"א‬
YAVNE 81101
]57[
A novel CC-chemokine binding protein is isolated from the saliva of Rhipicephalus
sanguineus. Compounds prepared in accordance with the present invention can be used
as anti-inflammatory compounds and in the treatment or prevention of CCchemokine-related diseases.
__________________
]11[]21[
]54[
PEG-URATE OXIDASE
CONJUGATES AND USE
THEREOF
]22[
]31[
]51[
]62[
]71[
02.08.1999
09/130392
]32[ 06.08.1998
Int. Cl.(2010.01) A61K 47//48
DIVISION FROM 141220
DUKE UNIVERSITY, U.S.A.
MOUNTAIN VIEW
PHARMACEUTICALS, INC., U.S.A.
WO/2000/007629
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
183948
‫ – אוראט אוקסידאזה ושימוש‬PEG ‫תצמידי‬
‫שלהם‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A naturally occurring or recombinant urate oxidase (uricase) covalently coupled to
poly(ethylene glycol) or poly(ethylene oxide) (both referred to as PEG), wherein an
average of 2 to 10 strands of PEG are conjugated to each uricase subunit and the PEG
has an average molecular weight between about 5 kDa and 100 kDa. The resulting
PEG-uricase conjugates are substantially non-immunogenic and retain at least 75 % of
the uricolytic activity of the unmodified enzyme .
__________________
]11[]21[
]54[
SURGICAL LASER SYSTEM
WITH REMOTE CONTROL
184147
‫מערכת לייזר כירורגית עם פונקנציונליות של‬
‫שלט רחוק‬
November 30, 2010-‫כג' בכסלו התשע"א‬
FUNCTIONALITY
]22[
]31[
]51[
]71[
]74[
]57[
21.06.2007
11/479636
]32[ 30.06.2006
]33[ US
Int. Cl.(2010.01) A61F 09//01
ALCON. INC., SWITZERLAND
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A laser surgical system, comprising:
a laser surgical unit (100) comprising a laser and associated control software adapted
to implement a first basic set of functionality;
a control unit (200) adapted to be coupled to the laser surgical unit, comprising a
microprocessor and software adapted to take operable control of the laser surgical unit,
and characterized in that it implements a second set of functionality,
at least some of the second set of functionality being distinct from the first basic set of
functionality.
__________________
]11[]21[
184380
‫מערכת לניצול מים‬
]54[
WATER UTILIZATION SYSTEM
]22[
]51[
]71[
03.07.2007
Int. Cl.(2009.01) E03B 01/04, 03/00, 07/04
ALON KAVA
EITAN TAGAR
]74[
MARC ZUTA,
PATENT 4U LIMITED,
P.O.B. 2162,
PETAH TIKVA 49120
]57[
:‫) או יותר הכוללת‬4( ‫ עבור בית שימוש‬,‫מערכת למחזור מי דלוחין שמקורם בדירה‬
‫) בגובה‬24( ‫) אשר מותקן מתחת לרצפה בדירה הכולל אגנית‬7( ‫אמצעי מיכל תחתון‬
‫) לכל אחד בדירה אשר מוציא מי‬14 ,13 ,12 ,11( ‫מפלס מי הדלוחין ומחוברת לפחות‬
‫) מתחת לרצפה ומכיל עליון המאפשר אספקת מים לבית‬16 ,15( ‫דלוחין באמצעות צנרת‬
‫ פתח תקוה‬,‫אלון קוה‬
‫ ראשון לציון‬,‫איתן תגר‬
,‫ עו"פ‬,‫מרק זוטא‬
‫ יו לימיטד‬4 ‫פטנט‬
‫תקוה‬-‫פתח‬2162 .‫ד‬.‫ ת‬,
November 30, 2010-‫כג' בכסלו התשע"א‬
‫שימוש אחד או יותר; כאשר המיכל עליון כולל אמצעי מצוף (‪ )37‬לצורך אספקת מים‬
‫נקיים בצורה מכנית במקרה של מחסור במים במיכל העליון ‪ ,‬אמצעי מצוף (‪ )34‬לצורך‬
‫פתיחת אמצעי פתח תחתון להוצאת חלק מהמים שמכיל בצור המכנית‪ ,‬במקרה של עודף‬
‫מים במכיל העליון ‪ ,‬פתח מים (‪ )31‬לצורך כניסת אספקת מי הדלוחין מהמערכת למחזור‬
‫מי דלוחין וכשאר המכיל עלילון כולל בסיס בעל שיפוע‪ ,‬לצורך ניתוב לכלוך לכוון‬
‫אמצעי הפתח התחתון ‪.‬‬
‫פירוט זה נבחן בהתאם לתקנה ‪ 35‬לתקנות‬
‫הפטנטים‪ ,‬תשכ"ח – ‪1968‬‬
‫‪This specification was examined in‬‬
‫‪accordance with regulation 35 of the Patent‬‬
‫‪Regulations, 5728 - 1968‬‬
‫__________________‬
‫‪184557‬‬
‫פניל מתנונים הטרוציקליים מותמרים כמעכבי‬
‫מסיע–גליצין ‪1‬‬
‫[‪]11[]21‬‬
‫‪HETEROCYCLIC SUBSTITUTED‬‬
‫‪PHENYL METHANONES AS‬‬
‫‪INHIBITORS OF THE GLYCINE‬‬
‫‪TRANSPORTER 1‬‬
‫[‪]54‬‬
‫‪30.01.2006‬‬
‫‪05100813.4‬‬
‫‪]32[ 07.02.2005‬‬
‫‪]33[ EP‬‬
‫‪Int. Cl.(2010.01) A61K 31//4035, 31//416, 31//437, 31//5377, A61P 25//00, 29//00,‬‬
‫‪C07D 20/9/44, 20/9/88, 23/5/06, 40/1/04, 40/3/04, 40/3/10, 40/5/04, 40/9/04, 41/3/04,‬‬
‫‪41/7/04, 47/1/04, 48/7/04, 49/1/08, 49/8/08‬‬
‫‪F. HOFFMANN-LA ROCHE AG,‬‬
‫‪SWITZERLAND‬‬
‫‪WO/2006/082001‬‬
‫‪LUZZATTO & LUZZATTO,‬‬
‫לוצאטו את לוצאטו‪,‬‬
‫‪INDUSTRIAL PARK, OMER,‬‬
‫גן תעשייה‪ ,‬עומר‬
‫‪P.O.B. 5352,‬‬
‫‪ ,‬ת‪.‬ד‪5352 .‬באר שבע‬
‫‪BEER-SHEVA 84152‬‬
‫[‪]22‬‬
‫[‪]31‬‬
‫[‪]51‬‬
‫‪The present invention relates to compounds of general formula (I) wherein (i) is an‬‬
‫כג' בכסלו התשע"א‪November 30, 2010-‬‬
‫[‪]71‬‬
‫[‪]87‬‬
‫[‪]74‬‬
‫[‪]57‬‬
aromatic or partially aromatic bicyclic amine, which may contain one or two additional
N-atoms, selected from the group consisting of (a), (b), (c), (d), (e), (f), (g), (h) and to
pharmaceutically acceptable acid addition salts thereof.
__________________
]11[]21[
184856
]54[
PROCESS FOR THE
MANUFACTURE OF A VENEER
]22[
]31[
]51[
]71[
11.11.2005
102005005339.4 ]32[ 27.01.2005
]33[
Int. Cl.(2010.01) B27L 05//00, B27M 03//00
HD WOOD TECHNOLOGIES
LIMITED, MALTA
MICHAEL ENGEL, WOLFGANG
LACROIX, PETER SPITALER,
PATRICK GUITTON, HANS-JOACHIM
DANZER
WO/2006/079374
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]72[
]87[
]74[
]57[
‫תהליך לייצור ליבוד‬
DE
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
Process for the manufacture of a veneer comprising steps (i) to (iv): (i) gluing boardlike, plane pieces of wood (10) by means of an adhesive to a beam-like block of wood
(12), (ii) watering and/or tempering said beam-like block of wood (12), (iii) cutting
said beam-like block of wood (12) to a veneer (14), (iv) drying said veneer obtained in
step (iii) until the humidity content is below the fiber saturation point.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
184867
‫או סוף איזור של‬/‫אלמנט מנחה להתחלה ו‬
‫ התקן הגנה המסופק עם האלמנט‬,‫התקן הגנה‬
‫המנחה וקיט של חלקים עבור התקן ההגנה‬
]54[
GUIDING ELEMENT FOR THE
BEGINNING AND/OR END AREA OF
A PROTECTIVE DEVICE, A
PROTECTIVE DEVICE PROVIDED
WITH SAID GUIDE ELEMENT AND
KIT OF PARTS FOR THE
PROTECTIVE DEVICE
]22[
]31[
]51[
]71[
]87[
]74[
19.05.2005
202005001801.5 ]32[ 01.02.2005
]33[
Int. Cl.(2010.01) E01F 15//00, 15//04, 15//14
OUTIMEX AG, GERMANY
WO/2006/081783
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a guiding element (1) for the beginning and/or end area of a
protective device (300). The inventive guiding element comprises connecting means
(3) for connecting the guiding element (1) to an additional guiding element (4) or to
the protective element (2) of the protective device (300) in such a manner than an
adjusting angle is formed. A protective device provided with said guiding element and
a kit of parts therefor are also disclosed.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
METHOD FOR REINFORCING
BUILDING STRUCTURES AND
COATING OBTAINED THEREBY
]22[
]31[
]51[
]71[
]72[
]87[
]74[
10.02.2006
RM2005A000066 ]32[ 17.02.2005
Int. Cl.(2010.01) E04G 23//02
TEC. INN. S.R.L., ITALY
EMO AGNELONI
WO/2006/087751
SIMON LAVIE,
21 HERZOG ST.,
JERUSALEM
]57[
185222
‫שיטה לחיזוק מבנים וציפויים המתקבלים‬
‫בשל כך‬
]33[
IT
,‫שמעון לביא‬
21 ‫הרצוג‬
‫ירושלים‬
A method for reinforcing building structures enables to obtain a reinforcing coating
through the steps of: anchoring a resistant film (2) of composite material to a building
structure (s) to be reinforced and superposing onto the resistant film (2) an elastic film
(8) at least partially uncoupled from the resistant film (2), in such a way that the elastic
film (8) can be deformed and slide tangentially relative to the resistant film (2).
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
185488
‫ראש חיתוך למקדד‬
]54[
CUTTING HEAD OF A REAMER
]22[
]51[
]71[
]72[
]74[
23.08.2007
Int. Cl.(2010.01) B23C 05//10, B23D 77//00
ISCAR LTD.
‫ תפן‬,‫ישקר בע"מ‬
TSUR COHEN
‫צור כהן‬
ISCAR LTD.,
,‫ישקר בע"מ‬
P.O.B. 11,
‫תפן‬11 .‫ד‬.‫ ת‬,
TEFEN 24959
A cutting head (10) of a reamer having an axis of rotation (A), the cutting head (10)
comprising:
a cutting head forward end (14), a cutting head rear end (16) distal the cutting head
forward end (14) and a peripheral surface (18) therebetween, the peripheral surface
(18) comprising at least two wiping pads (22) extending rearwardly from the cutting
head forward end (14), the peripheral surface (18) between two adjacent wiping pads
forms a peripheral section (58), and
at least one cutting section (20) located adjacent the cutting head forward end (14)
comprising:
cutting edge (30) extending from the cutting head forward end (14) to the peripheral
surface (18) and formed at an intersection of a rake surface (32) and a relief surface
(34), the rake surface (32) being generally tangentially directed facing a direction of
rotation (B) and having a rake surface first end (40) that is distal from the cutting edge
(30),
a deflecting surface (38) adjacent the rake surface (32) and generally transverse
thereto, the deflecting surface (38) extending, from the rake surface first end (40) in a
direction away from the cutting edge (30), wherein
the deflecting surface (38) makes an acute axial angle (α) with respect to the axis of
rotation (A), and a rear end (41) of the deflecting surface (38) joins the peripheral
surface (18) adjacent the cutting section (20) and distal the rear end (16) of the cutting
head (10).
]57[
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
185959
‫תוספות לפרוטוקול קישור רדיו להפחתת זמן‬
‫אתחול לקריאת נתונים‬
]54[
RADIO LINK PROTOCOL
ENHANCEMENTS TO REDUCE
SETUP TIME FOR DATA CALLS
]22[
]31[
]51[
]62[
]71[
09.11.2000
09/437417
]32[ 10.11.1999
]33[ US
Int. Cl.(2009.01) H04L 12/28, 29/08, H04W 80/02
DIVISION FROM 149456
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/035580
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An apparatus for transmitting a stream of information bytes comprising:
means for receiving a message specifying a radio link protocol (RLP) round-trip time
(RTT) estimate; and
means for conducting an RLP communication session using said RTT estimate to
determine negative acknowledgment (NAK) message timing.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
CONFIGURABLE DEVICE FOR
CLEANING THE BARREL OF A
FIREARM AND FIREARM
CLEANING KIT CONTAINING
COMPONENTS OF DEVICE
]22[
]31[
]51[
]71[
]87[
]74[
13.04.2006
11/113649
]32[ 25.04.2005
Int. Cl.(2010.01) F41A 29//00, 29//02
THE OTIS PATENT TRUST, U.S.A.
WO/2007/046856
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
186942
‫התקן הניתן לעיצוב עבור ניקוי קנה של נשק‬
‫וערכה לניקוי נשק המכילה רכיבים של ההתקן‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Methods and devices are provided for cleaning firearm barrels, including those of
military issue firearms, wherein the methods include a step for removing loose
materials from within the barrel, a step for dislodging materials not removed during the
first removal step, and a step for removing the materials dislodged during the
dislodging step, as well as one or more optional cleaning steps to be performed in
addition to or in lieu of the other cleaning steps, and wherein the firearm barrel
cleaning device can be adapted to have different configurations for use during one or
more of the various cleaning steps.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
RADIO NETWORK CONTROLLER
PEER-TO-PEER EXCHANGE OF
USER EQUIPMENT
MEASUREMENTS INFORMATION
]22[
]31[
]51[
]62[
]71[
25.06.2003
60/392122
]32[ 27.06.2002
Int. Cl.(2010.01) H04B 07//26, 17//00
DIVISION FROM 164656
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2004/004306
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
189070
‫בקר רשת רדיו עבור החלפת מידע עמית לעמית‬
‫על ציוד לקוח‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A drifting (WTRU) wireless transmit/receive unit has an associated (D-RNC) drift
radio network controller (38) and an associated (S-RNC) servicing radio network
controller (40). The D-RNC (38) sends a request message to the S-RNC (40)
requesting measurements of the drifting WTRU. The S-RNC (40) receives the request
message and sends an information message with the requested measurements to the DRNC (38). The D-RNC (38) receives the information message.
November 30, 2010-‫כג' בכסלו התשע"א‬
The parent application from which
this application has been divided has
not yet been published
The applications for division
from this application have
not yet been published
164656
‫בקשת הורה לבקשה זו שטרם פורסמה‬
,206599
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
FLUID CONTROL DEVICE
]22[
]31[
]51[
]71[
]87[
]74[
21.07.2006
2005-263231 ]32[ 12.09.2005
Int. Cl.(2010.01) F16L 27//00, 41//02
FUJIKIN INCORPORATED, JAPAN
WO/2007/032147
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]57[
189696
‫התקן לוויסות נוזלים‬
]33[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
A fluid controller enabling a reduction in size without reducing the diameter of bolts
and the diameters of passages. A fluid control device (31) comprising an inlet port
(31a) and an outlet port (31b) arranged parallel with each other in the direction of a
line and a line connection port (31c) positioned between the inlet port and the outlet
port in the direction of the line is supportedly installed across a pair of joint members
(7). Steps (7a) are formed in the upper faces of both joint members (7) facing each
other, and line connection passage formation members (9, 10) having line-to-line
passages (13, 18) communicating with the line connection port (31c) of the fluid
control device (31) and forming a line connection means (8) are supportedly installed
across the steps (7a) of these joint members (7).
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
190518
‫מערכת ושיטות לניתור קודים ניידים זדוניים‬
‫בזמן ריצה‬
]54[
MALICIOUS MOBILE CODE
RUNTIME MONITORING
SYSTEM AND METHODS
]22[
]31[
]51[
]62[
]71[
]87[
]74[
17.05.2001
60/205591
]32[ 17.05.2000
Int. Cl.(2009.01) G06F 01/00, 21/00
DIVISION FROM 147712
FINJAN, INC., U.S.A.
WO/2001/088673
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
A method, comprising:
receiving mobile protection code ("MPC") and a Downloadable at a Downloadabledestination;
causing, by the MPC, one or more operations attempted by the Downloadable to be
received by the MPC;
receiving, by the MPC, an attempted operation of the Downloadable; and
initiating, by the MPC, a protection policy corresponding to the attempted operation.
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
192542
‫שיטה לשינוי מוצרי עוף‬
]54[
METHOD FOR MODIFYING
POULTRY PRODUCTS
]22[
]51[
]71[
]87[
]74[
29.06.2009
Int. Cl.(2010.01) A23K 01//16, A23L 01//30
OMEG FOODS LTD.
‫ גן‬- ‫ רמת‬,‫אומג פודס בע"מ‬
WO/2007/023366
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method for modifying poultry products with beneficial fatty acids, wherein said
modified poultry products maintain the natural smell and taste, comprising feeding a
fowl with a standard feed in which the animal or vegetable fat blend component of the
diet is replaced by an oil blend consisting of fish oil (60-90%), canola oil (10-30%),
soy oil (0-10%) and linseed oil (0-10%) at total fat levels in the diet of up to 8.4%,
calculated based on the final feed composition, wherein said fish oil is not menhaden
oil or mackerel oil.
]57[
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
__________________
]11[]21[
194326
‫מעגל מוטה לאחזקת ערך קבוע של הולכי–דרך‬
‫מחולק בקיבול מעמסה‬
]54[
BIAS CIRCUIT FOR
MAINTAINING A CONSTANT
VALUE OF
TRANSCONDUCTANCE DIVIDED
BY LOAD CAPACITANCE
]22[
]31[
]51[
]62[
]71[
31.01.2002
/09773404
]32[ 31.01.2001
]33[ US
Int. Cl.(2009.01) G05F 03/20, 03/26, H03F 03/45
DIVISION FROM 157141
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/061519
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
November 30, 2010-‫כג' בכסלו התשע"א‬
]87[
]74[
]57[
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A bias circuit for use in biasing a differential pair, said bias circuit comprising:
a pair of current source devices;
a capacitor;
a first clock input connected between a first terminal of said capacitor and a current
output line of the differential pair being biased, said first clock input also connected
between a second terminal of said capacitor and a common mode input voltage line;
a second clock input connected between the first terminal of said capacitor and a
positive voltage reference signal line and also connected between the second terminal
of said capacitor and a negative voltage reference signal line;
a third clock input connected between the first terminal of said capacitor and a ground
and also connected between the second terminal of said capacitor and said ground;
with said first, second clock and third inputs providing mutually non-overlapping clock
signals at a predetermined sampling frequency; and
a bias line connecting a voltage output from the pair of cirrent source devices to the
differential pair.
__________________
]11[]21[
]54[
ANTISENSE OLIGONUCLEOTIDE
TARGETED TO INSULIN-LIKE
GROWTH BINDING PROTEIN 5
]22[
]31[
]51[
]62[
]71[
07.10.2002
09/975123
]32[ 09.10.2001
Int. Cl.(2010.01) C12N 15//11, 15//18
DIVISION FROM 161277
ISIS PHARMACEUTICALS, INC.,
U.S.A.
WO/2003/030826
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
194383
‫אוליגונוקליאוטיד של הסיב המשלים המכוון‬
‫ של פקטור גדילה דמוי‬5 ‫לחלבון קושר מספר‬
‫אינסולין‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
November 30, 2010-‫כג' בכסלו התשע"א‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]57[
Antisense compounds, compositions and methods are provided for modulating the
expression of insulin-like growth factor binding protein 5. The compositions comprise
antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids
encoding insulin-like growth factor binding protein 5. Methods of using these
compounds for modulation of insulin-like growth factor binding protein 5 expression
and for treatment of diseases associated with expression of insulin-like growth factor
binding protein 5 are provided.
The parent application from which
this application has been divided has
not yet been published
161277
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
__________________
]11[]21[
194574
‫שיטה ומכשור להקצות לזרמי מידע הגבלות‬
‫פסקי זמן העברה נתונים‬
]54[
METHOD AND APPARATUS FOR
ALLOCATING DATA STREAMS
GIVEN TRANSMISSION TIME
INTERVAL (TTI) CONSTRAINTS
]22[
]31[
]51[
]62[
]71[
16.01.2002
09/764788
]32[ 17.01.2001
]33[ US
Int. Cl.(2010.01) H04J 01//00, H04L 01//00, 29//04
DIVISION FROM 156946
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/065675
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method and system that enables multiplexing a plurality of data streams onto one
data stream based on data stream priorities, available transport format combinations
(TFCs), and transmission time interval (TTI) constraints of transport frames within the
TFCs is disclosed. A subscriber unit (12) has applications that produce separate data
streams. Example applications include voice (32), signalling (34), E-mail (36) and web
applications (38). The data streams are combined by a multiplexer module (48) into
one data stream called the transport stream (50). The transport stream (50) is sent over
the reverse link to base station transceivers (BTS) (14). The multiplexer module (48)
multiplexes the data streams onto a single stream according to available TFCs, TTI
constraints, and data stream priorities.
November 30, 2010-‫כג' בכסלו התשע"א‬
__________________
]11[]21[
]54[
DETECTION AND
AMPLIFICATION OF LIGANDS
]22[
]31[
]51[
]62[
]71[
]87[
]74[
29.03.2002
09/821396
]32[ 29.03.2001
Int. Cl.(2010.01) G01N 33//53, 33//545
DIVISION FROM 158165
KENT STATE UNIVERSITY, U.S.A.
WO/2002/079755
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
196076
‫זיהוי והגברה של ליגנדים‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Devices and systems for the detection of ligands comprising at least one receptor and
an amplification mechanism comprising a liquid crystalline, where an amplified signal
is produced as a result of receptor binding to a ligand are provided. Also provided are
methods for the automatic detection of ligands.
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
199420
‫קומץ חליבה‬
]54[
MILKING CLAW
]22[
]51[
]71[
]74[
18.06.2009
Int. Cl.(2009.01) A01J 05/00
RAN SILVIANU
RAN SILVIANU,
25 BEN ZION ISRAELI ST.,
KIRYAT HAIM 26285
]57[
A milking claw (10), comprising:
a container;
four milk inlets (20) to said container, each corresponding to a teat of a dairy animal,
each being disposed in the upper side (14) of said container, each connecting the space
of said container with a teat cup attached to a teat of said dairy animal;
a milk outlet (26) from said container, said outlet being disposed at the lower side
(16) of said container;
an air tube, wherein the lower side (42) thereof being disposed in said outlet, and the
upper side (44) thereof being disposed at the upper side of said container, for being
kept above the milk line (52) of said container;
thereby retaining vacuum inside said container, while allowing fluent passage of milk
through said outlet.
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
‫ קריית חיים‬,‫רן סילביאנו‬
,‫רן סילביאנו‬
25 ‫בן ציון ישראלי‬
‫קריית חיים‬
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
]11[]21[
199743
]54[
6-O-SUBSTITUTED KETOLIDES
HAVING ANTIBACTERIAL
ACTIVITY, A PROCESS FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME
]22[
]31[
02.09.1997
08/707776
]32[ 04.09.1996
]33[ US
08/888350
03.07.1997
US
Int. Cl.(2010.01) A61K 31//7042, A61P 31//04, C07H 17//08
DIVISION FROM 128681
ABBOTT LABORATORIES, U.S.A.
WO/1998/009978
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]51[
]62[
]71[
]87[
]74[
]57[
‫ בעלי‬O–6–‫קטולידים מותמרים במקום ה‬
‫ התהליך להכנתם‬,‫פעילות אנטי–חיידקית‬
‫ותרכובות פרמצבטיות המכילות אותם‬
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
Antimicrobial compounds having formula (II), (III), (IV), (IV-A) or (V) as well as
pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical
compositions comprising such compounds; methods of treating bacterial infections by
the administration of such compounds; and processes for the preparation of the
compunds.
__________________
]11[]21[
]54[
6-O-SUBSTITUTED KETOLIDES
HAVING ANTIBACTERIAL
ACTIVITY, A PROCESS FOR
199746
‫ בעלי‬O–6–‫קטולידים מותמרים במקום ה‬
‫ התהליך להכנתם‬,‫פעילות אנטי–חיידקית‬
‫ותרכובות פרמצבטיות המכילות אותם‬
November 30, 2010-‫כג' בכסלו התשע"א‬
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME
]22[
]31[
]51[
]62[
]71[
]87[
]74[
]57[
02.09.1997
08/707775
]32[ 04.09.1996
]33[ US
08/888350
03.07.1997
US
Int. Cl.(2010.01) A61K 31//7042, A61P 31//04, C07H 17//08
DIVISION FROM 128681
ABBOTT LABORATORIES, U.S.A.
WO/1998/009978
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
Antimicrobial compounds having formula (II), (III), (IV), (IV-A) or (V) as well as
pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical
compositions comprising such compounds; methods of treating bacterial infections by
the administration of such compounds; and processes for the preparation of the
compunds.
__________________
]11[]21[
201939
‫מיתוג ערוצים לתמיכה בשירותי מולטימדיה‬
‫לשידור רחב ולמנויים‬
]54[
CHANNEL SWITCHING FOR
SUPPORT OF MULTIMEDIA
BROADCAST AND MULTICAST
SERVICES
]22[
]31[
]51[
06.08.2003
60/402161
]32[ 07.08.2002
]33[ US
Int. Cl.(2010.01) H04B 01//16, 01//69, 07//26, H04L 12//56, H04M 03//00
November 30, 2010-‫כג' בכסלו התשע"א‬
]62[
]71[
]87[
]74[
]57[
DIVISION FROM 166558
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2004/015876
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A wireless transmit/receive unit (WTRU) for receiving multimedia
broadcasts\multicast services (MBMS), the WTRU comprising:
an MBMS receiver means for receiving information associated with a point-to-point
transmission of a point-to point MBMs service, the received point-to-point
transmission information including a point-to-point MBMS identity associated with
the point-to-point MBMS service;
the MBMS receiver means for receiving point-to-point MBMS segments over a
dedicated traffic channel of the point-to-point transmission in response to the received
point-to-point transmission information;
the MBMS receiver means for receiving information associated with a point-tomultipoint transmission of a point-to-multipoint MBMS service, the received point-tomultipoint transmission information including a point-to-multipoint MBMS identity
associated with the point-to-multipoint MBMS service;
the MBMS receiver means for receiving point-to-multipoint MBMS segments over
secondary common control physical channels (S-CCPCHs) of the point-to-multipoint
transmission in response to the received point-to-multipoint transmission information,
the S-CCPCHs originating from a plurality of cells and the transmission of the pointto-multipoint MBMS segments are not synchronized in time between the cells; and
an MBMS segment reassembly means for reassembling the point-to-multipoint MBMS
segments.
The parent application from which
this application has been divided has
not yet been published
The applications for division
from this application have
not yet been published
166558
‫בקשת הורה לבקשה זו שטרם פורסמה‬
,207026
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
November 30, 2010-‫כג' בכסלו התשע"א‬
‫כג' בכסלו התשע"א‪November 30, 2010-‬‬
‫פטנטים‬
‫‪PATENTS‬‬
‫פטנטים שניתנו‬
‫‪PATENTS GRANTED‬‬
‫‪151378‬‬
‫‪152750‬‬
‫‪154405‬‬
‫‪155245‬‬
‫‪173540‬‬
‫‪174526‬‬
‫‪174966‬‬
‫‪175816‬‬
‫‪176505‬‬
‫‪178307‬‬
‫‪140699‬‬
‫‪156233‬‬
‫‪156878‬‬
‫‪157340‬‬
‫‪158108‬‬
‫‪158782‬‬
‫‪159238‬‬
‫‪159857‬‬
‫‪160279‬‬
‫‪160911‬‬
‫‪187062‬‬
‫‪146623‬‬
‫‪148374‬‬
‫‪149568‬‬
‫‪166768‬‬
‫‪166985‬‬
‫‪167290‬‬
‫‪167659‬‬
‫‪167965‬‬
‫‪168183‬‬
‫‪168659‬‬
‫‪169271‬‬
‫‪170062‬‬
‫‪170216‬‬
‫‪170511‬‬
‫‪170838‬‬
‫‪171712‬‬
‫‪172152‬‬
‫‪172639‬‬
‫‪151315‬‬
‫‪152422‬‬
‫‪154131‬‬
‫‪155200‬‬
‫‪173520‬‬
‫‪174492‬‬
‫‪174891‬‬
‫‪175494‬‬
‫‪176477‬‬
‫‪177921‬‬
‫‪140232‬‬
‫‪156124‬‬
‫‪156857‬‬
‫‪157304‬‬
‫‪158021‬‬
‫‪158603‬‬
‫‪159210‬‬
‫‪159803‬‬
‫‪160254‬‬
‫‪160894‬‬
‫‪186251‬‬
‫‪146582‬‬
‫‪147652‬‬
‫‪149542‬‬
‫‪151019‬‬
‫‪166949‬‬
‫‪167233‬‬
‫‪167591‬‬
‫‪167941‬‬
‫‪168160‬‬
‫‪168541‬‬
‫‪169212‬‬
‫‪169994‬‬
‫‪170210‬‬
‫‪170494‬‬
‫‪170833‬‬
‫‪171663‬‬
‫‪172125‬‬
‫‪172557‬‬
‫‪151150‬‬
‫‪152315‬‬
‫‪153904‬‬
‫‪155071‬‬
‫‪173290‬‬
‫‪174411‬‬
‫‪174830‬‬
‫‪175208‬‬
‫‪176421‬‬
‫‪177373‬‬
‫‪139200‬‬
‫‪156101‬‬
‫‪156799‬‬
‫‪157274‬‬
‫‪157854‬‬
‫‪158539‬‬
‫‪159209‬‬
‫‪159788‬‬
‫‪160192‬‬
‫‪160759‬‬
‫‪184513‬‬
‫‪146579‬‬
‫‪147402‬‬
‫‪149520‬‬
‫‪150083‬‬
‫‪166941‬‬
‫‪167188‬‬
‫‪167492‬‬
‫‪167885‬‬
‫‪168096‬‬
‫‪168540‬‬
‫‪169141‬‬
‫‪169958‬‬
‫‪170204‬‬
‫‪170442‬‬
‫‪170827‬‬
‫‪171605‬‬
‫‪172084‬‬
‫‪172453‬‬
‫‪151094‬‬
‫‪152256‬‬
‫‪153733‬‬
‫‪154784‬‬
‫‪173281‬‬
‫‪174057‬‬
‫‪174795‬‬
‫‪175069‬‬
‫‪176419‬‬
‫‪176963‬‬
‫‪124133‬‬
‫‪155996‬‬
‫‪156611‬‬
‫‪157209‬‬
‫‪157753‬‬
‫‪158531‬‬
‫‪159139‬‬
‫‪159744‬‬
‫‪160062‬‬
‫‪160668‬‬
‫‪184429‬‬
‫‪132853‬‬
‫‪147400‬‬
‫‪149430‬‬
‫‪149971‬‬
‫‪166915‬‬
‫‪167172‬‬
‫‪167372‬‬
‫‪167846‬‬
‫‪168091‬‬
‫‪168536‬‬
‫‪169073‬‬
‫‪169895‬‬
‫‪170179‬‬
‫‪170378‬‬
‫‪170821‬‬
‫‪171395‬‬
‫‪172071‬‬
‫‪172342‬‬
‫כג' בכסלו התשע"א‪November 30, 2010-‬‬
‫‪137090‬‬
‫‪152012‬‬
‫‪153345‬‬
‫‪154693‬‬
‫‪173280‬‬
‫‪174027‬‬
‫‪174740‬‬
‫‪175053‬‬
‫‪176309‬‬
‫‪176729‬‬
‫‪179720‬‬
‫‪141813‬‬
‫‪156475‬‬
‫‪157201‬‬
‫‪157617‬‬
‫‪158513‬‬
‫‪159023‬‬
‫‪159704‬‬
‫‪160029‬‬
‫‪160629‬‬
‫‪182531‬‬
‫‪132719‬‬
‫‪147232‬‬
‫‪149337‬‬
‫‪149953‬‬
‫‪166891‬‬
‫‪167067‬‬
‫‪167344‬‬
‫‪167778‬‬
‫‪168061‬‬
‫‪168336‬‬
‫‪169007‬‬
‫‪169862‬‬
‫‪170166‬‬
‫‪170331‬‬
‫‪170820‬‬
‫‪171126‬‬
‫‪171981‬‬
‫‪172278‬‬
‫‪135688‬‬
‫‪151945‬‬
‫‪153318‬‬
‫‪154618‬‬
‫‪173139‬‬
‫‪174015‬‬
‫‪174720‬‬
‫‪175041‬‬
‫‪176221‬‬
‫‪176643‬‬
‫‪178987‬‬
‫‪141768‬‬
‫‪156439‬‬
‫‪157191‬‬
‫‪157507‬‬
‫‪158276‬‬
‫‪158989‬‬
‫‪159662‬‬
‫‪160021‬‬
‫‪160560‬‬
‫‪182360‬‬
‫‪130036‬‬
‫‪147143‬‬
‫‪148762‬‬
‫‪149882‬‬
‫‪166879‬‬
‫‪167056‬‬
‫‪167338‬‬
‫‪167776‬‬
‫‪168007‬‬
‫‪168274‬‬
‫‪168843‬‬
‫‪169569‬‬
‫‪170153‬‬
‫‪170320‬‬
‫‪170681‬‬
‫‪171026‬‬
‫‪171911‬‬
‫‪172220‬‬
‫‪134719‬‬
‫‪151918‬‬
‫‪153297‬‬
‫‪154566‬‬
‫‪155900‬‬
‫‪173877‬‬
‫‪174602‬‬
‫‪175038‬‬
‫‪176196‬‬
‫‪176544‬‬
‫‪178859‬‬
‫‪140892‬‬
‫‪156423‬‬
‫‪157047‬‬
‫‪157404‬‬
‫‪158242‬‬
‫‪158943‬‬
‫‪159356‬‬
‫‪159987‬‬
‫‪160529‬‬
‫‪181245‬‬
‫‪187097‬‬
‫‪147017‬‬
‫‪148631‬‬
‫‪149644‬‬
‫‪166815‬‬
‫‪167045‬‬
‫‪167325‬‬
‫‪167763‬‬
‫‪167971‬‬
‫‪168194‬‬
‫‪168768‬‬
‫‪169471‬‬
‫‪170128‬‬
‫‪170282‬‬
‫‪170545‬‬
‫‪170997‬‬
‫‪171872‬‬
‫‪172199‬‬
‫‪134407‬‬
‫‪151814‬‬
‫‪152925‬‬
‫‪154534‬‬
‫‪155658‬‬
‫‪173570‬‬
‫‪174601‬‬
‫‪174977‬‬
‫‪176009‬‬
‫‪176537‬‬
‫‪178726‬‬
‫‪140743‬‬
‫‪156249‬‬
‫‪156930‬‬
‫‪157392‬‬
‫‪158121‬‬
‫‪158914‬‬
‫‪159327‬‬
‫‪159930‬‬
‫‪160497‬‬
‫‪160949‬‬
‫‪187063‬‬
‫‪146677‬‬
‫‪148493‬‬
‫‪149628‬‬
‫‪166777‬‬
‫‪167036‬‬
‫‪167314‬‬
‫‪167683‬‬
‫‪167970‬‬
‫‪168185‬‬
‫‪168660‬‬
‫‪169340‬‬
‫‪170098‬‬
‫‪170235‬‬
‫‪170528‬‬
‫‪170868‬‬
‫‪171765‬‬
‫‪172190‬‬
‫‪142680‬‬
‫‪144202‬‬
‫‪161076‬‬
‫‪161866‬‬
‫‪162444‬‬
‫‪162789‬‬
‫‪163167‬‬
‫‪163693‬‬
‫‪164081‬‬
‫‪164625‬‬
‫‪165285‬‬
‫‪165714‬‬
‫‪165933‬‬
‫‪166309‬‬
‫‪189507‬‬
‫‪196059‬‬
‫‪142334‬‬
‫‪144118‬‬
‫‪146338‬‬
‫‪161610‬‬
‫‪162421‬‬
‫‪162706‬‬
‫‪163162‬‬
‫‪163636‬‬
‫‪163990‬‬
‫‪164513‬‬
‫‪165149‬‬
‫‪165697‬‬
‫‪165911‬‬
‫‪166307‬‬
‫‪166742‬‬
‫‪195540‬‬
‫‪102675‬‬
‫‪102766‬‬
‫‪102824‬‬
‫‪102896‬‬
‫‪102986‬‬
‫‪118984‬‬
‫‪119056‬‬
‫‪119116‬‬
‫‪122142‬‬
‫‪123034‬‬
‫‪123196‬‬
‫‪123331‬‬
‫‪123464‬‬
‫‪126815‬‬
‫‪134470‬‬
‫‪137560‬‬
‫‪137700‬‬
‫‪137841‬‬
‫‪137946‬‬
‫‪138162‬‬
‫‪141121‬‬
‫‪142692‬‬
‫‪144411‬‬
‫‪146703‬‬
‫‪147489‬‬
‫‪102616‬‬
‫‪102765‬‬
‫‪102813‬‬
‫‪102886‬‬
‫‪102976‬‬
‫‪118971‬‬
‫‪119048‬‬
‫‪119113‬‬
‫‪120740‬‬
‫‪123032‬‬
‫‪123171‬‬
‫‪123327‬‬
‫‪123442‬‬
‫‪125135‬‬
‫‪134259‬‬
‫‪137558‬‬
‫‪137698‬‬
‫‪137821‬‬
‫‪137945‬‬
‫‪138150‬‬
‫‪140699‬‬
‫‪142680‬‬
‫‪144385‬‬
‫‪146544‬‬
‫‪147435‬‬
‫‪127871‬‬
‫‪143596‬‬
‫‪145803‬‬
‫‪161541‬‬
‫‪162368‬‬
‫‪162651‬‬
‫‪163093‬‬
‫‪163527‬‬
‫‪163834‬‬
‫‪164359‬‬
‫‪164933‬‬
‫‪165666‬‬
‫‪165894‬‬
‫‪166255‬‬
‫‪166641‬‬
‫‪193405‬‬
‫‪116465‬‬
‫‪143352‬‬
‫‪145702‬‬
‫‪161493‬‬
‫‪162317‬‬
‫‪162638‬‬
‫‪163047‬‬
‫‪163481‬‬
‫‪163791‬‬
‫‪164335‬‬
‫‪164909‬‬
‫‪165611‬‬
‫‪165890‬‬
‫‪166224‬‬
‫‪166569‬‬
‫‪193404‬‬
‫‪198938‬‬
‫‪143057‬‬
‫‪144703‬‬
‫‪161453‬‬
‫‪162274‬‬
‫‪162617‬‬
‫‪162957‬‬
‫‪163451‬‬
‫‪163788‬‬
‫‪164320‬‬
‫‪164874‬‬
‫‪165579‬‬
‫‪165837‬‬
‫‪166092‬‬
‫‪166525‬‬
‫‪193218‬‬
‫‪173072‬‬
‫‪143049‬‬
‫‪144294‬‬
‫‪161436‬‬
‫‪162163‬‬
‫‪162593‬‬
‫‪162910‬‬
‫‪163449‬‬
‫‪163781‬‬
‫‪164317‬‬
‫‪164859‬‬
‫‪165453‬‬
‫‪165833‬‬
‫‪166019‬‬
‫‪166374‬‬
‫‪192947‬‬
‫‪172983‬‬
‫‪143020‬‬
‫‪144270‬‬
‫‪161090‬‬
‫‪162109‬‬
‫‪162558‬‬
‫‪162835‬‬
‫‪163395‬‬
‫‪163756‬‬
‫‪164278‬‬
‫‪164824‬‬
‫‪165384‬‬
‫‪165790‬‬
‫‪165942‬‬
‫‪166372‬‬
‫‪190930‬‬
‫‪172725‬‬
‫‪142796‬‬
‫‪144269‬‬
‫‪161086‬‬
‫‪162101‬‬
‫‪162544‬‬
‫‪162820‬‬
‫‪163299‬‬
‫‪163739‬‬
‫‪164086‬‬
‫‪164774‬‬
‫‪165381‬‬
‫‪165783‬‬
‫‪165938‬‬
‫‪166361‬‬
‫‪189508‬‬
‫‪197396‬‬
‫פטנטים שחודשו‬
‫‪PATENTS RENEWED‬‬
‫‪102559‬‬
‫‪102731‬‬
‫‪102795‬‬
‫‪102868‬‬
‫‪102974‬‬
‫‪118906‬‬
‫‪119017‬‬
‫‪119089‬‬
‫‪119225‬‬
‫‪122974‬‬
‫‪123167‬‬
‫‪123312‬‬
‫‪123441‬‬
‫‪123689‬‬
‫‪134103‬‬
‫‪137516‬‬
‫‪137690‬‬
‫‪137820‬‬
‫‪137925‬‬
‫‪138109‬‬
‫‪138760‬‬
‫‪142601‬‬
‫‪144294‬‬
‫‪146491‬‬
‫‪147419‬‬
‫‪102558‬‬
‫‪102727‬‬
‫‪102790‬‬
‫‪102861‬‬
‫‪102962‬‬
‫‪118895‬‬
‫‪119016‬‬
‫‪119088‬‬
‫‪119224‬‬
‫‪122958‬‬
‫‪123166‬‬
‫‪123293‬‬
‫‪123410‬‬
‫‪123663‬‬
‫‪133584‬‬
‫‪137462‬‬
‫‪137634‬‬
‫‪137816‬‬
‫‪137893‬‬
‫‪138094‬‬
‫‪138368‬‬
‫‪142596‬‬
‫‪143832‬‬
‫‪145702‬‬
‫‪147249‬‬
‫כג' בכסלו התשע"א‪November 30, 2010-‬‬
‫‪102516‬‬
‫‪102715‬‬
‫‪102778‬‬
‫‪102855‬‬
‫‪102960‬‬
‫‪118894‬‬
‫‪119014‬‬
‫‪119082‬‬
‫‪119154‬‬
‫‪122832‬‬
‫‪123162‬‬
‫‪123282‬‬
‫‪123409‬‬
‫‪123509‬‬
‫‪132533‬‬
‫‪137322‬‬
‫‪137633‬‬
‫‪137759‬‬
‫‪137880‬‬
‫‪138077‬‬
‫‪138183‬‬
‫‪142489‬‬
‫‪143767‬‬
‫‪145557‬‬
‫‪147143‬‬
‫‪102450‬‬
‫‪102700‬‬
‫‪102769‬‬
‫‪102851‬‬
‫‪102929‬‬
‫‪103133‬‬
‫‪119012‬‬
‫‪119080‬‬
‫‪119142‬‬
‫‪122774‬‬
‫‪123161‬‬
‫‪123264‬‬
‫‪123404‬‬
‫‪123500‬‬
‫‪128671‬‬
‫‪137305‬‬
‫‪137632‬‬
‫‪137711‬‬
‫‪137873‬‬
‫‪138061‬‬
‫‪138173‬‬
‫‪142341‬‬
‫‪142752‬‬
‫‪145291‬‬
‫‪147118‬‬
‫‪102440‬‬
‫‪102699‬‬
‫‪102768‬‬
‫‪102848‬‬
‫‪102917‬‬
‫‪103008‬‬
‫‪119006‬‬
‫‪119075‬‬
‫‪119139‬‬
‫‪122624‬‬
‫‪123153‬‬
‫‪123251‬‬
‫‪123387‬‬
‫‪123494‬‬
‫‪128670‬‬
‫‪137108‬‬
‫‪137626‬‬
‫‪137710‬‬
‫‪137866‬‬
‫‪138059‬‬
‫‪138170‬‬
‫‪142170‬‬
‫‪142694‬‬
‫‪144755‬‬
‫‪147072‬‬
‫‪97545‬‬
‫‪102698‬‬
‫‪102767‬‬
‫‪102825‬‬
‫‪102905‬‬
‫‪103000‬‬
‫‪118996‬‬
‫‪119063‬‬
‫‪119129‬‬
‫‪122620‬‬
‫‪123142‬‬
‫‪123241‬‬
‫‪123332‬‬
‫‪123465‬‬
‫‪126818‬‬
‫‪136055‬‬
‫‪137603‬‬
‫‪137709‬‬
‫‪137862‬‬
‫‪138057‬‬
‫‪138169‬‬
‫‪141405‬‬
‫‪142693‬‬
‫‪144703‬‬
‫‪146737‬‬
147523
147719
147803
147924
148003
148069
148121
148161
148220
148316
148414
149542
151945
153345
155200
156641
157514
158514
159327
160388
161360
162244
162855
163167
163370
163636
164307
165149
166169
166743
168261
169232
170203
171348
172162
172725
173708
175558
190634
147536
147721
147806
147926
148020
148079
148128
148169
148221
148317
148505
149699
152012
153733
155315
156678
157757
158646
159619
160743
161436
162267
162884
163243
163419
163679
164322
165178
166353
166970
168381
169328
170206
171418
172342
172784
174009
176309
190930
147553
147722
147827
147928
148023
148085
148137
148181
148232
148319
148568
149953
152054
153979
155658
156720
157964
158827
159827
160945
161591
162274
162951
163245
163450
163745
164359
165366
166358
167067
168408
169408
170216
171458
172432
172841
174411
176456
192393
147630
147737
147828
147958
148039
148095
148141
148196
148239
148357
148600
150124
152268
154131
155730
156733
158021
158912
159842
161124
161982
162286
163093
163257
163462
163761
164754
165469
166388
167233
168546
169459
170244
171669
172453
173038
174526
176516
192947
147651
147791
147870
147961
148042
148100
148152
148207
148274
148374
148621
150229
152315
154207
156233
157036
158086
158914
159903
161185
162041
162317
163114
163311
163491
163785
164763
165479
166506
167344
168688
169583
170805
171703
172538
173290
174598
177018
193875
147686
147792
147897
147963
148050
148108
148154
148216
148284
148384
148880
150622
152615
154271
156438
157209
158102
159139
159913
161282
162058
162628
163133
163322
163492
163791
164801
165559
166528
167372
168846
169783
170827
171765
172557
173304
174686
177241
147688
147794
147903
147974
148054
148116
148157
148218
148294
148404
149156
150692
152695
154350
156553
157340
158256
159257
159931
161318
162097
162706
163141
163328
163610
163889
164846
165598
166674
167970
169094
170098
170948
171981
172597
173388
174830
184513
147710
147795
147905
148002
148068
148119
148159
148219
148298
148412
149387
150851
152727
155124
156609
157380
158346
159258
160286
161347
162205
162728
163162
163367
163624
164246
165119
166092
166741
167971
169212
170166
171123
172071
172608
173459
174891
185118
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
99970
100129
99988
100145
99994
100146
100012
100164
100026
100173
100103
100174
100112
100205
100124
100206
November 30, 2010-‫כג' בכסלו התשע"א‬
‫‪100295‬‬
‫‪100365‬‬
‫‪100500‬‬
‫‪138253‬‬
‫‪158395‬‬
‫‪116315‬‬
‫‪116375‬‬
‫‪116430‬‬
‫‪116511‬‬
‫‪116597‬‬
‫‪116703‬‬
‫‪116792‬‬
‫‪142838‬‬
‫‪142955‬‬
‫‪143159‬‬
‫‪143291‬‬
‫‪143332‬‬
‫‪143393‬‬
‫‪143515‬‬
‫‪143717‬‬
‫‪143811‬‬
‫‪143925‬‬
‫‪144012‬‬
‫‪144127‬‬
‫‪144290‬‬
‫‪144672‬‬
‫‪162271‬‬
‫‪180940‬‬
‫‪133538‬‬
‫‪133660‬‬
‫‪133996‬‬
‫‪137338‬‬
‫‪154077‬‬
‫‪132860‬‬
‫‪133083‬‬
‫‪147443‬‬
‫‪150819‬‬
‫‪170489‬‬
‫‪100285‬‬
‫‪100351‬‬
‫‪100495‬‬
‫‪138252‬‬
‫‪157181‬‬
‫‪160082‬‬
‫‪116366‬‬
‫‪116428‬‬
‫‪116505‬‬
‫‪116581‬‬
‫‪116696‬‬
‫‪116719‬‬
‫‪142836‬‬
‫‪142942‬‬
‫‪143142‬‬
‫‪143290‬‬
‫‪143327‬‬
‫‪143390‬‬
‫‪143495‬‬
‫‪143706‬‬
‫‪143808‬‬
‫‪143892‬‬
‫‪144006‬‬
‫‪144126‬‬
‫‪144260‬‬
‫‪144539‬‬
‫‪161840‬‬
‫‪165597‬‬
‫‪133506‬‬
‫‪133622‬‬
‫‪133975‬‬
‫‪137276‬‬
‫‪152516‬‬
‫‪132855‬‬
‫‪133078‬‬
‫‪147038‬‬
‫‪150707‬‬
‫‪169550‬‬
‫‪100282‬‬
‫‪100349‬‬
‫‪100474‬‬
‫‪138122‬‬
‫‪156601‬‬
‫‪159673‬‬
‫‪116365‬‬
‫‪116414‬‬
‫‪116504‬‬
‫‪116578‬‬
‫‪116685‬‬
‫‪116718‬‬
‫‪142820‬‬
‫‪142914‬‬
‫‪143082‬‬
‫‪143241‬‬
‫‪143316‬‬
‫‪143361‬‬
‫‪143482‬‬
‫‪143703‬‬
‫‪143806‬‬
‫‪143874‬‬
‫‪144003‬‬
‫‪144106‬‬
‫‪144228‬‬
‫‪144454‬‬
‫‪145604‬‬
‫‪165367‬‬
‫‪133504‬‬
‫‪133607‬‬
‫‪133956‬‬
‫‪134905‬‬
‫‪138025‬‬
‫‪132847‬‬
‫‪132973‬‬
‫‪133409‬‬
‫‪150561‬‬
‫‪169432‬‬
‫‪100281‬‬
‫‪100347‬‬
‫‪100462‬‬
‫‪100624‬‬
‫‪156153‬‬
‫‪159648‬‬
‫‪116350‬‬
‫‪116394‬‬
‫‪116498‬‬
‫‪116559‬‬
‫‪116665‬‬
‫‪116708‬‬
‫‪142819‬‬
‫‪142899‬‬
‫‪143024‬‬
‫‪143210‬‬
‫‪143310‬‬
‫‪143358‬‬
‫‪143447‬‬
‫‪143693‬‬
‫‪143805‬‬
‫‪143873‬‬
‫‪143968‬‬
‫‪144080‬‬
‫‪144212‬‬
‫‪144406‬‬
‫‪145010‬‬
‫‪164121‬‬
‫‪133495‬‬
‫‪133587‬‬
‫‪133909‬‬
‫‪134110‬‬
‫‪138024‬‬
‫‪132823‬‬
‫‪132957‬‬
‫‪133355‬‬
‫‪150372‬‬
‫‪169000‬‬
‫‪100254‬‬
‫‪100343‬‬
‫‪100460‬‬
‫‪100623‬‬
‫‪142166‬‬
‫‪159245‬‬
‫‪116338‬‬
‫‪116389‬‬
‫‪116490‬‬
‫‪116554‬‬
‫‪116647‬‬
‫‪116707‬‬
‫‪142756‬‬
‫‪142878‬‬
‫‪143016‬‬
‫‪143202‬‬
‫‪143301‬‬
‫‪143355‬‬
‫‪143435‬‬
‫‪143660‬‬
‫‪143766‬‬
‫‪143844‬‬
‫‪143948‬‬
‫‪144078‬‬
‫‪144203‬‬
‫‪144383‬‬
‫‪144983‬‬
‫‪163446‬‬
‫‪108493‬‬
‫‪133580‬‬
‫‪133833‬‬
‫‪134053‬‬
‫‪137769‬‬
‫‪132766‬‬
‫‪132927‬‬
‫‪133245‬‬
‫‪149798‬‬
‫‪168398‬‬
‫‪100239‬‬
‫‪100330‬‬
‫‪100452‬‬
‫‪100592‬‬
‫‪139728‬‬
‫‪159234‬‬
‫‪116326‬‬
‫‪116379‬‬
‫‪116483‬‬
‫‪116552‬‬
‫‪116630‬‬
‫‪116706‬‬
‫‪142727‬‬
‫‪142864‬‬
‫‪143012‬‬
‫‪143186‬‬
‫‪143296‬‬
‫‪143354‬‬
‫‪143419‬‬
‫‪143590‬‬
‫‪143760‬‬
‫‪143831‬‬
‫‪143940‬‬
‫‪144077‬‬
‫‪144183‬‬
‫‪144341‬‬
‫‪144901‬‬
‫‪163077‬‬
‫‪107608‬‬
‫‪133564‬‬
‫‪133775‬‬
‫‪134052‬‬
‫‪137552‬‬
‫‪129620‬‬
‫‪132912‬‬
‫‪133127‬‬
‫‪149305‬‬
‫‪167389‬‬
‫‪100224‬‬
‫‪100314‬‬
‫‪100424‬‬
‫‪100589‬‬
‫‪138706‬‬
‫‪158894‬‬
‫‪116318‬‬
‫‪116378‬‬
‫‪116459‬‬
‫‪116550‬‬
‫‪116613‬‬
‫‪116705‬‬
‫‪142687‬‬
‫‪142850‬‬
‫‪143010‬‬
‫‪143176‬‬
‫‪143295‬‬
‫‪143347‬‬
‫‪143405‬‬
‫‪143565‬‬
‫‪143755‬‬
‫‪143829‬‬
‫‪143933‬‬
‫‪144070‬‬
‫‪144163‬‬
‫‪144303‬‬
‫‪144824‬‬
‫‪163005‬‬
‫‪106639‬‬
‫‪133542‬‬
‫‪133736‬‬
‫‪134029‬‬
‫‪137506‬‬
‫‪177501‬‬
‫‪132876‬‬
‫‪133121‬‬
‫‪148516‬‬
‫‪166896‬‬
‫‪100211‬‬
‫‪100313‬‬
‫‪100386‬‬
‫‪100572‬‬
‫‪138385‬‬
‫‪158705‬‬
‫‪116316‬‬
‫‪116377‬‬
‫‪116454‬‬
‫‪116528‬‬
‫‪116602‬‬
‫‪116704‬‬
‫‪117183‬‬
‫‪142848‬‬
‫‪142958‬‬
‫‪143171‬‬
‫‪143294‬‬
‫‪143340‬‬
‫‪143404‬‬
‫‪143545‬‬
‫‪143725‬‬
‫‪143823‬‬
‫‪143931‬‬
‫‪144025‬‬
‫‪144129‬‬
‫‪144293‬‬
‫‪144775‬‬
‫‪162330‬‬
‫‪106637‬‬
‫‪133539‬‬
‫‪133721‬‬
‫‪134026‬‬
‫‪137413‬‬
‫‪176244‬‬
‫‪132861‬‬
‫‪133084‬‬
‫‪148431‬‬
‫‪151031‬‬
‫צווי הארכה שחודשו‬
‫‪EXTENSION ORDERS RENEWED‬‬
‫‪95691‬‬
‫פטנטים שפג תוקפם‬
‫כג' בכסלו התשע"א‪November 30, 2010-‬‬
‫‪84601‬‬
PATENTS EXPIRED
92329
92457
92520
92639
92700
92766
92862
92955
92351
92460
92527
92653
92724
92780
92864
92958
92368
92470
92534
92654
92732
92786
92871
92990
92373
92487
92537
92673
92743
92788
92887
93020
92377
92491
92548
92674
92747
92832
92889
107437
92382
92499
92552
92688
92748
92851
92891
112750
92387
92507
92616
92692
92752
92854
92904
162181
92432
92519
92617
92699
92764
92856
92938
November 30, 2010-‫כג' בכסלו התשע"א‬
‫הודעה‬
NOTICE
‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
120614
4/1998
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫ בע"מ‬3000 ‫פאן‬-‫פיט‬
ADMONI MIKA
:‫שם האמצאה‬
‫מחוץ לבית ושיטה לייצורן‬/‫נעלי בית‬
INDOOR/OUTDOOR SLIPPERS AND METHOD FOR MAKING THEM
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1968
Title of invention:
November 30, 2010-‫כג' בכסלו התשע"א‬
‫הודעה‬
NOTICE
‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
151582
11/2006
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫אבנר רחמים‬
AVNER RAHAMIM
:‫שם האמצאה‬
Title of invention:
‫כובע שילוט למונית‬
TAXI-ROOF SIGN
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as
prescribed by section 61 of
the law and by regulation 92
of the Patent Regulations,
5728-1968
‫כל אדם רשאי להתנגד‬
‫לבקשה האמורה תוך‬
‫שלושה חודשים מתאריך‬
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
1968
November 30, 2010-‫כג' בכסלו התשע"א‬
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
November 30, 2010-‫כג' בכסלו התשע"א‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫‪NAME INDEX‬‬
‫ישקר בע"מ ‪185488 -‬‬
‫א‪.‬ר‪.‬י‪ .‬אבזרים להולכת נוזלים אגודה‬
‫שתופית חקלאית בע"מ ‪167383 -‬‬
‫אומג פודס בע"מ ‪192542 -‬‬
‫אי‪ .‬סי‪ .‬איי‪ .‬טלקום בע"מ ‪172454 -‬‬
‫אי‪.‬סי‪.‬איי‪ .‬טלקום בע"מ ‪160665 -‬‬
‫איתן תגר ‪184380 -‬‬
‫אלביט מערכות אלקטרו‪-‬אופטיקה אלאופ‬
‫בע"מ‪179135 - .‬‬
‫אלביט מערכות בע"מ ‪171578 -‬‬
‫אלון קוה ‪184380 -‬‬
‫אנקוטון בע"מ ‪122106 -‬‬
‫אספקטוס בע"מ ‪162879 -‬‬
‫אתוס רשתות בע"מ ‪167059 -‬‬
‫בי‪.‬וי‪.‬אר‪ .‬מערכות (‪ )1998‬בע"מ ‪171578 -‬‬
‫גאורג' נאומוב ‪176828 -‬‬
‫גיוון אימג'ינג בע"מ ‪166884 -‬‬
‫גליקומיינדס בע"מ ‪166539 -‬‬
‫דן וחנה גביש ‪170397 -‬‬
‫התעשייה הצבאית לישראל בע"מ ‪172589 -‬‬
‫וראז נטוורקס בע"מ ‪163092 -‬‬
‫כרמל‪-‬החברה הכלכלית של אוניברסיטת‬
‫חיפה בע"מ ‪172748 -‬‬
‫לב שורין ‪174712 -‬‬
‫מ‪.‬ל‪.‬י‪.‬ס‪ .‬בע"ם ‪160007 -‬‬
‫מגל מערכות בטחון בע"מ ‪154023 -‬‬
‫מדיגייד בע"מ ‪157262 -‬‬
‫מולטילוק טכנולוגיות בע"מ ‪156342 -‬‬
‫מיכאל נאומוב ‪176828 -‬‬
‫עמיטק בע"מ ‪171378 -‬‬
‫פאב ייצור ויבוא ציוד תעשייתי בע"מ ‪-‬‬
‫‪166542‬‬
‫פובוס אינטרנשניונל בע"מ ‪167928 -‬‬
‫פורמגלו בע"מ ‪174509 -‬‬
‫פייפאל ישראל בע"מ ‪161437 -‬‬
‫פינג'ן סופטוור בע"מ ‪190518 -‬‬
‫פלסטרו מערכות השקיה בע"מ ‪, 163606 -‬‬
‫‪169872 , 164043‬‬
‫פלקסיקט בע"מ ‪166863 -‬‬
‫קורפלוו פתרונות מדעיים בע"מ ‪177999 -‬‬
‫קל סל בע"מ ‪159104 -‬‬
‫חברת תנה תעשיות (‪ )1991‬בע"מ ‪181065 -‬‬
‫טוטנאואר ישראל בע"מ ‪174234 -‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪173752 -‬‬
‫יפים ריסקין ‪182389 -‬‬
‫יצחק לבטון ‪122106 -‬‬
‫כג' בכסלו התשע"א‪November 30, 2010-‬‬
‫רידנט‪-‬נובה בע"מ ‪179539 -‬‬
‫רן סילביאנו ‪199420 -‬‬
‫רפאל מערכות לחימה מתקדמות בע"מ ‪-‬‬
‫‪167740‬‬
‫שחל טלמדיסין אינטרנשיונל בע"מ ‪-‬‬
‫‪146776‬‬
181814 - ‫שילטקס בע"מ‬
176460 - ‫ישי‬-‫שמואל בן‬
3M INNOVATIVE PROPERTIES
COMPANY - 174647183477 ,
A.R.I. FLOW CONTROL ACCESSORIES
AGRICULTURAL COOPERATIVE
ASSOCIATION LTD. - 167383
ABBOTT LABORATORIES - 153567 ,
199743 , 199746
AFFYMAX, INC. - 171782
AGENSYS, INC. - 145775
AIC NEVADA, INC. - 176408
AIMSCO LIMITED - 178490
AKZO NOBEL N.V. - 164169
ALCON, INC. - 183322
ALCON. INC. - 184147
ALLWAY TOOLS, INC - 174259
ALON KAVA - 184380
ALPHAVAX, INC. - 178917
ALZA CORPORATION - 181117
AMITECH LTD. - 171378
ANTHROGENESIS CORPORATION 157350
APPLIED INTELLECTUAL CAPITAL
LIMITED - 176408
APPLIED MATERIALS ISRAEL, LTD 167352
APPLIED MATERIALS,INC. - 167352
APPLIED RESEARCH SYSTEMS ARS
HOLDING N.V. - 181908
ARENA PHARMACEUTICALS, INC. 142538
ARES TRADING S.A. - 154777
ARKEMA FRANCE - 167525
ASEPTIC TECHNOLOGIES S.A. - 166637
ASPECTUS LTD. - 162879
ASTRAZENECA AB - 163894
AVENTIS PHARMA S.A. - 173206
BASF AKTIENGESELLSCHAFT - 167983
BASF SE - 176149
November 30, 2010-‫כג' בכסלו התשע"א‬
BAYER
BETEILIGUNGSVERWALTUNG
GOSLAR GMBH - 175668
BAYER CROPSCIENCE AG - 152651 ,
155648 , 159839
BAYER SHEET EUROPE GMBH 171946
BAYLOR COLLEGE OF MEDICINE 165194
BESTEWIL HOLDING B.V.,
KONINGSPLEIN 1, - 172584
BIOARRAY SOLUTIONS LTD. - 167286
BIOGEN IDEC MA INC. - 154622
BIOSENSE WEBSTER, INC. - 175648
BOLDER BIOTECHNOLOGY, INC. 152804
BRISTOL-MYERS SQUIBB COMPANY 178141
BRITA GMBH - 179624
BVR SYSTEMS (1998) LTD. - 171578
C GEAR AUSTRALIA PTY LTD. 175451
CARMEL-HAIFA UNIVERSITY
ECONOMIC CORP. LTD. - 172748
CARNEGIE MELLON UNIVERSITY 163937
CHUGAI SEIYAKU KABUSHIKI
KAISHA - 178350
CISCO TECHNOLOGY, INC. - 144709
COMPARF S.R.L. - 183463
COREFLOW SCIENTIFIC SOLUTIONS
LTD. - 177999
CORIXA CORPORATION - 133056
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH - 164145
CRUCELL HOLLAND B.V. - 168374
CUROZONE IRELAND LTD. - 159850
DAIICHI SANKYO COMPANY,
LIMITED - 160204
DALLAN S.p.A. - 179990
DAN AND HANNA GAVISH - 170397
DATA-COMPLEX E.K. - 167281
DESALN8 PTY LTD. - 176695
DIEPON S.A. - 162963
DOLBY LABORATORIES LICENSING
November 30, 2010-‫כג' בכסלו התשע"א‬
CORPORATION - 165650 , 172108 ,
177094
DUKE UNIVERSITY - 183948
DUPONT PHARMACEUTICALS
COMPANY - 137019
EADS DEUTSCHLAND GMBH - 167324
ECI TELECOM LTD. - 160665
ECI TELECOM LTD. - 172454
ECOPHOS - 176373
EDELCOM - 151002
EISAI R & D MANAGEMENT CO. LTD. 176868
EITAN TAGAR - 184380
ELAN PHARMA INTERNATIONAL
LTD. - 146563
ELBIT SYSTEMS ELECTRO-OPTICS
ELOP LTD. - 179135
ELBIT SYSTEMS LTD. - 171578
ELI LILLY AND COMPANY - 177956
ENCOTONE LTD. - 122106
ETHOS NETWORKS LTD. - 167059
EVONIK DEGUSSA GMBH - 168026
EVONIK ROHM GMBH - 167334
EXXONMOBIL CHEMICAL PATENTS
INC. - 180622
F. HOFFMANN-LA ROCHE AG - 156264
, 184557
FAB MANUFACTURING & IMPORT OF
INDUSTRIAL EQUIPMENT LTD. 166542
FIDELIS SECURITY SYSTEMS - 174163
FINJAN SOFTWARE LTD - 190518
FINJAN, INC. - 190518
FLEXICATH LTD. - 166863
FOBUS INTERNATIONAL LTD. - 167928
FORMAGLOW LTD. - 174509
FORSVARETS MATERIELVERK 176722
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V. - 173223
FUJIKIN INCORPORATED - 189696
GE HEALTHCARE LIMITED - 163730
GENE DOLGOFF - 174490
November 30, 2010-‫כג' בכסלו התשע"א‬
GENE STREAM PTY LTD. - 158457
GENENTECH, INC. - 145675 , 163414
GENFIT - 172825
GEORGE NAUMOV - 176828
Ghazala HASHMI - 167286
GILEAD PALO ALTO, INC. - 160231
GIVEN IMAGING LTD. - 166884
GLAXO GROUP LIMITED - 173910
GLAXOSMITHKLINE BIOLOGICALS
S.A. - 155282 , 166637
GLAXOSMITHKLINE ISTRAZIVACKI
CENTAR ZAGREB D.O.O. - 165657
GLYCOMINDS LTD. - 166539
HARRIS CORPORATION - 169946
HD WOOD TECHNOLOGIES LIMITED 184856
HONEYWELL INTERNATIONAL INC. 162220
HUDSON TECHNOLOGIES, INC. 169052
IBM CORPORATION - 161653
IGO, INC. - 163615
IMPERIAL INNOVATIONS LIMITED 160983
INCOE CORPORATION - 174200
INDIAN INSTITUTE OF TECHNOLOGY
- 164145
INGENIA HOLDINGS LTD. - 177966
INGENIA TECHNOLOGY LIMITED 177966
INTERDIGITAL TECHNOLOGY
CORPORATION - 174227 , 189070 ,
201939
IPR LICENSING, INC. - 167993
ISAAC J. LABATON - 122106
ISCAR LTD. - 185488
ISIS PHARMACEUTICALS, INC. 194383
ISRAEL MILITARY INDUSTRIES LTD. 172589
JANE, S.A. - 177749
JANSSEN PHARMACEUTICA N.V. 168147
JANSSEN PHARMACEUTICA, N.V. November 30, 2010-‫כג' בכסלו התשע"א‬
154705 , 163325 , 164006
JENEIL BIOTECH, INC. - 161631
Joachim MESSING - 167286
JSR CORPORATION - 174569
JULIAN MCKINLAY KING - 174072
KABUSHIKI KAISHA YAKULT
HONSHA - 170350
KAL SAL LTD. - 159104
KENT STATE UNIVERSITY - 196076
KONINKLIJKE PHILIPS ELECTRONICS
N.V. - 171011
LANXESS CORPORATION - 182376
LANXESS INC. - 182376
LESTER WU - 158433
LEV SHURIN - 174712
LIFESCAN SCOTLAND LIMITED 159051
LONZA AG - 182808
M.L.I.S. PROJECTS LTD. - 160007
MAGAL SECURITY SYSTEMS LTD. 154023
MAGOTTEAUX INTERNATIONAL S.A.
- 177338
MASONITE CORPORATION - 152283
MDG MEDICAL INC. - 169083
MEDIGUIDE LTD. - 157262
MERCIAN CORPORATION - 176868
MERCK SERONO S.A. - 181908 , 183925
MERCK SHARP & DOHME CORP. 164586
MERCK SHARP & DOHME LTD 164586
MERCKLE GMBH - 163552
MICHAEL NAUMOV - 176828
Michael SEUL - 167286
MICROSOFT CORPORATION - 173581
MILLENNIUM SPECIALTY
CHEMICALS - 172088
MITSUBISHI TANABE PHARMA
CORPORATION - 154305
MONSANTO TECHNOLOGY LLC 170161
MONTERIS MEDICAL, INC. - 162483
MOTOROLA, INC. - 171584
November 30, 2010-‫כג' בכסלו התשע"א‬
MOUNTAIN VIEW
PHARMACEUTICALS, INC. - 183948
MUL-T-LOCK TECHNOLOGIES LTD. 156342
MURRAY CHRISTIAN PICKFORD 174072
N.V. ORGANON - 164169
NDS LIMITED - 135647
NDS LIMITED - 153945
NELSON M. KARP - 174986
NESTRONIX, INC. - 163760
NEURALAB LIMITED - 146563
NEW YORK UNIVERSITY - 137848
NIPPON SHERWOOD MEDICAL
INDUSTRIES LTD - 181380
NMK RESEARCH, LLC - 174986
NORFERM DA - 164517
NORTH CAROLINA STATE
UNIVERSITY - 132184
NOVARTIS AG - 150551
NOVO NORDISK A/S - 174823
OMEG FOODS LTD. - 192542
ONCOLYTICS BIOTECH INC. - 152391
OPEXA PHARMACEUTICALS INC. 165194
OPHTHONIX, INC. - 175497
OREGON HEALTH & SCIENCE
UNIVERSITY - 160983
ORREX PLASTICS COMPANY, LLC. 182376
ORTHO-MCNEIL PHARMACEUTICAL,
INC. - 152872
OUTIMEX AG - 184867
OWR AG - 167066
PAYPAL ISRAEL LTD - 161437
PELLINI S.P.A. - 174019
PERFORMANCE PLANTS, INC. - 134267
PFIZER INC. - 162822
PHARMACIA CORPORATION - 167121
PLASTRO IRRIGATION SYSTEMS
LTD. - 163606 , 164043 , 169872
PRESIDENT AND FELLOWS OF
HARVARD COLLEGE - 161121
PTS INTERNATIONAL INC. - 158433
November 30, 2010-‫כג' בכסלו התשע"א‬
PTS INTERNATIONAL INC. - 158433
QINETIQ LIMITED - 168467
QUALCOMM INCORPORATED - 154591
, 162812 , 166788 , 170333 , 170784 ,
171201 , 174366 , 194326
QUALCOMM INCORPORATED - 174120
, 181977 , 185959
QUALCOMM INCORPORATED - 194574
R.P. SCHERER TECHNOLOGIES, INC. 171827
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 167740
RAN SILVIANU - 199420
RAYTHEON COMPANY - 165561 ,
166916 , 181205
REDENT-NOVA LTD. - 179539
RELIANCE LIFE SCIENCES PVT. LTD. 170788
RENE DURANTON - 151002
RIMA HAERING - 139051
ROCKY S.H. SHIH - 158433
ROLLOMATIC SA, - 180920
ROSS CAMPBELL MCKINLAY - 174072
SANOFI AVENTIS - 145041
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 156097
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 158289
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 158504
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 170315
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 171477
SCHERING CORPORATION - 161120
SHAHAL TELEMEDICINE
INTERNATIONAL LTD. - 146776
SHERWOOD SERVICES AG - 181380
SHILTEX LTD. - 181814
SHMUEL BEN-ISHAI - 176460
SILVERBROOK RESEARCH PTY. LTD.
- 164692 , 169597
SILVERBROOK RESEARCH PTY. LTD.
- 155465 , 155470 , 160633
November 30, 2010-‫כג' בכסלו התשע"א‬
SMITHKLINE BEECHAM
BIOLOGICALS S.A. - 154608
SNAPTRACK INCORPORATED - 165721
SNECMA - 176441
SO & SO SOMMERHOFER OEG - 170168
SOLICORE INC. - 171847
SOLVAY PHARMACEUTICALS GMBH
- 174762
SOUTH ALABAMA MEDICAL SCIENCE
FOUNDATION - 137848
SP BERNER PLASTIC GROUP, S.L. 177699
STARCORE, LLC - 174312
STATOILHYDRO ASA - 164517
SUMITOMO CHEMICAL COMPANY,
LIMITED. - 172441
SUMITOMO ELECTRIC HARDMETAL
CORP. - 181930 , 183812
SWEDISH BIOFUELS AB - 174793
SYMPORE GMBH - 163552
SYNGENTA PARTICIPATIONS AG 145538
SYNOVO GMBH - 163552
SYNTONIX PHARMACEUTICALS, INC
- 177049
TANA INDUSTRIES (1991) LTD. 181065
TASER INTERNATIONAL, INC. - 174776
TEC. INN. S.R.L. - 185222
TEJAS ISRAEL LTD - 167059
TEXTRON SYSTEMS CORPORATION 160110
THALES - 173125 , 173234
THE COUNCIL FOR THE CENTRAL
LABORATORY OF THE RESEARCH
COUNCILS - 174313
THE FEINSTEIN INSTITUTE FOR
MEDICAL RESEARCH - 168787
THE OTIS PATENT TRUST - 186942
THE PEELLE COMPANY LTD. - 183394
THE SCIENCE AND TECHNOLOGY
FACILITIES COUNCIL - 174313
THE SCRIPPS RESEARCH INSTITUTE 167715
THE TRUSTEES OF THE UNIVERSITY
OF PENNSYLVANIA - 153576
November 30, 2010-‫כג' בכסלו התשע"א‬
THOMAS HAERING - 139051
THOMAS THEIL - 168712
TR ASSOCIATES, L.L.C. - 150571
TUTTNAUER ISRAEL LTD. - 174234
UC TECHNOLOGIES & ENGINEERING
LIMITED - 160007
UCB PHARMA S.A. - 170181
UCB, S.A. - 170181
UNIVERSITA DEGLI STUDI DI
FIRENZE - 170429
UNIVERSITAT STUTTGART (INST.
FUR CHEMISCHE
VERFAHRENSTECHNIK) - 139051
VERAZ NETWORKS LTD. - 163092
VERTEX PHARMACEUTICALS
INCORPORATED - 138469
VITAL THERAPIES, INC. - 178898
WALTER MEHNERT - 168712
WARNER-LAMBERT COMPANY LLC 177376
WISCONSIN ALUMNI RESEARCH
FOUNDATION - 161461
YEFIM RISKIN - 182389
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM - 173752
ZYMOGENETICS INC. - 167748
SUBJECT MATTER INDEX
‫מפתח ענייני‬
SUBJECT MATTER INDEX
November 30, 2010-‫כג' בכסלו התשע"א‬
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Code
MX
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Country or Organization
Mexico
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property
Organization (W.I.P.O.)
South Africa
November 30, 2010-‫כג' בכסלו התשע"א‬
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
‫ ירושלים‬,‫הודפס במדפיס הממשלתי‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED BY THE GOVERNMENT PRINTER
November 30, 2010-‫כג' בכסלו התשע"א‬